pdb_code,resolution,release_year,binding_data,label_type,label_unit,rel_label_value,abs_label_value,nelog10_abs_label_value,reference
1fc2,2.80,1981,Kd=22.5nM,Kd,nM,22.5,0.0225,1.6478174818886375,"1fc2.pdf (224-mer) Human Fc fragment, Kd=22.5+/-4.6nM, SpAb-1 and Fc gamma-1, pKd=7.65"
3sgb,1.80,1983,Kd=17.9pM,Kd,pM,17.9,1.7899999999999998e-05,4.747146969020107,"3sgb.pdf (56-mer) TURKEY OVOMUCOID INHIBITOR (OMTKY3), 1.79 x 10-11M"
2tgp,1.90,1983,Kd=2.4uM,Kd,uM,2.4,2.4,-0.38021124171160603,"2tgp.pdf (58-mer) TRYPSIN INHIBITOR, 2.4 x 10-6M"
2ptc,1.90,1983,Kd=60fM,Kd,fM,60,6.000000000000001e-08,7.221848749616356,2ptc.pdf (58-mer) Kd=6x10-14M is for trypsin and the pancreatic trypsin inhibitor
2sni,2.10,1988,Kd=2pM,Kd,pM,2,2e-06,5.698970004336019,"2sni.pdf (83-mer) CHYMOTRYPSIN INHIBITOR 2, Kd=2 x 10-12M"
1atn,2.80,1992,Kd=0.45nM,Kd,nM,0.45,0.00045000000000000004,3.3467874862246565,"1atn.pdf (260-mer) bovine pancreatic deoxyribonuclease I, Dnase I; Kd=0.45nM"
1gla,2.60,1993,Kd=0.18uM,Kd,uM,0.18,0.18,0.744727494896694,"1gla.pdf (168-mer) Glucose specific phosphocarrier, 1.8 x 10-7M"
1acb,2.00,1993,Kd=0.2nM,Kd,nM,0.2,0.0002,3.6989700043360187,"1acb.pdf (70-mer) leech (Hirudo medicinalis) protein proteinase inhibitor eglin c, 2 x 10-10M"
2pcc,2.30,1993,Kd=1.6uM,Kd,uM,1.6,1.6,-0.2041199826559248,"2pcc.pdf (108-mer) yeast iso-1-cytochrome c, Kd=1.6uM, not found in reference"
2pcb,2.80,1993,Kd=10uM,Kd,uM,10,10.0,-1.0,"2pcb.pdf (104-mer) cytochrome c, Ka=10^5M-1, Kd=10-5M"
2sic,1.80,1993,Kd=71.2pM,Kd,pM,71.2,7.12e-05,4.147520006363144,"2sic.pdf (107-mer) Streptomyces Subtilisin Inhibitor, Kd=7.12 x 10-11M"
2cpk,2.70,1993,Ki=2.3nM,Ki,nM,2.3,0.0023,2.638272163982407,"2cpk.pdf (20-mer) a 20-amino acid substrate analog inhibitor, Ki=2.3nM"
2iff,2.65,1994,Kd=10nM,Kd,nM,10,0.01,2.0,"2iff.pdf (212-mer) Kd(HyHEL-5/Lysozyme-R68K)=1 E-8 M, Kd(HyHEL-5/Lysozyme-WT)=2.5 E-11M"
1brs,2.00,1994,Kd=13fM,Kd,fM,13,1.3e-08,7.886056647693163,"1brs.pdf (89-mer) barstar(C40, 82A), barnase-barstar complex, calculated Kd=1.3 E-14 M"
2btf,2.55,1994,Kd=2.3uM,Kd,uM,2.3,2.3,-0.36172783601759284,"2btf.pdf (375-mer) beta-actin, Kd=2.3+/-0.9uM for wildtype Profilin"
1vfb,1.80,1994,Kd=3.03nM,Kd,nM,3.03,0.0030299999999999997,2.518557371497695,"1vfb.pdf (129-mer) hen egg white lysozyme, Kb=3.3x10^8M-1, get Kd=3.03x10-9M"
1hrt,2.80,1994,Kd=3pM,Kd,pM,3,3e-06,5.522878745280337,"1hrt.pdf (65-mer) noncovalent equimolar complex of hirudin with bovine thrombin, Kd=3pM"
1ppe,2.00,1994,Kd=3pM,Kd,pM,3,3e-06,5.522878745280337,"1ppe.pdf (29-mer) CMTI-squash inhibitor, Association constant 3.3x10^11 M-1, Kd=3pM"
2mta,2.40,1994,Kd=4.5uM,Kd,uM,4.5,4.5,-0.6532125137753437,2mta.pdf (105-mer) Kd=4.5x10-6M for methylamine dehydrogenase and amicyanin; structure is ternary complex with C-type cytochrome C551I
1nca,2.50,1994,Kd=8.3nM,Kd,nM,8.3,0.0083,2.0809219076239263,"1nca.pdf (214-mer) antigen-binding fragment (Fab) of monoclonal antibody NC41, fluorescence quenching Ka=12x10^7M-1, get Kd=8.3x10-9M"
1smf,2.10,1994,Ki=0.12uM,Ki,uM,0.12,0.12,0.9208187539523752,1smf.pdf (22-mer) incomplete ligand structure
1ihs,2.00,1994,Ki=0.3nM,Ki,nM,0.3,0.0003,3.5228787452803374,"1ihs.pdf (21-mer) hirutonin-2 with human a-thrombin, led to Ki=0.3nM"
1nsn,2.80,1995,Kd=0.1nM,Kd,nM,0.1,0.0001,4.0,"1nsn.pdf (149-mer) staphylococcal nuclease (SNase), Ka=1x10^10M-1, Kd=10 x 10-11M"
1bql,2.60,1995,Kd=0.1uM,Kd,uM,0.1,0.1,1.0,"1bql.pdf (212-mer) ANTI-HEL FAB FRAGMENT COMPLEXED WITH BOBWHITE QUAIL LYSOZYME, Kd=1 E-7 M"
1nma,3.00,1995,Kd=14nM,Kd,nM,14,0.014,1.853871964321762,"1nma.pdf (109-mer) N9 NEURAMINIDASE COMPLEXE WITH ANTIBODIE NC10 Fab, Kd=1.4 E-8 M"
1mlc,2.50,1995,Kd=91nM,Kd,nM,91,0.091,1.0409586076789064,"1mlc.pdf (129-mer) HEN EGG WHITE LYSOZYME, Kd=9.1 x 10-8M"
1rlb,3.10,1996,Kd=0.8uM,Kd,uM,0.8,0.8,0.09691001300805639,"1rlb.pdf (174-mer) all-trans retinoic acid-RBP, Kd=0.8uM"
1mah,3.20,1996,Kd=25pM,Kd,pM,25,2.4999999999999998e-05,4.6020599913279625,"1mah.pdf (61-mer) Fasciculin 2, 2.5 x 10-11M"
1mtn,2.80,1996,Kd=9.5nM,Kd,nM,9.5,0.0095,2.0222763947111524,"1mtn.pdf (58-mer) BOVINE ALPHA-CHYMOTRYPSIN:BPTI CRYSTALLIZATION, Kd=9.5 E-9 M"
1tbr,2.60,1996,Ki=0.2pM,Ki,pM,0.2,2e-07,6.698970004336019,"1tbq.pdf (103-mer) INHIBITOR RHODNIIN IN COMPLEX WITH THROMBIN, monoclinic crystals, ki=2 E-13 M"
1tbq,3.10,1996,Ki=0.2pM,Ki,pM,0.2,2e-07,6.698970004336019,"1tbq.pdf (103-mer) INHIBITOR RHODNIIN IN COMPLEX WITH THROMBIN, orthorhombic crystals, ki=2 E-13 M"
1dit,2.30,1996,Ki=1pM,Ki,pM,1,1e-06,6.0,"1dit.pdf (20-mer) A DIVALENT PEPTIDE INHIBITOR CVS995, Ki=1pM"
1efn,2.50,1997,Kd=0.38uM,Kd,uM,0.38,0.38,0.42021640338318983,"1efn.pdf (152-mer) HIV-1 NEF PROTEIN IN COMPLEX WITH Fyn(R96I) SH3 domain, Kd=0.38uM"
1akj,2.65,1997,Kd=126uM,Kd,uM,126,126.0,-2.100370545117563,"1akj.pdf (120-mer) T-cell CD8 coreceptor, 1.26 x 10-4M"
1ak4,2.36,1997,Kd=17uM,Kd,uM,17,17.0,-1.2304489213782739,"1ak4.pdf (145-mer) AMINO-TERMINAL Domain of HIV-1 capsid(1-151), Kd=1.7 X 10-5M, unpublished data"
1gua,2.00,1997,Kd=40nM,Kd,nM,40,0.04,1.3979400086720375,1gua.pdf (81-mer) protein rap1a and protein C-RAF1; Kd for Rap double mutants/RafRBD
1ycs,2.20,1997,Kd~30nM,Kd,nM,30,0.03,1.5228787452803376,"1ycs.pdf (239-mer) P53 core domain and 53BP2 COMPLEX, Kd~30nM"
1taw,1.80,1997,Ki<0.02nM,Ki,nM,0.02,2e-05,4.698970004336019,"1taw.pdf (58-mer) BOVINE TRYPSIN COMPLEXED TO APPI, Ki<0.02nM"
1bth,2.30,1997,Ki=10nM,Ki,nM,10,0.01,2.0,"1bth.pdf (58-mer) human thrombin mutant E192Q complex with BPTI, Ki=1 E-8 M"
1hia,2.40,1997,Ki=13nM,Ki,nM,13,0.013000000000000001,1.8860566476931633,"1hia.pdf (48-mer) hirustasin-kallikrein complex, Ki of porcine kallikrein and hirustatin is 13nM"
1cbw,2.60,1997,Ki=16nM,Ki,nM,16,0.016,1.7958800173440752,1cbw.pdf (58-mer) protein-protein
1toc,3.10,1997,Ki=1pM,Ki,pM,1,1e-06,6.0,"1toc.pdf (120-mer) ornithodorin-thrombin complex, ki=1 E-12 M"
1dhk,1.85,1997,Ki=35pM,Ki,pM,35,3.5e-05,4.455931955649724,"1dhk.pdf (223-mer) ALPHA-AMYLASE inhibitor, Ki=3.5 E-11 M"
1dfj,2.50,1997,Ki=59fM,Ki,fM,59,5.9000000000000006e-08,7.229147988357855,"1dfj.pdf (457-mer) Crystal is from Cattle/pig Rnase inhibitor, Ki=59fM yeast, 67fM porcine"
1fle,1.90,1997,Ki=6nM,Ki,nM,6,0.006,2.221848749616356,"1fle.pdf (57-mer) ELAFIN COMPLEXED WITH PORCINE PANCREATIC ELASTASE, Ki=6nM. Ki(elafin7-57/PPE)=10nM"
1ca0,2.10,1997,Ki=7.1nM,Ki,nM,7.1,0.0070999999999999995,2.1487416512809245,1ca0.pdf (54-mer) protein-protein
1b27,2.10,1998,Kd=0.01pM,Kd,pM,0.01,1e-08,8.0,"1b27.pdf (90-mer) WT, Kd=0.01pM, ligand mutation:C40A, C82A, it is referred to as peudo wild-type"
1wej,1.80,1998,Kd=0.06uM,Kd,uM,0.06,0.06,1.2218487496163564,"1wej.pdf (214-mer) FAB E8 COMPLEXED WITH HORSE CYTOCHROME C, Kd=0.6 E-7 M"
1a22,2.60,1998,Kd=0.34nM,Kd,nM,0.34,0.00034,3.4685210829577446,"1a22.pdf (191-mer) G120R mutant human growth hormone (hGH) and receptor, Kd=0.34+/-0.07nM"
1a3b,1.80,1998,Kd=0.3nM,Kd,nM,0.3,0.0003,3.5228787452803374,1a3b.pdf (21-mer) incomplete ligand structure
1b2u,2.10,1998,Kd=100nM,Kd,nM,100,0.1,1.0,"1b27.pdf (90-mer) bnK27A-bsD35A, Kd=1 E5 pM. D35 in reference is D35 in structure"
1xdt,2.65,1998,Kd=10nM,Kd,nM,10,0.01,2.0,"1xdt.pdf (79-mer) DIPHTHERIA TOXIN AND HEPARIN-BINDING EPIDERMAL GROWTH FACTOR, Kd=E-8~E-9M"
1b3s,2.39,1998,Kd=117pM,Kd,pM,117,0.000117,3.9318141382538383,"1b27.pdf (90-mer) bnH102A-bsY29F, Kd=117 pM. Y30 in reference is Y29 in structure"
1jrh,2.80,1998,Kd=14.2nM,Kd,nM,14.2,0.014199999999999999,1.8477116556169435,"1jrh.pdf (213-mer) INTERFERON-GAMMA RECEPTOR ALPHA CHAIN(WT) and ANTIBODY A6 complex, Kd=14.2nM"
1axi,2.10,1998,Kd=14nM,Kd,nM,14,0.014,1.853871964321762,"1axi.pdf (191-mer) GROWTH HORMONE(W104A) and RECEPTOR(mutant) complex, Kd=14nM"
1avz,3.00,1998,Kd=15.8uM,Kd,uM,15.8,15.8,-1.1986570869544226,"1avz.pdf (57-mer) Fyn kinase SH3 domain, Kd=1.58 x 10-5M"
1a2k,2.50,1998,Kd=150nM,Kd,nM,150,0.15,0.8239087409443188,"1a2k.pdf (127-mer) Nuclear Transport Factor 2, microtiter plates: 240+/-90nM, microcalorimetry: 150+/-30nM, fluorescence: 75+/-40nM(yeast)"
1b2s,1.82,1998,Kd=157pM,Kd,pM,157,0.000157,3.8041003475907664,"1b27.pdf (90-mer) bnK27A-bsT42A, Kd=157pM. T42 in reference should be T43"
1wq1,2.50,1998,Kd=17uM,Kd,uM,17,17.0,-1.2304489213782739,"1wq1.pdf (334-mer) Ras GAP, 1.7 x 10-5M"
2vir,3.25,1998,Kd=1nM,Kd,nM,1,0.001,3.0,"2vir.pdf (210-mer) Neutralizing Antibody Immunoglobulin (Igg1, Lambda), Kd=1nM"
2jel,2.50,1998,Kd=2.8nM,Kd,nM,2.8,0.0028,2.5528419686577806,"2jel.pdf (217-mer) JEL42 FAB/HPR COMPLEX, Kd=2.8nM"
1avg,2.60,1998,Kd=3pM,Kd,pM,3,3e-06,5.522878745280337,"1avg.pdf (142-mer) Triabin and bovine alpha-thrombin complex, Kd=3pM"
2vis,3.25,1998,Kd=4uM,Kd,uM,4,4.0,-0.6020599913279624,"2vis.pdf (210-mer) T131I BHA and Fab Kd=4uM, Wildtype HA Top and Fab Kd=5nM (code 2VIR)"
1avx,1.90,1998,Kd=60fM,Kd,fM,60,6.000000000000001e-08,7.221848749616356,"1avx.pdf (177-mer) Soybean trypsin inhibitor (Kunitz), 6.00 x 10-14M"
1buh,2.60,1998,Kd=77nM,Kd,nM,77,0.077,1.1135092748275182,"1buh.pdf (79-mer) CELL CYCLE-REGULATORY PROTEIN CKSHS1, HUMAN CDK2-CksHs1 complex, Kd=7.7 E-8 M"
1a4y,2.00,1998,Ki<1fM,Ki,fM,1,1e-09,9.0,"1a4y.pdf (123-mer) RIBONUCLEASE INHIBITOR-ANGIOGENIN COMPLEX, Ki<1fM"
1kig,3.00,1998,Ki=0.18nM,Ki,nM,0.18,0.00017999999999999998,3.744727494896694,"1kig.pdf (60-mer) recombinant tick anticoagulant peptide (rTAP) complexed to bovine factor Xa, Ki=0.18nM"
1an1,2.03,1998,Ki=0.9nM,Ki,nM,0.9,0.0009000000000000001,3.0457574905606752,"1an1.pdf (46-mer) LEECH-DERIVED TRYPTASE INHIBITOR/TRYPSIN COMPLEX, Ki=0.9nM"
1ldt,1.90,1998,Ki=1.8nM,Ki,nM,1.8,0.0018000000000000002,2.744727494896694,"1ldt.pdf (46-mer) LEECH-DERIVED TRYPTASE INHIBITOR, Ki(bovine pancretic trypsin/rLDTI)=1.8nM"
1fmo,2.20,1998,Ki=2.3nM,Ki,nM,2.3,0.0023,2.638272163982407,1fmo.pdf (20-mer) protein-protein
1ahw,3.00,1998,Ki=3.4nM,Ki,nM,3.4,0.0034,2.468521082957745,"1ahw.pdf (214-mer) HUMAN TISSUE FACTOR WITH AN INHIBITORY FAB (5G9), ki=3.4+/-0.3nM"
1azz,2.30,1998,Ki=510pM,Ki,pM,510,0.0005099999999999999,3.2924298239020637,"1azz.pdf (142-mer) FIDDLER CRAB COLLAGENASE COMPLEXED TO ECOTIN, Ki=510+/-60pM"
1bvn,2.50,1998,Ki=9pM,Ki,pM,9,9e-06,5.045757490560675,"1bvn.pdf (74-mer) PIG PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH TENDAMISTAT, Ki=9 E-12 M"
1ugh,1.90,1999,IC50=12pM,IC50,pM,12,1.2e-05,4.920818753952375,"1ugh.pdf (82-mer) inhibition of Human UDG by PBS2 Ugi, IC50=1.2 E-11 M"
1vpp,1.90,1999,IC50=8.2uM,IC50,uM,8.2,8.2,-0.9138138523837167,"1vpp.pdf (20-mer) A receptor blocking peptide V108, IC50=8.2uM"
1b6c,2.60,1999,Kd=0.28uM,Kd,uM,0.28,0.28,0.5528419686577808,1b6c.pdf (342-mer) 2.8 x 10-7M
1ibr,2.30,1999,Kd=0.3nM,Kd,nM,0.3,0.0003,3.5228787452803374,"1ibr.pdf (462-mer) Importin beta-1 subunit, 3.0 x 10-10M"
1flt,1.70,1999,Kd=1.356nM,Kd,nM,1.356,0.0013560000000000002,2.8677403104689554,"1flt.pdf (95-mer) VEGF IN COMPLEX WITH DOMAIN 2 OF THE FLT-1 RECEPTOR, Kd=113x12pM"
1uug,2.40,1999,Kd=1.3uM,Kd,uM,1.3,1.3,-0.11394335230683679,"1uug.pdf (84-mer) URACIL-DNA GLYCOSYLASE and Uracil-DNA glycosylase inhibitor, Kd=1.3uM"
1lfd,2.10,1999,Kd=1.9uM,Kd,uM,1.9,1.9,-0.2787536009528289,"1lfd.pdf (87-mer) Ras-Interacting Domain Of Ralgds, Kd=1.9x10-6M"
1kac,2.60,1999,Kd=14.8nM,Kd,nM,14.8,0.0148,1.8297382846050425,"1kac.pdf (124-mer) Adenovirus receptor, 1.48 x 10-8M"
1sbb,2.40,1999,Kd=140uM,Kd,uM,140,140.0,-2.146128035678238,"1sbb.pdf (239-mer) T-CELL RECEPTOR BETA CHAIN COMPLEXED WITH wt SUPERANTIGEN SEB, Kd=140uM"
1bvk,2.70,1999,Kd=14nM,Kd,nM,14,0.014,1.853871964321762,"1bvk.pdf (129-mer) hen egg lysozyme, 1.4 x 10-8M"
1eer,1.90,1999,Kd=1nM,Kd,nM,1,0.001,3.0,"1cn4.pdf (166-mer) ERYTHROPOIETIN COMPLEXED WITH ERYTHROPOIETIN RECEPTOR, site 1 Kd=1nM"
1tba,NMR,1999,Kd=1nM,Kd,nM,1,0.001,3.0,"1tba.pdf (180-mer) TATA box-binding protein TBP-TAFII230 COMPLEX, about Kd=1nM"
1ay7,1.70,1999,Kd=1uM,Kd,uM,1,1.0,-0.0,"1ay7.pdf (89-mer) RIBONUCLEASE SA COMPLEX WITH BARSTAR, Kd=1 E-6 M"
1cn4,2.80,1999,Kd=1uM,Kd,uM,1,1.0,-0.0,"1cn4.pdf (166-mer) ERYTHROPOIETIN COMPLEXED WITH ERYTHROPOIETIN RECEPTOR, site 2 Kd=1uM"
1qa9,3.20,1999,Kd=1uM,Kd,uM,1,1.0,-0.0,"1qa9.pdf (95-mer) hCD2-hCD58 complex, Kd=1uM, protein mutation:hCD2(K61E, F63L, T67A), hCD58(F1S, V9K, V21Q, V58K, T85S, L93G)"
1bj1,2.40,1999,Kd=3.4nM,Kd,nM,3.4,0.0034,2.468521082957745,"1bj1.pdf (214-mer) VEGF IN COMPLEX WITH A NEUTRALIZING ANTIBODY, Kd=3.4+/-0.9nM, IC50=4.7+/-1.1nM"
1grn,2.10,1999,Kd=388nM,Kd,nM,388,0.388,0.41116827440579273,"1grn.pdf (203-mer) CDC42 GAP, Kd=3.88 x 10-7M"
1qfu,2.80,1999,Kd=3nM,Kd,nM,3,0.003,2.5228787452803374,"1qfu.pdf (217-mer) X31 BHA-HC45 Fab complex, IgG Kd=3+/-1nM"
1vrk,1.90,1999,Kd=6.8nM,Kd,nM,6.8,0.0068,2.167491087293764,"1vrk.pdf (21-mer) E84K-CALMODULIN and RS20 PEPTIDE COMPLEX, 6.8+/-5.2nM"
1qse,2.80,1999,Kd=7.2uM,Kd,uM,7.2,7.2,-0.8573324964312685,1qse.pdf (100-mer) TCR-pMHC complex;
4thn,2.50,1999,Ki=0.09nM,Ki,nM,0.09,8.999999999999999e-05,4.045757490560675,4thn.pdf (26-mer) incomplete ligand structure
1ava,1.90,1999,Ki=0.22nM,Ki,nM,0.22,0.00022,3.657577319177794,"1ava.pdf (181-mer) AMY2/BARLEY ALPHA-AMYLASE/SUBTILISIN INHIBITOR COMPLEX, ki=2.2 E-10 M, PH8"
1qur,2.00,1999,Ki=0.29pM,Ki,pM,0.29,2.9e-07,6.537602002101044,1qur.pdf (22-mer) protein-protein
1fak,2.10,1999,Ki=0.4nM,Ki,nM,0.4,0.0004,3.3979400086720375,1fak.pdf (58-mer) protein-protein
1cmx,2.25,1999,Ki=1.7uM,Ki,uM,1.7,1.7,-0.2304489213782739,"1cmx.pdf (76-mer) yeast UCH yuh1 complex with ubiquitin aldehyde, ki=1.7+/-0.38uM"
1es0,2.60,2000,IC50=0.08uM,IC50,uM,0.08,0.08,1.0969100130080565,"1es0.pdf (190-mer) I-A g7 complex with peptide from the autoantigen glutamic acid decarboxylase (GAD) 65, IC50=0.08uM"
1fg9,2.90,2000,Kd=0.10nM,Kd,nM,0.10,0.0001,4.0,"1fg9.pdf (134-mer) IFN-gamma Receptor alpha chain binds IFN-gamma, Kd=1 E-10M"
1cz8,2.40,2000,Kd=0.11nM,Kd,nM,0.11,0.00011,3.958607314841775,"1cz8.pdf (213-mer) VEGF(109):Y0317 Fab complex, Kd=0.11+/-0.02nM. protein residue:4-107"
1g9i,2.20,2000,Kd=0.12uM,Kd,uM,0.12,0.12,0.9208187539523752,"1g9i.pdf (22-mer) BOWMAN-BIRK TYPE TRYPSIN INHIBITOR, SPC1 with bovine beta-trypsin, Ki=1.2 X 10-7M"
1d6r,2.30,2000,Kd=0.13nM,Kd,nM,0.13,0.00013000000000000002,3.886056647693163,"1d6r.pdf (58-mer) bovine TRYPSIN COMPLEXED WITH soybean Bowman-Birk inhibitor, Ki=0.13nM"
1fsk,2.90,2000,Kd=0.24nM,Kd,nM,0.24,0.00024,3.619788758288394,"1fsk.pdf (159-mer) major allergen from birch pollen Bet v 1-A, 2.4 x 10-10M"
1ffx,3.95,2000,Kd=0.2uM,Kd,uM,0.2,0.2,0.6989700043360187,1ffx.pdf (91-mer) PROTEIN (STATHMIN-LIKE DOMAIN OF RB3); Kd for tubulin/stathmin
1dee,2.70,2000,Kd=0.4uM,Kd,uM,0.4,0.4,0.3979400086720376,"1dee.pdf (214-mer) domain D of SpA complex with the Fab fragment of IgM antibody, Kd=0.4-5.0uM"
1e4k,3.20,2000,Kd=1.7uM,Kd,uM,1.7,1.7,-0.2304489213782739,1e4k.pdf (176-mer) Immobilized HUMAN IGG1 FC FRAGMENT and FC-GAMMA RECEPTOR III COMPLEX
1qfw,3.50,2000,Kd=10nM,Kd,nM,10,0.01,2.0,"1qfw.pdf (114-mer) ternary complex of hCG and Fv2, Anti alpha Kd=1E-8M, Anti beta Kd=1E-10M"
1qty,2.70,2000,Kd=10pM,Kd,pM,10,9.999999999999999e-06,5.0,"1qty.pdf (102-mer) VEGF and Flt-1D2 complex, Kd=10pM"
1du3,2.20,2000,Kd=15.9nM,Kd,nM,15.9,0.0159,1.7986028756795485,"1du3.pdf (168-mer) wild type TNF-RELATED APOPTOSIS INDUCING LIGAND-sDR5 complex, Kd=1.59+/-0.23 E-8M"
1e96,2.40,2000,Kd=2.7uM,Kd,uM,2.7,2.7,-0.43136376415898736,1e96.pdf (203-mer) NEUTROPHIL CYTOSOL FACTOR 2 (NCF-2) TPR DOMAIN
1dqj,2.00,2000,Kd=2.8nM,Kd,nM,2.8,0.0028,2.5528419686577806,1dqj.pdf (129-mer) hen egg white lysozyme
1ees,NMR,2000,Kd=20nM,Kd,nM,20,0.02,1.6989700043360187,"1ees.pdf (46-mer) Cdc42Hs and PBD46 complex, Kd=20nM"
1emv,1.70,2000,Kd=24fM,Kd,fM,24,2.4000000000000003e-08,7.619788758288394,"1emv.pdf (86-mer) cognate immunity protein Im9, Kd=2.4+/-0.4x10-14M"
1de4,2.80,2000,Kd=24nM,Kd,nM,24,0.024,1.6197887582883939,"1de4.pdf (640-mer) Transferrin receptor ectodomain, 2.4 x 10-8M"
1e6j,3.00,2000,Kd=29nM,Kd,nM,29,0.029,1.537602002101044,"1e6j.pdf (210-mer) HIV-capsid protein 24, 2.9 x 10-8M"
1djs,2.40,2000,Kd=41nM,Kd,nM,41,0.041,1.3872161432802645,"1djs.pdf (135-mer) 1:1 FGF1:FGFR2 complex, compatible with FGF2:FGFR1 complex, Kd=41nM"
1dzb,2.00,2000,Kd=520nM,Kd,nM,520,0.52,0.28399665636520083,"1dzb.pdf (253-mer) Fv 1F9 in complex with turkey egg-white lysozyme (TEL), Kd=5.2 E-7 M"
1f3v,2.00,2000,Kd=7.8uM,Kd,uM,7.8,7.8,-0.8920946026904804,"1f3v.pdf (171-mer) native TRADD-N/TRAF2 Complex, Kd=7.8+/-3.6uM"
1g6v,3.50,2000,Kd=72nM,Kd,nM,72,0.07200000000000001,1.1426675035687315,"1g6v.pdf (126-mer) CAB-CA05 binds to bovine carbonic anhydrase, Kd=72nM"
1eo8,2.80,2000,Kd=8.9nM,Kd,nM,8.9,0.0089,2.050609993355087,"1eo8.pdf (210-mer) X31 HA with the Fab fragment of antibody BH151 Complex, Kd=8.9+/-2nM"
1efx,3.00,2000,Kd=9.5uM,Kd,uM,9.5,9.5,-0.9777236052888477,1efx.pdf (200-mer) protein-protein; Kd for kir2dl2/hla-cw3
1clv,2.00,2000,Kd~1nM,Kd,nM,1,0.001,3.0,1clv.pdf (32-mer) complex between TMA andalpha-amylase inhibitor (AAI); Kd should be nanomolar range
1ezu,2.40,2000,Ki=0.08nM,Ki,nM,0.08,8e-05,4.096910013008056,"1ezs.pdf (142-mer) Ecotin Y69F, D70P BOUND TO RAT ANIONIC TRYPSIN II, Ki=0.08nM"
1ezs,2.30,2000,Ki=0.18nM,Ki,nM,0.18,0.00017999999999999998,3.744727494896694,"1ezs.pdf (142-mer) Ecotin 67-70A, M84R BOUND TO RAT ANIONIC TRYPSIN II, Ki=0.18nM"
1dp5,2.20,2000,Ki=0.9nM,Ki,nM,0.9,0.0009000000000000001,3.0457574905606752,"1dp5.pdf (68-mer) PROTEINASE A COMPLEXED WITH IA3 MUTANT INHIBITOR(K31M, K32M), Ki=0.9+/-0.3nM"
1c9t,3.30,2000,Ki=1.0nM,Ki,nM,1.0,0.001,3.0,"1c9p.pdf (59-mer) BDELLASTASIN WITH BOVINE TRYPSIN, Ki=1.0nM nanomolar range"
1c9p,2.80,2000,Ki=1.0nM,Ki,nM,1.0,0.001,3.0,"1c9p.pdf (59-mer) BDELLASTASIN WITH PORCINE TRYPSIN, Ki=1.0nM nanomolar range"
1icf,2.00,2000,Ki=1.7pM,Ki,pM,1.7,1.6999999999999998e-06,5.769551078621726,"1icf.pdf (65-mer) P41 II FRAGMENT binds to CATHEPSIN L, Ki=1.7pM"
1dpj,1.80,2000,Ki=3nM,Ki,nM,3,0.003,2.5228787452803374,"1dpj.pdf (33-mer) IA3 residues 2-34, ki=3+/-0.6nM"
1fy8,1.70,2000,Ki=9uM,Ki,uM,9,9.0,-0.9542425094393249,"1f5r.pdf (58-mer) BPTI complexes of rat Delta I16V17 trypsinogen, Ki=9uM"
1hqr,3.20,2001,Kd=0.10uM,Kd,uM,0.10,0.1,1.0,"1hqr.pdf (208-mer) MHC class II binds bacterial SAGs on beta chain, Kd=1 E-7M"
1i4e,3.00,2001,Kd=0.12uM,Kd,uM,0.12,0.12,0.9208187539523752,"1i4e.pdf (299-mer) EARLY P35 KDA PROTEIN, Kd=1.16+/-0.01 X 10-7M, with caspase-3"
1hez,2.70,2001,Kd=0.145uM,Kd,uM,0.145,0.145,0.8386319977650252,"1hez.pdf (214-mer) PpL domain C(D55A-Y64W mutant) Complexed with Human IgM Fab 2A2, Kd=0.145uM"
1f34,2.45,2001,Kd=0.1nM,Kd,nM,0.1,0.0001,4.0,"1f34.pdf (149-mer) pepsin inhibitor-3 (PI-3) from Ascaris suum, KI=0.10x10-9M"
1i8l,3.00,2001,Kd=0.2uM,Kd,uM,0.2,0.2,0.6989700043360187,"1i8l.pdf (208-mer) HUMAN B7-1/CTLA-4 CO-STIMULATORY COMPLEX, Kd=0.2-0.4uM"
1hxy,2.60,2001,Kd=0.5nM,Kd,nM,0.5,0.0005,3.3010299956639813,"1hxy.pdf (182-mer) SEH IN COMPLEX WITH HLA-DR1, Kd=0.5nM, Bmax, 1/2=0.5nM"
1g5j,NMR,2001,Kd=0.6nM,Kd,nM,0.6,0.0006,3.2218487496163566,"1g5j.pdf (25-mer) Kd=0.6nM, 25-mer peptide from Bad"
1e6e,2.30,2001,Kd=0.86uM,Kd,uM,0.86,0.86,0.06550154875643228,"1e6e.pdf (128-mer) Adrenoxin, 0.86 x 10-6M"
1ffw,2.70,2001,Kd=1.2uM,Kd,uM,1.2,1.2,-0.07918124604762482,1ffw.pdf (134-mer) kinase cheA(124-257)
1iqd,2.00,2001,Kd=14pM,Kd,pM,14,1.4e-05,4.853871964321762,"1iqd.pdf (211-mer) human monoclonal BO2C11 Fab, 1.4 x 10-11M"
1gcq,1.68,2001,Kd=16.8uM,Kd,uM,16.8,16.8,-1.2253092817258628,"1gcq.pdf (70-mer) VAV PROTO-ONCOGENE, Kd=16.8+/-0.5uM, protein-protein complex"
1e3u,1.66,2001,Kd=1uM,Kd,uM,1,1.0,-0.0,"1e3u.pdf (246-mer) MAD phasing OXA10, dimeric, KD~1uM"
1i2m,1.76,2001,Kd=2.5pM,Kd,pM,2.5,2.4999999999999998e-06,5.6020599913279625,"1i2m.pdf (402-mer) chromosome condensation (RCC1), Kinetics constant K2=4x10^11 M-1, Kd=2.5pM"
1he8,3.00,2001,Kd=2.5uM,Kd,uM,2.5,2.5,-0.3979400086720376,"1he8.pdf (965-mer) phosphoinositide 3-kinase gamma, 2.5 x 10-6M"
1hcf,2.70,2001,Kd=260pM,Kd,pM,260,0.00026,3.5850266520291822,"1hcf.pdf (130-mer) TrkB-d5:neurotrophin-4/5 complex, with BDNF Kd=790nM"
1fe8,2.03,2001,Kd=2uM,Kd,uM,2,2.0,-0.3010299956639812,"1fe8.pdf (210-mer) Multimeric vWF binds RU5(collagen inhibitor), collagen Kd=1-7nM. recombinant A3 binds RU5, Kd=2uM"
1ewy,2.38,2001,Kd=3.57uM,Kd,uM,3.57,3.57,-0.5526682161121932,1ewy.pdf (98-mer) Ferredoxin
1ib1,2.70,2001,Kd=350uM,Kd,uM,350,350.0,-2.5440680443502757,"1ib1.pdf (245-mer) 14-3-3 ZETA:SEROTONIN N-ACETYLTRANSFERASE COMPLEX(2:1), Kd=350+/-24uM"
1j7v,2.90,2001,Kd=35pM,Kd,pM,35,3.5e-05,4.455931955649724,"1j7v.pdf (160-mer) HUMAN IL-10/IL-10R1 COMPLEX, Kd=35-200pM"
1i4d,2.50,2001,Kd=3uM,Kd,uM,3,3.0,-0.47712125471966244,1i4d.pdf (192-mer) protein RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 1
1i5k,2.70,2001,Kd=42nM,Kd,nM,42,0.042,1.3767507096020994,"1i5k.pdf (30-mer) Kd=42+/-5nM, mK2pg complex with VEK-30"
1jiw,1.74,2001,Kd=4pM,Kd,pM,4,4e-06,5.3979400086720375,"1jiw.pdf (106-mer) APR-alkaline protease inhibitor complex, Kd=4pM"
1fqj,2.02,2001,Kd=67nM,Kd,nM,67,0.067,1.1739251972991736,"1fqj.pdf (325-mer) ligand is complex of GAMMA SUBUNIT OF PHOSPHODIESTERASE and GT/I1 CHIMERA ALPHA SUBUNIT, Kd=6.7 x 10-8M"
1j7d,1.85,2001,Kd~2uM,Kd,uM,2,2.0,-0.3010299956639812,"1j7d.pdf (145-mer) UBIQUITIN-CONJUGATING ENZYME E2-17 KDA  and hMms2 (Uev1), Kd~2uM"
1g0v,2.00,2001,Ki<0.1nM,Ki,nM,0.1,0.0001,4.0,"1g0v.pdf (31-mer) PROTEASE A INHIBITOR 3, K24M MUTANT OF IA3, ki=1.3+/-0.4nM (pH=3.1); ki<0.1nM (pH=4.7)"
1jtg,1.73,2001,Ki=0.11nM,Ki,nM,0.11,0.00011,3.958607314841775,"1jtd.pdf (165-mer) inhibition of TEM-1 by beta-lactamase inhibitor protein, Ki=0.11nM"
1gl1,2.10,2001,Ki=0.13nM,Ki,nM,0.13,0.00013000000000000002,3.886056647693163,"1gl0.pdf (36-mer) BOVINE ALPHA-CHYMOTRYPSIN AND PMP-C, Ki=0.13nM"
1gl0,3.00,2001,Ki=0.8nM,Ki,nM,0.8,0.0008,3.0969100130080562,"1gl0.pdf (35-mer) BOVINE ALPHA-CHYMOTRYPSIN AND PMP(R29L), Ki=0.8nM; Ki(PMP, K30M)=2nM"
1i3o,2.70,2001,Ki=0.97nM,Ki,nM,0.97,0.0009699999999999999,3.0132282657337552,"1i3o.pdf (121-mer) Inhibition of XIAP BIR2 on Caspase-3, Ki=9.7+/-5.0 E-10M"
1eja,2.70,2001,Ki=1.0nM,Ki,nM,1.0,0.001,3.0,"1eja.pdf (59-mer) PORCINE beta TRYPSIN COMPLEXED WITH BDELLASTASIN, Ki=1.0nM"
1id5,2.50,2001,Ki=1.5nM,Ki,nM,1.5,0.0015,2.8239087409443187,"1id5.pdf (142-mer) bovine thrombin in complex with ecotin M84R mutant, Ki=1.5nM"
1f7z,1.55,2001,Ki=12.4uM,Ki,uM,12.4,12.4,-1.0934216851622351,"1f5r.pdf (65-mer) BPTI complexes of rat K15A trypsinogen, Ki=12.4uM"
3tgk,1.70,2001,Ki=12uM,Ki,uM,12,12.0,-1.0791812460476249,"3tgk.pdf (65-mer) ligand is BPTI, ITC Ki=12uM, enzyme inhibition Ki=29uM"
1jtd,2.30,2001,Ki=27.2pM,Ki,pM,27.2,2.7199999999999997e-05,4.565431095965802,"1jtd.pdf (273-mer) inhibition of TEM-1 by beta-lactamase inhibitor protein II, Ki=0.0272nM"
1f5r,1.65,2001,Ki=65uM,Ki,uM,65,65.0,-1.8129133566428555,"1f5r.pdf (65-mer) BPTI complexes of rat Delta I16V17/Q156K trypsinogen, Ki=65uM"
1gpw,2.40,2002,Kd=0.019uM,Kd,uM,0.019,0.019,1.7212463990471711,"1gpw.pdf (201-mer) AMIDOTRANSFERASE HISH, Kd=0.019+/-0.009uM"
1jmo,2.20,2002,Kd=0.115uM,Kd,uM,0.115,0.115,0.9393021596463883,"1jmo.pdf (480-mer) wild type recombinant Heparin Cofactor II with thrombin, Kd=kd/ka=1.5x10-3/1.3x104=1.15x10-7M"
1jps,1.85,2002,Kd=0.1nM,Kd,nM,0.1,0.0001,4.0,"1jps.pdf (214-mer) tissue factor in complex with humanized Fab D3h44, Kd=0.1nM"
1lm8,1.85,2002,Kd=0.22uM,Kd,uM,0.22,0.22,0.6575773191777937,"1lm8.pdf (20-mer) intact HIF-1a-pVHL-ElonginB-ElonginC Complex, Kd=0.22+/-0.04uM"
1lzw,2.50,2002,Kd=0.33uM,Kd,uM,0.33,0.33,0.4814860601221125,"1lzw.pdf (146-mer) wild type ClpS with N-Ternimal domain of ClpA, Kd=3.3 X 10-7M; structure is H66A mutant ClpS and ClpA;Kd=1uM is for E79A, K84A double mutant ClpS"
1l2w,2.00,2002,Kd=0.3nM,Kd,nM,0.3,0.0003,3.5228787452803374,"1l2w.pdf (123-mer) SycE-YopE complex, Kd=0.3nM"
1i51,2.45,2002,Kd=0.63uM,Kd,uM,0.63,0.63,0.2006594505464183,1i51.pdf (117-mer) structure is CASPASE-7 with XIAP; binding data is for caspase-7 and GST-linker peptide (residues 124-157); Kd=0.63+/-0.04uM
1go4,2.05,2002,Kd=1.04uM,Kd,uM,1.04,1.04,-0.01703333929878037,"1go4.pdf (100-mer) MAD1 (MITOTIC ARREST DEFICIENT)-LIKE 1, mad1-mad2 complex"
1jwh,3.10,2002,Kd=12.6nM,Kd,nM,12.6,0.0126,1.899629454882437,"1jwh.pdf (215-mer) ligand is Human Protein Kinase CK2 Holoenzyme beta chain, 1.26 x 10-8M"
1l4z,2.80,2002,Kd=196.6nM,Kd,nM,196.6,0.1966,0.7064164865038832,"1l4d.pdf (248-mer) SKa delta-Plasminogen uPg(R561A, S741A) complex(Form II) in presence of CADMIUM IONS, Kd=196.6+/-2.4nM"
1l4d,2.30,2002,Kd=196.6nM,Kd,nM,196.6,0.1966,0.7064164865038832,"1l4d.pdf (249-mer) SKa delta- PLASMINOGEN u Pg(S741A) complex(Form I), Kd=196.6+/-2.4nM"
1kxp,2.10,2002,Kd=1nM,Kd,nM,1,0.001,3.0,1kxp.pdf (458-mer) HUMAN VITAMIN D-BINDING PROTEIN with actin
1mxe,1.70,2002,Kd=1pM,Kd,pM,1,1e-06,6.0,1mxe.pdf (148-mer) complex between Calcium-saturated calmodulin (CaM) and CaMKIp
1k5d,2.70,2002,Kd=1uM,Kd,uM,1,1.0,-0.0,1k5d.pdf (386-mer) Kd between Ran-GppNHp-RanBP1 and RanGAP in buffer containing 0M NaCl
1k93,2.95,2002,Kd=20nM,Kd,nM,20,0.02,1.6989700043360187,"1k93.pdf (144-mer) anthrax edema factor (EF) in complex with calmodulin(CaM), Kd=20nM"
1ktk,3.00,2002,Kd=20uM,Kd,uM,20,20.0,-1.3010299956639813,"1ktk.pdf (247-mer) SpeC(C13A, C191A) with T cell receptor beta chain, Kd=2 E-5M"
1i8k,1.80,2002,Kd=22nM,Kd,nM,22,0.022,1.6575773191777938,"1i8i.pdf (107-mer) DSFV MR1 binds to EGFRVIII PEPTIDE ANTIGEN(Liquid Nitrogen Temp), Kd=22nM"
1kxt,2.00,2002,Kd=235nM,Kd,nM,235,0.23500000000000001,0.6289321377282637,"1kxt.pdf (127-mer) PPA/IMMUNOGLOBULIN VHH FRAGMENT AMB7 complexs, Kd=235nM"
1ijk,2.60,2002,Kd=23nM,Kd,nM,23,0.023,1.6382721639824072,"1ijk.pdf (125-mer) vWF A1 domain-botrocetin Complex, Kd=23nM"
1kgy,2.70,2002,Kd=25nM,Kd,nM,25,0.025,1.6020599913279623,"1kgy.pdf (138-mer) EphB receptor 2-ephrinB2 complex, Kd=25nM"
1kxv,1.60,2002,Kd=25nM,Kd,nM,25,0.025,1.6020599913279623,"1kxt.pdf (121-mer) PPA/CAMELID VHH DOMAIN CAB10, AMD10 complexs"
1lj2,2.38,2002,Kd=27uM,Kd,uM,27,27.0,-1.4313637641589874,"1lj2.pdf (28-mer) PABP.NSP3-C with eukaryotic protein synthesis initiation factor, eIF4G"
1ktz,2.15,2002,Kd=290nM,Kd,nM,290,0.29,0.5376020021010439,"1ktz.pdf (112-mer) ligand is TGF-beta3, 2.9 x 10-7M"
1lw6,1.50,2002,Kd=2pM,Kd,pM,2,2e-06,5.698970004336019,"1lw6.pdf (64-mer) subtilisin BPN-Chymotrypsin Inhibitor 2(E45A) complex, Kd=2 E-12M"
1kxq,1.60,2002,Kd=3.5nM,Kd,nM,3.5,0.0035,2.4559319556497243,"1kxq.pdf (120-mer) porcine pancreatic alpha-amylase PPA, with AMD9 VHH"
1lqb,2.00,2002,Kd=31nM,Kd,nM,31,0.031,1.5086383061657274,"1lqb.pdf (34-mer) Binding of VCB to HIF-1a peptides, Kd=3.1 E-8M"
1kbh,NMR,2002,Kd=34nM,Kd,nM,34,0.034,1.4685210829577449,"1kbh.pdf (47-mer) nuclear receptor coactivator ACTR, Kd=3.4 X 10-8M"
1h59,2.10,2002,Kd=37nM,Kd,nM,37,0.037,1.431798275933005,"1h59.pdf (70-mer) COMPLEX OF IGFBP-5 WITH IGF-I, Kd=37nM"
1gng,2.60,2002,Kd=39nM,Kd,nM,39,0.039,1.408935392973501,1gng.pdf (26-mer) protein-protein
1kkl,2.80,2002,Kd=45nM,Kd,nM,45,0.045,1.3467874862246563,1kkl.pdf (100-mer) B.subtilis phosphocarrier protein HPr
1eaw,2.93,2002,Kd=49.7pM,Kd,pM,49.7,4.97e-05,4.303643611266668,1eaw.pdf (58-mer) BPTI
1lqs,2.70,2002,Kd=4nM,Kd,nM,4,0.004,2.3979400086720375,"1lqs.pdf (157-mer) INTERLEUKIN-10-LIKE PROTEIN cmvIL-10 bound to sIL-10R1, Kd=4nM"
1gxd,3.10,2002,Kd=5.2nM,Kd,nM,5.2,0.005200000000000001,2.283996656365201,"1gxd.pdf (194-mer) tissue inhibitor of metalloproteinase 2, high affinity site Kd=5.2nM, low affinity site Kd=0.19uM"
1m10,3.10,2002,Kd=5.8nM,Kd,nM,5.8,0.0058,2.2365720064370627,"1m10.pdf (208-mer) complex of Glycoprotein Ib- alpha  (M239V)and vWF A1 Domain(R543Q), Kd=5.8nM"
1jsp,NMR,2002,Kd=50uM,Kd,uM,50,50.0,-1.6989700043360187,"1jsp.pdf (121-mer) CBP bromodomain/p53 peptide complex, Kd~50uM"
1l0x,2.80,2002,Kd=6uM,Kd,uM,6,6.0,-0.7781512503836436,"1l0x.pdf (221-mer) Exotoxin type A SpeA without zinc, Kd~6 X 10-6M"
1l8c,NMR,2002,Kd=7nM,Kd,nM,7,0.007,2.154901959985743,"1l8c.pdf (51-mer) Hypoxia-inducible factor 1 alpha Hifa, ITC Kd=7+/-1nM"
1m1e,2.10,2002,Kd~1nM,Kd,nM,1,0.001,3.0,"1m1e.pdf (81-mer) ICAT protein, approximately interaction Kd~1nM"
1l0y,2.50,2002,Kd~6uM,Kd,uM,6,6.0,-0.7781512503836436,"1l0x.pdf (221-mer) Exotoxin type A SpeA with zinc, Kd~6 X 10-6M"
1k2d,2.20,2003,IC50=100uM,IC50,uM,100,100.0,-2.0,"1k2d.pdf (23-mer) MHC class II I-Au complexed with myelin basic protein 1-11, IC50>100uM"
1ob1,2.90,2003,Kd=0.2nM,Kd,nM,0.2,0.0002,3.6989700043360187,"1ob1.pdf (215-mer) mAb G17.12 binds to PfMSP1-19, Kd=2 E-10 M"
1jgn,NMR,2003,Kd=0.35uM,Kd,uM,0.35,0.35,0.4559319556497244,"1jgn.pdf (22-mer) PABP-interacting protein-2 (Paip2), Kd=3.5 X 10-7M"
1ogy,3.20,2003,Kd=0.5nM,Kd,nM,0.5,0.0005,3.3010299956639813,"1ogy.pdf (130-mer) di-heme cytochrome C NapB molecule cytochrome subunit, estimated Kd=0.1-1.5nM"
1op9,1.86,2003,Kd=0.7nM,Kd,nM,0.7,0.0007,3.154901959985743,"1op9.pdf (121-mer) human lysozyme Complex with HL6 camel VHH fragment, Kd=0.7nM"
1p27,2.00,2003,Kd=0.7nM,Kd,nM,0.7,0.0007,3.154901959985743,"1p27.pdf (106-mer) Human Y14/Magoh complex, Kd=0.7+/-0.1nM"
1p9m,3.65,2003,Kd=0.8nM,Kd,nM,0.8,0.0008,3.0969100130080562,"1p9m.pdf (299-mer) for Interleukin-6 Receptor alpha with gp130 D2-D3, Kd=40nM"
1lx5,3.30,2003,Kd=1.2nM,Kd,nM,1.2,0.0012,2.9208187539523753,"1lx5.pdf (139-mer) Immobilized Receptor, bone morphogenetic protein 7 BMP7/ActRII Complex, Kd=1.2nM"
1p3q,1.70,2003,Kd=1.2uM,Kd,uM,1.2,1.2,-0.07918124604762482,"1p3q.pdf (76-mer) ubiquitin, Kd=1.2uM"
1n64,2.34,2003,Kd=1.3nM,Kd,nM,1.3,0.0013000000000000002,2.886056647693163,"1n64.pdf (218-mer) Hepatitis C virus protein P13-40 bound to mAb 19D9D6, Kd=1.3+/-0.1nM"
1j2j,1.60,2003,Kd=1.4uM,Kd,uM,1.4,1.4,-0.146128035678238,1j2j.pdf (45-mer) ADP-ribosylation factor binding protein GGA1
1jh4,NMR,2003,Kd=1.5uM,Kd,uM,1.5,1.5,-0.17609125905568124,"1jgn.pdf (22-mer) PABP-interacting protein-1 (Paip1), Kd=1.5 X 10-6M"
1mzw,2.00,2003,Kd=1.97uM,Kd,uM,1.97,1.97,-0.2944662261615929,"1mzw.pdf (31-mer) U4/U6-60K peptide bind to CypH, Kd=1.97uM"
1oqe,2.50,2003,Kd=109nM,Kd,nM,109,0.109,0.9625735020593764,"1oqd.pdf (144-mer) tumour necrosis factor (TNF) ligand sTALL-1 and eBAFF-R(1-62), Kd=109nM"
1nys,3.05,2003,Kd=10nM,Kd,nM,10,0.01,2.0,"1nys.pdf (116-mer) Activin A, space group p41 form, Kd<10nM"
1nyu,3.10,2003,Kd=10nM,Kd,nM,10,0.01,2.0,"1nys.pdf (116-mer) Activin A, space group p41212 form, Kd<10nM"
1mi5,2.50,2003,Kd=10uM,Kd,uM,10,10.0,-1.0,1mi5.pdf (201-mer) LC13 TcR in complex with HLAB8-EBV peptide complex
1p9d,NMR,2003,Kd=12.9uM,Kd,uM,12.9,12.9,-1.110589710299249,"1p9d.pdf (78-mer) Ubl:S5a-UIM-2 complex, Kd=12.9 E-6 M"
1uad,2.10,2003,Kd=137nM,Kd,nM,137,0.137,0.8632794328435932,1uad.pdf (99-mer) Exocyst complex component Sec5
1otr,NMR,2003,Kd=155uM,Kd,uM,155,155.0,-2.1903316981702914,"1otr.pdf (76-mer) CUE2-1-ubiquitin complex, Kd=155+/-9uM"
1pjm,2.50,2003,Kd=180nM,Kd,nM,180,0.18,0.744727494896694,"1pjm.pdf (20-mer) Kd=180nM, for mouse Importin-alpha alone, with RB, human retinoblastoma protein"
1mhh,2.10,2003,Kd=1nM,Kd,nM,1,0.001,3.0,"1mhh.pdf (220-mer) a protein L mutant complexed to an Fab fragment, Kd=1nM"
1o9a,NMR,2003,Kd=1uM,Kd,uM,1,1.0,-0.0,1o9a.pdf (36-mer) Kd=1.0+/-0.1uM
1m5n,2.90,2003,Kd=2.1nM,Kd,nM,2.1,0.0021000000000000003,2.6777807052660805,1m5n.pdf (28-mer) importin beta (1-485):PTHrP-ncNLS(67-94)
1psb,NMR,2003,Kd=20uM,Kd,uM,20,20.0,-1.3010299956639813,"1psb.pdf (26-mer) S100B/NDR62-87 peptide complex, Kd=20+/-10uM"
1pjn,2.50,2003,Kd=22nM,Kd,nM,22,0.022,1.6575773191777938,"1pjm.pdf (21-mer) Kd=22nM, for mouse Importin-alpha alone with X. laevis phosphoprotein N1N2"
1h1v,3.00,2003,Kd=23nM,Kd,nM,23,0.023,1.6382721639824072,"1h1v.pdf (331-mer) GELSOLIN G4-G6 RESIDUES 412-742, Kd=2.3 x 10-8M"
1q0w,NMR,2003,Kd=277uM,Kd,uM,277,277.0,-2.4424797690644486,"1q0w.pdf (76-mer) Kd=277+/-8uM, for Vps27 UIM-2 and ubiquitin Kd=117+/-17uM"
1r0r,1.10,2003,Kd=29.4pM,Kd,pM,29.4,2.9399999999999996e-05,4.531652669587843,"1r0r.pdf (51-mer) Protein Inhibitor OMTKY3, Ka=3.4x10^10 M-1, Kd=2.94x10-11M"
1uex,2.85,2003,Kd=2nM,Kd,nM,2,0.002,2.6989700043360187,"1uex.pdf (125-mer) von Willebrand Factor A1 domain complex with bitiscetin, Kd=2nM"
1lp1,2.30,2003,Kd=2uM,Kd,uM,2,2.0,-0.3010299956639812,"1lp1.pdf (58-mer) protein Z and the antiprotein A affibody ZSPA-1, Kd=2-6uM"
1p4l,2.90,2003,Kd=3.0uM,Kd,uM,3.0,3.0,-0.47712125471966244,1p4l.pdf (122-mer) peptide-selective receptor Ly49C
1ozs,NMR,2003,Kd=31uM,Kd,uM,31,31.0,-1.4913616938342726,"1ozs.pdf (20-mer) cardiac troponin I-(128-147) (cIp), Kd=31+/-11uM"
1mq8,3.30,2003,Kd=3uM,Kd,uM,3,3.0,-0.47712125471966244,"1mq8.pdf (291-mer) alphaL I Domain(L161C, F299C) Binding to ICAM-1, Kd=3.0+/-0.44uM"
1q68,NMR,2003,Kd=400nM,Kd,nM,400,0.4,0.3979400086720376,"1q68.pdf (29-mer) Src-family tyrosine kinase Lck, Kd=400nM"
1p22,2.95,2003,Kd=480nM,Kd,nM,480,0.48,0.3187587626244128,"1p22.pdf (26-mer) beta-TrCP1-Skp1 and beta-catenin complex, Kd=480+/-40nM"
1oey,2.00,2003,Kd=4nM,Kd,nM,4,0.004,2.3979400086720375,"1oey.pdf (83-mer) HETERODIMER OF P40PHOX AND P67PHOX PB1 DOMAINS, Kd=4nM"
1o95,3.70,2003,Kd=5uM,Kd,uM,5,5.0,-0.6989700043360189,"1o94.pdf (264-mer) TMADH:2 electron transferring flavoprotein (ETF) complex, Kd~5uM, X-ray space group p21"
1h0t,NMR,2003,Kd=6uM,Kd,uM,6,6.0,-0.7781512503836436,"1h0t.pdf (58-mer) ZSPA-1 AFFIBODY complex, Kd=6uM"
1pvh,2.50,2003,Kd=80nM,Kd,nM,80,0.08,1.0969100130080565,"1pvh.pdf (169-mer) human leukemia inhibitory factor (LIF)/gp130-CHR Complex, Kd=80+/-6.2nM"
1p1z,3.26,2003,Kd=80uM,Kd,uM,80,80.0,-1.9030899869919435,1p1z.pdf (120-mer) LY49-C antigen; Kd for H-2Kb-OVAwt Ly49C
1q69,NMR,2003,Kd=900nM,Kd,nM,900,0.9,0.045757490560675115,"1q68.pdf (29-mer) Src-family tyrosine kinase Lck, Kd=900nM"
1nez,2.10,2003,Kd~10uM,Kd,uM,10,10.0,-1.0,"1nez.pdf (274-mer) TL, a non-classical MHC class I molecule/CD8 alpha  alpha  Complex, Kd~10uM"
1oc0,2.28,2003,Kd~1nM,Kd,nM,1,0.001,3.0,1oc0.pdf (51-mer) Somatomedin B Domain Of Vitronectin
1nvu,2.20,2003,Kd~3.6uM,Kd,uM,3.6,3.6,-0.5563025007672873,"1nvu.pdf (481-mer) Son of sevenless protein homolog 1, residues 566-1046"
1nf3,2.10,2003,Kd~50nM,Kd,nM,50,0.05,1.3010299956639813,"1nf3.pdf (128-mer) GTPase-binding domain of the cell polarity protein, Par6"
1oph,2.30,2003,Kd~5nM,Kd,nM,5,0.005,2.3010299956639813,"1oph.pdf (394-mer) ALPHA-1-PI-PITTSBURGH AND S195A TRYPSIN, Kd=5nM. Ligand mutations:F51L, T59A, T68A, A70G, C232S, M358R, M274I, S381A, K387R"
1o94,2.00,2003,Kd~5uM,Kd,uM,5,5.0,-0.6989700043360189,"1o94.pdf (264-mer) TMADH:2 electron transferring flavoprotein (ETF) complex, Kd~5uM, X-ray space group C2"
1nw9,2.40,2003,Ki=0.013uM,Ki,uM,0.013,0.013,1.8860566476931633,"1nw9.pdf (98-mer) XIAP-BIR3, Ki=0.013uM"
1pxv,1.80,2003,Ki=0.31nM,Ki,nM,0.31,0.00031,3.5086383061657274,"1pxv.pdf (111-mer) cysteine protease Inhibitor, Staphostatins, Ki=3.1x10-10M"
1p0s,2.80,2003,Ki=11pM,Ki,pM,11,1.1e-05,4.958607314841775,"1p0s.pdf (142-mer) Blood Coagulation Factor Xa Complex with Ecotin M84R, Ki=11pM"
1nb5,2.40,2003,Ki=69pM,Ki,pM,69,6.9e-05,4.161150909262744,"1nb5.pdf (220-mer) stefin A and stefin B complex with cathepsin H, Ki=0.027nM and Ki=0.069nM, author confuse two data himself"
1mcv,1.80,2003,Ki=98nM,Ki,nM,98,0.098,1.0087739243075051,"1mcv.pdf (28-mer) hybrid squash inhibitor HEI-TOE I and porcine pancreatic elastase complex, Ki=9.8 X 10-8M"
1oyv,2.50,2003,Ki=9nM,Ki,nM,9,0.009000000000000001,2.0457574905606752,"1oyv.pdf (123-mer) tomato inhibitor-II complex with subtilisin Carlsberg, Ki=9nM"
1rpq,3.00,2004,IC50=0.032uM,IC50,uM,0.032,0.032,1.494850021680094,1rpq.pdf (21-mer) protein-protein
1xxf,2.60,2004,IC50=200nM,IC50,nM,200,0.2,0.6989700043360187,"1xx9.pdf (142-mer) rhFXI(370-607) and EcotinP complex, IC50>200nM. Ligand mutation:V81D, S82F, M84R, M85V, A86V"
1rv6,2.45,2004,IC50=275nM,IC50,nM,275,0.275,0.5606673061697374,1rv6.pdf (100-mer) FLT1 protein; IC50 for plgf/vegfr1
1xx9,2.20,2004,IC50=3nM,IC50,nM,3,0.003,2.5228787452803374,"1xx9.pdf (142-mer) rhFXI(370-607) and Ecotin M84R complex, IC50=3nM"
1xu1,1.90,2004,IC50=5.9nM,IC50,nM,5.9,0.005900000000000001,2.2291479883578558,"1xu1.pdf (138-mer) ligand APRIL, IC50=5.9+/-1.4nM"
1xxd,2.91,2004,IC50=600nM,IC50,nM,600,0.6,0.2218487496163564,"1xx9.pdf (142-mer) rhFXI(370-607) and Ecotin D complex, IC50=600nM. Ligand mutation:P80N, V81D, S82F, M84R, M85V, A86V"
1v7p,1.90,2004,IC50=6nM,IC50,nM,6,0.006,2.221848749616356,"1v7p.pdf (128-mer) EMS16 in complex with  alpha 2-I domain, IC50=6nM. protein mutation:Q138G, P139S, C140S"
1ry7,3.20,2004,Kd=0.23uM,Kd,uM,0.23,0.23,0.638272163982407,"1ry7.pdf (155-mer) 3 Ig form of FGFR3c in complex with full length FGF1, Kd=2.3 E-7 M"
1u0s,1.90,2004,Kd=0.23uM,Kd,uM,0.23,0.23,0.638272163982407,"1u0s.pdf (118-mer) CheA P1-P2 domain and CheY for T. maritima, Temp.28 Kd=0.23+/-0.02uM, Temp.70 Kd=1.0+/-0.2uM"
1xqh,1.75,2004,Kd=0.2uM,Kd,uM,0.2,0.2,0.6989700043360187,1xqh.pdf (20-mer) incomplete ligand structure
1pd7,NMR,2004,Kd=0.3uM,Kd,uM,0.3,0.3,0.5228787452803376,"1pd7.pdf (24-mer) Mad1-SID length 24, Kd=0.3+/-0.2uM"
1xd3,1.45,2004,Kd=0.3uM,Kd,uM,0.3,0.3,0.5228787452803376,"1xd3.pdf (75-mer) UBC protein, Kd=3 x 10-7M"
1t6b,2.50,2004,Kd=0.4nM,Kd,nM,0.4,0.0004,3.3979400086720375,"1t6b.pdf (189-mer) Anthrax toxin receptor 2, 4.0 x 10-10M"
1nl0,2.20,2004,Kd=1.6nM,Kd,nM,1.6,0.0016,2.795880017344075,"1nl0.pdf (213-mer) human factor IX Gla domain complex with inhibitory antibody 10C12, Kd=1.6nM. one of the smallest interface between protein-anti body complexes"
1tzh,2.60,2004,Kd=1.8nM,Kd,nM,1.8,0.0018000000000000002,2.744727494896694,"1tzh.pdf (213-mer) Fab YADS1 Complexed with h-VEGF, Kd=1.8+/-0.3nM"
1us7,2.30,2004,Kd=1.8uM,Kd,uM,1.8,1.8,-0.25527250510330607,1us7.pdf (265-mer) COMPLEX OF yeast N-HSP90 AND C-P50
1tzi,2.80,2004,Kd=10nM,Kd,nM,10,0.01,2.0,"1tzh.pdf (214-mer) Fab YADS2 Complexed with h-VEGF, Kd=10+/-2nM"
1xr0,NMR,2004,Kd=10uM,Kd,uM,10,10.0,-1.0,"1xr0.pdf (129-mer) FGFR signalling adaptor SNT-1 PTB domain, estimated kd=10uM"
1sv0,2.07,2004,Kd=11.1nM,Kd,nM,11.1,0.0111,1.9546770212133426,"1sv0.pdf (82-mer) Yan-SAM A86R/Mae-SAM Complex, Kd=11.1+/-0.1nM"
1vet,1.90,2004,Kd=12.8nM,Kd,nM,12.8,0.0128,1.8927900303521317,"1vet.pdf (125-mer) Late endosomal/lysosomal Mp1 interacting protein, code 1veu is the same protein at 2.15A"
1veu,2.15,2004,Kd=12.8nM,Kd,nM,12.8,0.0128,1.8927900303521317,"1veu.pdf (126-mer) p14/MP1 complex, resolution=1.9 or 2.15 angstrom? Kd=12.8nM"
1q5w,NMR,2004,Kd=126uM,Kd,uM,126,126.0,-2.100370545117563,"1q5w.pdf (31-mer) Ubiquitin Recognition by Npl4 Zinc-Fingers, Kd=126+/-26uM"
1tdq,2.60,2004,Kd=12nM,Kd,nM,12,0.012,1.9208187539523751,"1tdq.pdf (283-mer) CLD:rat tenascin-R(TN3-5), Kd=12nM"
1r8u,NMR,2004,Kd=13nM,Kd,nM,13,0.013000000000000001,1.8860566476931633,"1r8u.pdf (100-mer) CBP TAZ1/CITED2 complex, Kd=13+/-10nM"
1syq,2.42,2004,Kd=14.7nM,Kd,nM,14.7,0.0147,1.832682665251824,"1syq.pdf (25-mer) Kd for vinculin binding site 1 (VBS1)=14.7nM, VBS2=32.8nM, VBS3=3.1nM"
1w72,2.15,2004,Kd=14nM,Kd,nM,14,0.014,1.853871964321762,1w72.pdf (210-mer) HLA-A1:MAGE-A1 IN COMPLEX WITH FAB-HYB3
1sb0,NMR,2004,Kd=15uM,Kd,uM,15,15.0,-1.1760912590556813,"1sb0.pdf (25-mer) Transactivation Domain of c-Myb, buffer tris Kd=15uM, phosphate Kd=12.5uM"
1tzn,4.30,2004,Kd=170pM,Kd,pM,170,0.00016999999999999999,3.769551078621726,"1tzn.pdf (181-mer) CMG2 VWA domain protein, Kd=170pM"
1sg1,2.40,2004,Kd=186nM,Kd,nM,186,0.186,0.7304870557820837,"1sg1.pdf (120-mer) 2:1 Nerve Growth Factor/p75 complex, Kd=186nM"
1t44,2.00,2004,Kd=1uM,Kd,uM,1,1.0,-0.0,1t44.pdf (370-mer) actin with chimera of gelsolin domain 1 and c-terminal
1th1,2.50,2004,Kd=2.1nM,Kd,nM,2.1,0.0021000000000000003,2.6777807052660805,"1th1.pdf (179-mer) Beta-catenin(full length) complex with a phosphorylated APC-2, 3 , Kd=2.1nM"
1sy6,2.10,2004,Kd=2.73uM,Kd,uM,2.73,2.73,-0.436162647040756,"1sy6.pdf (213-mer) CD3 epsilon  gamma  Heterodimer in Complex with OKT3 Fab, Kd=27.3+/-4.74 E-7 M"
1xt9,2.20,2004,Kd=200nM,Kd,nM,200,0.2,0.6989700043360187,"1xt9.pdf (76-mer) Den1 in complex with Nedd8, Kd=200nM"
1vyt,2.60,2004,Kd=20nM,Kd,nM,20,0.02,1.6989700043360187,"1vyt.pdf (25-mer) alpha interaction domain 1, AID with beta subunit, Kd=20nM"
1w1w,2.90,2004,Kd=260uM,Kd,uM,260,260.0,-2.4149733479708178,1w1w.pdf (121-mer) protein-protein; Kd of two Smc1hd/Scc-C monomers
1u7v,2.70,2004,Kd=296nM,Kd,nM,296,0.296,0.5287082889410615,"1u7f.pdf (236-mer) Smad2/Smad4 heterotrimeric complex, Kd=296+/-165.8nM"
1usu,2.15,2004,Kd=3.3uM,Kd,uM,3.3,3.3,-0.5185139398778874,"1usu.pdf (170-mer) COMPLEX BETWEEN N-AHA1 AND M-HSP90, crystal form1, Kd=3.3+/-0.8uM"
1usv,2.70,2004,Kd=3.3uM,Kd,uM,3.3,3.3,-0.5185139398778874,"1usu.pdf (170-mer) COMPLEX BETWEEN N-AHA1 AND M-HSP90, crystal form2, Kd=3.3+/-0.8uM"
1uel,NMR,2004,Kd=3.4uM,Kd,uM,3.4,3.4,-0.5314789170422551,"1uel.pdf (95-mer) hHR23B UBl complexed with UIM wild type S5a, Kd=3.4+/-0.3uM"
1tlh,NMR,2004,Kd=300uM,Kd,uM,300,300.0,-2.4771212547196626,"1tlh.pdf (81-mer) T4 AsiA/sigma70 EcSR4 complex, Kd=300uM"
1sq0,2.60,2004,Kd=30nM,Kd,nM,30,0.03,1.5228787452803376,"1sq0.pdf (214-mer) wt Von Willebrand Factor A1 domain and Glycoprotein Ib alpha, Kd=30nM"
1p6a,2.90,2004,Kd=35nM,Kd,nM,35,0.035,1.4559319556497243,"1p69.pdf (185-mer) Ad12 knob mutants S489Y-CAR D1, Kd=35+/-4.4nM"
1rkc,2.70,2004,Kd=39nM,Kd,nM,39,0.039,1.408935392973501,"1rkc.pdf (26-mer) Vh domain in complex with talin vinculin-binding site3 VBS3, Kd=39nM"
1t01,2.06,2004,Kd=39nM,Kd,nM,39,0.039,1.408935392973501,"1t01.pdf (24-mer) still vh, talin 482-636, with talin (vinculin binding site 1)VBS1, IC50=3nM"
1p4b,2.35,2004,Kd=40pM,Kd,pM,40,3.9999999999999996e-05,4.3979400086720375,"1p4b.pdf (135-mer) sc Fv Fragment Complexed With The peptide GCN4(7P-14P), Kd=40pM"
1oyh,2.62,2004,Kd=42nM,Kd,nM,42,0.042,1.3767507096020994,"1oyh.pdf (432-mer) Antithrombin-III beta glycoform, ionic strength=2, Kd=4.2+/-0.1 X 10-8M"
1rvj,2.75,2004,Kd=4uM,Kd,uM,4,4.0,-0.6020599913279624,"1rvj.pdf (260-mer) RH(H177) revertant RC in the trigonal form, Kd=4+/-1uM"
1rke,2.35,2004,Kd=50nM,Kd,nM,50,0.05,1.3010299956639813,"1rke.pdf (185-mer) vinculin head (1-258) complex with vinculin tail (879-1066), Kd=50-80nM"
1u7f,2.60,2004,Kd=58nM,Kd,nM,58,0.058,1.2365720064370627,"1u7f.pdf (239-mer) Smad3/Smad4 heterotrimeric complex, Kd=58+/-2.9nM"
1vg0,2.20,2004,Kd=5nM,Kd,nM,5,0.005,2.3010299956639813,1vg0.pdf (207-mer) protein-protein; Kd for Rab7/REP-1
1ty4,2.20,2004,Kd=6.4nM,Kd,nM,6.4,0.0064,2.193820026016113,"1ty4.pdf (170-mer) EGL-1 with cell-killing caspase CED-9, Kd=6.4nM"
1s4y,2.30,2004,Kd=6.87nM,Kd,nM,6.87,0.00687,2.1630432629404495,"1s4y.pdf (98-mer) two ActRIIb-ECD, Kd=6.87nM"
1u0i,NMR,2004,Kd=70nM,Kd,nM,70,0.07,1.154901959985743,"1u0i.pdf (21-mer) IAAL-E3 K3 complex, Kd=70nM"
1p69,3.10,2004,Kd=76nM,Kd,nM,76,0.076,1.1191864077192086,"1p69.pdf (185-mer) Ad12 knob mutants P417S-CAR D1, Kd=76+/-4.1nM"
1shy,3.22,2004,Kd=90nM,Kd,nM,90,0.09,1.0457574905606752,"1shy.pdf (234-mer) HGF beta complex with Met ECD, Kd=90nM"
1p2c,2.00,2004,Kd=98pM,Kd,pM,98,9.8e-05,4.008773924307505,"1p2c.pdf (129-mer) Lysozyme C, Ka=1.02x10^10 M-1, Kd=0.98x10-10M"
1s1q,2.00,2004,Kd~500uM,Kd,uM,500,500.0,-2.6989700043360187,"1s1q.pdf (76-mer) TSG101 UEV-Ubiquitin complex, Kd~500uM"
1nm5,2.40,2004,Kd~60nM,Kd,nM,60,0.06,1.2218487496163564,"1nm5.pdf (203-mer) (dI.Q132N)2(dIII)1 asymmetric complex, Kd~60nM"
1tm7,1.59,2004,Ki=0.0033nM,Ki,nM,0.0033,3.3e-06,5.481486060122113,1tm7.pdf (64-mer) protein-protein
1tm1,1.70,2004,Ki=0.003nM,Ki,nM,0.003,3e-06,5.522878745280337,1tm1.pdf (64-mer) protein-protein
1tm5,1.45,2004,Ki=0.017nM,Ki,nM,0.017,1.7000000000000003e-05,4.769551078621726,1tm5.pdf (64-mer) protein-protein
1tm3,1.57,2004,Ki=0.019nM,Ki,nM,0.019,1.9e-05,4.721246399047171,1tm3.pdf (64-mer) protein-protein
1tm4,1.70,2004,Ki=0.13nM,Ki,nM,0.13,0.00013000000000000002,3.886056647693163,1tm4.pdf (64-mer) protein-protein
1to1,1.68,2004,Ki=0.46nM,Ki,nM,0.46,0.00046,3.337242168318426,1to1.pdf (64-mer) protein-protein
1tt5,2.60,2004,Ki=22uM,Ki,uM,22,22.0,-1.3424226808222062,"1tt5.pdf (26-mer) Ubc12 N-terminus Ubc12N26, Ki=22+/-5uM"
1uuz,1.80,2004,Ki=25nM,Ki,nM,25,0.025,1.6020599913279623,1uuz.pdf (137-mer) Ki app=25nM
1te1,2.50,2004,Ki=3.4nM,Ki,nM,3.4,0.0034,2.468521082957745,"1ta3.pdf (190-mer) family 11 xylanase (GH11) in complex with inhibitor (XIP-I), Ki=3.4nM"
1ta3,1.70,2004,Ki=9nM,Ki,nM,9,0.009000000000000001,2.0457574905606752,"1ta3.pdf (303-mer) xylanase (GH10) in complex with inhibitor (XIP), Ki=9nM"
1zjd,2.60,2005,IC50=1.28nM,IC50,nM,1.28,0.00128,2.8927900303521317,"1zjd.pdf (57-mer) wt PN2KPI domain inhibition of FXIac, IC50=1.28nM. protein mutation:S434A, T475A, C482S"
1yc0,2.60,2005,IC50=4nM,IC50,nM,4,0.004,2.3979400086720375,"1yc0.pdf (75-mer) Kunitz-type protease inhibitor 1, IC50=4.0+/-0.3nM"
2ass,3.00,2005,Kd=0.006uM,Kd,uM,0.006,0.006,2.221848749616356,2ass.pdf (69-mer) protein-protein
1vyh,3.40,2005,Kd=0.08uM,Kd,uM,0.08,0.08,1.0969100130080565,1vyh.pdf (410-mer)
1z7x,1.95,2005,Kd=0.29fM,Kd,fM,0.29,2.9e-10,9.537602002101044,"1z7x.pdf (461-mer) Ribonuclease inhibitor-RNase 1 complex, Kd=2.9x10-16M"
1zhi,2.70,2005,Kd=0.2uM,Kd,uM,0.2,0.2,0.6989700043360187,"1zhi.pdf (138-mer) Regulatory protein SIR1, 2 x 10-7M"
1r6q,2.35,2005,Kd=0.33uM,Kd,uM,0.33,0.33,0.4814860601221125,"1r6q.pdf (106-mer) ligand is ATP-dependent Clp protease adaptor protein clpS, Kd=3.3 x 10-7M"
1wlp,NMR,2005,Kd=0.64uM,Kd,uM,0.64,0.64,0.1938200260161128,"1wlp.pdf (25-mer) p47phox-(151-286) complex p22phox-(149-168), Kd for p22phox-(149-162)=8.67uM"
1zm4,2.90,2005,Kd=0.98uM,Kd,uM,0.98,0.98,0.00877392430750515,1zm4.pdf (207-mer) exotoxin A
1y8n,2.60,2005,Kd=1.17uM,Kd,uM,1.17,1.17,-0.06818586174616162,1y8n.pdf (97-mer) protein-protein
2c1m,2.20,2005,Kd=1.1nM,Kd,nM,1.1,0.0011,2.958607314841775,"2c1m.pdf (46-mer) NUP50(1-109):IMPORTIN-ALPHA(70-529) COMPLEX, Kd=1.1+/-0.2nM. Structure is not intact."
1ze3,1.84,2005,Kd=1.2uM,Kd,uM,1.2,1.2,-0.07918124604762482,"1ze3.pdf (125-mer) Complex of FimD N-terminal domain with FIMC and the Pilin Domain of FIMH, Kd=1.2uM"
1uwx,2.20,2005,Kd=1.6uM,Kd,uM,1.6,1.6,-0.2041199826559248,"1uwx.pdf (225-mer) P1.2 SEROSUBTYPE ANTIGEN IN COMPLEX WITH FAB FRAGMENT, Kd=1.6+/-0.5uM"
1ydi,1.80,2005,Kd=1.78nM,Kd,nM,1.78,0.0017800000000000001,2.749579997691106,"1ydi.pdf (24-mer) ligand is Alpha-actinin 4, Kd=1.78nM"
2b4j,2.02,2005,Kd=10.9nM,Kd,nM,10.9,0.0109,1.9625735020593764,"2b4j.pdf (98-mer) IN-binding domain of lens epithelium-derived growth factor (LEDGF), 1.09 x 10-8M"
2b0z,2.70,2005,Kd=100uM,Kd,uM,100,100.0,-2.0,"2b0z.pdf (108-mer) F82I cytochrome c and cytochrome c peroxidase, Kd=100uM"
1v18,2.10,2005,Kd=10nM,Kd,nM,10,0.01,2.0,"1v18.pdf (47-mer) BETA-CATENIN(full length) COMPLEXED WITH PHOSPHORYLATED APC R3, Kd=10+/-1.3nM"
1z92,2.80,2005,Kd=10nM,Kd,nM,10,0.01,2.0,"1z92.pdf (219-mer) Interleukin-2 Complexed with Its Alpha Receptor, low Kd=10nM"
2ajf,2.90,2005,Kd=10nM,Kd,nM,10,0.01,2.0,"2ajf.pdf (180-mer) SARS-CoV RBD and human ACE2 complex, Kd=1 E-8 M"
2b5i,2.30,2005,Kd=10pM,Kd,pM,10,9.999999999999999e-06,5.0,"2b5i.pdf (133-mer) Interleukin-2 alpha beta gamma chain, quaternary complex, Kd=10pM. Protein mutation:alpha, N68Q; beta, N3, 17, 45Q; gamma, N53Q"
2b10,2.80,2005,Kd=10uM,Kd,uM,10,10.0,-1.0,"2b0z.pdf (108-mer) F82S cytochrome c and cytochrome c peroxidase, Kd=10uM"
1wa8,NMR,2005,Kd=11nM,Kd,nM,11,0.011,1.958607314841775,"1wa8.pdf (95-mer) CFP-10 and ESAT-6 complex, Kd=1.1 X 10-8M"
1x1y,1.90,2005,Kd=12.7uM,Kd,uM,12.7,12.7,-1.1038037209559568,"1x1y.pdf (90-mer) barnase(Q2A)-barstar(D35A), Kd=1.27 E-7 M, ligand mutation:D35A, C40A, C82A"
2a7u,NMR,2005,Kd=120nM,Kd,nM,120,0.12,0.9208187539523752,"2a7u.pdf (22-mer) E.coli F-ATPase delta subunit N-terminal domain complex with alpha subunit N-terminal 22 residues, strongest Kd~120nM"
2aep,2.10,2005,Kd=12nM,Kd,nM,12,0.012,1.9208187539523751,"2aep.pdf (214-mer) Memphis/98 NA-Mem5 fab complex, frozen crystals(-166 centigrade ), Kd=12nM"
2aeq,3.00,2005,Kd=12nM,Kd,nM,12,0.012,1.9208187539523751,"2aep.pdf (214-mer) Memphis/98 NA-Mem5 fab complex, room temperature(20 centigrade ), Kd=12nM"
1x1u,2.30,2005,Kd=13.2nM,Kd,nM,13.2,0.0132,1.8794260687941502,"1x1u.pdf (89-mer) barnase(wt)-barstar(pwt), Kd=1.32 E-10 M, ligand mutation:C40A, C82A"
2bnr,1.90,2005,Kd=13.3uM,Kd,uM,13.3,13.3,-1.1238516409670858,2bnr.pdf (100-mer) TCR-pMHC complex;
1wdw,3.00,2005,Kd=14.3nM,Kd,nM,14.3,0.0143,1.8446639625349381,"1wdw.pdf (385-mer) Tryptophan synthase beta chain, K=0.7x10^8M-1, Kd=1.43x10-8M, temperature is 35 degree"
1wr1,NMR,2005,Kd=14.8uM,Kd,uM,14.8,14.8,-1.1702617153949575,"1wr1.pdf (76-mer) Dsk2p UBA with ubiquitin, Kd=14.8uM"
1t63,2.07,2005,Kd=15uM,Kd,uM,15,15.0,-1.1760912590556813,1t63.pdf (20-mer) incomplete ligand structure
1x75,2.80,2005,Kd=17.5nM,Kd,nM,17.5,0.0175,1.7569619513137056,"1x75.pdf (101-mer) GyrA14 protects against Cytotoxic protein ccdB, Kd=17.5nM"
1y6m,2.80,2005,Kd=173nM,Kd,nM,173,0.17300000000000001,0.7619538968712045,"1y6m.pdf (145-mer) Epstein-Barr virus IL-10 and sIL-10R1 complex, Kd=173nM"
1yd8,2.80,2005,Kd=181uM,Kd,uM,181,181.0,-2.2576785748691846,"1yd8.pdf (98-mer) ligand is GAT domain of GGA3, Kd=181+/-39uM"
1y6k,2.52,2005,Kd=1nM,Kd,nM,1,0.001,3.0,"1y6k.pdf (214-mer) ligand is Interleukin-10 receptor alpha chain, ITC Kd=1nM, solution affinity Kd=8nM"
1yru,2.50,2005,Kd=1nM,Kd,nM,1,0.001,3.0,"1yrt.pdf (74-mer) wild type CyaA-ACD and C-CaM complex with exogenous CaCl2, Kd=1nM"
2bp7,2.90,2005,Kd=1nM,Kd,nM,1,0.001,3.0,"2bp7.pdf (339-mer) the peripheral subunit binding domain (PSBD) E2, Kd less than 10-9M"
2c1t,2.60,2005,Kd=2.0nM,Kd,nM,2.0,0.002,2.6989700043360187,"2c1m.pdf (51-mer) KAP60P:NUCLEOPORIN NUP2 COMPLEX, Kd=2.0+/-0.2nM"
1yy9,2.60,2005,Kd=2.3nM,Kd,nM,2.3,0.0023,2.638272163982407,"1yy9.pdf (213-mer) sEGFR binds to immobilized FabC225, Kd=2.3+/-0.5nM"
2byk,2.40,2005,Kd=2.3uM,Kd,uM,2.3,2.3,-0.36172783601759284,"2byk.pdf (140-mer) CHRAC14 and CHRAC16 HETERODIMER, crystal form I, Kd=2.3uM"
2bym,2.80,2005,Kd=2.3uM,Kd,uM,2.3,2.3,-0.36172783601759284,"2byk.pdf (140-mer) CHRAC14 and CHRAC16 HETERODIMER, crystal form II, Kd=2.3uM"
2be6,2.00,2005,Kd=2.63nM,Kd,nM,2.63,0.00263,2.580044251510242,"2be6.pdf (150-mer) ligand is Ca2+/CaM  C lobe, for C lobe Kd=2.63+/-0.07nM, for N lobe Kd=57.6+/-35.5nM"
1ri8,1.85,2005,Kd=2.9nM,Kd,nM,2.9,0.0029,2.537602002101044,"1ri8.pdf (134-mer) camelid ANTIBODY HEAVY CHAIN D2-L19 and HEWL, Kd=2.9nM"
2b12,3.02,2005,Kd=20uM,Kd,uM,20,20.0,-1.3010299956639813,"2b0z.pdf (108-mer) F82Y cytochrome c and cytochrome c peroxidase, Kd=20uM"
2bqz,1.50,2005,Kd=20uM,Kd,uM,20,20.0,-1.3010299956639813,2bqz.pdf (29-mer) incomplete ligand structure
1wr6,2.60,2005,Kd=231uM,Kd,uM,231,231.0,-2.3636119798921444,"1wr6.pdf (76-mer) GGA3 GAT domain in complex with ubiquitin, Kd=231+/-13uM"
2aw2,2.80,2005,Kd=25nM,Kd,nM,25,0.025,1.6020599913279623,2aw2.pdf (108-mer) ligand is Tumor necrosis factor receptor superfamily member 14
1t0p,1.66,2005,Kd=25uM,Kd,uM,25,25.0,-1.3979400086720377,"1t0p.pdf (175-mer) binding domains of ICAM-3 and  alpha L I domain, untreated Kd=25.0+/-2.80uM (ICAM-3 uncleaved, from 293T cell)"
1x1w,2.10,2005,Kd=26.4nM,Kd,nM,26.4,0.0264,1.578396073130169,"1x1w.pdf (90-mer) barnase(wt)-barstar(E80A), Kd=2.64 E-10 M, ligand mutation:E80A, C40A, C82A"
1y6n,2.70,2005,Kd=27nM,Kd,nM,27,0.027,1.5686362358410126,"1y6m.pdf (145-mer) Epstein-Barr virus IL-10 A87I/sIL-10R1 complex, Kd=27nM"
1vrc,NMR,2005,Kd=28.4uM,Kd,uM,28.4,28.4,-1.4533183400470377,"1vrc.pdf (85-mer) Binding of HPr to IIAMan, Kd=28.4+/-0.5uM"
1z5s,3.01,2005,Kd=3.04uM,Kd,uM,3.04,3.04,-0.48287358360875376,"1z5s.pdf (83-mer) SUMO-RanGAP1-Ubc9 and Nup358/RanBP2, Kd=3.04+/-0.47uM"
1t5z,2.30,2005,Kd=33uM,Kd,uM,33,33.0,-1.5185139398778875,1t5z.pdf (20-mer) incomplete ligand structure
1za3,3.35,2005,Kd=34nM,Kd,nM,34,0.034,1.4685210829577449,"1za3.pdf (134-mer) YSd1:human death receptor Extra-cellular domain(hDR5-ECD) complex, Kd=34nM"
1yx5,NMR,2005,Kd=350uM,Kd,uM,350,350.0,-2.5440680443502757,"1yx5.pdf (98-mer) S5a UIM-1/Ubiquitin Complex, Kd=350uM"
1xwd,2.92,2005,Kd=388uM,Kd,uM,388,388.0,-2.5888317255942073,"1xwd.pdf (111-mer) FSH-FSHRHB complex, monomer-dimer equilibrium Kd=388+/-120uM"
1xj7,2.70,2005,Kd=39uM,Kd,uM,39,39.0,-1.591064607026499,1xj7.pdf (20-mer) incomplete ligand structure
1u5s,NMR,2005,Kd=3mM,Kd,mM,3,3000.0,-3.4771212547196626,"1u5s.pdf (66-mer) complex between Nck-2 SH3 domain and PINCH-1 LIM4 domain, Kd=3 E-3 M"
1shz,2.85,2005,Kd=3uM,Kd,uM,3,3.0,-0.47712125471966244,1shz.pdf (233-mer) ligand is Rho guanine nucleotide exchange factor 1
1wrd,1.75,2005,Kd=409uM,Kd,uM,409,409.0,-2.611723308007342,"1wrd.pdf (76-mer) Tom1 GAT domain in complex with ubiquitin, Kd=409+/-13uM"
1zc3,2.00,2005,Kd=42nM,Kd,nM,42,0.042,1.3767507096020994,1zc3.pdf (113-mer) ligand is exocyst complex protein Exo84
1zc4,2.50,2005,Kd=42nM,Kd,nM,42,0.042,1.3767507096020994,1zc4.pdf (120-mer) ligand is exocyst complex protein Exo84; same as 1zc3
1yyl,2.75,2005,Kd=4nM,Kd,nM,4,0.004,2.3979400086720375,"1yyl.pdf (214-mer) CD4M33/core YU2 gp120/Fab 17b, Kd=4+/-1nM"
1x1x,2.30,2005,Kd=53nM,Kd,nM,53,0.053,1.275724130399211,"1x1x.pdf (89-mer) barnase(wt)-barstar(E76A), Kd=5.30 E-10 M, ligand mutation:E76A, C40A, C82A"
1pk1,1.80,2005,Kd=54nM,Kd,nM,54,0.054,1.2676062401770316,"1pk1.pdf (89-mer) Hetero SAM domain structure of Ph and Scm, Kd=54+/-2nM"
1xg2,1.90,2005,Kd=5nM,Kd,nM,5,0.005,2.3010299956639813,"1xg2.pdf (153-mer) pectin methylesterase complex with PME inhibitor protein, Kd=5nM(PH5.5)"
1y76,NMR,2005,Kd=5uM,Kd,uM,5,5.0,-0.6989700043360189,"1y74.pdf (60-mer) Patj/Pals1N L27 Domain Complex(tetramer), Kd value significantly <5uM"
2b11,2.30,2005,Kd=5uM,Kd,uM,5,5.0,-0.6989700043360189,"2b0z.pdf (108-mer) F82W cytochrome c and cytochrome c peroxidase, Kd=5uM"
2b2w,2.40,2005,Kd=5uM,Kd,uM,5,5.0,-0.6989700043360189,"2b2t.pdf (20-mer) human CHD1 with Histone H3 Tail (trimethyllysine 4), Kd=5uM"
2bnq,1.70,2005,Kd=5uM,Kd,uM,5,5.0,-0.6989700043360189,2bnq.pdf (100-mer) TCR-pMHC complex
1xqs,2.90,2005,Kd=6.5uM,Kd,uM,6.5,6.5,-0.8129133566428556,"1xqs.pdf (191-mer) ligand is Hsp70 ATPase domain, 5mM AMP ADP ATP, Kd=6.5uM"
1ul1,2.90,2005,Kd=60nM,Kd,nM,60,0.06,1.2218487496163564,"1ul1.pdf (261-mer) human FEN1-Proliferating cell nuclear antigen (PCNA) complex, Kd=60nM"
2a78,1.81,2005,Kd=60nM,Kd,nM,60,0.06,1.2218487496163564,2a78.pdf (223-mer) ligand is Mono-ADP-ribosyltransferase C3
2a9k,1.73,2005,Kd=60nM,Kd,nM,60,0.06,1.2218487496163564,"2a9k.pdf (223-mer) RalA-GDP-C3bot complex, Kd=60+/-20nM"
2c5d,3.30,2005,Kd=6nM,Kd,nM,6,0.006,2.221848749616356,"2c5d.pdf (422-mer) human Gas6-LG/Axl-IG complex, Kd=6+/-2nM"
1zsg,NMR,2005,Kd=7.5uM,Kd,uM,7.5,7.5,-0.8750612633917001,"1zsg.pdf (22-mer) the PIX-SH3/PAK peptide complex, Kd=7.5+/-0.3uM"
1zmy,3.00,2005,Kd=7.6nM,Kd,nM,7.6,0.0076,2.1191864077192086,"1zmy.pdf (142-mer) cAbBCII-10 VHH with CDR loops of cAbLys3 complex with HEWL, Kd=7.6nM"
1z0k,1.92,2005,Kd=7.7uM,Kd,uM,7.7,7.7,-0.8864907251724818,"1z0k.pdf (69-mer) RAB4 binding domain of Rabenosyn, SPR Kd=7.7+/-1.9uM"
1yx6,NMR,2005,Kd=73uM,Kd,uM,73,73.0,-1.863322860120456,"1yx5.pdf (98-mer) S5a UIM-2/Ubiquitin Complex, Kd=73uM"
1rjc,1.40,2005,Kd=77pM,Kd,pM,77,7.7e-05,4.113509274827518,"1ri8.pdf (137-mer) camelid heavy chain antibody cAb-Lys2 and HEWL, Kd=77pM"
1wve,1.85,2005,Kd=7nM,Kd,nM,7,0.007,2.154901959985743,"1wve.pdf (80-mer) flavoprotein and cytochrome c subunit of 4-cresol dehydrogenase [hydroxylating], strong interaction Kd=7nM"
2ast,2.30,2005,Kd=7uM,Kd,uM,7,7.0,-0.8450980400142568,2ast.pdf (24-mer) incomplete ligand structure
1wqj,1.60,2005,Kd=865nM,Kd,nM,865,0.865,0.06298389253518578,"1wqj.pdf (70-mer) binary complex of NBP-4 and IGF-I, Kd=865+/-78nM"
1yym,2.20,2005,Kd=9.48uM,Kd,uM,9.48,9.48,-0.9768083373380663,"1yyl.pdf (214-mer) F23/core YU2 gp120/Fab 17b, Kd=9480+/-440nM"
1wa7,NMR,2005,Kd=9.58uM,Kd,uM,9.58,9.58,-0.9813655090785445,"1wa7.pdf (22-mer) ligand is TYROSINE KINASE INTERACTION PROTEIN Tip, LYN-Tip Kd=9.58+/-0.95uM, LCK-Tip Kd=30.13+/-1.06uM"
2ak4,2.50,2005,Kd=9.9uM,Kd,uM,9.9,9.9,-0.9956351945975499,"2ak4.pdf (276-mer) SB27 TCR in complex with HLA-B*3508-LPEP, Kd=9.9uM"
1y3c,1.69,2005,Ki=0.025nM,Ki,nM,0.025,2.5e-05,4.6020599913279625,1y3c.pdf (64-mer) protein-protein
1y3b,1.80,2005,Ki=0.31nM,Ki,nM,0.31,0.00031,3.5086383061657274,1y3b.pdf (64-mer) protein-protein
1y1k,1.56,2005,Ki=0.3nM,Ki,nM,0.3,0.0003,3.5228787452803374,1y1k.pdf (64-mer) protein-protein
1y34,1.55,2005,Ki=0.52nM,Ki,nM,0.52,0.0005200000000000001,3.283996656365201,1y34.pdf (64-mer) protein-protein
1y3d,1.80,2005,Ki=0.56nM,Ki,nM,0.56,0.0005600000000000001,3.2518119729937993,1y3d.pdf (64-mer) protein-protein
1y4a,1.60,2005,Ki=1.2nM,Ki,nM,1.2,0.0012,2.9208187539523753,1y4a.pdf (64-mer) ligand is chymotrypsin inhibitor 2
1y4d,2.00,2005,Ki=1.2nM,Ki,nM,1.2,0.0012,2.9208187539523753,1y4d.pdf (63-mer) protein-protein
1zli,2.09,2005,Ki=1.3nM,Ki,nM,1.3,0.0013000000000000002,2.886056647693163,"1zli.pdf (75-mer) Tick carboxypeptidase inhibitor, Ki=1.3+/-0.2nM"
1y33,1.80,2005,Ki=1.7nM,Ki,nM,1.7,0.0017,2.769551078621726,1y33.pdf (64-mer) protein-protein
1y48,1.84,2005,Ki=1.7nM,Ki,nM,1.7,0.0017,2.769551078621726,1y48.pdf (64-mer) protein-protein
1wpx,2.70,2005,Ki=1.80nM,Ki,nM,1.80,0.0018000000000000002,2.744727494896694,"1wpx.pdf (220-mer) carboxypeptidase Y complexed with cognate proteinase, Ki=1.80nM"
1zr0,1.80,2005,Ki=13nM,Ki,nM,13,0.013000000000000001,1.8860566476931633,"1zr0.pdf (63-mer) Tissue Factor Pathway Inhibitor-2 with Bovine Trypsin, Ki=13nM"
2bo9,1.60,2005,Ki=3nM,Ki,nM,3,0.003,2.5228787452803374,"2bo9.pdf (222-mer) HUMAN CARBOXYPEPTIDASE A4 IN COMPLEX WITH HUMAN LATEXIN, ki=3+/-0.3nM"
2hev,2.41,2006,IC50=62nM,IC50,nM,62,0.062,1.207608310501746,"2hev.pdf (137-mer) complex between human OX40L(N90D, N114D) and OX40, IC50=62+/-2nM"
2gng,1.87,2006,IC50=6uM,IC50,uM,6,6.0,-0.7781512503836436,"2gng.pdf (20-mer) 2gng is just PKAR5 mutant, IC50 for Y-27632 is 6+/-0uM"
2cmr,2.00,2006,Kd=0.05nM,Kd,nM,0.05,5e-05,4.301029995663981,"2cmr.pdf (208-mer) HIV-1 NEUTRALIZING ANTIBODY D5 FAB BOUND TO THE GP41 INNER-CORE MIMETIC 5-HELIX, Kd=0.05nM"
2gww,2.72,2006,Kd=0.11nM,Kd,nM,0.11,0.00011,3.958607314841775,"2gww.pdf (30-mer) Vh1 IpaA-VBS complex, Kd=0.11nM"
2nyy,2.61,2006,Kd=0.125nM,Kd,nM,0.125,0.000125,3.9030899869919438,"2nyy.pdf (218-mer) BoNT A complexed with monoclonal antibody CR1, Kd=0.125nM"
2a6i,2.50,2006,Kd=0.12uM,Kd,uM,0.12,0.12,0.9208187539523752,"2a6d.pdf (214-mer) germline antibody 36-65 complex with dodecapeptide KLASIPTHTSPL, Kd=0.12uM"
2nz9,3.79,2006,Kd=0.136nM,Kd,nM,0.136,0.00013600000000000003,3.8664610916297826,"2nyy.pdf (218-mer) BoNT A complexed with monoclonal antibody AR2, Kd=0.136nM"
2a6d,2.90,2006,Kd=0.15uM,Kd,uM,0.15,0.15,0.8239087409443188,"2a6d.pdf (214-mer) germline antibody 36-65 complex with dodecapeptide RLLIADPPSPRE, Kd=0.15uM"
1zvy,1.63,2006,Kd=0.1nM,Kd,nM,0.1,0.0001,4.0,"1zv5.pdf (136-mer) VHH D3-L11 in complex with hen egg white lysozyme, Kd>0.1nM"
2cjs,1.78,2006,Kd=0.1uM,Kd,uM,0.1,0.1,1.0,"2cjs.pdf (62-mer) Munc13-1 3-150(K32E) and Rim2a 82-142 complex, apparent Kd=0.10uM"
2a6k,3.00,2006,Kd=0.21uM,Kd,uM,0.21,0.21,0.6777807052660807,"2a6d.pdf (214-mer) germline antibody 36-65 complex with dodecapeptide SLGDNLTNHNLR, Kd=0.21uM"
2d1k,2.50,2006,Kd=0.23uM,Kd,uM,0.23,0.23,0.638272163982407,2d1k.pdf (32-mer) Dnase I is necessary to prevent actin polymerization during crystallization
2f6a,3.29,2006,Kd=0.2uM,Kd,uM,0.2,0.2,0.6989700043360187,"2f6a.pdf (30-mer) CNA31-344 and collagen peptide complex, Kd=0.2+/-0.02uM"
2dx5,3.35,2006,Kd=0.33mM,Kd,mM,0.33,330.0,-2.5185139398778875,"2dx5.pdf (76-mer) ligand is Ubiquitin, Kd=0.33+/-0.02mM"
2gl7,2.60,2006,Kd=0.459uM,Kd,uM,0.459,0.459,0.33818731446273875,2gl7.pdf (550-mer) Kd( beta -catenin(Y142E)-BCL9)=0.459+/-0.053uM
2b7c,1.80,2006,Kd=0.4uM,Kd,uM,0.4,0.4,0.3979400086720376,"2b7c.pdf (94-mer) elongation factor-1 beta K1205A mutant in complex with eEF1A, Kd=0.4+/-0.1uM"
2hfg,2.61,2006,Kd=0.6nM,Kd,nM,0.6,0.0006,3.2218487496163566,"2hfg.pdf (214-mer) hBR3 bound to CB3s-Fab, Kd=0.6nM"
2f5z,2.18,2006,Kd=0.78nM,Kd,nM,0.78,0.0007800000000000001,3.1079053973095196,"2f5z.pdf (64-mer) E3-Binding Domain/E3 Complex, Kd=7.8 E-10 M"
2fu5,2.00,2006,Kd=0.7nM,Kd,nM,0.7,0.0007,3.154901959985743,"2fu5.pdf (183-mer) MSS4 and Rab8 GTPase complex, Kd=0.7nM"
2ixq,NMR,2006,Kd=0.7uM,Kd,uM,0.7,0.7,0.1549019599857432,"2ixq.pdf (143-mer) ligand is AFIMBRIAL ADHESIN AFA-III(AfaE), Kd=0.72+/-0.2uM"
1yk0,2.40,2006,Kd=0.96nM,Kd,nM,0.96,0.00096,3.0177287669604316,"1yk0.pdf (21-mer) atrial natriuretic peptide (ANP), NPR-C and ANP complex, Kd=0.96nM"
2f9z,2.40,2006,Kd=0.9uM,Kd,uM,0.9,0.9,0.045757490560675115,"2f9z.pdf (205-mer) Complex between chemotaxis deamidase CheD and chemotaxis phosphatase CheC, Kd=0.9-1.4uM"
2b42,2.50,2006,Kd=1.07nM,Kd,nM,1.07,0.00107,2.9706162223147903,"2b42.pdf (381-mer) Xylanase inhibitor, 1.07 x 10-9M"
2j1k,2.30,2006,Kd=1.1nM,Kd,nM,1.1,0.0011,2.958607314841775,"2j1k.pdf (128-mer) CAV-2 FIBRE HEAD IN COMPLEX WITH Coxsackievirus and adenovirus receptor, CAR D1, Kd=1.1nM"
2g2u,1.60,2006,Kd=1.25uM,Kd,uM,1.25,1.25,-0.09691001300805642,"2g2u.pdf (165-mer) SHV-1 Beta-lactamase/inhibitor protein (BLIP) complex, Kd=1252+/-52nM"
2i32,2.70,2006,Kd=1.3uM,Kd,uM,1.3,1.3,-0.11394335230683679,"2i32.pdf (182-mer) the ASF1a N-terminal core domain (1-157) with Human HIRA, Kd=1.3uM"
2fjg,2.80,2006,Kd=1.5nM,Kd,nM,1.5,0.0015,2.8239087409443187,"2fjg.pdf (214-mer) G6 Fab, in complex with human VEGF, Kd=1.5nM"
2d10,2.50,2006,Kd=1.7nM,Kd,nM,1.7,0.0017,2.769551078621726,"2d10.pdf (28-mer) NHERF-1 Peptides with Radixin FERM Domain, Kd=1.69+/-0.4nM"
2b2x,2.20,2006,Kd=1.9nM,Kd,nM,1.9,0.0019,2.721246399047171,"2b2x.pdf (213-mer) VLA1 RdeltaH I-domain complex with H:T50V, K64E, L:S28Q, N52Y mutant Antibody AQC2 Fab; Kd=1.9nM"
2iy0,2.77,2006,Kd=10.7nM,Kd,nM,10.7,0.0107,1.9706162223147903,"2iy0.pdf (156-mer) SENP1 (C603A)) and SUMO1 RANGAP complex, Kd=10.7+/-3.12nM"
2b87,NMR,2006,Kd=100nM,Kd,nM,100,0.1,1.0,"2b87.pdf (58-mer) ZTaq:anti-ZTaq Affibody:Affibody Complex, Kd=100nM"
2f31,2.10,2006,Kd=102nM,Kd,nM,102,0.10200000000000001,0.9913998282380824,"2f31.pdf (20-mer) ligand is FH2+DAD protein segment; DID-DAD complex, GST-DAD Kd=240nM, FH2+DAD Kd=102nM"
2hth,2.70,2006,Kd=105uM,Kd,uM,105,105.0,-2.0211892990699383,"2hth.pdf (76-mer) ubiquitin complex with human EAP45/ESCRT-II GLUE domain, Kd=105uM"
2c0l,2.30,2006,Kd=109nM,Kd,nM,109,0.109,0.9625735020593764,"2c0l.pdf (122-mer) TPR DOMAIN OF HUMAN PEX5P IN COMPLEX WITH HUMAN MSCP2, Kd=109+/-34nM"
1zv5,2.00,2006,Kd=10nM,Kd,nM,10,0.01,2.0,"1zv5.pdf (130-mer) antibody D2-L29 complex with hen egg white lysozyme, Kd=10nM"
2erj,3.00,2006,Kd=10pM,Kd,pM,10,9.999999999999999e-06,5.0,"2erj.pdf (133-mer) Interleukin-2(C125A) and IL2 receptor alpha beta gamma chain, Kd=10pM"
2aq2,1.80,2006,Kd=11nM,Kd,nM,11,0.011,1.958607314841775,"2aq1.pdf (112-mer) TCR V beta A52V/S54N/K66E and SEC3-1D3 complex, Kd=1.1 E-8 M"
2fjh,3.10,2006,Kd=12nM,Kd,nM,12,0.012,1.9208187539523751,"2fjg.pdf (214-mer) B20-4 Fab, in complex with human VEGF, Kd=12nM"
2fdb,2.28,2006,Kd=155nM,Kd,nM,155,0.155,0.8096683018297085,"2fdb.pdf (164-mer) Fibroblast growth factor 8b complex with FGF Receptor (FGFR)2c, Kd=1.55 E-7 M"
2ftm,1.65,2006,Kd=16pM,Kd,pM,16,1.6e-05,4.795880017344075,"2ftl.pdf (58-mer) trypsin complexed with Y35G BPTI at 100K, Kd=1.6 E-11M"
2den,NMR,2006,Kd=17uM,Kd,uM,17,17.0,-1.2304489213782739,"2den.pdf (76-mer) BMSC-UbP UBA domain Complex with Ubiquitin, Kd=17uM"
1yrt,2.10,2006,Kd=1nM,Kd,nM,1,0.001,3.0,"1yrt.pdf (74-mer) wild type CyaA-ACD and C-CaM complex without exogenous CaCl2, Kd=1nM"
2i5y,2.20,2006,Kd=2.7nM,Kd,nM,2.7,0.0027,2.5686362358410126,"2i5y.pdf (214-mer) ternary complexes of CD4M47 with HIV-1 gp120 and the 17b antibody, Kd=2.71+/-0.65nM"
2g45,1.99,2006,Kd=2.82uM,Kd,uM,2.82,2.82,-0.45024910831936105,"2g45.pdf (76-mer) znf ubp domain in complex with ubiquitin, Kd=2.82+/-0.09uM"
2fyl,NMR,2006,Kd=2.8uM,Kd,uM,2.8,2.8,-0.4471580313422192,"2fyl.pdf (81-mer) CR56 and receptor-associated protein domain 1, RAPd1 complex, Kd=2.8uM"
2hd5,1.85,2006,Kd=2.8uM,Kd,uM,2.8,2.8,-0.4471580313422192,"2hd5.pdf (76-mer) USP2 in complex with ubiquitin, ki=2.8+/-0.14uM"
2dd8,2.30,2006,Kd=20nM,Kd,nM,20,0.02,1.6989700043360187,"2dd8.pdf (213-mer) SARS-CoV Complex with Fab m396, Kd=20nM"
2j12,1.50,2006,Kd=20nM,Kd,nM,20,0.02,1.6989700043360187,"2j12.pdf (194-mer) AD37 FIBRE HEAD IN COMPLEX WITH CAR D1, Kd=20nM"
2hwn,1.60,2006,Kd=2nM,Kd,nM,2,0.002,2.6989700043360187,"2hwn.pdf (22-mer) RII alpha D/D domain and helical motif from d-AKAP2, typically Kd=2nM in 1-5nM"
2few,NMR,2006,Kd=3.7mM,Kd,mM,3.7,3700.0,-3.568201724066995,"2few.pdf (101-mer) IIAMtl(H554Q) and Phospho-IIBMtl(C384SEP), Kd=3.7+/-0.2mM"
2fuh,NMR,2006,Kd=300uM,Kd,uM,300,300.0,-2.4771212547196626,"2fuh.pdf (76-mer) UbcH5c/Ubiquitin Non-covalent Complex, Kd=300uM"
2a24,NMR,2006,Kd=30uM,Kd,uM,30,30.0,-1.4771212547196624,"2a24.pdf (107-mer) HIF-2a/ARNT PAS-B Heterodimer, similar Kd=30uM"
2dsr,2.10,2006,Kd=317nM,Kd,nM,317,0.317,0.4989407377822485,"2dsp.pdf (82-mer) ternary complex of N- and C-terminal domain fragments of IGFBP4 and IGF1, Kd=317+/-19nM"
2dsp,2.50,2006,Kd=3uM,Kd,uM,3,3.0,-0.47712125471966244,"2dsp.pdf (92-mer) binary complex of the N-terminal domains of IGFBP4 and IGF1, Kd=3020+/-410nM"
2bdn,2.53,2006,Kd=4.6pM,Kd,pM,4.6,4.599999999999999e-06,5.337242168318426,"2bdn.pdf (214-mer) human MCP-1 bound to a blocking antibody, 11K2, Kd=4.6pM"
2aze,2.55,2006,Kd=4.9uM,Kd,uM,4.9,4.9,-0.6901960800285137,"2aze.pdf (106-mer) ligand is Transcription factor E2F1CM-DP1CM heterodimer, Kd=4.9+/-3uM"
2hle,2.05,2006,Kd=40nM,Kd,nM,40,0.04,1.3979400086720375,"2hle.pdf (138-mer) EphB4 in complex with the extracellular domain of ephrinB2, Kd=40+/-20nM"
2djy,NMR,2006,Kd=40uM,Kd,uM,40,40.0,-1.6020599913279623,"2djy.pdf (20-mer) The Smurf2 WW3 Domain Binds to the Smad7 PY Motif, Ka=40+/-0.1uM, not Kd"
2h4m,3.05,2006,Kd=42nM,Kd,nM,42,0.042,1.3767507096020994,"2h4m.pdf (865-mer) Kap beta2-Transportin-M9NLS, ITC Kd=42+/-2nM, fluorescence titration Kd=2nM"
2arp,2.00,2006,Kd=430nM,Kd,nM,430,0.43,0.36653154442041347,"2arp.pdf (152-mer) Activin A in complex with Fs12 fragment of follistatin, Kd=430nM"
1yk1,2.90,2006,Kd=45.7nM,Kd,nM,45.7,0.045700000000000005,1.3400837999301498,"1yk0.pdf (21-mer) brain natriuretic peptide (BNP), NPR-C and BNP complex, Kd=45.7nM"
2fju,2.20,2006,Kd=5.3uM,Kd,uM,5.3,5.3,-0.724275869600789,2fju.pdf (799-mer) Activated Rac1 bound to its effector phospholipase C beta 2
2aq1,2.10,2006,Kd=5.5nM,Kd,nM,5.5,0.0055,2.2596373105057563,"2aq1.pdf (112-mer) TCR V beta H72Q-r and SEC3-1A4 complex, Kd=5.5 E-9 M"
2dsq,2.80,2006,Kd=544nM,Kd,nM,544,0.544,0.26440110030182007,"2dsp.pdf (92-mer) hybrid ternary complex using the C-terminal domain fragment of IGFBP1 instead of IGFBP4, Kd=544+/-45nM"
2g2w,1.80,2006,Kd=582nM,Kd,nM,582,0.582,0.23507701535011155,"2g2u.pdf (165-mer) SHV D104K Beta-lactamase/inhibitor protein (BLIP) complex, Kd=582+/-42nM"
2es4,1.85,2006,Kd=5nM,Kd,nM,5,0.005,2.3010299956639813,"2es4.pdf (319-mer) Lif-cognate lipase LipA complex, Kd=5nM"
2h9g,2.32,2006,Kd=5nM,Kd,nM,5,0.005,2.3010299956639813,"2h9g.pdf (130-mer) Fab-BDF1:hDR5 complex, Kd=5+/-1nM"
2i60,2.40,2006,Kd=6.24nM,Kd,nM,6.24,0.006240000000000001,2.204815410317576,"2i5y.pdf (214-mer) ternary complexes of [Phe23]M47 with HIV-1 gp120 and the 17b antibody, Kd=6.24+/-0.1nM"
2c7m,2.40,2006,Kd=6.4uM,Kd,uM,6.4,6.4,-0.8061799739838872,"2c7m.pdf (76-mer) RUZ-MIU:ubiquitin complex, crystal form I Kd=6.4uM"
2c7n,2.10,2006,Kd=6.4uM,Kd,uM,6.4,6.4,-0.8061799739838872,"2c7m.pdf (76-mer) RUZ-MIU:ubiquitin complex, crystal form II Kd=6.4uM"
2hsq,3.97,2006,Kd=6.61nM,Kd,nM,6.61,0.00661,2.17979854051436,"2gww.pdf (23-mer) Vh1 IpaA-VBS2 complex, Kd=6.61nM"
2ftl,1.62,2006,Kd=60fM,Kd,fM,60,6.000000000000001e-08,7.221848749616356,"2ftl.pdf (58-mer) trypsin complexed with wt BPTI at 100K, Kd=6 E-14M"
2f4m,1.85,2006,Kd=65nM,Kd,nM,65,0.065,1.1870866433571443,"2f4m.pdf (61-mer) Mouse PNGase core and HR23B-XPCB domain Complex, Kd=65nM"
2aq3,2.30,2006,Kd=7.6uM,Kd,uM,7.6,7.6,-0.8808135922807914,"2aq1.pdf (112-mer) TCR V beta-SEC3 complex, Kd=7.6 E-6 M"
1zvh,1.50,2006,Kd=70nM,Kd,nM,70,0.07,1.154901959985743,"1zv5.pdf (134-mer) VHH domain D2-L24 in complex with hen egg white lysozyme, Kd=70nM"
2iy1,2.46,2006,Kd=787nM,Kd,nM,787,0.787,0.10402526764093542,"2iy0.pdf (83-mer) SENP1 (MUTANT) with FULL LENGTH SUMO1, Kd=787+/-90.4nM"
2bwe,3.10,2006,Kd=80uM,Kd,uM,80,80.0,-1.9030899869919435,"2bwe.pdf (77-mer) The yeast protein Dsk2 UBA-UBL domain complex, Kd=80+/-15uM"
2a9h,NMR,2006,Kd=900nM,Kd,nM,900,0.9,0.045757490560675115,"2a9h.pdf (37-mer) potassium channel KcsA(mutant) / charybdotoxin complex, Kd=900nM. protein mutation:Q58A, T61S, R64D, F103Y, T107F, L110V"
2gh0,1.92,2006,Kd=90nM,Kd,nM,90,0.09,1.0457574905606752,"2gh0.pdf (101-mer) artemin, ARTN-GFR alpha3 complex, Kd=90nM"
1zgu,NMR,2006,Kd=98uM,Kd,uM,98,98.0,-1.9912260756924949,"1zgu.pdf (76-mer) human Mms2-Ubiquitin(K48R) complex, Kd=98+/-15uM"
2hrk,2.05,2006,Kd=9nM,Kd,nM,9,0.009000000000000001,2.0457574905606752,2hrk.pdf (122-mer) Kd for Arc1p and full-length GluRS; structure is GluRS-N(1-207) and Arc1p-N(1-222)
2g9h,2.00,2006,Kd~0.1uM,Kd,uM,0.1,0.1,1.0,"2g9h.pdf (218-mer) Staphylococcal Enterotoxin I Complex with a Human MHC class II Molecule(+peptide from HA), Zn2+ dependent, Kd~1E-7M"
2j7p,1.97,2006,Kd~10nM,Kd,nM,10,0.01,2.0,2j7p.pdf (283-mer) GMPPNP-mediated assembly of the T. aquaticus Ffh NG:FtsY NGd20 heterodimer
2j0t,2.54,2006,Ki=0.4nM,Ki,nM,0.4,0.0004,3.3979400086720375,"2j0t.pdf (126-mer) INHIBITORY DOMAIN OF TIMP-1 and MMP-1cd complex, Ki=0.4nM"
2abz,2.16,2006,Ki=2.8nM,Ki,nM,2.8,0.0028,2.5528419686577806,"2abz.pdf (67-mer) C19A/C43A LCI (Metallocarboxypeptidase inhibitor) in complex with bovine carboxypeptidase A, Ki=2.8+/-0.3nM"
2o3b,2.30,2006,Ki=3.2pM,Ki,pM,3.2,3.2e-06,5.494850021680094,"2o3b.pdf (136-mer) NucA and intra-cellular inhibitor NuiA complex, Ki=3.2+/-1.9 E-12 M"
1yvb,2.70,2006,Ki=6.5nM,Ki,nM,6.5,0.006500000000000001,2.1870866433571443,"1yvb.pdf (111-mer) Cystatin, Ki=6.5 x 10-9M"
2j8x,2.30,2006,Ki=8nM,Ki,nM,8,0.008,2.0969100130080562,"2j8x.pdf (84-mer) wt EBV UNG(delta24) and URACIL-DNA GLYCOSYLASE INHIBITOR complex, Ki=8nM"
2jby,2.41,2007,IC50=50nM,IC50,nM,50,0.05,1.3010299956639813,"2jby.pdf (26-mer) M11L:Bak BH3 domain, IC50=50nM"
2p5e,1.89,2007,Kd=0.048nM,Kd,nM,0.048,4.8e-05,4.318758762624412,2p5e.pdf (100-mer) human T-cell receptors bound to peptide MHC complex
2omy,1.70,2007,Kd=0.2uM,Kd,uM,0.2,0.2,0.6989700043360187,"2omv.pdf (105-mer) InlA S192N and N-terminal domain of human E-cadherin, hEC1 complex, InlA Kd=0.2+/-0.05uM"
2uzi,2.00,2007,Kd=0.35nM,Kd,nM,0.35,0.00035,3.4559319556497243,2uzi.pdf (166-mer) ligand is GTPASE HRAS(G12V) mutant; Kd=6.2nM(for ANTI-RAS FV VH#6 with HRAS)
2qxv,1.82,2007,Kd=0.38uM,Kd,uM,0.38,0.38,0.42021640338318983,"2qxv.pdf (30-mer) Enhancer of zeste homolog 2 recognition by EED, Kd=0.38uM"
2oin,2.50,2007,Kd=0.51uM,Kd,uM,0.51,0.51,0.2924298239020636,"2oin.pdf (21-mer) NS4A co-factor peptide, enzymatic IC50=0.51+/-0.23uM, Replicon IC50=3.6+/-0.3uM"
2odg,NMR,2007,Kd=0.59uM,Kd,uM,0.59,0.59,0.22914798835785583,"2odg.pdf (89-mer) Complex of barrier-to-autointegration factor(BAF) dimer and emerin-LEM domain, Kd=0.59+/-0.03uM"
2j4w,2.50,2007,Kd=0.6nM,Kd,nM,0.6,0.0006,3.2218487496163566,"2j4w.pdf (213-mer) PLASMODIUM VIVAX APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX, Kd=0.6nM"
2omu,1.80,2007,Kd=0.6nM,Kd,nM,0.6,0.0006,3.2218487496163566,"2omt.pdf (462-mer) Internalin-A G194S+S Y369S-HEC1 COMPLEX, Kd=0.6+/-0.2nM"
2r0k,3.51,2007,Kd=0.6nM,Kd,nM,0.6,0.0006,3.2218487496163566,"2r0k.pdf (214-mer) inhibitor antibody Fab58:HGFA complex, Kd=0.6+/-0.1nM"
2j6e,3.00,2007,Kd=0.6uM,Kd,uM,0.6,0.6,0.2218487496163564,"2j6e.pdf (232-mer) RF61 Fab-IgG1 Fc complex, Kd=6 X 10-7M"
2oje,3.00,2007,Kd=0.6uM,Kd,uM,0.6,0.6,0.2218487496163564,"2oje.pdf (214-mer) MAM/HLA-DR1/HA complex, Kd=0.6uM"
2o98,2.70,2007,Kd=0.85nM,Kd,nM,0.85,0.00085,3.070581074285707,"2o98.pdf (242-mer) ligand is T14-3cDeltaC, 1 uM FC in presence, CT52 YDI, Kd=0.85nM, YTV Kd=41nM"
2gox,2.20,2007,Kd=0.8nM,Kd,nM,0.8,0.0008,3.0969100130080562,"2gox.pdf (297-mer) ligand is Complement C3-inhibitory domain, Kd(Efb-C/C3dg)=0.8+/-0.1nM"
2i9b,2.80,2007,Kd=0.96nM,Kd,nM,0.96,0.00096,3.0177287669604316,2i9b.pdf (145-mer) ligand is Urokinase plasminogen activator
2ifg,3.40,2007,Kd=0.9nM,Kd,nM,0.9,0.0009000000000000001,3.0457574905606752,"2ifg.pdf (120-mer) Beta-nerve growth factor and receptor complex, Kd(TrkA-NGF)=0.9+/-0.3nM"
2nyz,2.60,2007,Kd=0.9nM,Kd,nM,0.9,0.0009000000000000001,3.0457574905606752,"2nyz.pdf (93-mer) ligand is C-Chemokine XCL1, NaCl 0.2M, Kd=0.9+/-0.2nM"
2pkg,3.30,2007,Kd=1.06uM,Kd,uM,1.06,1.06,-0.02530586526477026,"2pkg.pdf (88-mer) binding between phosphatase 2A and the small t core domain, Kd=1.06+/-0.09uM, Kd(full-length ST/A subunit of PP2A)=2.14+/-0.08uM"
2i25,1.80,2007,Kd=1.0nM,Kd,nM,1.0,0.001,3.0,"2i25.pdf (129-mer) PBLA8 variable domain in complex with lysozyme, Kd=1.0nM"
2qej,3.20,2007,Kd=1.1nM,Kd,nM,1.1,0.0011,2.958607314841775,"2qej.pdf (201-mer) Staphylococcus aureus protein (SSL7) in complex with Fc of human IgA1, Kd=0.0011 E-6 M"
2omv,1.90,2007,Kd=1.2nM,Kd,nM,1.2,0.0012,2.9208187539523753,"2omv.pdf (105-mer) InlA S192N Y369S and N-terminal domain of human E-cadherin, hEC1 complex, InlAm Kd=1.2+/-0.3nM"
2pon,NMR,2007,Kd=1.4uM,Kd,uM,1.4,1.4,-0.146128035678238,"2pon.pdf (23-mer) ligand is Beclin-1, Kd=1.4uM"
2ot3,2.10,2007,Kd=1.8uM,Kd,uM,1.8,1.8,-0.25527250510330607,"2ot3.pdf (170-mer) rabex-5 VPS9 domain in complex with nucleotide free RAB21, Kd=1.8uM"
2pms,2.91,2007,Kd=10.3nM,Kd,nM,10.3,0.0103,1.9871627752948278,"2pms.pdf (125-mer) human lactoferrin N-lobe and PSPA complex, Kd=10.3+/-3.2nM"
2ju0,NMR,2007,Kd=100nM,Kd,nM,100,0.1,1.0,"2ju0.pdf (52-mer) Frq1 with Phosphatidylinositol 4-kinase PIK1 Residues(121-174), Kd~100nM"
2omt,2.00,2007,Kd=100nM,Kd,nM,100,0.1,1.0,"2omt.pdf (462-mer) Internalin-A G194S+S-HEC1 COMPLEX, Kd=100+/-30nM"
2q7n,4.00,2007,Kd=10pM,Kd,pM,10,9.999999999999999e-06,5.0,"2q7n.pdf (180-mer) human Leukemia inhibitory factor binds to mLIFR, Kd=10-46pM, Kd(mLIF:mLIFR)1-4nM, Kd(hLIF:hLIFR)=300-900pM"
2qc1,1.94,2007,Kd=10pM,Kd,pM,10,9.999999999999999e-06,5.0,"2qc1.pdf (74-mer) alpha-bungarotoxin, Endo-H not treated Kd=1.02 X10-11M, treated Kd=7.3 X10-9M"
2nup,2.80,2007,Kd=10uM,Kd,uM,10,10.0,-1.0,"2nup.pdf (196-mer) human Sec23a/24a heterodimer with the SNARE protein Sec22b, about Kd=10-50uM, Crystal I"
2nut,2.30,2007,Kd=10uM,Kd,uM,10,10.0,-1.0,"2nup.pdf (196-mer) human Sec23a/24a heterodimer with the SNARE protein Sec22b, about Kd=10-50uM, Crystal II"
2omw,1.85,2007,Kd=10uM,Kd,uM,10,10.0,-1.0,"2omv.pdf (105-mer) InlA S192N Y369S and N-terminal domain of murine E-cadherin, mEC1 complex, InlAm Kd=10+/-2uM"
2qiy,1.69,2007,Kd=119nM,Kd,nM,119,0.11900000000000001,0.9244530386074692,"2qiy.pdf (48-mer) BRE5 with Ubiquitin carboxyl-terminal hydrolase 3, UBP3, Kd=119nM"
2omx,1.70,2007,Kd=120nM,Kd,nM,120,0.12,0.9208187539523752,"2omt.pdf (462-mer) Internalin-A S192N G194S+S and HEC1 COMPLEX, Kd=120+/-40nM"
2noj,2.70,2007,Kd=13nM,Kd,nM,13,0.013000000000000001,1.8860566476931633,"2noj.pdf (297-mer) Ehp / C3d complex, Kd=13nM"
2rf9,3.50,2007,Kd=13uM,Kd,uM,13,13.0,-1.1139433523068367,"2rf9.pdf (65-mer) complex between the EGFR kinase domain and a Mig6 peptide, Kd=13+/-1.3uM"
2r0l,2.20,2007,Kd=14.6nM,Kd,nM,14.6,0.0146,1.8356471442155629,"2r0k.pdf (214-mer) inhibitor antibody Fab75:HGFA complex, Kd=14.6+/-1.5nM"
2q0o,2.00,2007,Kd=14.9nM,Kd,nM,14.9,0.0149,1.826813731587726,"2q0o.pdf (107-mer) ligand is Probable transcriptional repressor traM (chain C, D)"
2h64,1.92,2007,Kd=140nM,Kd,nM,140,0.14,0.8538719643217619,"2h62.pdf (129-mer) ligand is BMPR-IA/ActR-IIB, Kd(BMP-2(L100K/N102D)/BMPR-IA)=22uM, Kd(BMP-2(L100K/N102D)/ActR-IIB)=140nM"
2r9p,1.40,2007,Kd=14uM,Kd,uM,14,14.0,-1.146128035678238,"2r9p.pdf (58-mer) Mesotrypsin and bovine pancreatic trypsin inhibitor(BPTI), Kd=1.4 X10-5M"
2jcc,2.50,2007,Kd=15.4uM,Kd,uM,15.4,15.4,-1.187520720836463,"2j8u.pdf (100-mer) TCR-pMHC complex; W167A mutant protein; Kd(equilibrium)=15.4uM, Kd(kinetic)=14.8uM"
2oor,2.32,2007,Kd=15.5nM,Kd,nM,15.5,0.0155,1.8096683018297086,2oor.pdf (174-mer) transhydrogenase (dI.NAD+)2(dIII.H2NADPH)1 asymmetric complex    mean value=15.5nM
2phe,NMR,2007,Kd=15uM,Kd,uM,15,15.0,-1.1760912590556813,"2phe.pdf (66-mer) ligand is human transcriptional coactivator positive cofactor 4 (PC4); full length VP16 Kd=0.7+/-0.2uM, activation domain Kd=15+/-6uM"
2rmk,NMR,2007,Kd=170nM,Kd,nM,170,0.17,0.769551078621726,2rmk.pdf (192-mer) Rac1 binding to the HR1a and HR1b domains  Kd~70-170nM
2ij0,2.25,2007,Kd=180pM,Kd,pM,180,0.00017999999999999998,3.744727494896694,"2ij0.pdf (118-mer) TSST-1 with penultimate affinity-matured variant of hVbeta 2.1, D10, Kd=180pM"
2p4a,1.90,2007,Kd=180pM,Kd,pM,180,0.00017999999999999998,3.744727494896694,"2p49.pdf (121-mer) a camelid affinity matured single-domain vhh antibody fragment, affinity mature Kd=180+/-18pM"
2jgz,2.90,2007,Kd=1mM,Kd,mM,1,1000.0,-3.0,"2jgz.pdf (260-mer) PHOSPHO-CDK2 IN COMPLEX WITH CYCLIN B, Kd>1mM"
2p5t,3.20,2007,Kd=1nM,Kd,nM,1,0.001,3.0,"2p5t.pdf (253-mer) ligand is fragment of PezA helix-turn-helix motif complex with PezT, Kd<1nM"
2v2w,1.60,2007,Kd=2.2uM,Kd,uM,2.2,2.2,-0.3424226808222063,2v2w.pdf (100-mer) TCR-pMHC complex
2p1l,2.50,2007,Kd=2.3uM,Kd,uM,2.3,2.3,-0.36172783601759284,"2p1l.pdf (31-mer) Bcl-XL:wild type Beclin 1 complex, Kd=2.3uM"
2oza,2.70,2007,Kd=2.5nM,Kd,nM,2.5,0.0025,2.6020599913279625,"2oza.pdf (356-mer) p38alpha MAPK and MAPK-activated protein kinase 2 (MK2), Kd=2.5nM, recent data Kd=0.5nM"
2h62,1.85,2007,Kd=2.7uM,Kd,uM,2.7,2.7,-0.43136376415898736,"2h62.pdf (129-mer) ligand is BMPR-IA/ActR-IIB, Kd(BMP-2/ActR-IIB)=2.7uM, Kd(BMP-2/BMPR-IA)=24uM"
2i3t,2.80,2007,Kd=2.7uM,Kd,uM,2.7,2.7,-0.43136376415898736,"2i3s.pdf (54-mer) Bub3 complex with Mad3 (BubR1) GLEBS motif, Kd=2.7uM"
2ot8,3.10,2007,Kd=20nM,Kd,nM,20,0.02,1.6989700043360187,"2ot8.pdf (30-mer) human Kapb2 bound to the bPY-NLS of human hnRNP M2, 6-8, Kd=20nM"
2ra3,1.46,2007,Kd=20pM,Kd,pM,20,1.9999999999999998e-05,4.698970004336019,"2r9p.pdf (58-mer) Cationic trypsin and bovine pancreatic trypsin inhibitor(BPTI), Kd=2.0 X10-11M"
2v8s,2.22,2007,Kd=22uM,Kd,uM,22,22.0,-1.3424226808222062,"2v8s.pdf (147-mer) Vti1b / human clathrin adaptor epsinR (EPNR) complex, Kd=22+/-3uM, n=6 (ITC)"
2p49,1.38,2007,Kd=23nM,Kd,nM,23,0.023,1.6382721639824072,"2p49.pdf (123-mer) ligand is camelid single-domain vhh antibody fragment, Kd=23+/-3nM"
2hqs,1.50,2007,Kd=27nM,Kd,nM,27,0.027,1.5686362358410126,"2hqs.pdf (118-mer) TolB and Peptidoglycan-associated lipoprotein (Pal) complex, Kd=27nM(PH7.5)"
2j8s,2.54,2007,Kd=28nM,Kd,nM,28,0.028,1.5528419686577808,"2j8s.pdf (169-mer) DARPIN inhibitor 1108_19, protein-protein complex"
2v6x,1.98,2007,Kd=28uM,Kd,uM,28,28.0,-1.4471580313422192,"2v6x.pdf (54-mer) yeast Vps2 and Vps4 MIT-domain, Kd=28uM"
2yvj,1.90,2007,Kd=294uM,Kd,uM,294,294.0,-2.4683473304121573,"2e4p.pdf (109-mer) ligand is Biphenyl dioxygenase ferredoxin subunit, aerobic condition; Kd=14.6uM at reducing condition"
2hqw,1.90,2007,Kd=2nM,Kd,nM,2,0.002,2.6989700043360187,"2hqw.pdf (24-mer) ligand is NR1C1 (peptide spanning 875-898), titrations Kd=2.0+/-0.1nM"
2iou,3.16,2007,Kd=3.47uM,Kd,uM,3.47,3.47,-0.5403294747908738,"2iou.pdf (535-mer) Mtd-P1 and Pertactin Extracellular Domain, Kd=3.47+/-0.13uM"
2i3s,1.90,2007,Kd=3.6uM,Kd,uM,3.6,3.6,-0.5563025007672873,"2i3s.pdf (36-mer) Bub3 complex with Bub1 GLEBS motif, Kd=3.6uM"
2iyb,2.35,2007,Kd=3.6uM,Kd,uM,3.6,3.6,-0.5563025007672873,"2iyb.pdf (114-mer) Lim3 and EVH1 domain of MENA, Kd=3.6+/-0.4uM"
2jix,3.20,2007,Kd=30nM,Kd,nM,30,0.03,1.5228787452803376,"2jix.pdf (225-mer) ligand is Erythropoietin receptor EPOR, unpublished Biacore Kd=30nM"
2psm,2.19,2007,Kd=30pM,Kd,pM,30,2.9999999999999997e-05,4.522878745280337,2psm.pdf (78-mer) ligand is Interleukin-15 receptor alpha chain; Kd=30-100pM
2j8u,2.88,2007,Kd=31.8uM,Kd,uM,31.8,31.8,-1.5024271199844328,"2j8u.pdf (100-mer) TCR-pMHC complex; K66A mutant protein; Kd(equilibrium)=31.8uM, Kd(kinetic)=34.0uM"
2iwg,2.35,2007,Kd=37nM,Kd,nM,37,0.037,1.431798275933005,2iwg.pdf (181-mer) COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC
2z3q,1.85,2007,Kd=38pM,Kd,pM,38,3.7999999999999995e-05,4.42021640338319,"2z3q.pdf (119-mer) IL-15/IL-15Ra complex, native 1 Kd=38pM"
2z3r,2.00,2007,Kd=38pM,Kd,pM,38,3.7999999999999995e-05,4.42021640338319,"2z3q.pdf (119-mer) Interleukin-15/IL-15Ra complex, native 2 Kd=38pM"
2vda,NMR,2007,Kd=3uM,Kd,uM,3,3.0,-0.47712125471966244,"2vda.pdf (28-mer) ligand is signal peptide KRR-LamB, Kd=3uM"
2pop,3.10,2007,Kd=4.2uM,Kd,uM,4.2,4.2,-0.6232492903979004,"2pop.pdf (95-mer) TAB1D and BIR1 complex, Kd=4.2+/-0.2uM"
2z8w,2.45,2007,Kd=4.7nM,Kd,nM,4.7,0.0047,2.3279021420642825,"2z8v.pdf (116-mer) New antigen receptor variable domain, IgNAR-AMA1 complex, 2Z8W (AMA1/14I1-M15), Kd=4.7+/-2.0nM"
2uwe,2.40,2007,Kd=4.7uM,Kd,uM,4.7,4.7,-0.6720978579357175,"2j8u.pdf (100-mer) TCR-pMHC complex; T163A mutant protein; Kd(equilibrium)=4.7uM, Kd(kinetic)=4.6uM"
2z8v,2.35,2007,Kd=4.8nM,Kd,nM,4.8,0.0048,2.318758762624413,"2z8v.pdf (116-mer) New antigen receptor variable domain, 2Z8V (AMA1/14I-1), Kd=4.8+/-2.2nM"
2omz,1.60,2007,Kd=400nM,Kd,nM,400,0.4,0.3979400086720376,"2omt.pdf (466-mer) Internalin-A Y369A-HEC1 COMPLEX, Kd=400+/-100nM"
2ihs,2.20,2007,Kd=40nM,Kd,nM,40,0.04,1.3979400086720375,"2ihs.pdf (20-mer) 20-mer from ATP-dependent RNA helicase vasa, Kd about 40nM"
2jt4,NMR,2007,Kd=40uM,Kd,uM,40,40.0,-1.6020599913279623,"2jt4.pdf (76-mer) Sla1 SH3-3-Ubiquitin Complex, Kd=40uM"
2ptt,1.63,2007,Kd=4uM,Kd,uM,4,4.0,-0.6020599913279624,2ptt.pdf (110-mer) NK cell receptor 2B4 (CD244) bound to its ligand CD48
2j59,2.10,2007,Kd=55nM,Kd,nM,55,0.055,1.2596373105057561,"2j59.pdf (168-mer) ligand is RHO-GTPASE ACTIVATING PROTEIN 10, in presence of GTP"
2oob,1.90,2007,Kd=57uM,Kd,uM,57,57.0,-1.7558748556724915,"2oob.pdf (76-mer) ligand is ubiquitin, Kd=57+/-3uM"
2r56,2.80,2007,Kd=5uM,Kd,uM,5,5.0,-0.6989700043360189,"2r56.pdf (162-mer) beta-lactoglobulin (BLG, Bos d 5)"
2v3b,2.45,2007,Kd=5uM,Kd,uM,5,5.0,-0.6989700043360189,"2v3b.pdf (55-mer) RUBREDOXIN-RUBREDOXIN REDUCTASE complex(in presence of Fe3+), kd=5+/-2uM"
2qho,1.85,2007,Kd=60uM,Kd,uM,60,60.0,-1.7781512503836436,"2qho.pdf (76-mer) ligand is ubiquitin, Kd=60+/-15uM"
2onl,4.00,2007,Kd=6nM,Kd,nM,6,0.006,2.221848749616356,"2okr.pdf (406-mer) full length p38a-MAPKAP kinase 2 Heterodimer group P41, Kd=6nM"
2ibf,3.20,2007,Kd=7.8nM,Kd,nM,7.8,0.0078,2.1079053973095196,"2ibf.pdf (25-mer) IpaA-VBS2, two binding sites Kd=7.8nM and 510nM"
2qr0,3.50,2007,Kd=7.8nM,Kd,nM,7.8,0.0078,2.1079053973095196,"2qr0.pdf (213-mer) VEGF COMPLEXED TO FAB-D1, Kd=7.8nM"
2j5l,2.90,2007,Kd=77nM,Kd,nM,77,0.077,1.1135092748275182,"2j4w.pdf (213-mer) PLASMODIUM FALCIPARUM APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX, Kd=77nM"
2v9t,1.70,2007,Kd=8.2nM,Kd,nM,8.2,0.008199999999999999,2.0861861476162833,"2v9t.pdf (220-mer) Slit2 D2-Robo1 Ig complex, Kd=8.2nM"
2pye,2.30,2007,Kd=81.6nM,Kd,nM,81.6,0.08159999999999999,1.088309841246139,2p5e.pdf (100-mer) human T-cell receptors bound to peptide/MHC complex
2uyz,1.40,2007,Kd=82nM,Kd,nM,82,0.082,1.0861861476162833,"2uyz.pdf (79-mer) NON-COVALENT COMPLEX BETWEEN UBC9 AND SUMO1, Kd=82+/-23nM(PH8.0).previous Kd=250+/-70nM(PH7.5)"
2px9,NMR,2007,Kd=87.4uM,Kd,uM,87.4,87.4,-1.941511432634403,"2px9.pdf (158-mer) ligand is SUMO-conjugating enzyme UBC9, Kd=87.4+/-23.6uM"
2i26,2.50,2007,Kd=9.4nM,Kd,nM,9.4,0.0094,2.0268721464003012,"2i25.pdf (129-mer) ancestral variable domain in complex with lysozyme, Kd=9.4nM"
3biw,3.50,2007,Kd=97nM,Kd,nM,97,0.097,1.0132282657337552,"3biw.pdf (574-mer) Neuroligin-1, 3BIW, NL1/Nrx1b"
2v1d,3.10,2007,Ki=0.05uM,Ki,uM,0.05,0.05,1.3010299956639813,"2v1d.pdf (21-mer) LSD1-CoREST in complex with pLys4Met H3 peptide, Ki=0.05+/-0.02uM"
2o8v,3.00,2007,Ki=1.1uM,Ki,uM,1.1,1.1,-0.04139268515822508,"2o8v.pdf (128-mer) PAPS reductase in a covalent complex with thioredoxin C35A, Ki=1.1uM"
2uxn,2.72,2007,Ki=120nM,Ki,nM,120,0.12,0.9208187539523752,2uxn.pdf (235-mer) N-methylpropargyl-K4 H3 1-21 compound CoREST inhibited LSD1
2g81,1.55,2007,Ki=13.6nM,Ki,nM,13.6,0.0136,1.8664610916297826,"2g81.pdf (83-mer) Bowman-Birk inhibitor (BTCI), Ki=1.36+/-0.16 X 10-8M"
2nz1,2.50,2007,Ki=18nM,Ki,nM,18,0.018000000000000002,1.744727494896694,"2nyz.pdf (76-mer) ligand is CC-Chemokine CCL2/MCP-1, competition with Heparin, Ki=18+/-7nM"
2ijo,2.30,2007,Ki=24nM,Ki,nM,24,0.024,1.6197887582883939,"2ijo.pdf (58-mer) NS2B-NS3(WT) protease complex with pancreatic trypsin inhibitor, Ki=24nM"
2pw8,1.84,2007,Ki=25fM,Ki,fM,25,2.5000000000000002e-08,7.6020599913279625,"2pw8.pdf (65-mer) sulfo-hirudin complexed to thrombin, Ki=25fM"
2jod,NMR,2007,Ki=350nM,Ki,nM,350,0.35000000000000003,0.45593195564972433,"2jod.pdf (33-mer) Pac1-Rshort N-terminal EC domain Pacap(6-38) complex, Ki=350nM"
2nqd,1.75,2007,Ki=39pM,Ki,pM,39,3.9e-05,4.4089353929735005,"2nqd.pdf (109-mer) cysteine protease inhibitor, chagasin complex with human cathepsin L, Ki=39pM"
2p3f,3.10,2007,Ki=43pM,Ki,pM,43,4.2999999999999995e-05,4.366531544420414,"2p3f.pdf (78-mer) FACTOR XA-NAP5 COMPLEX, Ki=43pM"
2uuy,1.15,2007,Ki=5.6nM,Ki,nM,5.6,0.0056,2.2518119729937998,"2uuy.pdf (52-mer) Tick Tryptase Inhibitor, Ki=5.6+/-2.0nM"
3c5t,2.10,2008,IC50=0.6nM,IC50,nM,0.6,0.0006,3.2218487496163566,3c59.pdf (31-mer) Exendin-4(9-39)
2z7f,1.70,2008,IC50=13nM,IC50,nM,13,0.013000000000000001,1.8860566476931633,"2z7f.pdf (50-mer) human neutrophil elastase with 1/2SLPI, IC50=1.3 X 10-8M"
2w2n,2.30,2008,IC50=140nM,IC50,nM,140,0.14,0.8538719643217619,"2w2m.pdf (107-mer) WT PCSK9-DELTAC BOUND TO EGF-A H306Y MUTANT OF LDLR, IC50=140+/-50nM"
3brt,2.25,2008,IC50=36nM,IC50,nM,36,0.036000000000000004,1.4436974992327127,"3brt.pdf (47-mer) NEMO and IKK alpha/beta hybrids complexes, IC50=36nM"
3brv,2.20,2008,IC50=47nM,IC50,nM,47,0.047,1.3279021420642825,"3brt.pdf (48-mer) NEMO/IKK beta complexes, IC50=47nM"
2qur,2.50,2008,IC50=500nM,IC50,nM,500,0.5,0.3010299956639812,"2qur.pdf (20-mer) IC50~500nM(RIIbeta subunit), 20-mer fragment from cAMP-dependent protein kinase inhibitor alpha"
3c59,2.30,2008,IC50=5nM,IC50,nM,5,0.005,2.3010299956639813,3c59.pdf (31-mer) Exendin-4(56-86)
3ehu,1.96,2008,IC50=6.6uM,IC50,uM,6.6,6.6,-0.8195439355418687,"3ehs.pdf (21-mer) Corticotropin-releasing factor, CRF(22-41)"
3bow,2.40,2008,IC50=64nM,IC50,nM,64,0.064,1.193820026016113,"3bow.pdf (95-mer) M-calpain in complex with Calpastatin, IC50=64nM"
2za4,1.58,2008,Kd=0.14nM,Kd,nM,0.14,0.00014000000000000001,3.853871964321762,"2za4.pdf (90-mer) Barnase (K98A) and barstar (D39A, C40A, C82A) Complex, Kd=1.4 X 10-10M"
2vdb,2.52,2008,Kd=0.15nM,Kd,nM,0.15,0.00015,3.8239087409443187,"2vdb.pdf (55-mer) ligand is PEPTOSTREPTOCOCCAL ALBUMIN-BINDING PROTEIN, Ka=6.7x10^9M-1, get Kd=1.5x10-10M"
3dxc,2.10,2008,Kd=0.22uM,Kd,uM,0.22,0.22,0.6575773191777937,"3dxc.pdf (35-mer) APP intracellular domain / Fe65-PTB2 complexes, Kd=0.22+/-0.02uM"
2vfx,1.95,2008,Kd=0.25uM,Kd,uM,0.25,0.25,0.6020599913279624,2vfx.pdf (206-mer) SYMMETRIC MAD2 DIMER equilibrium dissociation constant
2k05,NMR,2008,Kd=0.2uM,Kd,uM,0.2,0.2,0.6989700043360187,"2k03.pdf (40-mer) fully sulfated SDF12 complex with C-X-C chemokine receptor type 4 (CXCR4 p38-sY3), Kd=0.2+/-0.2uM"
3dvu,2.50,2008,Kd=0.2uM,Kd,uM,0.2,0.2,0.6989700043360187,"3dvu.pdf (26-mer) M11-Beclin 1 BH3 domain complex, Kd=0.2+/-0.1uM"
2roz,NMR,2008,Kd=0.32uM,Kd,uM,0.32,0.32,0.494850021680094,"2roz.pdf (32-mer) C-terminal PID Domain with the Cytoplasmic Tail of APP, Kd range 0.32uM to 0.79uM"
3dxe,2.00,2008,Kd=0.33uM,Kd,uM,0.33,0.33,0.4814860601221125,"3dxc.pdf (35-mer) APP intracellular domain (T668A mutant) / Fe65-PTB2 complexes, Kd=0.33+/-0.01uM"
3dxd,2.20,2008,Kd=0.34uM,Kd,uM,0.34,0.34,0.46852108295774486,"3dxc.pdf (35-mer) APP intracellular domain (T668E mutant) / Fe65-PTB2 complexes, Kd=0.34+/-0.02uM"
2vlp,2.00,2008,Kd=0.543pM,Kd,pM,0.543,5.43e-07,6.265200170411153,"2vln.pdf (86-mer) R54A MUTANT OF E9 DNASE DOMAIN IN COMPLEX WITH IM9, Kd=0.543+/-0.066pM"
2jti,NMR,2008,Kd=0.588uM,Kd,uM,0.588,0.588,0.23062267392386154,"2jti.pdf (108-mer) ligand is yeast iso-1-cytochrome c (T12A); ITC equilibrium binding constant KB=1.7+/-1 x10^6M-1, Kd=0.588x10-6M"
2jzn,NMR,2008,Kd=0.5mM,Kd,mM,0.5,500.0,-2.6989700043360187,"1vsq.pdf (165-mer) ligand is Mannose-specific phosphotransferase enzyme IIB component, conformers 1, Kd=0.5mM"
1vsq,NMR,2008,Kd=0.5mM,Kd,mM,0.5,500.0,-2.6989700043360187,"1vsq.pdf (165-mer) ligand is Mannose-specific phosphotransferase enzyme IIB component, conformers 2, Kd=0.5mM"
2pjy,3.00,2008,Kd=0.5uM,Kd,uM,0.5,0.5,0.3010299956639812,"2pjy.pdf (108-mer) ternary complex, Transforming growth factor beta-3 with TGF-beta receptor type-1 and type-2"
3ddc,1.80,2008,Kd=0.77uM,Kd,uM,0.77,0.77,0.11350927482751812,3ddc.pdf (163-mer) ligand is NORE1A K302D
2vof,1.80,2008,Kd=0.7nM,Kd,nM,0.7,0.0007,3.154901959985743,"2vof.pdf (26-mer) ligand is Puma BH3-domain, Kd=0.7nM"
2vlo,1.80,2008,Kd=0.892pM,Kd,pM,0.892,8.92e-07,6.049635145623877,"2vln.pdf (93-mer) K97A MUTANT OF E9 DNASE DOMAIN IN COMPLEX WITH IM9, Kd=0.892+/-0.11pM"
2z34,2.40,2008,Kd=0.89uM,Kd,uM,0.89,0.89,0.05060999335508721,"2cu9.pdf (29-mer) ligand is Hip1 B domain peptide, hir1; Kd=0.89+/-0.01uM"
3c4m,1.95,2008,Kd=0.98uM,Kd,uM,0.98,0.98,0.00877392430750515,3c4m.pdf (21-mer)
3f5c,3.00,2008,Kd=0.9uM,Kd,uM,0.9,0.9,0.045757490560675115,"3f5c.pdf (268-mer) Dax-1 bound to liver receptor homolog 1 (LRH-1), Kd=0.9+/-0.1uM"
3dbr,3.05,2008,Kd=1.02uM,Kd,uM,1.02,1.02,-0.00860017176191757,"3dbh.pdf (88-mer) APPBP1-UBA3Arg190Gln complex with NEDD8 Ala72Arg mutant, Kd=1020+/-10nM"
3b2u,2.58,2008,Kd=1.0nM,Kd,nM,1.0,0.001,3.0,"3b2u.pdf (213-mer) ligand is Fab fragment of IMC-11F8, Kd=1.0+/-0.1nM"
2v51,2.35,2008,Kd=1.0uM,Kd,uM,1.0,1.0,-0.0,"2v51.pdf (32-mer) Kd=1.0+/-0.3uM, G-actin bound to RPEL1-MAL peptide"
2qja,2.60,2008,Kd=1.1nM,Kd,nM,1.1,0.0011,2.958607314841775,"2qj9.pdf (116-mer) ligand is Bone morphogenetic protein 2, BMP2, Kd=1.1nM"
2voi,2.10,2008,Kd=1.1nM,Kd,nM,1.1,0.0011,2.958607314841775,"2vof.pdf (34-mer) ligand is Bid BH3-domain, Kd=1.1nM"
2v4z,2.80,2008,Kd=1.25uM,Kd,uM,1.25,1.25,-0.09691001300805642,"2v4z.pdf (142-mer) ligand is REGULATOR OF G-PROTEIN SIGNALING 2, RGS2(C106S, N184D, E191K) triple mutant"
2jjt,2.30,2008,Kd=1.2uM,Kd,uM,1.2,1.2,-0.07918124604762482,"2jjs.pdf (126-mer) CD47 complex with HUMAN SIGNAL Human signal regulatory protein (SIRP) alpha, space group p21 21 21"
2jjs,1.85,2008,Kd=1.2uM,Kd,uM,1.2,1.2,-0.07918124604762482,"2jjs.pdf (126-mer) CD47 complex with Human signal regulatory protein (SIRP) alpha, space group p21"
2jki,3.30,2008,Kd=1.64uM,Kd,uM,1.64,1.64,-0.21484384804769785,"2jki.pdf (90-mer) COMPLEX OF HSP90 N-TERMINAL AND SGT1 CS DOMAIN, Kd=1.64uM"
3dbh,2.85,2008,Kd=1.66uM,Kd,uM,1.66,1.66,-0.22010808804005508,"3dbh.pdf (88-mer) APPBP1-UBA3Arg190Ala complex with NEDD8 Ala72Arg mutant, Kd=1660+/-10nM"
2vln,1.60,2008,Kd=1.68pM,Kd,pM,1.68,1.6799999999999998e-06,5.774690718274138,"2vln.pdf (86-mer) N75A MUTANT OF E9 DNASE DOMAIN IN COMPLEX WITH IM9, Kd=1.68+/-0.3pM"
2v52,1.45,2008,Kd=1.9uM,Kd,uM,1.9,1.9,-0.2787536009528289,"2v51.pdf (32-mer) Kd=1.9+/-0.1uM, G-actin bound to RPEL2-MAL peptide"
3c8k,2.90,2008,Kd=102uM,Kd,uM,102,102.0,-2.0086001717619175,3c8k.pdf (274-mer) Natural killer cell receptor Ly-49C recognize H-2 class I histocompatibility antigen
2vwe,3.40,2008,Kd=113.7pM,Kd,pM,113.7,0.0001137,3.9442395353122652,2vwe.pdf (167-mer) Fab fragment of antibody (Fab-2H10) with VEGF-B
2p45,1.10,2008,Kd=116nM,Kd,nM,116,0.116,0.9355420107730815,"2p42.pdf (123-mer) cAb-RN05 VHH complexes with RNase A, SE5b-Orthol-1(clone 22) form, Kd=116+/-33nM"
2p46,2.50,2008,Kd=116nM,Kd,nM,116,0.116,0.9355420107730815,"2p42.pdf (123-mer) cAb-RN05 VHH complexes with RNase A, SE5b-Orthol-2(clone 22) form, Kd=116+/-33nM"
2p48,2.30,2008,Kd=116nM,Kd,nM,116,0.116,0.9355420107730815,"2p42.pdf (123-mer) cAb-RN05 VHH complexes with RNase A, SE5b-tetra(clone 22) form, Kd=116+/-33nM"
2p47,2.50,2008,Kd=116nM,Kd,nM,116,0.116,0.9355420107730815,"2p42.pdf (123-mer) cAb-RN05 VHH complexes with RNase A, SE5b-tri(clone 22) form, Kd=116+/-33nM"
3e3q,2.95,2008,Kd=116nM,Kd,nM,116,0.116,0.9355420107730815,3e2h.pdf (110-mer) m13 high-affinity mutant of the 2C TCR in complex with Ld/QL9
3ch5,2.10,2008,Kd=120uM,Kd,uM,120,120.0,-2.0791812460476247,"3ch5.pdf (52-mer) ligand is mutant Nup153-ZnF2, Kd=120uM; Kd=60uM for wt ZnF2"
3eg5,2.70,2008,Kd=1253nM,Kd,nM,1253,1.2530000000000001,-0.09795107099415004,"3eg5.pdf (178-mer) Kd=1253+/-86nM, complex between Cdc42-Gpp(NH)p and the mDiaN-TSH mutant"
3eab,2.50,2008,Kd=12uM,Kd,uM,12,12.0,-1.0791812460476249,"3eab.pdf (89-mer) C-terminal tail of CHMP1B with the MIT domain of spastin, Kd=12uM"
2ver,NMR,2008,Kd=13.1uM,Kd,uM,13.1,13.1,-1.1172712956557642,"2ver.pdf (143-mer) AFIMBRIAL ADHESIN AFA-III, DraE adhesin, Kd=13.1+/-2.5uM"
2rms,NMR,2008,Kd=134nM,Kd,nM,134,0.134,0.8728952016351923,"2rms.pdf (61-mer) mSin3A PAH1-SAP25 SID complex, Kd=134+/-13nM"
2q5d,3.20,2008,Kd=15.6nM,Kd,nM,15.6,0.0156,1.8068754016455384,"2p8q.pdf (40-mer) importin beta and Snurportin-1 sIBB-(25-65) complexes, crystal form II, Kd=15.6+/-6.8nM"
2p8q,2.35,2008,Kd=15.6nM,Kd,nM,15.6,0.0156,1.8068754016455384,"2p8q.pdf (40-mer) importin beta sIBB-(25-65) complexes, crystal form I, Kd=15.6+/-6.8nM"
2rnr,NMR,2008,Kd=150nM,Kd,nM,150,0.15,0.8239087409443188,"2rnr.pdf (110-mer) hTFIIEa AC-D complex with hTFIIH p62 PH-D, NaCl free buffer Kd=150nM"
2z58,1.88,2008,Kd=16nM,Kd,nM,16,0.016,1.7958800173440752,"2z56.pdf (318-mer) ligand is S324A-subtilisin, Kd=16+/-0.8nM"
2k6d,NMR,2008,Kd=171uM,Kd,uM,171,171.0,-2.2329961103921536,"2k6d.pdf (76-mer) CIN85 SH3-C-ubiquitin complex, Kd=171+/-7uM"
2otk,NMR,2008,Kd=17nM,Kd,nM,17,0.017,1.7695510786217261,"2otk.pdf (40-mer) ligand is Amyloid beta A4 protein(1-40), Kd=17+/-2nM"
2w2m,2.40,2008,Kd=196nM,Kd,nM,196,0.196,0.707743928643524,"2w2m.pdf (107-mer) WT PCSK9-DELTAC BOUND TO WT EGF-A OF LDLR, nuetral PH Kd=196nM"
3d5r,2.10,2008,Kd=19nM,Kd,nM,19,0.019,1.7212463990471711,"3d5r.pdf (297-mer) 3D5R(N138A/Complement C3d), ITC Kd=19+/-4nM, SPR Kd=19.8+/-6.0nM"
2voh,1.90,2008,Kd=1nM,Kd,nM,1,0.001,3.0,"2vof.pdf (26-mer) ligand is Bak BH3-domain, Bak Kd=1-20nM, not listed. but Bad Kd=1700nM"
3dgc,2.50,2008,Kd=1nM,Kd,nM,1,0.001,3.0,3dgc.pdf (141-mer) Interleukin-22/Interleukin-22 receptor subunit alpha-1 DDQ mutant
3d5o,2.80,2008,Kd=1uM,Kd,uM,1,1.0,-0.0,"3d5o.pdf (177-mer) human SAP complex with the extracellular domain of Fc gama RIIa, Kd=1-3uM"
3eba,1.85,2008,Kd=2.36nM,Kd,nM,2.36,0.00236,2.6270879970298933,3eba.pdf (127-mer) CAbHul6 FGLW mutant (humanized) in complex with human lysozyme
3e2u,2.60,2008,Kd=2.3uM,Kd,uM,2.3,2.3,-0.36172783601759284,"3e2u.pdf (97-mer) ligand is CAP-Gly domain of human dynactin-1 (p150-GLUED), Kd=2.3+/-0.4uM"
2qj9,2.44,2008,Kd=2.4nM,Kd,nM,2.4,0.0024,2.619788758288394,"2qj9.pdf (116-mer) ligand is Bone morphogenetic protein 2, BMP2, Kd=2.4nM"
2k3s,NMR,2008,Kd=2.7uM,Kd,uM,2.7,2.7,-0.43136376415898736,"2k3s.pdf (67-mer) CH-domain of the smoothelin-like 1 complexed with the C-domain of apo calmodulin, Kd=2.7 X 10-6M"
3eoy,3.40,2008,Kd=2.8nM,Kd,nM,2.8,0.0028,2.5528419686577806,"3eoy.pdf (104-mer) Reovirus sigma1 with Junctional Adhesion Molecule-A, in ref27 Kd=2.8nM"
2oqj,2.80,2008,Kd=200uM,Kd,uM,200,200.0,-2.3010299956639813,2oqj.pdf (21-mer) Biacore Kd=200uM
2p44,1.80,2008,Kd=20nM,Kd,nM,20,0.02,1.6989700043360187,"2p42.pdf (123-mer) cAb-RN05 VHH complexes with RNase A, SE5a-Mono-1(clone 7) form, Kd=20+/-11nM"
3bpo,3.00,2008,Kd=20nM,Kd,nM,20,0.02,1.6989700043360187,"3bpl.pdf (205-mer) IL13-IL4R-IL13Ra ternary complex, Kd of IL13-IL13Ra for Interleukin-4 receptor alpha chain is 20nM"
2jy6,NMR,2008,Kd=20uM,Kd,uM,20,20.0,-1.3010299956639813,"2jy6.pdf (76-mer) UQ1-UBA/Ubiquitin protein complex, Kd=20uM"
3bn3,2.10,2008,Kd=20uM,Kd,uM,20,20.0,-1.3010299956639813,"3bn3.pdf (180-mer) ICAM-5 in complex with F265S, F292G double mutant Integrin alpha-L, I domain, Kd around 20uM"
2vog,1.90,2008,Kd=210nM,Kd,nM,210,0.21,0.6777807052660807,"2vof.pdf (27-mer) ligand is Bmf BH3-domain, Kd=210nM"
2vlq,1.60,2008,Kd=22.8pM,Kd,pM,22.8,2.28e-05,4.642065152999546,"2vln.pdf (86-mer) F86A MUTANT OF E9 DNASE DOMAIN IN COMPLEX WITH IM9, Kd=22.8+/-3.7pM"
3bk3,2.70,2008,Kd=22nM,Kd,nM,22,0.022,1.6575773191777938,"3bk3.pdf (114-mer) CV-2 VWC1 and BMP-2, Kd=22nM"
2p43,1.65,2008,Kd=23nM,Kd,nM,23,0.023,1.6382721639824072,"2p42.pdf (123-mer) cAb-RN05 VHH complexes with RNase A, native SE3-Mono-1 form"
2p42,1.80,2008,Kd=23nM,Kd,nM,23,0.023,1.6382721639824072,"2p42.pdf (123-mer) cAb-RN05 VHH complexes with RNase A, native SE3-Mono-2 form"
3b9f,1.60,2008,Kd=24uM,Kd,uM,24,24.0,-1.380211241711606,3b9f.pdf (395-mer) ligand is protein C inhibitor(PCI); Kd=24+/-8uM(positivepH 7.0)
3eo1,3.10,2008,Kd=250pM,Kd,pM,250,0.00025,3.6020599913279625,"3eo0.pdf (112-mer) Fab Fragment of GC-1008 Complex with Transforming Growth Factor-Beta 3, Kd=250pM, IC50=7+/-2nM"
3be1,2.90,2008,Kd=26nM,Kd,nM,26,0.026000000000000002,1.585026652029182,3bdy.pdf (624-mer) Dual specific bH1 Fab in complex with the extracellular domain of HER2/ErbB-2
3bgf,3.00,2008,Kd=26nM,Kd,nM,26,0.026000000000000002,1.585026652029182,3bgf.pdf (212-mer) SARS coronavirus spike receptor binding domain in complex with F26G19 Fab
3d5s,2.30,2008,Kd=26nM,Kd,nM,26,0.026000000000000002,1.585026652029182,"3d5r.pdf (297-mer) 3D5S (R131A/Complement C3d), ITC Kd=26+/-6nM, SPR Kd=62.1+/-32.4nM"
3b2v,3.30,2008,Kd=3.3nM,Kd,nM,3.3,0.0033,2.4814860601221125,"3b2u.pdf (213-mer) ligand is Fab fragment of IMC-11F8, Kd=3.3+/-0.5nM"
3bdy,2.60,2008,Kd=300nM,Kd,nM,300,0.3,0.5228787452803376,3bdy.pdf (102-mer) Dual specific bH1 Fab in complex with VEGF
3blh,2.48,2008,Kd=300nM,Kd,nM,300,0.3,0.5228787452803376,"3blh.pdf (260-mer) CDK9/CycT1, Kd=300nM, unpublished data"
3ech,1.80,2008,Kd=300nM,Kd,nM,300,0.3,0.5228787452803376,3ech.pdf (25-mer) Kd=300+/-70nM
3bky,2.61,2008,Kd=30nM,Kd,nM,30,0.03,1.5228787452803376,"3bky.pdf (25-mer) Fab fragment of the antibody C2H7 complex with CD20 epitope peptide, Kd=3 X 10-8M"
3d7u,4.11,2008,Kd=30uM,Kd,uM,30,30.0,-1.4771212547196624,"3d7t.pdf (277-mer) ligand is Proto-oncogene tyrosine-protein kinase Src, Kd~30uM"
3cx8,2.00,2008,Kd=340nM,Kd,nM,340,0.34,0.46852108295774486,3cx6.pdf (203-mer) RhoGEF-RGS (rgRGS) Domain Complex with Galpha-13 Bound to GTP gamma S
2k42,NMR,2008,Kd=35nM,Kd,nM,35,0.035,1.4559319556497243,"2k42.pdf (36-mer) GTPase Binding Domain of WASP in Complex with EspFU, Kd=35+/-4.9nM"
2vsm,1.80,2008,Kd=35nM,Kd,nM,35,0.035,1.4559319556497243,2vsk.pdf (140-mer) NIPAH VIRUS ATTACHMENT GLYCOPROTEIN WITH HUMAN CELL SURFACE RECEPTOR EPHRINB2
2k2u,NMR,2008,Kd=360nM,Kd,nM,360,0.36,0.44369749923271273,"2k2u.pdf (35-mer) Tfb1 subunit of TFIIH and the activation domain of VP16, Kd=360+/-40nM"
2efh,2.10,2008,Kd=36nM,Kd,nM,36,0.036000000000000004,1.4436974992327127,"2efc.pdf (181-mer) ARA7-GDP / VPS9a-D185N mutant complex, Kd=3.6x10-8M with Mg2+"
2rgn,3.50,2008,Kd=36nM,Kd,nM,36,0.036000000000000004,1.4436974992327127,"2rgn.pdf (354-mer) ligand is p63 (149-502), Kd=36+/-3nM, Ki=29+/-4nM"
3c66,2.60,2008,Kd=3uM,Kd,uM,3,3.0,-0.47712125471966244,3c66.pdf (26-mer) ligand is Fip1 residues 80-105 (Fippbd)
3d2u,2.21,2008,Kd=4.0nM,Kd,nM,4.0,0.004,2.3979400086720375,3d2u.pdf (281-mer) UL18 protein
3bp8,2.85,2008,Kd=4.14nM,Kd,nM,4.14,0.00414,2.382999658879101,"3bp8.pdf (406-mer) Putative NAGC-like transcriptional regulator, Mlc/EIIB complex, Kd=4.14+/-1.22nM"
3dvm,2.60,2008,Kd=4.32nM,Kd,nM,4.32,0.00432,2.364516253185088,"3dve.pdf (22-mer) Ca2+/CaM-CaV2.1 IQ domain complex, N-lobe Kd=51+/-20nM, C-lobe Kd=4.32+/-0.39nM"
3c4p,1.75,2008,Kd=4.4nM,Kd,nM,4.4,0.0044,2.3565473235138126,"3c4o.pdf (165-mer) SHV-1 complex with Beta-lactamase inhibitory protein, BLIP (E73M) mutant, Kd=4.4+/-0.6nM"
3cqx,2.30,2008,Kd=4.5uM,Kd,uM,4.5,4.5,-0.6532125137753437,"3cqx.pdf (88-mer) Hsc70-NBD complex with BAG family molecular chaperone regulator 2, Kd=4.5+/-2uM for Bag2-BNB dimer, not for the Hsc70-NBD-Bag2-BNB complex"
3c4o,1.70,2008,Kd=4.6nM,Kd,nM,4.6,0.0046,2.337242168318426,"3c4o.pdf (165-mer) SHV-1 complex with Beta-lactamase inhibitory protein, BLIP (E73M, S130K, S146M) mutant, Kd=4.6+/-0.2nM"
3e2h,3.80,2008,Kd=4.6uM,Kd,uM,4.6,4.6,-0.6627578316815741,3e2h.pdf (110-mer) m67 high-affinity mutant of the 2C TCR in complex with Ld/QL9
3cx6,2.50,2008,Kd=4.8uM,Kd,uM,4.8,4.8,-0.6812412373755872,3cx6.pdf (203-mer) RhoGEF-RGS (rgRGS) Domain Complex with Galpha-13 Bound to GDP
2qjb,2.50,2008,Kd=4.9nM,Kd,nM,4.9,0.004900000000000001,2.309803919971486,"2qj9.pdf (116-mer) ligand is Bone morphogenetic protein 2, BMP2, Kd=4.9nM"
2jtt,NMR,2008,Kd=4.9uM,Kd,uM,4.9,4.9,-0.6901960800285137,"2jtt.pdf (35-mer) ligand is C-terminal Siah-1 interacting protein (189-219), ITC Kd=4.9+/-0.6uM"
2vlr,2.30,2008,Kd=4.9uM,Kd,uM,4.9,4.9,-0.6901960800285137,2vlj.pdf (100-mer) TCR-pMHC complex
3c09,3.20,2008,Kd=43nM,Kd,nM,43,0.043000000000000003,1.3665315444204134,"3c08.pdf (212-mer) Fab fragment of matuzumab (Fab72000) complex with sEGFR domain 3, Kd=43.0+/-12.9nM"
2vyr,2.00,2008,Kd=44nM,Kd,nM,44,0.044,1.3565473235138126,"2vyr.pdf (101-mer) VH9 and Humain MDM4 N-terminal domain, Kd=44nM"
3ejj,2.40,2008,Kd=455nM,Kd,nM,455,0.455,0.34198860334288755,"3ejj.pdf (289-mer) ligand is domains (D1-D3) of FMS; (D1-D3) of FMS Kd=455nM, (D1-D5) of FMS Kd=9.0nM"
3bpn,3.02,2008,Kd=487nM,Kd,nM,487,0.487,0.3124710387853657,"3bpl.pdf (314-mer) ternary complex of IL-4Ra/IL-4 complex and Interleukin-13 receptor alpha-1 chain, Kd=487nM"
3cqc,2.53,2008,Kd=4nM,Kd,nM,4,0.004,2.3979400086720375,"3cqc.pdf (227-mer) ligand is human Nucleoporin Nup133; His-tagged hNup107 658-925, kd=4+/-2nM"
3cqg,3.00,2008,Kd=4nM,Kd,nM,4,0.004,2.3979400086720375,"3cqg.pdf (227-mer) ligand is human Nucleoporin His-tagged hNup133 (934-1156), kd=4+/-2nM"
2k5b,NMR,2008,Kd=4uM,Kd,uM,4,4.0,-0.6020599913279624,"2k5b.pdf (129-mer) Human CDC37M-HSP90N complex, Kd=4uM"
2ve7,2.88,2008,Kd=4uM,Kd,uM,4,4.0,-0.6020599913279624,2ve7.pdf (250-mer) ligand is Nuf2(1-169)-Spc24(122-197); Kd=4~5uM
2vlj,2.40,2008,Kd=5.2uM,Kd,uM,5.2,5.2,-0.7160033436347992,2vlj.pdf (100-mer) TCR-pMHC complex
3beg,2.90,2008,Kd=50nM,Kd,nM,50,0.05,1.3010299956639813,"3beg.pdf (115-mer) ASF/SF2, kd~50nM"
3cx7,2.25,2008,Kd=520nM,Kd,nM,520,0.52,0.28399665636520083,3cx6.pdf (203-mer) RhoGEF-RGS (rgRGS) Domain Complex with Galpha-13 Bound to ALF and GDP
3bpl,2.93,2008,Kd=559nM,Kd,nM,559,0.559,0.25258819211357664,"3bpl.pdf (199-mer) ternary complex of IL-4Ra/IL-4 complex and Cytokine receptor common gamma chain, Kd=559nM"
3chw,2.30,2008,Kd=57nM,Kd,nM,57,0.057,1.2441251443275085,3chw.pdf (139-mer) Profilin
2efd,3.00,2008,Kd=7.3nM,Kd,nM,7.3,0.0073,2.136677139879544,"2efc.pdf (181-mer) GDP Nucleotide-free ARA7 / VPS9a complex, with Mg2+, Kd=7.3nM"
3c9a,1.60,2008,Kd=7.7nM,Kd,nM,7.7,0.0077,2.113509274827518,"3c9a.pdf (52-mer) ligand is Spitz EGF-domain(SpitzEGF: residues 48-99), for full length Argos419, Kd=20nM"
2vay,1.94,2008,Kd=7.9nM,Kd,nM,7.9,0.0079,2.1023729087095586,2vay.pdf (21-mer) ligand is  CAV1.1 IQ PEPTIDE
3d7t,2.90,2008,Kd=70uM,Kd,uM,70,70.0,-1.845098040014257,"3d7t.pdf (286-mer) ligand is Proto-oncogene tyrosine-protein kinase Src, Kd~70uM"
2v5q,2.30,2008,Kd=71nM,Kd,nM,71,0.07100000000000001,1.1487416512809248,"2v5q.pdf (167-mer) DESIGN ANKYRIN REPEAT PROTEIN VARIANT 3H10, rough estimated Kd=71nM"
3crk,2.30,2008,Kd=8.3uM,Kd,uM,8.3,8.3,-0.919078092376074,"3crk.pdf (87-mer) PDHK2 complex with inner lipoyl-bearing domain of dihydrolipoamide transacetylase (L2), Potassium phosphate buffer, Kd=8.3+/-0.3uM"
3dbl,2.90,2008,Kd=8.75uM,Kd,uM,8.75,8.75,-0.9420080530223133,"3dbh.pdf (88-mer) APPBP1-UBA3Arg190 (wt) complex with NEDD8 Ala72Gln mutant, Kd=8750+/-70nM"
3dvg,2.60,2008,Kd=8.7nM,Kd,nM,8.7,0.0087,2.0604807473813813,3dvg.pdf (80-mer) Apu3.A8-K63-linked diubiquitin
2qna,2.84,2008,Kd=83nM,Kd,nM,83,0.083,1.080921907623926,"2qna.pdf (66-mer) ligand is IBB domain of Snurportin-1 (1-65); for full length Imp beta Kd=79nM, for 127-876, Kd=83nM"
3bik,2.65,2008,Kd=8uM,Kd,uM,8,8.0,-0.9030899869919435,"3bik.pdf (222-mer) murine PD-1 and Programmed cell death 1 ligand 1 (human PD-L1), Kd=8uM"
3bs5,2.00,2008,Kd=92.5nM,Kd,nM,92.5,0.0925,1.0338582672609673,3bs5.pdf (106-mer) ligand is SAM domain of HYP; SAM domain dimer complex
3dvn,2.70,2008,Kd=92nM,Kd,nM,92,0.092,1.0362121726544447,3dvg.pdf (80-mer) Apu2.16-K63-linked diubiquitin
3bh6,2.60,2008,Kd=95nM,Kd,nM,95,0.095,1.0222763947111522,"3bh6.pdf (352-mer) ligand is wild type RP2, Kd=95+/-2nm"
3bx1,1.85,2008,Kd~1.3uM,Kd,uM,1.3,1.3,-0.11394335230683679,"3bx1.pdf (181-mer) Alpha-amylase/subtilisin inhibitor, BASI in complex with the B. lentus subtilisin Savinase"
3d1m,1.70,2008,Kd~1.3uM,Kd,uM,1.3,1.3,-0.11394335230683679,3d1m.pdf (102-mer) wt Sonic hedgehog protein complex with third FNIII domain of CDO
3b4v,2.48,2008,Kd~30pM,Kd,pM,30,2.9999999999999997e-05,4.522878745280337,"3b4v.pdf (116-mer) Activin in complex with FSTL3, Kd~30pM"
3fju,1.60,2008,Ki=1.6nM,Ki,nM,1.6,0.0016,2.795880017344075,"3fju.pdf (65-mer) metallocarboxypeptidase (MCP) inhibitor, ACI, Ki=1.6+/-0.2nM"
2oul,2.20,2008,Ki=1.7nM,Ki,nM,1.7,0.0017,2.769551078621726,"2oul.pdf (241-mer) chagasin, in complex with a cysteine protease Falcipain 2, Ki=1.7+/-0.53nM"
2ody,2.35,2008,Ki=1.8nM,Ki,nM,1.8,0.0018000000000000002,2.744727494896694,"2ody.pdf (127-mer) bovine a-thrombin  boophilin complex, Ki=1.8nM"
3bg4,2.50,2008,Ki=34.33nM,Ki,nM,34.33,0.03433,1.4643261965742498,"3bg4.pdf (57-mer) Guamerin, ki=34.33+/-4.76nM"
3ixe,1.90,2009,IC50=2.3uM,IC50,uM,2.3,2.3,-0.36172783601759284,3ixe.pdf (72-mer) PINCH2 LIM1 domain in complex with ILK ARD
3iol,2.10,2009,IC50=500nM,IC50,nM,500,0.5,0.3010299956639812,"3iol.pdf (31-mer) GLP-1 complex the extracellular domain of GLP-1 Receptor, IC50>500nM"
3gjn,2.48,2009,Kd<1pM,Kd,pM,1,1e-06,6.0,"3gjn.pdf (86-mer) ColE7-R12-13 complex, Kd<1x10-12M"
2w84,NMR,2009,Kd=0.07uM,Kd,uM,0.07,0.07,1.154901959985743,"2w84.pdf (20-mer) protein 2 is Pex5(108-127), not Pex5(116-124)"
3a6b,1.80,2009,Kd=0.108uM,Kd,uM,0.108,0.108,0.9665762445130504,"3a67.pdf (129-mer) ligand is hen egg white lysozyme; Ka=0.93x10^7M-1, Kd=1.08x10-7M"
2vxq,1.90,2009,Kd=0.11nM,Kd,nM,0.11,0.00011,3.958607314841775,"2vxq.pdf (96-mer) huMab2 and POLLEN ALLERGEN PHL P 2, KD=1.1x10-10M"
3da7,2.25,2009,Kd=0.13uM,Kd,uM,0.13,0.13,0.8860566476931632,"3da7.pdf (90-mer) Circular Permutant of Barnase and Barstar, 20C Kd=0.13uM, 30C Kd=1.9uM, 37C Kd=60uM"
3k2u,2.35,2009,Kd=0.16nM,Kd,nM,0.16,0.00016,3.795880017344075,"3k2u.pdf (225-mer) HGFA/Fab40 complex, KD=0.16+/-0.01nM"
2w9e,2.90,2009,Kd=0.1nM,Kd,nM,0.1,0.0001,4.0,2w9d.pdf (113-mer) ICSM-18 with HUMAN PRP FRAGMENT 119-231
3fp6,1.49,2009,Kd=0.1pM,Kd,pM,0.1,1e-07,7.0,3fp6.pdf (58-mer) Kd=0.1pM for bovine trypsin with pancreatic trypsin inhibitor; not for rattus norvegicus
2wjv,2.85,2009,Kd=0.2uM,Kd,uM,0.2,0.2,0.6989700043360187,"2wjv.pdf (97-mer) UPF1(115-914) and UPF2(1105-1198), Kd is for UPF2(1105-1207) and UPF1(115-287)"
3huj,2.50,2009,Kd=0.2uM,Kd,uM,0.2,0.2,0.6989700043360187,3he6.pdf (284-mer) human CD1d-alpha-Galactosylceramide with semi-invariant NKT cell receptor
3inb,3.10,2009,Kd=0.2uM,Kd,uM,0.2,0.2,0.6989700043360187,3inb.pdf (126-mer) MV-H-CD46 complex
2kbw,NMR,2009,Kd=0.32uM,Kd,uM,0.32,0.32,0.494850021680094,2kbw.pdf (35-mer)
2khs,NMR,2009,Kd=0.36uM,Kd,uM,0.36,0.36,0.44369749923271273,"2khs.pdf (35-mer) SNase121:SNase-(111-143) complex, Kd=0.36+/-0.09uM"
2wel,1.90,2009,Kd=0.3uM,Kd,uM,0.3,0.3,0.5228787452803376,"2vn9.pdf (150-mer) Kd=0.3-0.6uM; protein Fragment: KINASE DOMAIN, RESIDUES 11-335 ;"
3dxa,3.50,2009,Kd=0.3uM,Kd,uM,0.3,0.3,0.5228787452803376,"3dx6.pdf (276-mer) DM1 TCR and HLA-B4405 EENL complex, Kd=0.3+/-0.1uM"
2w83,1.93,2009,Kd=0.42uM,Kd,uM,0.42,0.42,0.37675070960209955,"2w83.pdf (77-mer) JIP4-LZII (fused to GST) and Delta 12-ARF6GTP-Q67L, Kd=0.42+/-0.05uM"
3g3a,2.20,2009,Kd=0.43uM,Kd,uM,0.43,0.43,0.36653154442041347,3g3a.pdf (129-mer) lamprey variable lymphocyte receptor in complex with a protein antigen
3d3v,2.80,2009,Kd=0.46uM,Kd,uM,0.46,0.46,0.3372421683184259,"3d39.pdf (275-mer) A6 TCR binding affinities for modified Tax Y5F-34F peptides presented by HLA-A2, ligand is a complex"
3gty,3.40,2009,Kd=0.47nM,Kd,nM,0.47,0.00047,3.3279021420642825,3gty.pdf (149-mer) ligand is 30S ribosomal protein S7; overall dissociation constant of K(AABB) is 4.7x10-10M
2zvk,2.70,2009,Kd=0.4uM,Kd,uM,0.4,0.4,0.3979400086720376,2zvk.pdf (21-mer) ligand is DNA polymerase eta fragment
3d39,2.81,2009,Kd=0.64uM,Kd,uM,0.64,0.64,0.1938200260161128,"3d39.pdf (275-mer) A6 TCR binding affinities for modified Tax Y5F4F peptides presented by HLA-A2, ligand is a complex"
2k79,NMR,2009,Kd=0.67mM,Kd,mM,0.67,670.0,-2.8260748027008264,2k79.pdf (63-mer) average-minimized structure ensemble of interleukin-2 tyrosine kinase SH3 and SH2 domain
2k7a,NMR,2009,Kd=0.67mM,Kd,mM,0.67,670.0,-2.8260748027008264,2k7a.pdf (63-mer) the 20 lowest-energy structure ensemble of interleukin-2 tyrosine kinase SH3 and SH2 domain
3idc,2.70,2009,Kd=0.6nM,Kd,nM,0.6,0.0006,3.2218487496163566,3idb.pdf (164-mer) RII beta(102-265):C in the presence of AMP-PNP and 2Mn2+ ions
2wp0,2.67,2009,Kd=0.93uM,Kd,uM,0.93,0.93,0.03151705144606486,2wp0.pdf (112-mer) the HobA/DnaAI-II structure
3knb,1.40,2009,Kd=0.94uM,Kd,uM,0.94,0.94,0.026872146400301365,"3knb.pdf (107-mer) ligand is obscurin-like protein 1, Kd=0.94+/-0.08uM"
3gd1,3.50,2009,Kd=0.98uM,Kd,uM,0.98,0.98,0.00877392430750515,"3gc3.pdf (363-mer) ligand is Clathrin-(1-363), Kd=0.98+/-0.01uM"
3h3g,1.94,2009,Kd=0.99uM,Kd,uM,0.99,0.99,0.004364805402450088,3h3g.pdf (24-mer) ligand is 24-mer parathyroid hormone-related protein (PTHrP)
3ew3,3.80,2009,Kd=1.2nM,Kd,nM,1.2,0.0012,2.9208187539523753,"3ew3.pdf (203-mer) 1:2 complex between prolactin and prolactin receptor, site 1 Kd=1.2nM, site 2+3 Kd=312nM"
2wy2,NMR,2009,Kd=1.3mM,Kd,mM,1.3,1300.0,-3.113943352306837,"2wy2.pdf (103-mer) ligand is C10S mutant IIB COMPONENT of N, N-diacetylchitobiose (Chb) transporter of E.coli"
3hcu,2.60,2009,Kd=1.48uM,Kd,uM,1.48,1.48,-0.17026171539495738,"3hct.pdf (155-mer) TRAF6 in complex with Ubc13 in the C2 space group, Kd=1.48+/-0.02uM for TRAF6 RZ123"
3hct,2.10,2009,Kd=1.48uM,Kd,uM,1.48,1.48,-0.17026171539495738,"3hct.pdf (155-mer) TRAF6 in complex with Ubc13 in the P1 space group, Kd=1.48+/-0.02uM for TRAF6 RZ123(Supplementary data)"
3kpr,2.60,2009,Kd=1.5uM,Kd,uM,1.5,1.5,-0.17609125905568124,3kpl.pdf (276-mer) LC13 TCR in complex with HLA B*4405 bound to EEYLKAWTF
2zvo,2.90,2009,Kd=1.6uM,Kd,uM,1.6,1.6,-0.2041199826559248,2zvn.pdf (87-mer) NEMO CoZi domain incomplex with diubiquitin in C2 space group
2zvn,3.00,2009,Kd=1.6uM,Kd,uM,1.6,1.6,-0.2041199826559248,2zvn.pdf (87-mer) NEMO CoZi domain incomplex with diubiquitin in P212121 space group
2k8c,NMR,2009,Kd=1.8mM,Kd,mM,1.8,1800.0,-3.255272505103306,2k8b.pdf (76-mer) ligand is Ubiquitin;  Kd=1.8+/-0.6mM
2k8b,NMR,2009,Kd=1.8mM,Kd,mM,1.8,1800.0,-3.255272505103306,2k8b.pdf (76-mer) ligand is Ubiquitin; Kd=1.8+/-0.6mM
3htu,2.00,2009,Kd=1.8uM,Kd,uM,1.8,1.8,-0.25527250510330607,"3htu.pdf (39-mer) human VPS25c-VPS20 alpha1-3 complex; Kd=1.8+/-0.2uM for helix 1-3, structure is helix 1 only"
3g6j,3.10,2009,Kd=1.9nM,Kd,nM,1.9,0.0019,2.721246399047171,"3g6j.pdf (214-mer) C3b in complex with a C3b specific Fab antibody, S77 IgG"
2wo2,2.45,2009,Kd=10.8uM,Kd,uM,10.8,10.8,-1.0334237554869496,2wo2.pdf (153-mer) EphA4-ephrinB2 complex
3k8p,2.60,2009,Kd=10nM,Kd,nM,10,0.01,2.0,"3k8p.pdf (357-mer) Dsl1Clactis-Sec39 complex, ref Kd data not shown"
3hi1,2.90,2009,Kd=11.2nM,Kd,nM,11.2,0.0112,1.9507819773298183,3hi1.pdf (215-mer) YU2 HIV-1 gp120 (core with V3) complex CD4-Binding-Site Antibody F105(supplementary data)
3idb,1.62,2009,Kd=11.3nM,Kd,nM,11.3,0.011300000000000001,1.9469215565165803,3idb.pdf (161-mer) RII beta(108-268):C in the presence of AMP-PNP and 2Mn2+ ions
3dco,11.00,2009,Kd=11.6uM,Kd,uM,11.6,11.6,-1.0644579892269184,"3dc4.pdf (445-mer) Kd1=11.6uM in the presence of excess ADP(1mM), NOD bound to Bovine Alpha Tubulin"
3eiq,3.50,2009,Kd=110nM,Kd,nM,110,0.11,0.958607314841775,"3eiq.pdf (358-mer) Programmed cell death protein 4, mPdcd4 DeltaN-eIF4A complex"
3ifq,2.80,2009,Kd=116nM,Kd,nM,116,0.116,0.9355420107730815,"3ifq.pdf (107-mer) ligand is pE--cadherin-CBD, Kd=116+/-31nM"
2knb,NMR,2009,Kd=11uM,Kd,uM,11,11.0,-1.0413926851582251,"2knb.pdf (71-mer) Parkin Ubl-Endophilin-A1 SH3(as ligand) Complex, Kd=11+/-4uM"
2wii,2.70,2009,Kd=11uM,Kd,uM,11,11.0,-1.0413926851582251,"2wii.pdf (277-mer) COMPLEMENT C3B IN COMPLEX WITH FACTOR H DOMAINS 1-4, Kd=11+/-2uM"
3hh2,2.15,2009,Kd=12.3nM,Kd,nM,12.3,0.0123,1.9100948885606022,"3hh2.pdf (109-mer) myostatin in complex with Fst288, Kd for Fst317=12.3nM, not Fst288"
3h2u,2.75,2009,Kd=12.6uM,Kd,uM,12.6,12.6,-1.100370545117563,"3h2u.pdf (188-mer) Human raver1 RRM1, RRM2, and RRM3 domains with human vinculin tail domain Vt"
3f1p,1.17,2009,Kd=120uM,Kd,uM,120,120.0,-2.0791812460476247,3f1n.pdf (121-mer) human HIF2alpha-ARNT PAS-B heterodimer
3gni,2.35,2009,Kd=12nM,Kd,nM,12,0.012,1.9208187539523751,"3gni.pdf (389-mer) STRAD alpha binds MO25 alpha, in present of ATP, two sites Kd1=2.5uM, Kd2=12nM"
3fku,3.20,2009,Kd=130pM,Kd,pM,130,0.00013,3.886056647693163,"3fku.pdf (280-mer) H5-VN04 and Neutralizing antibody F10 complex, Kd=130+/-28pM in sup.info"
3ff8,2.00,2009,Kd=130uM,Kd,uM,130,130.0,-2.113943352306837,"3ff7.pdf (100-mer) mKLRG1-hEC1, Kd=1.3x10-4M"
3jsv,2.70,2009,Kd=131uM,Kd,uM,131,131.0,-2.1172712956557644,3jsv.pdf (76-mer) mouse NEMO CC2-LZ in complex with K63-Ub2
2wqz,3.90,2009,Kd=132nM,Kd,nM,132,0.132,0.8794260687941501,"2vh8.pdf (588-mer) ligand is Neuroligin4, X-Linked; 2VH8 (Nrxb1-NL4 complex)"
3hpw,1.45,2009,Kd=13uM,Kd,uM,13,13.0,-1.1139433523068367,"3g7z.pdf (36-mer) CcdB dimer in complex with two C-terminal CcdA domains, low Kd=13uM, high=20pM"
2w19,2.15,2009,Kd=140nM,Kd,nM,140,0.14,0.8538719643217619,"2vkl.pdf (90-mer) COMPLEX BETWEEN DAHP SYNTHASE AND CHORISMATE MUTASE, Kd=140+/-30nM"
2wfx,3.20,2009,Kd=14nM,Kd,nM,14,0.014,1.853871964321762,"2wfx.pdf (152-mer) ShhN-eHHIP Delta N with Ca2+, Kd=14+/-1.6nM"
2wub,2.90,2009,Kd=150nM,Kd,nM,150,0.15,0.8239087409443188,"2wub.pdf (224-mer) HGFA complex with Fab40.DeltaTrp, Kd=150+/-9.1nM"
3g6d,3.20,2009,Kd=15pM,Kd,pM,15,1.4999999999999999e-05,4.823908740944319,3g6a.pdf (113-mer) anti-IL-13 antibody fab CNTO607/IL-13 complex
3h6g,2.70,2009,Kd=15uM,Kd,uM,15,15.0,-1.1760912590556813,"3h6g.pdf (395-mer) GluR6 amino terminal domain, monomer dimer equilibrium"
2wuc,2.70,2009,Kd=161nM,Kd,nM,161,0.161,0.7931741239681502,"2wuc.pdf (224-mer) Kd=161+/-7.6nM, Antibody FAB40.DELTA TRP Binding to HGFA, not ligand"
3hg0,2.10,2009,Kd=16nM,Kd,nM,16,0.016,1.7958800173440752,"3hg0.pdf (136-mer) Kd=16nM for BppL alone, Kd=22nM for BppU/BppL complex"
3di2,2.70,2009,Kd=18uM,Kd,uM,18,18.0,-1.255272505103306,"3di2.pdf (154-mer) E106A mutant human IL-7 with unglycosylated IL-7R alpha(EC), Kd=18uM; IC50=3.0uM"
3g9v,2.76,2009,Kd=1pM,Kd,pM,1,1e-06,6.0,3g9v.pdf (151-mer) receptor IL-22BP bound to interleukin-22
3jrm,2.90,2009,Kd=1pM,Kd,pM,1,1e-06,6.0,3jrm.pdf (228-mer) ligand is  V230Y mutated P26 activator
3kv4,2.19,2009,Kd=1uM,Kd,uM,1,1.0,-0.0,3kv4.pdf (24-mer) ligand is 24-mer Histone H3 peptide
2vxs,2.63,2009,Kd=2.1nM,Kd,nM,2.1,0.0021000000000000003,2.6777807052660805,2vxs.pdf (216-mer) IL-17A IN COMPLEX WITH ANTIBODY CAT-2200
3gc3,2.20,2009,Kd=2.1uM,Kd,uM,2.1,2.1,-0.3222192947339193,"3gc3.pdf (363-mer) ligand is Clathrin-(1-363), Kd=2.1+/-0.4uM"
3eoa,2.80,2009,Kd=2.2nM,Kd,nM,2.2,0.0022,2.657577319177794,"3eo9.pdf (181-mer) Efalizumab Fab and LFA-1 alpha L I domain, Form I, Kd=2.2+/-0.5nM"
3eob,3.60,2009,Kd=2.2nM,Kd,nM,2.2,0.0022,2.657577319177794,"3eo9.pdf (181-mer) Efalizumab Fab and LFA-1 alpha L I domain, Form II, Kd=2.2+/-0.5nM"
2wo3,2.35,2009,Kd=2.3uM,Kd,uM,2.3,2.3,-0.36172783601759284,2wo2.pdf (157-mer) EphA4-ephrinA2 complex
2k8f,NMR,2009,Kd=2.7uM,Kd,uM,2.7,2.7,-0.43136376415898736,"2k8f.pdf (39-mer) Taz2/p53 1-39 complex, Kd=2.7+/-0.5uM"
2kc8,NMR,2009,Kd=200nM,Kd,nM,200,0.2,0.6989700043360187,2kc8.pdf (36-mer) ligand is antitoxin RelBc (K47-L79) peptide; Kd=200+/-24nM
3ff7,1.80,2009,Kd=200uM,Kd,uM,200,200.0,-2.3010299956639813,"3ff7.pdf (100-mer) hKLRG1-hEC1, Kd=2x10-4M"
3gxu,2.50,2009,Kd=203nM,Kd,nM,203,0.203,0.6925039620867871,3gxu.pdf (143-mer) ligand is Ephrin-B2
2wby,2.60,2009,Kd=20nM,Kd,nM,20,0.02,1.6989700043360187,"2wby.pdf (20-mer) insulin, Kd1 = 20nM(insulin-binding site 1); Kd2 =280nM(insulin-binding site 2), IC50=180nM"
3doe,2.25,2009,Kd=20nM,Kd,nM,20,0.02,1.6989700043360187,"3doe.pdf (165-mer) ligand is ARL2 binding protein, BART; Crystal Form 1"
3g7z,2.35,2009,Kd=20pM,Kd,pM,20,1.9999999999999998e-05,4.698970004336019,"3g7z.pdf (36-mer) CcdB dimer in complex with two C-terminal CcdA domains, low Kd=13uM, high=20pM"
3fhc,2.80,2009,Kd=21.6nM,Kd,nM,21.6,0.0216,1.665546248849069,"3fhc.pdf (405-mer) human DBP5(1-405), Kd=21.6+/-1.7nM"
2w2x,2.30,2009,Kd=21.9uM,Kd,uM,21.9,21.9,-1.3404441148401183,2w2t.pdf (185-mer) RAS-Related C3 Botulinum Toxin Substrate 2
3di3,2.90,2009,Kd=21nM,Kd,nM,21,0.021,1.6777807052660807,"3di2.pdf (154-mer) E106A mutant human IL-7 with glycosylated IL-7R alpha(S2), Kd=21nM"
3h8k,1.80,2009,Kd=21nM,Kd,nM,21,0.021,1.6777807052660807,"3h8k.pdf (28-mer) Ube2g2:G2BR complex, Kd=21+/-4nM"
3h2v,2.90,2009,Kd=22.1uM,Kd,uM,22.1,22.1,-1.3443922736851108,"3h2v.pdf (74-mer) ligand is Human raver1 RRM1 domain; Kd=22.1uM; for RRM1-3, Kd=12.6uM"
3ho5,3.01,2009,Kd=220nM,Kd,nM,220,0.22,0.6575773191777937,"3ho5.pdf (169-mer) ligand is Sonic hedgehog (SHH) ; Kd=220nM, IC50=53nM"
3gsn,2.80,2009,Kd=27.7uM,Kd,uM,27.7,27.7,-1.4424797690644486,"3gsn.pdf (274-mer) RA14 TCR and HLA-A*0201 loaded with a NLV peptide(NLVPMVATV); Kd=27.7+/2.3uM, ligand is a complex"
3jvf,3.30,2009,Kd=292nM,Kd,nM,292,0.292,0.5346171485515817,"3jvf.pdf (133-mer) Interleukin-17 receptor A and Interleukin-17F complex, Kd=292+/-19nM"
3he7,2.80,2009,Kd=296nM,Kd,nM,296,0.296,0.5287082889410615,3he6.pdf (302-mer) mouse CD1d-alpha-galactosylceramide with mouse Valpha14-Vbeta7 NKT TCR
3etb,3.80,2009,Kd=29pM,Kd,pM,29,2.9e-05,4.5376020021010435,"3etb.pdf (252-mer) antibody M18 complex PAD4, KD=2.9x10-11"
3gqi,2.50,2009,Kd=33nM,Kd,nM,33,0.033,1.4814860601221125,3gqi.pdf (226-mer) The Secondary Binding Site on the N-SH2 Domain of Phospholipase C-gamma-1
3g3b,2.40,2009,Kd=34nM,Kd,nM,34,0.034,1.4685210829577449,3g3a.pdf (129-mer) lamprey variable lymphocyte receptor mut13 complex with a protein antigen
3g9w,2.17,2009,Kd=36uM,Kd,uM,36,36.0,-1.5563025007672873,"3g9w.pdf (52-mer) talin2/Integrin beta-1D complex, Kd=36+/-2uM"
2w8b,1.86,2009,Kd=38nM,Kd,nM,38,0.038,1.4202164033831899,"2w8b.pdf (118-mer) PROCESSED TOLB IN COMPLEX WITH PAL, Kd=38+/-3nM"
3jse,2.90,2009,Kd=3pM,Kd,pM,3,3e-06,5.522878745280337,3jrm.pdf (228-mer) ligand is V230F mutated P26 activator
3gj8,1.82,2009,Kd=3uM,Kd,uM,3,3.0,-0.47712125471966244,3gj0.pdf (92-mer) human RanGDP-Nup153 ZnF34 complex
3idx,2.50,2009,Kd=4.04nM,Kd,nM,4.04,0.00404,2.393618634889395,"3hi1.pdf (215-mer) HXBc2 HIV-1 gp120 complex CD4-Binding-Site antibody b13, space group C222(supplementary data)"
3idy,3.20,2009,Kd=4.04nM,Kd,nM,4.04,0.00404,2.393618634889395,"3hi1.pdf (215-mer) HXBc2 HIV-1 gp120 complex CD4-Binding-Site antibody b13, space group C2221(supplementary data)"
2zxx,2.80,2009,Kd=4.4nM,Kd,nM,4.4,0.0044,2.3565473235138126,"2zxx.pdf (79-mer) mouse tGeminin (residues 79-157) and tCdt1 (residues 172-368), Kd=4.4+/-2.2nM"
3hi6,2.30,2009,Kd=4.7uM,Kd,uM,4.7,4.7,-0.6720978579357175,3hi5.pdf (180-mer) Fab fragment of AL-57 in complex with IA
3it8,2.80,2009,Kd=43pM,Kd,pM,43,4.2999999999999995e-05,4.366531544420414,3it8.pdf (161-mer) TNF alpha complexed with a poxvirus MHC-related TNF binding protein
3hae,2.90,2009,Kd=46nM,Kd,nM,46,0.046,1.337242168318426,"3gje.pdf (212-mer) HLA-A2-NYESO-1-3M4E5, in reference 3gje and 3gjg exchange"
3gj5,1.79,2009,Kd=47uM,Kd,uM,47,47.0,-1.6720978579357175,3gj0.pdf (34-mer) human RanGDP-Nup153 ZnF4 complex
3f7p,2.75,2009,Kd=49uM,Kd,uM,49,49.0,-1.6901960800285136,"3f7p.pdf (248-mer) integrin beta4(1126-1370) and plectin(1-293), Kd=49+/-7uM"
3gj3,1.79,2009,Kd=49uM,Kd,uM,49,49.0,-1.6901960800285136,3gj0.pdf (33-mer) human RanGDP-Nup153 ZnF2 complex
3kps,2.70,2009,Kd=49uM,Kd,uM,49,49.0,-1.6901960800285136,"3kpl.pdf (276-mer) Kd=49uM, LC13 TCR in complex with HLA B*4405 bound to EEYLQAFTY, ligand is a complex"
2w81,2.35,2009,Kd=4nM,Kd,nM,4,0.004,2.3979400086720375,"2w80.pdf (123-mer) FACTOR H BINDING PROTEIN AND CCPS 6-7, Space Group C2, Kd=4+/-1nM"
2w80,2.35,2009,Kd=4nM,Kd,nM,4,0.004,2.3979400086720375,"2w80.pdf (123-mer) FACTOR H BINDING PROTEIN AND CCPS 6-7, Space Group P1, Kd=4+/-1nM"
3h42,2.30,2009,Kd=4pM,Kd,pM,4,4e-06,5.3979400086720375,3h42.pdf (217-mer) PCSK9 in complex with Fab from LDLR competitive antibody
3gj7,1.93,2009,Kd=4uM,Kd,uM,4,4.0,-0.6020599913279624,3gj0.pdf (98-mer) human RanGDP-Nup153 ZnF12 complex
3kls,3.60,2009,Kd=5.5nM,Kd,nM,5.5,0.0055,2.2596373105057563,3kls.pdf (231-mer) ligand is SSL7 protein from Staphylococcus aureus; ITC test
3a67,1.80,2009,Kd=5.62nM,Kd,nM,5.62,0.00562,2.250263684430939,"3a67.pdf (129-mer) ligand is hen egg white lysozyme; Ka=17.8x10^7M-1, Kd=5.62x10-9M"
2ka6,NMR,2009,Kd=52nM,Kd,nM,52,0.052000000000000005,1.2839966563652008,"2ka4.pdf (45-mer) CBP-TAZ2/STAT1-TAD complex, Kd=52+/-31nM"
2k2s,NMR,2009,Kd=53nM,Kd,nM,53,0.053,1.275724130399211,"2k2s.pdf (61-mer) the TgMIC1-GLD  CTgMIC6-EGF2 complex, Kd=53+/-13nM"
2wbj,3.00,2009,Kd=565uM,Kd,uM,565,565.0,-2.7520484478194387,2wbj.pdf (279-mer)
2ka4,NMR,2009,Kd=58nM,Kd,nM,58,0.058,1.2365720064370627,"2ka4.pdf (57-mer) CBP-TAZ1/STAT2-TAD complex, Kd=58+/-3nM"
3ejh,2.10,2009,Kd=5uM,Kd,uM,5,5.0,-0.6989700043360189,"3ejh.pdf (23-mer) Fibronectin 8-9FnI Domain Pair complex a Type-I Collagen Peptide, Kd=5+/-1uM"
3gb8,2.90,2009,Kd=6.5uM,Kd,uM,6.5,6.5,-0.8129133566428556,"3gb8.pdf (329-mer) CRM1/Snurportin-1 complex, Kd=1.4uM at temp 15, Kd=6.5uM at temp 23"
3gj6,2.70,2009,Kd=6.5uM,Kd,uM,6.5,6.5,-0.8129133566428556,3gj0.pdf (34-mer) human RanGDP-Nup153 ZnF1 complex
3gj4,2.15,2009,Kd=6.6uM,Kd,uM,6.6,6.6,-0.8195439355418687,3gj0.pdf (33-mer) human RanGDP-Nup153 ZnF3 complex
3gjf,1.90,2009,Kd=63nM,Kd,nM,63,0.063,1.2006594505464183,"3gje.pdf (212-mer) HLA-A2-NYESO-1-3M4F4, T-cell receptor-like antibody"
2kj4,NMR,2009,Kd=65nM,Kd,nM,65,0.065,1.1870866433571443,2kj4.pdf (32-mer) VEK-30/K2Pg complex
3he6,2.90,2009,Kd=69.1nM,Kd,nM,69.1,0.0691,1.1605219526258017,3he6.pdf (302-mer) mouse CD1d-alpha-galactosylceramide with mouse Valpha14-Vbeta8.2 NKT TCR
3a6c,1.80,2009,Kd=7.14nM,Kd,nM,7.14,0.00714,2.1463017882238256,"3a67.pdf (129-mer) ligand is hen egg white lysozyme; Ka=14x10^7M-1, Kd=7.14x10-9M"
2wg3,2.60,2009,Kd=73.6nM,Kd,nM,73.6,0.0736,1.1331221856625011,"2wfx.pdf (164-mer) DHHN-eHHIP Delta N without Ca2+, Kd=73.6+/-12.9nM"
2wg4,3.15,2009,Kd=73.9nM,Kd,nM,73.9,0.07390000000000001,1.1313555616051743,"2wfx.pdf (155-mer) ShhN-eHHIP Delta N without Ca2+, Kd=73.9+/-12.3nM"
2wwx,1.50,2009,Kd=79nM,Kd,nM,79,0.079,1.1023729087095586,2wwx.pdf (217-mer) SIDM/DRRA(GEF/GDF DOMAIN)-RAB1 (GTPASE DOMAIN) COMPLEX
3jtl,3.20,2009,Kd=7pM,Kd,pM,7,7e-06,5.154901959985743,3jrm.pdf (228-mer) ligand is C7PAN mutated P26 activator
3dmm,2.60,2009,Kd=8.2uM,Kd,uM,8.2,8.2,-0.9138138523837167,3dmm.pdf (275-mer) ligand is murine MHCI molecule H-2Dd
2k3u,NMR,2009,Kd=8.4nM,Kd,nM,8.4,0.008400000000000001,2.0757207139381184,2k3u.pdf (24-mer) ligand is C5aR(P7-28S) peptide; Kd=8.4+/-1.1nM
2kde,NMR,2009,Kd=8.9uM,Kd,uM,8.9,8.9,-0.9493900066449128,"2kde.pdf (76-mer) major S5a (196-306):K48 linked diubiquitin species, Kd=8.9+/-0.6uM"
3ffc,2.80,2009,Kd=8.9uM,Kd,uM,8.9,8.9,-0.9493900066449128,"3ffc.pdf (202-mer) CF34 TCR in complex with HLA-B8/FLRGRAYGL, Kd=8.89+/-1.31uM"
2wss,3.20,2009,Kd=80nM,Kd,nM,80,0.08,1.0969100130080565,"2wss.pdf (190-mer) F1-ATPase; the OSCP; and a subcomplex between subunits b, d, and F6, Kd=80nM high-affinity site; Kd=6-8uM low-affinity site."
2wx0,2.40,2009,Kd=8uM,Kd,uM,8,8.0,-0.9030899869919435,2wx0.pdf (31-mer) TAB2 NZF 663-693 and K63 U2. Kd=8+/-1.7uM
3ia3,3.20,2009,Kd=93nM,Kd,nM,93,0.093,1.031517051446065,"3ia3.pdf (145-mer) ligand is wild-type bishis-Hemoglobin subunit alpha, Kd=93+/-5nM"
3bzd,2.30,2009,Kd=96uM,Kd,uM,96,96.0,-1.9822712330395684,"3bzd.pdf (237-mer) ligand is Enterotoxin type C-3; Kd=9.6x10-8M, SEC3-1A4 and mVBeta8.2; SEC3-wt and mVBeta8.2, Kd=12uM"
2kgx,NMR,2009,Kd=9uM,Kd,uM,9,9.0,-0.9542425094393249,"2kgx.pdf (91-mer) Talin 1655-1822 Interacts with the Talin F3 Domain, Kd=9+/-0.8uM"
3gmw,2.10,2009,Kd~0.05nM,Kd,nM,0.05,5e-05,4.301029995663981,"3gmv.pdf (156-mer) BLIP-I and TEM-1 complex, BLIP and BLIP-I share Ki=0.1-0.6nM, Kd~0.05nM"
2vxt,1.49,2009,Kd~0.2nM,Kd,nM,0.2,0.0002,3.6989700043360187,2vxt.pdf (157-mer) ligand is HUMAN INTERLEUKIN-18  cysteine mutant
3fxd,2.10,2009,Kd~20nM,Kd,nM,20,0.02,1.6989700043360187,"3fxd.pdf (73-mer) ligand is Protein IcmR; Kd~20nM, actual Kd may be lower"
3fsh,2.76,2009,Kd~5nM,Kd,nM,5,0.005,2.3010299956639813,3fsh.pdf (28-mer) the binding affinity is for Ube2ge bound GST-gp78C.
3h8d,2.20,2009,Kd~80nM,Kd,nM,80,0.08,1.0969100130080565,3h8d.pdf (39-mer) myosin VI CBD in complex with the Dab2 MIR residues 675-713
3f4y,2.00,2009,Ki<0.2nM,Ki,nM,0.2,0.0002,3.6989700043360187,"3f4y.pdf (40-mer) HIV gp41 NHR domain complex HIV gp41 CHR domain mutant 3, Ki<0.2nM"
3e1z,1.86,2009,Ki=0.036nM,Ki,nM,0.036,3.6e-05,4.443697499232712,"3e1z.pdf (110-mer) chagasin, a protein inhibitor from Trypanosoma cruzi"
3h6s,2.22,2009,Ki=0.08nM,Ki,nM,0.08,8e-05,4.096910013008056,"3h6s.pdf (152-mer) ligand is clitocypin, Ki=0.08+/-0.03nM"
3fii,2.17,2009,Ki=1.9nM,Ki,nM,1.9,0.0019,2.721246399047171,3fie.pdf (33-mer) BoNT F-inh2 complex
3fie,2.10,2009,Ki=1nM,Ki,nM,1,0.001,3.0,3fie.pdf (38-mer) BoNT F-inh1 complex
3k9m,2.61,2009,Ki=2nM,Ki,nM,2,0.002,2.6989700043360187,"3k9m.pdf (98-mer) affinity data is not for human source stefin A and cathepsin B, Ki=2+/-0.42nM"
3e2l,1.87,2009,Ki=69pM,Ki,pM,69,6.9e-05,4.161150909262744,"3e2k.pdf (165-mer) KPC-2 Beta-lactamase G175S mutant and BLIP, space group C2, Ki=69+/-6pM"
3e2k,2.10,2009,Ki=69pM,Ki,pM,69,6.9e-05,4.161150909262744,"3e2k.pdf (165-mer) KPC-2 Beta-lactamase G175S mutant and BLIP, space group P212121, Ki=69+/-6pM"
3g7a,2.80,2009,Ki=9nM,Ki,nM,9,0.009000000000000001,2.0457574905606752,"3f4y.pdf (38-mer) HIV gp41 NHR domain complex HIV gp41 CHR domain mutant 10, Ki=9nM"
3f50,2.80,2009,Ki=9nM,Ki,nM,9,0.009000000000000001,2.0457574905606752,3f50.pdf (40-mer) Oligomer 10. The binding affinity is for gp41-5. IC50=5+/-2nM.
3n00,2.60,2010,IC50=0.22uM,IC50,uM,0.22,0.22,0.6575773191777937,"3n00.pdf (21-mer) ligand is Nuclear receptor corepressor 1 peptide, affinity may for non-truncated"
3ma9,2.05,2010,Kd<10nM,Kd,nM,10,0.01,2.0,"3ma9.pdf (217-mer) gp41 derived protein complexed with fab 8066, Kd<<10nM"
3ixt,2.75,2010,Kd=0.035nM,Kd,nM,0.035,3.5000000000000004e-05,4.455931955649724,3ixt.pdf (26-mer) ligand is Peptide Epitope
3mc0,2.00,2010,Kd=0.125uM,Kd,uM,0.125,0.125,0.9030899869919435,"3mc0.pdf (239-mer) ITC KD=0.125uM, SPR KD=0.270uM"
3fpu,1.76,2010,Kd=0.12nM,Kd,nM,0.12,0.00012,3.9208187539523753,3fpu.pdf (70-mer) ligand is C-C motif chemokine 3
3iu3,2.90,2010,Kd=0.14nM,Kd,nM,0.14,0.00014000000000000001,3.853871964321762,3iu3.pdf (223-mer) ligand is IL-2Ra (CD25) ectodomain
3laq,3.20,2010,Kd=0.17nM,Kd,nM,0.17,0.00017,3.769551078621726,3laq.pdf (134-mer) ligand is murine Urokinase-type plasminogen activator
2wpt,1.78,2010,Kd=0.1uM,Kd,uM,0.1,0.1,1.0,2wpt.pdf (86-mer) ligand is COLICIN-E2 IMMUNITY PROTEIN
3lk2,2.20,2010,Kd=0.1uM,Kd,uM,0.1,0.1,1.0,"3lk2.pdf (52-mer) ligand is CARMIL, capping protein interacting motif, CBR52; Kd=0.1~0.2uM"
3nfp,2.86,2010,Kd=0.27nM,Kd,nM,0.27,0.00027,3.5686362358410126,3nfp.pdf (223-mer) ligand is Interleukin-2 receptor subunit alpha (CD25) ectodomain; SPR Kd=0.27nM
3ogo,2.80,2010,Kd=0.32nM,Kd,nM,0.32,0.00032,3.494850021680094,"3ogo.pdf (123-mer) ligand is GFP-nanobody; ITC Kd<1nM, in reference SPR Kd=0.32nM"
3l9j,2.10,2010,Kd=0.34nM,Kd,nM,0.34,0.00034,3.4685210829577446,"3l9j.pdf (149-mer) trimeric TN-2-B1-C31, Biacore Kd=3.4 x 10-10M"
3mca,2.74,2010,Kd=0.39uM,Kd,uM,0.39,0.39,0.4089353929735008,"3mca.pdf (390-mer) ligand is Protein dom34; Kd=0.39+/-0.02uM, in support info"
3kuc,1.92,2010,Kd=0.442uM,Kd,uM,0.442,0.442,0.3545777306509081,3kuc.pdf (81-mer) ligand is RafRBD(A85K/N71R)
3o6q,2.50,2010,Kd=0.46nM,Kd,nM,0.46,0.00046,3.337242168318426,"3o6q.pdf (56-mer) ligand is Stage II sporulation protein SB; a Toxin-Antitoxin System, Kd=4.6x10-10M"
2kwj,NMR,2010,Kd=0.5uM,Kd,uM,0.5,0.5,0.3010299956639812,2kwj.pdf (20-mer) ligand is  Histone H3K14ac peptide; Kd1=0.5+/-0.1uM(ITC); Kd2=1.2+/-0.2uM(Fluorescent Polarization Assay ); IC50=0.5+/-0.1uM
3lev,2.50,2010,Kd=0.600nM,Kd,nM,0.600,0.0006,3.2218487496163566,"3lev.pdf (179-mer) epitope scaffold ES2, Kd=0.600+/-0.004 nM"
2wp3,1.48,2010,Kd=0.794uM,Kd,uM,0.794,0.794,0.10017949757290372,"2wp3.pdf (109-mer) ligand is OBSCURIN LIKE 1 IG, Form I, trigonal, Ka=12.6+/-1.5 x10^5M-1"
3n85,3.20,2010,Kd=0.79nM,Kd,nM,0.79,0.00079,3.1023729087095586,3n85.pdf (217-mer) ligand is ryptophan-rich antibody fragment fab37; Kd=0.79+/-0.33nM
3mxw,1.83,2010,Kd=0.7nM,Kd,nM,0.7,0.0007,3.154901959985743,"3mxv.pdf (169-mer) ITC in solution, Kd=0.7nM"
2wwk,1.70,2010,Kd=1.28uM,Kd,uM,1.28,1.28,-0.10720996964786837,"2wp3.pdf (109-mer) ligand is OBSCURIN LIKE 1 IG F17R MUTANT, Ka=7.8+/-1.3 x10^5M-1"
2ki4,NMR,2010,Kd=1.34uM,Kd,uM,1.34,1.34,-0.12710479836480765,2ki4.pdf (98-mer)
3oky,2.19,2010,Kd=1.3uM,Kd,uM,1.3,1.3,-0.11394335230683679,3okw.pdf (565-mer) mouse Sema6A-PlxnA2(1-4); Kd for monomerized Sema
3ma2,2.05,2010,Kd=1.53uM,Kd,uM,1.53,1.53,-0.1846914308175988,3ma2.pdf (125-mer) ligand is Metalloproteinase inhibitor 1
3lk4,1.99,2010,Kd=1.5nM,Kd,nM,1.5,0.0015,2.8239087409443187,"3lk4.pdf (29-mer) ligand is CARMIL, capping protein interacting motif, CBR115"
3lqa,3.40,2010,Kd=1.6uM,Kd,uM,1.6,1.6,-0.2041199826559248,3lmj.pdf (217-mer) CAP210 plus sCD4 interaction with human anti HIV 21c Fab
3kud,2.15,2010,Kd=1.7uM,Kd,uM,1.7,1.7,-0.2304489213782739,3kuc.pdf (81-mer) ligand is RafRBD(A85K) mutant
3m0a,2.61,2010,Kd=1.7uM,Kd,uM,1.7,1.7,-0.2304489213782739,3m0a.pdf (75-mer)
3osl,6.00,2010,Kd=1.8nM,Kd,nM,1.8,0.0018000000000000002,2.744727494896694,3osl.pdf (74-mer)
3k75,2.95,2010,Kd=110nM,Kd,nM,110,0.11,0.958607314841775,3k75.pdf (252-mer) ligand is DNA polymerase beta catalytic domain; Kd=110+/-10nM
3kz1,2.70,2010,Kd=110nM,Kd,nM,110,0.11,0.958607314841775,3kz1.pdf (182-mer) Fragment:residues 710-1085; Kd= 110+/-15 nM
2xb6,2.60,2010,Kd=115nM,Kd,nM,115,0.115,0.9393021596463883,"2xb6.pdf (179-mer) ligand is NEUREXIN-1-BETA LNS DOMAIN; Kd=115nM, in reference similar Kd=132nM"
3pl6,2.55,2010,Kd=14.3uM,Kd,uM,14.3,14.3,-1.1553360374650619,"3pl6.pdf (268-mer) Autoimmune TCR Hy.1B11 in complex with HLA-DQ1 and MBP 85-99, Kd=14.3+/-1.5uM"
3k3q,2.60,2010,Kd=147pM,Kd,pM,147,0.000147,3.832682665251824,"3k3q.pdf (151-mer) ligand is llama Aa1 VHH domain, Kd=1.47x10-10M, IC50=4.7x10-10M"
3h3p,2.70,2010,Kd=14nM,Kd,nM,14,0.014,1.853871964321762,"3h3p.pdf (85-mer) ligand is epitope peptide; Kd=14nM by SPR, ITC data is not successful"
2kxh,NMR,2010,Kd=14uM,Kd,uM,14,14.0,-1.146128035678238,2kxh.pdf (31-mer) ligand is peptide of Far upstream element-binding protein 1(FBP Nbox); Kd=14+/-8uM
3k6g,1.95,2010,Kd=16.5nM,Kd,nM,16.5,0.0165,1.7825160557860937,3k6g.pdf (42-mer) ligand is Telomeric repeat-binding factor 2 (275-316)
3oak,2.15,2010,Kd=169nM,Kd,nM,169,0.169,0.7721132953863264,3oak.pdf (31-mer) Spn1 (Iws1)-Spt6 complex
2x1w,2.70,2010,Kd=16nM,Kd,nM,16,0.016,1.7958800173440752,"2x1w.pdf (110-mer) ligand is VASCULAR ENDOTHELIAL GROWTH FACTOR C(VEGF-C); Kd=16+/-6.7nM(measured  by ITC) , Kd=18.2+/-5.3nM(measured  by SPR)"
2x1x,3.10,2010,Kd=16nM,Kd,nM,16,0.016,1.7958800173440752,2x1x.pdf (110-mer) ligand is VEGF-C(VASCULAR ENDOTHELIAL GROWTH FACTOR C); Kd=16+/-6.7nM(ITC); Kd=18.2+/-5.3nM(SPR)
2l0f,NMR,2010,Kd=172uM,Kd,uM,172,172.0,-2.2355284469075487,2ktf.pdf (76-mer) ligand is ubiquitin; Kd=172+/-21uM
3m63,2.40,2010,Kd=175nM,Kd,nM,175,0.17500000000000002,0.7569619513137055,3m63.pdf (101-mer)
3l5n,7.54,2010,Kd=180nM,Kd,nM,180,0.18,0.744727494896694,"3l3o.pdf (88-mer) ligand is Staphylococcal Complement Inhibitor (SCIN), SCIN binds directly to activated C3b in near-physiological buffers"
3m18,1.95,2010,Kd=180pM,Kd,pM,180,0.00017999999999999998,3.744727494896694,"3m18.pdf (129-mer) ligand is hen egg lysozyme C; code 3m19 is pure VLRA.R5.1, complex Kd=120pM"
2kwi,NMR,2010,Kd=184nM,Kd,nM,184,0.184,0.7351821769904635,2kwi.pdf (56-mer) ligand is RalA-binding protein 1 C411S mutant
2wh6,1.50,2010,Kd=18nM,Kd,nM,18,0.018000000000000002,1.744727494896694,"2v6q.pdf (26-mer) ligand is THE BIM BH3 DOMAIN, Kd=18+/-2nM"
2rr3,NMR,2010,Kd=2.1uM,Kd,uM,2.1,2.1,-0.3222192947339193,2rr3.pdf (47-mer) wildtype ITC Kd=2.1+/-0.1uM
3mv7,2.00,2010,Kd=2.2uM,Kd,uM,2.2,2.2,-0.3424226808222063,"3mv7.pdf (241-mer) with Beta-2-microglobulin and HPVG peptide, Kd= 2.2+/-0.2uM, WT TK3 TCR with two chain"
3o4o,3.30,2010,Kd=2.36uM,Kd,uM,2.36,2.36,-0.37291200297010657,"3o4o.pdf (158-mer) ligand is Interleukin-1 beta; Interleukin-1 beta with IL1-RI, Kd=6.38nM, type II Kd=2.36uM"
3onw,2.38,2010,Kd=2.3nM,Kd,nM,2.3,0.0023,2.638272163982407,3onw.pdf (36-mer) G-alpha-i1 mutation: Q147L; Kd=1.9-2.6 nM with GDP
2kwk,NMR,2010,Kd=2.3uM,Kd,uM,2.3,2.3,-0.36172783601759284,2kwk.pdf (114-mer)
3mjh,2.03,2010,Kd=2.4uM,Kd,uM,2.4,2.4,-0.38021124171160603,3mjh.pdf (34-mer) 34-mer C2H2 Zinc Finger of EEA1
3l95,2.19,2010,Kd=2.5nM,Kd,nM,2.5,0.0025,2.6020599913279625,3l95.pdf (244-mer) ligand is human Notch1 Negative Regulatory Region (NRR); Kd=2.5x10-9M
3mhp,1.70,2010,Kd=2.75uM,Kd,uM,2.75,2.75,-0.43933269383026263,"3mhp.pdf (26-mer) FNR:Tic62 peptide, Kd=2.75+/-0.33uM"
3a4s,2.70,2010,Kd=2.81uM,Kd,uM,2.81,2.81,-0.4487063199050799,3a4s.pdf (79-mer) Kd=2.81+/-0.81um
3ohm,2.70,2010,Kd=200nM,Kd,nM,200,0.2,0.6989700043360187,"3ohm.pdf (885-mer) ligand: phospholipase C beta 3; AlF4-, Mg2+ containing"
3hug,2.35,2010,Kd=20nM,Kd,nM,20,0.02,1.6989700043360187,3hug.pdf (92-mer) ligand is RNA polymerase sigma factor of SigL; Zn2+ containing;  Kd=150nM(Zn2+ free Mycobacterium tuberculosis RslA to sigma SigL)
3nh7,2.70,2010,Kd=20nM,Kd,nM,20,0.02,1.6989700043360187,3nh7.pdf (129-mer) ligand is Bone morphogenetic protein receptor type-1A extracellular domain
3ncc,2.50,2010,Kd=212mM,Kd,mM,212,212000.0,-5.326335860928752,"3mzg.pdf (210-mer) KD=3.6 x 10-6M, PH=7.0, Kd=0.212M"
3kyi,2.80,2010,Kd=218uM,Kd,uM,218,218.0,-2.3384564936046046,3kyi.pdf (145-mer) ligand is CheY6 from R. sphaeroides; Kd=218+/-8uM
3aaa,2.20,2010,Kd=21nM,Kd,nM,21,0.021,1.6777807052660807,3aa0.pdf (123-mer) Actin capping protein in complex with V-1 Myotrophin
2xdf,NMR,2010,Kd=21uM,Kd,uM,21,21.0,-1.3222192947339193,2xdf.pdf (85-mer) ligand is PHOSPHOCARRIER PROTEIN HPR; Kd=21+/-1.1uM
3o6b,3.10,2010,Kd=227nM,Kd,nM,227,0.227,0.6439741428068773,"3o6b.pdf (76-mer) ligand is Cell division control protein 53, WHB Subdomain; Kd=227+/-37nM"
2wd5,2.70,2010,Kd=22nM,Kd,nM,22,0.022,1.6575773191777938,2wd5.pdf (213-mer) SMC hinge heterodimer (Mouse)
3mzw,2.90,2010,Kd=22pM,Kd,pM,22,2.2e-05,4.657577319177793,3mzw.pdf (58-mer) ligand is ZHER2 affibody molecule
3ouw,2.91,2010,Kd=23nM,Kd,nM,23,0.023,1.6382721639824072,3ouw.pdf (65-mer) ligand is nonphosphorylated  Lymphoid enhancer-binding factor 1; Kd=23+/-3nM
2ktf,NMR,2010,Kd=23uM,Kd,uM,23,23.0,-1.3617278360175928,"2ktf.pdf (76-mer) ligand is ubiquitin; Kd=23+/-0.9uM, ITC temperature is 10 degree"
3aa6,1.90,2010,Kd=260nM,Kd,nM,260,0.26,0.585026652029182,"3aa0.pdf (23-mer) CP/CD23, Cp-binding motif derived from CD2AP"
3l5x,1.90,2010,Kd=269pM,Kd,pM,269,0.000269,3.570247719997592,"3l5w.pdf (113-mer) complex between IL-13 and H2L6 FAB, Kd=269+/-24pM"
3kxf,3.10,2010,Kd=27uM,Kd,uM,27,27.0,-1.4313637641589874,"3kww.pdf (276-mer) ligand is HLA-B*3508 (Q65A, T69A, Q155A); Kd=27uM for AAA mutant"
3l89,3.50,2010,Kd=284nM,Kd,nM,284,0.28400000000000003,0.5466816599529623,"3l89.pdf (126-mer) ligand is domains SCR1 and SCR2 of CD46 (membrane cofactor protein, MCP)"
3nvq,2.40,2010,Kd=287nM,Kd,nM,287,0.28700000000000003,0.5421181032660076,3nvn.pdf (476-mer) ligand is Semaphorin-binding module of PlexinC1
3lhp,2.70,2010,Kd=28pM,Kd,pM,28,2.8e-05,4.552841968657781,"3lh2.pdf (123-mer) ligand is HIV epitope-scaffold 4E10_D0_1ISEA_004_N (T93); SPR, mAb 4E10 fv in solution, Kd=28pM and Epitope-scaffold in solution Kd=7.5pM"
3kj2,2.35,2010,Kd=2nM,Kd,nM,2,0.002,2.6989700043360187,"3kj0.pdf (22-mer) ligand is Bim BH3 mutant F4aE, Kd<2nM"
3kj1,1.95,2010,Kd=2nM,Kd,nM,2,0.002,2.6989700043360187,"3kj0.pdf (22-mer) ligand is Bim BH3 mutant I2dA, Kd<2nM"
3kj0,1.70,2010,Kd=2nM,Kd,nM,2,0.002,2.6989700043360187,"3kj0.pdf (27-mer) ligand is Bim BH3 mutant I2dY, Kd<2nM"
2wvw,9.00,2010,Kd=2uM,Kd,uM,2,2.0,-0.3010299956639812,2wvw.pdf (155-mer) ligand is RbcL.
3npz,3.35,2010,Kd=3.15uM,Kd,uM,3.15,3.15,-0.4983105537896005,"3npz.pdf (199-mer) ligand is Natural Hormone (PRL), wild type Kd=3.15+/-0.16uM, unit should be uM"
3n06,2.00,2010,Kd=3.1mM,Kd,mM,3.1,3100.0,-3.4913616938342726,"3mzg.pdf (210-mer) KD=2.9+/-2  x 10-8M, PH=7.0, Kd=0.0031M"
2l14,NMR,2010,Kd=3.1uM,Kd,uM,3.1,3.1,-0.4913616938342727,"2l14.pdf (49-mer) N-terminally truncated peptides p53(13-61), Kd=3.1+/-0.2uM"
2xra,2.30,2010,Kd=3.3nM,Kd,nM,3.3,0.0033,2.4814860601221125,2xra.pdf (228-mer) ligand is TRANSMEMBRANE PROTEIN GP41 MIMETIC 5-HELIX; SPR Kd=3.3nM
3m9d,4.50,2010,Kd=3.4uM,Kd,uM,3.4,3.4,-0.5314789170422551,"3m91.pdf (68-mer) Kd range from 3.4uM to 4.2uM, Pup and Mpa 1-234 complex"
3oiq,2.40,2010,Kd=3.8uM,Kd,uM,3.8,3.8,-0.5797835966168101,3oiq.pdf (36-mer) ligand is catalytic subunit of DNA polymerase alpha Pol1
2xgy,1.80,2010,Kd=30uM,Kd,uM,30,30.0,-1.4771212547196624,"2xgy.pdf (173-mer) ligand is PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A, CYCLOPHILIN A"
2xqr,2.58,2010,Kd=31nM,Kd,nM,31,0.031,1.5086383061657274,"2xqr.pdf (149-mer) ligand is protein inhibitor (CIF, or cellwall inhibitor of beta-fructosidase) from tobacco; Kd=31+/-10nM at PH4.5"
3mv8,2.10,2010,Kd=34.66uM,Kd,uM,34.66,34.66,-1.5398285583778981,"3mv7.pdf (242-mer) TK3 TCR with two chain, mutation at chain B Gln55His; with Beta-2-microglobulin and HPVG peptide, Kd= 34.66+/-1.66uM"
2xa0,2.70,2010,Kd=35.3nM,Kd,nM,35.3,0.0353,1.4522252946121774,"2xa0.pdf (31-mer) BCL-2 IN COMPLEX WITH A 31-mer BAX BH3 PEPTIDE, Kd=35.3+/-2.42nM"
3oux,2.40,2010,Kd=35nM,Kd,nM,35,0.035,1.4559319556497243,3oux.pdf (67-mer) ligand is Casein kinase II phosphorylated Lymphoid enhancer-binding factor 1; Kd=35+/-12nM
2wy8,1.70,2010,Kd=360nM,Kd,nM,360,0.36,0.44369749923271273,"2wy7.pdf (80-mer) ligand is STAPHYLOCOCCUS AUREUS COMPLEMENT SUBVERSION PROTEIN SBI-IV; ITC Kd=360nM, IC50=10uM"
3kw5,2.83,2010,Kd=385nM,Kd,nM,385,0.385,0.4145392704914993,3ifw.pdf (75-mer) ligand is ubiquitin vinylmethylester
3jza,1.80,2010,Kd=3pM,Kd,pM,3,3e-06,5.522878745280337,"3jza.pdf (197-mer) ligand is GEF domain of DrrA/SidM from Legionella pneumophila(DrrA(340-533)), Kd=3pM(without GDP or GTP) , Kd=7uM(with GDP)"
2xtj,2.70,2010,Kd=4.4nM,Kd,nM,4.4,0.0044,2.3565473235138126,2xtj.pdf (131-mer) apparent equilibrium affinity constant KD=4.4+/-1.4nM
2x9a,2.47,2010,Kd=4.4uM,Kd,uM,4.4,4.4,-0.6434526764861874,"2x9a.pdf (65-mer) ligand is C-TERMINAL DOMAIN OF TOLA; Kd=4.4uM for isolated N1, Kd=7.1uM for N1 within G3P"
3lb6,3.05,2010,Kd=4.7pM,Kd,pM,4.7,4.7e-06,5.327902142064283,"3lb6.pdf (132-mer) ligand is Interleukin-13; Kd=4.7pM(measured by ITC); IL-13R alpha2 has sub-100fM affinity for IL-13 by SPR,"
3mzg,2.10,2010,Kd=4.97mM,Kd,mM,4.97,4970.0,-3.696356388733332,"3mzg.pdf (210-mer) KD=3.3+/-2  x 10-8M, PH=7.0, Kd=0.00497M"
3ajb,2.50,2010,Kd=40.8nM,Kd,nM,40.8,0.040799999999999996,1.3893398369101202,"3ajb.pdf (49-mer) ligand is Peroxisomal biogenesis factor 19 N-terminal peptide; Kd=40.8+/-1.6nM for pex19p N-terminal, full length pex19p is 3.4nM"
3lbx,2.80,2010,Kd=400nM,Kd,nM,400,0.4,0.3979400086720376,"3lbx.pdf (185-mer) The overall structure of the alpha 0-1/beta 16-17 complex, Kd=400+/-100nM"
3h7b,1.88,2010,Kd=41uM,Kd,uM,41,41.0,-1.6127838567197355,3h7b.pdf (100-mer) TCR-pMHC complex
2kwo,NMR,2010,Kd=46.9uM,Kd,uM,46.9,46.9,-1.6711728427150832,2kwo.pdf (20-mer) Supplementary information; ligand is Histone H4K16ac peptide; Kd=46.9+/-10.0uM; IC50=36.5+/-1.1uM.
2kri,NMR,2010,Kd=46uM,Kd,uM,46,46.0,-1.662757831681574,2kri.pdf (40-mer) complex b2GPI-DV/LA4
3lh2,2.65,2010,Kd=47pM,Kd,pM,47,4.7e-05,4.327902142064283,"3lh2.pdf (114-mer) ligand is HIV epitope-scaffold 4E10_1VI7A_S0_002_N (T88); SPR, mAb 4E10 fv in solution, Kd=47pM and Epitope-scaffold in solution Kd=5.6nM"
3im4,2.29,2010,Kd=48nM,Kd,nM,48,0.048,1.3187587626244128,3im4.pdf (45-mer)
3kr3,2.20,2010,Kd=49pM,Kd,pM,49,4.9e-05,4.309803919971486,3kr3.pdf (251-mer)
3aa0,1.70,2010,Kd=4uM,Kd,uM,4,4.0,-0.6020599913279624,"3aa0.pdf (21-mer) ligand is  peptide from Leucine-rich repeat-containing protein 16A(CA21), Kd=4000nM"
3n0p,2.10,2010,Kd=5.1mM,Kd,mM,5.1,5100.0,-3.7075701760979363,"3mzg.pdf (210-mer) KD=5.3+/-2  x 10-8M, PH=7.0, Kd=0.0051M"
3h9h,2.00,2010,Kd=5.4uM,Kd,uM,5.4,5.4,-0.7323937598229685,3h9h.pdf (100-mer) TCR-pMHC complex; Kd=5.4+/-0.1uM
3ol2,2.99,2010,Kd=5.5uM,Kd,uM,5.5,5.5,-0.7403626894942439,3okw.pdf (528-mer) human Sema4D-PlxnB1(1-2); Kd for monomerized Sema
3mv9,2.70,2010,Kd=5.76uM,Kd,uM,5.76,5.76,-0.7604224834232121,"3mv7.pdf (241-mer) TK3 TCR with two chain, mutation at chain B Gln55Ala; with Beta-2-microglobulin and HPVG peptide, Kd= 5.76+/-0.07uM"
2kvq,NMR,2010,Kd=50uM,Kd,uM,50,50.0,-1.6989700043360187,2kvq.pdf (63-mer) affinity for NusB:NusE:NusG-CTD
2kwu,NMR,2010,Kd=51uM,Kd,uM,51,51.0,-1.7075701760979363,2kwu.pdf (76-mer) Kd=51+/-13uM
2xqb,2.60,2010,Kd=52pM,Kd,pM,52,5.2e-05,4.2839966563652006,2xqb.pdf (114-mer) ligand is human INTERLEUKIN 15
3l5w,2.00,2010,Kd=52pM,Kd,pM,52,5.2e-05,4.2839966563652006,"3l5w.pdf (113-mer) complex between IL-13 and C836 FAB, Kd=52+/-10pM"
2kqs,NMR,2010,Kd=55.3uM,Kd,uM,55.3,55.3,-1.7427251313046983,2kqs.pdf (22-mer) Kd=55.3+/-14.2uM
3mj7,2.80,2010,Kd=5uM,Kd,uM,5,5.0,-0.6989700043360189,"3mj7.pdf (225-mer) ligand is Coxsackie and Adenovirus receptor, CAR"
2x2d,1.90,2010,Kd=6.1uM,Kd,uM,6.1,6.1,-0.785329835010767,2x2d.pdf (147-mer) Kd=6.1+/-0.9uM; ligand is HIV-1 N-TERM CAPSID DOMAIN
3o9w,2.80,2010,Kd=6.2uM,Kd,uM,6.2,6.2,-0.7923916894982539,"3o8x.pdf (209-mer) with BbGL-2c ligand.TCR(Valpha14 chimera:Mouse variable domain, Human T-cell receptor alpha chain C region constant domain; Vbeta8.2 chimera:Mouse variable domain, Human T-cell receptor beta-2 chain C region constant domain )"
2l0t,NMR,2010,Kd=64uM,Kd,uM,64,64.0,-1.806179973983887,"2l0t.pdf (163-mer) Kd=64+/-8uM(VHS/Ub, 0mM NaCl);Kd=54+/-6uM(Ub/VHS, 0mM NaCl);Kd=156+/-14uM(VHS/Ub, 100mM NaCl);Kd=166+/-12uM(Ub/VHS, 100mM NaCl);"
2wy3,1.80,2010,Kd=66nM,Kd,nM,66,0.066,1.1804560644581312,"2wy3.pdf (158-mer) ligand is UNCHARACTERIZED PROTEIN UL16; MICBpf Kd=66nM, complete ectodomain Kd=67nM"
3lb8,2.60,2010,Kd=66uM,Kd,uM,66,66.0,-1.8195439355418688,"3lb8.pdf (106-mer) covalent putidaredoxin reductase-putidaredoxin complex, Determined by cyclic voltammetry"
2kyg,NMR,2010,Kd=67nM,Kd,nM,67,0.067,1.1739251972991736,2kyg.pdf (50-mer) ligand is cAMP-dependent protein kinase type II-alpha regulatory subunit
3me2,2.80,2010,Kd=68pM,Kd,pM,68,6.8e-05,4.167491087293763,3me2.pdf (171-mer) ligand is Tumor necrosis factor ligand superfamily member 1; Kd=6.8x10-11M
3o8x,2.74,2010,Kd=690nM,Kd,nM,690,0.6900000000000001,0.16115090926274464,"3o8x.pdf (209-mer) with GalA-GSL ligand.TCR(Valpha14 chimera:Mouse variable domain, Human T-cell receptor alpha chain C region constant domain; Vbeta8.2 chimera:Mouse variable domain, Human T-cell receptor beta-2 chain C region constant domain )"
3lk3,2.68,2010,Kd=6nM,Kd,nM,6,0.006,2.221848749616356,3lk3.pdf (115-mer) ligand is CD2AP peptide
3ngb,2.68,2010,Kd=7.7nM,Kd,nM,7.7,0.0077,2.113509274827518,"3ngb.pdf (353-mer) ligand is HIV-1 gp120; non-CD4-bound conformations Kd=7.7nM, CD4-bound Kd=0.617nM, see support info"
3k2m,1.75,2010,Kd=7nM,Kd,nM,7,0.007,2.154901959985743,"3k2m.pdf (101-mer) ligand is Monobody HA4, Kd for HA4 and Abl2 SH2 is 18nM"
3egg,1.85,2010,Kd=8.7nM,Kd,nM,8.7,0.0087,2.0604807473813813,3egg.pdf (170-mer) ligand is PP1 binding and PDZ domains of Spinophilin
3o34,1.90,2010,Kd=8.8uM,Kd,uM,8.8,8.8,-0.9444826721501687,3o34.pdf (22-mer) ligand:H3(13-32)K23ac peptide; Kd=8.8+/-0.1uM; imcomplete ligand structure
3kbt,2.75,2010,Kd=9.29nM,Kd,nM,9.29,0.00929,2.031984286006358,3kbt.pdf (161-mer) wild type Kd=9.29nM
3gs2,1.70,2010,Kd=9.2nM,Kd,nM,9.2,0.0092,2.036212172654445,"3gs2.pdf (30-mer) ligand is Chromobox protein homolog 7, Cbox domain"
3nvn,2.26,2010,Kd=9.4nM,Kd,nM,9.4,0.0094,2.0268721464003012,3nvn.pdf (476-mer) ligand is Semaphorin-binding module of PlexinC1
3orv,1.91,2010,Kd=9.4uM,Kd,uM,9.4,9.4,-0.9731278535996987,3orv.pdf (373-mer) ligand is Methylamine utilization protein mauG Y294H mutant; Kd=9.4+/-0.1uM for quinone MADH and diferrous Y294H MauG
3ixa,2.10,2010,Kd=9.8uM,Kd,uM,9.8,9.8,-0.9912260756924949,3ixa.pdf (100-mer) TCR-pMHC complex; Kd=9.8+/-0.1uM
3ixs,1.70,2010,Kd=90nM,Kd,nM,90,0.09,1.0457574905606752,3gs2.pdf (37-mer) ligand is RING1 and YY1-binding protein C-terminal domain
2kwv,NMR,2010,Kd=90uM,Kd,uM,90,90.0,-1.954242509439325,2kwu.pdf (76-mer) Kd=90+/-14uM
3ncb,2.10,2010,Kd=93mM,Kd,mM,93,93000.0,-4.968482948553935,"3mzg.pdf (210-mer) KD=1.36 x 10-6M, PH=7.0, Kd=0.093M"
3k1r,2.30,2010,Kd~1nM,Kd,nM,1,0.001,3.0,"3k1r.pdf (74-mer) ligand is SAM-PBM of Sans, for only SAM Kd=40uM, for only PBM Kd~1uM"
3mac,2.50,2010,Kd~200nM,Kd,nM,200,0.2,0.6989700043360187,"3ma9.pdf (217-mer) GP41-derived protein complexed with fab 8062, Kd~200nM"
2wus,2.90,2010,Kd~5uM,Kd,uM,5,5.0,-0.6989700043360189,"2wus.pdf (112-mer) Kd~5-10uM, temperature is 10 C"
3lms,2.50,2010,Ki=1.2nM,Ki,nM,1.2,0.0012,2.9208187539523753,"3lms.pdf (74-mer) ligand is tick-derived carboxypeptidase inhibitor(TCI), Ki=1.2nM"
3l33,2.48,2010,Ki=136nM,Ki,nM,136,0.136,0.8664610916297825,"3l33.pdf (52-mer) Ki=1.36 +/- 0.19 x 10-7M, so Ki is 136nM, not 19nM"
2xtt,0.93,2010,Ki=20pM,Ki,pM,20,1.9999999999999998e-05,4.698970004336019,"2xtt.pdf (36-mer) liand is PROTEASE INHIBITOR SGPI-1;  SGPI with bovine trypsin Ki micromolar range, SGPI-1-P02 Ki is pM range, in ref. 20"
3kz0,2.35,2010,Ki=273nM,Ki,nM,273,0.273,0.563837352959244,3kz0.pdf (23-mer) ligand is Mcl-1 specific peptide MB7; Ki=273+/-37nM
3ssb,1.80,2011,IC50=0.6nM,IC50,nM,0.6,0.0006,3.2218487496163566,3ssb.pdf (40-mer)
2yj1,2.24,2011,IC50=26nM,IC50,nM,26,0.026000000000000002,1.585026652029182,2yj1.pdf (23-mer) IC50=26+/-2nM
3qbr,2.60,2011,IC50=68nM,IC50,nM,68,0.068,1.1674910872937636,3qbr.pdf (34-mer) ligand is Bcl-2 homologous antagonist/killer from Homo sapiens;  solution competition assays
3p8m,2.90,2011,Kd<0.007uM,Kd,uM,0.007,0.007,2.154901959985743,2xqq.pdf (46-mer)
3tnf,2.50,2011,Kd<0.01nM,Kd,nM,0.01,1e-05,5.0,3tnf.pdf (174-mer) mGppNHp form
3zrz,1.70,2011,Kd=0.030nM,Kd,nM,0.030,3e-05,4.522878745280337,3zrz.pdf (20-mer) complex Fn and SfbI-5; Kd=0.030+/-0.001nM
2xqw,2.30,2011,Kd=0.18uM,Kd,uM,0.18,0.18,0.744727494896694,2xqw.pdf (133-mer)
2ybr,2.55,2011,Kd=0.21nM,Kd,nM,0.21,0.00021,3.677780705266081,2ybr.pdf (66-mer) crystal space group P212121
3p71,2.70,2011,Kd=0.38uM,Kd,uM,0.38,0.38,0.42021640338318983,"3p71.pdf (304-mer) Ka=2.62+/-0.77uM-1; LCMT-1: Mutation: C19M, A21E, D22N, P115S; PP2A: Fragment: CATALYTIC SUBUNIT ALPHA ISOFORM;"
3p11,3.70,2011,Kd=0.39nM,Kd,nM,0.39,0.00039000000000000005,3.408935392973501,"3p11.pdf (522-mer) see support information table S1, Kd=0.39+/-0.03nM for DL11f and HER3 ECD domain I-IV"
3alz,4.51,2011,Kd=0.52uM,Kd,uM,0.52,0.52,0.28399665636520083,3alz.pdf (149-mer) Kd=0.52+/-0.21uM
3au4,1.90,2011,Kd=0.53uM,Kd,uM,0.53,0.53,0.27572413039921095,3au4.pdf (63-mer) Kd=0.53+/-0.06uM
3tac,2.20,2011,Kd=0.55uM,Kd,uM,0.55,0.55,0.2596373105057561,3tac.pdf (334-mer) ITC Kd=0.55+/-0.03uM
3ry6,3.80,2011,Kd=0.5mM,Kd,mM,0.5,500.0,-2.6989700043360187,3ry6.pdf (167-mer) Kd=0.5+/-0.02mM
3oed,3.16,2011,Kd=0.5uM,Kd,uM,0.5,0.5,0.3010299956639812,"3oed.pdf (310-mer) Kd=0.5+/-0.05uM, asymmetric unit"
3ona,2.60,2011,Kd=0.68uM,Kd,uM,0.68,0.68,0.16749108729376366,3ona.pdf (80-mer) mean KD value of two measurements
3syn,3.06,2011,Kd=0.6uM,Kd,uM,0.6,0.6,0.2218487496163564,3syn.pdf (23-mer)
2y8s,2.55,2011,Kd=0.989nM,Kd,nM,0.989,0.000989,3.0048037084028207,2y8s.pdf (37-mer) Kd=9.89 x 10-10M
3qbt,2.00,2011,Kd=0.9uM,Kd,uM,0.9,0.9,0.045757490560675115,"3qbt.pdf (174-mer) Kd=1.1uM (from kinetics), OCRL1 (539-901) was used to determine the kinetics, crystal is OCRL1 (540-678)"
3n4i,1.56,2011,Kd=1.1nM,Kd,nM,1.1,0.0011,2.958607314841775,3n4i.pdf (165-mer) Kd=1.1+/-0.2nM
3qhy,2.06,2011,Kd=1.1pM,Kd,pM,1.1,1.1e-06,5.958607314841775,3qhy.pdf (271-mer) Stopped-flow Tryptophan Fluorescence Spectrometric Measurements
3rt0,2.11,2011,Kd=1.2uM,Kd,uM,1.2,1.2,-0.07918124604762482,3rt0.pdf (183-mer) in the absence of ABA
3r1g,2.80,2011,Kd=1.3nM,Kd,nM,1.3,0.0013000000000000002,2.886056647693163,3r1g.pdf (222-mer)
3uc0,2.71,2011,Kd=1.3nM,Kd,nM,1.3,0.0013000000000000002,2.886056647693163,"3uaj.pdf (236-mer) Indirect ELISAs, PH=7.0, Kd=1.3nM"
3noc,2.70,2011,Kd=1.5nM,Kd,nM,1.5,0.0015,2.8239087409443187,3noc.pdf (169-mer)
3o5t,2.09,2011,Kd=1.5uM,Kd,uM,1.5,1.5,-0.17609125905568124,3o5t.pdf (112-mer) Kd=1.5+/-0.1uM
3qq8,2.00,2011,Kd=1.5uM,Kd,uM,1.5,1.5,-0.17609125905568124,3qq8.pdf (85-mer) ITC Kd=1.5+/-0.42uM
3p0y,1.80,2011,Kd=1.92nM,Kd,nM,1.92,0.00192,2.7166987712964503,"3p0y.pdf (214-mer) see support information table S1, Kd=1.92+/-0.32nM for DL11f and EGFR ECD domain I-IV"
3p6z,1.70,2011,Kd=1.95uM,Kd,uM,1.95,1.95,-0.290034611362518,3p6z.pdf (71-mer) Kd1=1.95+/-0.05uM(SA-FPR-alpha-thrombin); Kd2=2.06+/-0.05uM(CM5-FPR-alpha-thrombin)
3sdc,3.10,2011,Kd=10.69uM,Kd,uM,10.69,10.69,-1.028977705208778,3scm.pdf (302-mer) ligand is Gb3; Kd=10.69+/-0.62uM
2kxw,NMR,2011,Kd=10nM,Kd,nM,10,0.01,2.0,"2kxw.pdf (27-mer) fluorescence anisotropy, Kd<10nM"
3qc8,2.20,2011,Kd=11.2uM,Kd,uM,11.2,11.2,-1.0492180226701815,3qc8.pdf (84-mer)
2xze,1.75,2011,Kd=113nM,Kd,nM,113,0.113,0.9469215565165803,2xze.pdf (40-mer)
3qlu,2.91,2011,Kd=11nM,Kd,nM,11,0.011,1.958607314841775,"3qlu.pdf (395-mer) GluR6 Delta 1/KA2 heterodimer, affinity is for GluR6 Delta 2/KA2"
2xbb,2.68,2011,Kd=11uM,Kd,uM,11,11.0,-1.0413926851582251,2xbb.pdf (76-mer)
3rbb,2.35,2011,Kd=12.3nM,Kd,nM,12.3,0.0123,1.9100948885606022,3rbb.pdf (61-mer) Kd=12.3+/-2nM
2l2l,NMR,2011,Kd=12.4nM,Kd,nM,12.4,0.012400000000000001,1.9065783148377649,2l2l.pdf (36-mer)
3onl,2.20,2011,Kd=12uM,Kd,uM,12,12.0,-1.0791812460476249,3onl.pdf (97-mer)
3qib,2.70,2011,Kd=13.7uM,Kd,uM,13.7,13.7,-1.1367205671564067,3qib.pdf (270-mer)
3oj2,2.20,2011,Kd=130nM,Kd,nM,130,0.13,0.8860566476931632,"3oj2.pdf (231-mer) Kd(FGFR2b WT), X-ray(FGFR2b A172F)"
3ojm,2.10,2011,Kd=130nM,Kd,nM,130,0.13,0.8860566476931632,"3oj2.pdf (231-mer) Kd(FGFR2b WT), X-ray(FGFR2b P253R)"
3qml,2.31,2011,Kd=13nM,Kd,nM,13,0.013000000000000001,1.8860566476931633,3qfu.pdf (315-mer)
2y8t,1.95,2011,Kd=14.2nM,Kd,nM,14.2,0.014199999999999999,1.8477116556169435,"2y8s.pdf (37-mer) wild type, Kd=1.42 x 10-8M"
2xpx,2.05,2011,Kd=150nM,Kd,nM,150,0.15,0.8239087409443188,2xpx.pdf (26-mer) KD=150+/-69nM
3zs9,2.10,2011,Kd=150nM,Kd,nM,150,0.15,0.8239087409443188,3zs8.pdf (38-mer) Kd=150+/-20nM
3rgv,2.90,2011,Kd=15uM,Kd,uM,15,15.0,-1.1760912590556813,3rgv.pdf (236-mer) YAe62 recognized pWM presented by Kb
3t4a,3.40,2011,Kd=16.9uM,Kd,uM,16.9,16.9,-1.2278867046136734,3t4a.pdf (73-mer)
3zwl,2.20,2011,Kd=160nM,Kd,nM,160,0.16,0.7958800173440752,3zwl.pdf (50-mer)
3b08,1.70,2011,Kd=17.2uM,Kd,uM,17.2,17.2,-1.235528446907549,3b08.pdf (152-mer) Kd=17.2+/-0.1uM
3qeq,2.59,2011,Kd=170uM,Kd,uM,170,170.0,-2.230448921378274,"3qdg.pdf (275-mer) for DMF4-nonamer/HLA-A2 complex, Kd=170+/-11uM"
3rea,2.00,2011,Kd=179nM,Kd,nM,179,0.179,0.7471469690201068,3rea.pdf (61-mer) Kd=179+/-29nM
3q9n,2.00,2011,Kd=17nM,Kd,nM,17,0.017,1.7695510786217261,3q9n.pdf (158-mer) measured by yeast display in 10 mM phosphate + 150 mM NaCl +0.1% BSA
3sja,3.00,2011,Kd=17nM,Kd,nM,17,0.017,1.7695510786217261,3sja.pdf (65-mer) Kd=17+/-2nM
3vh8,1.80,2011,Kd=17uM,Kd,uM,17,17.0,-1.2304489213782739,3vh8.pdf (275-mer) Kd=16.63+/-1.52uM
3sua,4.39,2011,Kd=18.9uM,Kd,uM,18.9,18.9,-1.276461804173244,3su8.pdf (633-mer) Kd=18.9+/-0.8uM
3quy,2.25,2011,Kd=187nM,Kd,nM,187,0.187,0.7281583934635011,"3qux.pdf (285-mer) ligand is BnNH-GSL-1', modify the complex type"
3sdy,2.85,2011,Kd=1nM,Kd,nM,1,0.001,3.0,3sdy.pdf (227-mer)
3sip,3.50,2011,Kd=1uM,Kd,uM,1,1.0,-0.0,"3sip.pdf (115-mer) drICE inhibition by BIR1, Three weak interfaces between BIR1 and drICE cooperate to yield a stable hetero-tetramer with a KD of approximately 1~2uM"
3tn0,3.20,2011,Kd=2.20uM,Kd,uM,2.20,2.2,-0.3424226808222063,3tn0.pdf (302-mer) ligand is Alpha-C-GalCer; Kd=2.20+/-0.73uM
2l9s,NMR,2011,Kd=2.2uM,Kd,uM,2.2,2.2,-0.3424226808222063,2l9s.pdf (94-mer)
3owt,2.00,2011,Kd=2.49uM,Kd,uM,2.49,2.49,-0.3961993470957364,3owt.pdf (27-mer) ITC Kd=2.49+/-0.38uM
3sf4,2.60,2011,Kd=2.4nM,Kd,nM,2.4,0.0024,2.619788758288394,3sf4.pdf (52-mer)
3rdz,2.26,2011,Kd=2.69nM,Kd,nM,2.69,0.00269,2.570247719997592,3rdz.pdf (79-mer)
3sgk,2.40,2011,Kd=2.9nM,Kd,nM,2.9,0.0029,2.537602002101044,3sgj.pdf (204-mer)
3uaj,3.23,2011,Kd=2.9nM,Kd,nM,2.9,0.0029,2.537602002101044,"3uaj.pdf (236-mer) Indirect ELISAs, PH=5.5, Kd=2.9nM"
3r4d,3.10,2011,Kd=21.4nM,Kd,nM,21.4,0.0214,1.6695862266508092,3r4d.pdf (288-mer)
3nog,3.34,2011,Kd=22.4nM,Kd,nM,22.4,0.0224,1.6497519816658373,3noc.pdf (169-mer)
3qbq,2.50,2011,Kd=230nM,Kd,nM,230,0.23,0.638272163982407,3nzy.pdf (170-mer) extracellular domains of mouse RANK-RANKL complex
3qux,2.91,2011,Kd=247nM,Kd,nM,247,0.247,0.6073030467403343,"3qux.pdf (285-mer) ligand is alpha-C-GalCer, modify the complex type"
2kt5,NMR,2011,Kd=28uM,Kd,uM,28,28.0,-1.4471580313422192,2kt5.pdf (40-mer) Kd=28+/-8.7uM
3r2x,3.10,2011,Kd=29nM,Kd,nM,29,0.029,1.537602002101044,3r2x.pdf (93-mer)
3qdm,2.80,2011,Kd=29uM,Kd,uM,29,29.0,-1.462397997898956,"3qdg.pdf (275-mer) for DMF4-decamer/HLA-A2 complex, Kd=29+/-4uM"
2y9m,2.60,2011,Kd=2nM,Kd,nM,2,0.002,2.6989700043360187,2y9m.pdf (130-mer) Kd=2+/-0.08nM
3rk3,3.50,2011,Kd=2uM,Kd,uM,2,2.0,-0.3010299956639812,"3rk2.pdf (63-mer) for wt CPX, Kd=16uM, for ScCPX, Kd=2uM"
3scm,2.50,2011,Kd=3.03uM,Kd,uM,3.03,3.03,-0.48144262850230496,3scm.pdf (302-mer) ligand is iGb3; Kd=3.03+/-0.24uM
3aon,2.00,2011,Kd=3.2nM,Kd,nM,3.2,0.0032,2.494850021680094,3aon.pdf (115-mer) structure is Eh-D and Eh-F; binding data is for Eh-A3B3D and Eh-F
3r9a,2.35,2011,Kd=3.5uM,Kd,uM,3.5,3.5,-0.5440680443502757,3r9a.pdf (394-mer) KD=3.5uM for protein cargo
2xhe,2.80,2011,Kd=3.9nM,Kd,nM,3.9,0.0039,2.408935392973501,2xhe.pdf (279-mer)
3t6g,2.50,2011,Kd=30nM,Kd,nM,30,0.03,1.5228787452803376,"3t6a.pdf (229-mer) support information figure S5-d, ITC Kd=30nM"
3sjd,4.60,2011,Kd=31nM,Kd,nM,31,0.031,1.5086383061657274,"3sjd.pdf (46-mer) ADP state, bioassay use Get1-CD"
3qiu,2.70,2011,Kd=321nM,Kd,nM,321,0.321,0.4934949675951279,3qib.pdf (243-mer)
3ru8,2.07,2011,Kd=33.5nM,Kd,nM,33.5,0.0335,1.4749551929631548,3ru8.pdf (230-mer)
3oxu,2.10,2011,Kd=34uM,Kd,uM,34,34.0,-1.5314789170422551,3oxu.pdf (317-mer) SPR Kd=34+/-1uM
3quz,2.30,2011,Kd=39.6nM,Kd,nM,39.6,0.0396,1.4023048140744876,"3qux.pdf (285-mer) ligand is NU-alpha-GalCer, modify the complex type"
3t2n,2.55,2011,Kd=39.8nM,Kd,nM,39.8,0.039799999999999995,1.4001169279263121,3t2n.pdf (225-mer) KD=39.8nM
3q4f,5.50,2011,Kd=4.1uM,Kd,uM,4.1,4.1,-0.6127838567197355,3q4f.pdf (186-mer) Kd=4.1+/-0.2uM(Xrcc4 1-157);Kd=3.9+/-0.2uM(Xrcc4 1-203);
3rug,2.20,2011,Kd=4.4uM,Kd,uM,4.4,4.4,-0.6434526764861874,"3axl.pdf (302-mer) not a very strict binary complex, ternary complex"
3r0l,1.35,2011,Kd=4.5nM,Kd,nM,4.5,0.0045000000000000005,2.346787486224656,3r0l.pdf (39-mer) the more toxic class I isoforms are more stable (Kd=4.5 nM)
3sdd,3.00,2011,Kd=4.84uM,Kd,uM,4.84,4.84,-0.6848453616444125,3scm.pdf (302-mer) ligand is beta-LacCer; Kd=4.84+/-0.53uM
3q3g,2.70,2011,Kd=4.97nM,Kd,nM,4.97,0.00497,2.303643611266668,"3q3g.pdf (190-mer) Fab 107 did not bind to low-affinity rWT, but for human hWT Kd=4.97+/-0.24nM"
3qs7,4.30,2011,Kd=40nM,Kd,nM,40,0.04,1.3979400086720375,3qs7.pdf (423-mer)
3qdj,2.30,2011,Kd=40uM,Kd,uM,40,40.0,-1.6020599913279623,"3qdg.pdf (275-mer) for DMF5-nonamer/HLA-A2 complex, Kd=40+/-2uM"
3r85,1.95,2011,Kd=41.3uM,Kd,uM,41.3,41.3,-1.615950051656401,3r85.pdf (26-mer)
3pvm,4.30,2011,Kd=42nM,Kd,nM,42,0.042,1.3767507096020994,3prx.pdf (1642-mer)
2x89,2.16,2011,Kd=44nM,Kd,nM,44,0.044,1.3565473235138126,2x89.pdf (94-mer)
3uai,3.06,2011,Kd=45nM,Kd,nM,45,0.045,1.3467874862246563,"3uai.pdf (400-mer) Gar1 and Nhp2 did not affect the binding affinity within experimental error, Kd=45+/-27nM"
3sda,2.80,2011,Kd=5.24uM,Kd,uM,5.24,5.24,-0.7193312869837266,3scm.pdf (302-mer) ligand is beta-GalCer; Kd=5.24+/-0.58uM
3q9u,2.30,2011,Kd=5.2nM,Kd,nM,5.2,0.005200000000000001,2.283996656365201,3q9n.pdf (158-mer) measured by yeast display in 10 mM phosphate + 150 mM NaCl +0.1% BSA
3s5l,2.10,2011,Kd=5.3uM,Kd,uM,5.3,5.3,-0.724275869600789,3s4s.pdf (191-mer)
3o6f,2.80,2011,Kd=5.5uM,Kd,uM,5.5,5.5,-0.7403626894942439,3o6f.pdf (245-mer)
3qdg,2.69,2011,Kd=5.6uM,Kd,uM,5.6,5.6,-0.7481880270062004,"3qdg.pdf (275-mer) for DMF5-decamer/HLA-A2 complex, Kd=5.6+/-1.5uM"
3rkd,1.90,2011,Kd=5.89nM,Kd,nM,5.89,0.005889999999999999,2.2298847052128985,3rkd.pdf (230-mer) Biacore ITC assay
3pbp,2.60,2011,Kd=50nM,Kd,nM,50,0.05,1.3010299956639813,"3pbp.pdf (148-mer) yeast heterotrimeric Nup82-Nup159-Nup116 nucleoporin complex, Kd=50+/-30nM in the presence of Nup159T"
3s8v,3.10,2011,Kd=50nM,Kd,nM,50,0.05,1.3010299956639813,3s8v.pdf (88-mer) Alpha Technology binding assay
3to4,3.10,2011,Kd=50nM,Kd,nM,50,0.05,1.3010299956639813,3to4.pdf (253-mer) Kd=50+/-10nM
3zs8,3.00,2011,Kd=51nM,Kd,nM,51,0.051000000000000004,1.2924298239020635,3zs8.pdf (84-mer) Kd=51+/-3nM
3rpg,2.65,2011,Kd=5uM,Kd,uM,5,5.0,-0.6989700043360189,3rpg.pdf (149-mer) Kd=5+/-1uM
3t1q,2.70,2011,Kd=5uM,Kd,uM,5,5.0,-0.6989700043360189,3t12.pdf (136-mer) Kd=5+/-0.8uM
3uyo,1.83,2011,Kd=6.8uM,Kd,uM,6.8,6.8,-0.8325089127062363,3uyo.pdf (95-mer) Kd=6800+/-200nM
3rzw,2.15,2011,Kd=68nM,Kd,nM,68,0.068,1.1674910872937636,3rzw.pdf (99-mer)
2y0b,2.10,2011,Kd=6nM,Kd,nM,6,0.006,2.221848749616356,2xzd.pdf (136-mer)
3rdt,2.70,2011,Kd=6uM,Kd,uM,6,6.0,-0.7781512503836436,3rdt.pdf (217-mer)
3rgf,2.20,2011,Kd=7.05nM,Kd,nM,7.05,0.00705,2.151810883008601,3rgf.pdf (285-mer) Kd=7.05+/-0.85nM
3zyi,2.60,2011,Kd=7.3nM,Kd,nM,7.3,0.0073,2.136677139879544,3zyi.pdf (353-mer)
3zyj,3.25,2011,Kd=7.9nM,Kd,nM,7.9,0.0079,2.1023729087095586,3zyi.pdf (426-mer)
3sku,4.00,2011,Kd=70nM,Kd,nM,70,0.07,1.154901959985743,3sku.pdf (319-mer)
3s2k,2.80,2011,Kd=71.5nM,Kd,nM,71.5,0.07150000000000001,1.1456939581989194,3s2k.pdf (97-mer) Kd=71.5+/-12nM
3rzc,2.80,2011,Kd=718nM,Kd,nM,718,0.718,0.14387555575769967,3rzc.pdf (241-mer) Kd=718+/-14nM
3q1s,2.15,2011,Kd=73nM,Kd,nM,73,0.073,1.136677139879544,3q1s.pdf (151-mer) Kd=73+/-8nM
2l1l,NMR,2011,Kd=7nM,Kd,nM,7,0.007,2.154901959985743,"2l1l.pdf (27-mer) Phi0 PKI NES Peptide in Complex with CRM1-RanGTP, Kd=10uM with -RanGTP, and Kd=7nM with +RanGTP"
3pp4,1.60,2011,Kd=7uM,Kd,uM,7,7.0,-0.8450980400142568,3pp3.pdf (25-mer)
3s4s,2.40,2011,Kd=8.8uM,Kd,uM,8.8,8.8,-0.9444826721501687,3s4s.pdf (191-mer)
2xns,3.41,2011,Kd=810nM,Kd,nM,810,0.81,0.09151498112135022,2xns.pdf (40-mer) protein Fragment: RESIDUES 30-354 ; peptide Fragment:RESIDUES 497-517; GDP-containing; ternary complexes;
3skj,2.50,2011,Kd=810pM,Kd,pM,810,0.00081,3.0915149811213505,"3skj.pdf (206-mer) assay by ProteOn XPR36 instrument (Bio-Rad, Hercules, CA), Kd=810+/-296pM"
3pmh,3.20,2011,Kd=81nM,Kd,nM,81,0.081,1.0915149811213503,"3pmh.pdf (36-mer) Tyr276, 278, 279 to modified Tys; Kd=81+/-20 nM; Fragment: unp residues 17-306; Mutation: C65A;"
3qht,2.40,2011,Kd=82nM,Kd,nM,82,0.082,1.0861861476162833,3qht.pdf (97-mer)
3qwo,1.90,2011,Kd=87nM,Kd,nM,87,0.08700000000000001,1.0604807473813815,3qwo.pdf (57-mer)
3mj9,2.95,2011,Kd=8nM,Kd,nM,8,0.008,2.0969100130080562,3mj9.pdf (223-mer)
2ld7,NMR,2011,Kd=9.2nM,Kd,nM,9.2,0.0092,2.036212172654445,2ld7.pdf (75-mer)
2xzd,2.10,2011,Kd=9.6nM,Kd,nM,9.6,0.0096,2.0177287669604316,2xzd.pdf (136-mer)
3olm,2.50,2011,Kd=90.6uM,Kd,uM,90.6,90.6,-1.9571281976768131,"3olm.pdf (79-mer) fluorescence anisotropy, Kd=90.6+/-6.4uM"
3qsk,1.75,2011,Kd=91nM,Kd,nM,91,0.091,1.0409586076789064,3qsk.pdf (123-mer)
3reb,3.45,2011,Kd=96nM,Kd,nM,96,0.096,1.0177287669604316,3reb.pdf (90-mer) Kd=96+/-15nM
3qiw,3.30,2011,Kd>500uM,Kd,uM,500,500.0,-2.6989700043360187,3qib.pdf (243-mer)
3opz,3.40,2011,Kd~0.72nM,Kd,nM,0.72,0.0007199999999999999,3.1426675035687315,3opz.pdf (222-mer) Kd~7.2x10-10M
2ygg,2.23,2011,Kd~20nM,Kd,nM,20,0.02,1.6989700043360187,2ygg.pdf (150-mer) Kd~20nM(residue637-657);Kd~350nM(residue 657-700)
3t04,2.10,2011,Kd~52nM,Kd,nM,52,0.052000000000000005,1.2839966563652008,3t04.pdf (103-mer)
3ay4,2.20,2011,Kd~60nM,Kd,nM,60,0.06,1.2218487496163564,"3ay4.pdf (179-mer) SPR Kd=6x10-8M, just a figure, no exact data listed, estimated Kd value"
2y6t,2.74,2011,Ki<0.002nM,Ki,nM,0.002,2e-06,5.698970004336019,2y6t.pdf (148-mer) data from ref. 23
3u1j,1.80,2011,Ki=0.026uM,Ki,uM,0.026,0.026,1.585026652029182,"3u1i.pdf (58-mer) Dengue virus protease covalently bound to aprotinin, a 58-amino-acid polypeptide"
2y48,3.00,2011,Ki=0.21mM,Ki,mM,0.21,210.0,-2.322219294733919,"2y48.pdf (20-mer) using a monomethyl-Lys4 H3-peptide as substrate, Ki=0.21+/-0.07mM, using a dimethylated substrate, Ki=0.22+/-0.09mM"
3b23,2.40,2011,Ki=0.318nM,Ki,nM,0.318,0.00031800000000000003,3.4975728800155674,3b23.pdf (32-mer) Ki=0.318+/-0.02nM;IC50=8.25+/-0.45nM
4a1u,1.54,2011,Ki=0.54uM,Ki,uM,0.54,0.54,0.26760624017703144,4a1u.pdf (20-mer) ligand is ALPHA-BETA-FOLDAMER 2C
3qtl,2.60,2011,Ki=1.43nM,Ki,nM,1.43,0.00143,2.844663962534938,3qtl.pdf (75-mer)
3o40,2.10,2011,Ki=1.4nM,Ki,nM,1.4,0.0014,2.853871964321762,3o40.pdf (40-mer) fluorescence polarization assay
3p95,1.30,2011,Ki=1.5uM,Ki,uM,1.5,1.5,-0.17609125905568124,3p92.pdf (58-mer) Ki=1.50+/-0.09uM
3pnr,2.60,2011,Ki=11.9nM,Ki,nM,11.9,0.0119,1.9244530386074692,"3pnr.pdf (187-mer) fluorimetric protease assay, Ki=11.9+/-4.7nM"
3zv0,2.80,2011,Ki=110uM,Ki,uM,110,110.0,-2.041392685158225,"3zv0.pdf (195-mer) Kd of hTERC-3'sl for SHQ1 is 75uM, and NAP57 competitive inhibition of SHQ1 with hTERC-3'sl is Ki=110uM"
4a94,1.70,2011,Ki=4.9pM,Ki,pM,4.9,4.9000000000000005e-06,5.309803919971486,4a94.pdf (53-mer) Ki=4.9+/-0.6pM
3p92,1.60,2011,Ki=5.9nM,Ki,nM,5.9,0.005900000000000001,2.2291479883578558,3p92.pdf (58-mer) Ki=5.9+/-1.7nM
3nps,1.50,2011,Ki=70.4pM,Ki,pM,70.4,7.04e-05,4.152427340857888,3nps.pdf (226-mer) Apparent KI values calculated from the IC50 value
3o43,2.80,2011,Ki=9nM,Ki,nM,9,0.009000000000000001,2.0457574905606752,3o40.pdf (40-mer) fluorescence polarization assay
4eah,3.40,2012,IC50=1.7nM,IC50,nM,1.7,0.0017,2.769551078621726,4eah.pdf (402-mer)
3ujg,2.60,2012,IC50=1.7uM,IC50,uM,1.7,1.7,-0.2304489213782739,3ujg.pdf (350-mer) IC50=1.7+/-0.4uM. Inhibition of the interaction between H6GST-SnRK2.6 and biotin-HAB1 by SnRK2.6
4ers,2.64,2012,IC50=1.9nM,IC50,nM,1.9,0.0019,2.721246399047171,4ers.pdf (231-mer)
3v6o,1.95,2012,IC50=1nM,IC50,nM,1,0.001,3.0,3v6o.pdf (221-mer) LBD-9F8 Fab complex
3v1c,1.13,2012,Kd<30nM,Kd,nM,30,0.03,1.5228787452803376,3v1c.pdf (46-mer) symmetric homodimer in presence of Zinc; Kd<30nM(with zinc); Kd=4uM(with out zinc)
3ukx,2.20,2012,Kd=0.03nM,Kd,nM,0.03,3e-05,4.522878745280337,3ukw.pdf (28-mer)
3ro2,2.30,2012,Kd=0.046uM,Kd,uM,0.046,0.046,1.337242168318426,3ro2.pdf (28-mer)
2lnh,NMR,2012,Kd=0.04uM,Kd,uM,0.04,0.04,1.3979400086720375,2lnh.pdf (67-mer)
4di3,3.05,2012,Kd=0.06uM,Kd,uM,0.06,0.06,1.2218487496163564,4di3.pdf (301-mer) 2:1 complex of Treponema pallidum TatP(T) (Tp0957) bound to TatT (Tp0956)
3uzq,1.60,2012,Kd=0.082nM,Kd,nM,0.082,8.2e-05,4.086186147616283,3uyp.pdf (253-mer)
2lxm,NMR,2012,Kd=0.08nM,Kd,nM,0.08,8e-05,4.096910013008056,2lxm.pdf (57-mer)
4drb,2.63,2012,Kd=0.11uM,Kd,uM,0.11,0.11,0.958607314841775,"4dra.pdf (141-mer) Kd1=0.11uM, Kd2=4.42uM"
4dke,3.00,2012,Kd=0.12nM,Kd,nM,0.12,0.00012,3.9208187539523753,4dkd.pdf (230-mer) method:biolayer interferometry.
4dck,2.20,2012,Kd=0.12uM,Kd,uM,0.12,0.12,0.9208187539523752,4dck.pdf (192-mer) binding data is for NaV1.5WT and FGF12B WT
4etq,2.10,2012,Kd=0.18nM,Kd,nM,0.18,0.00017999999999999998,3.744727494896694,4ebq.pdf (221-mer)
3v6b,3.21,2012,Kd=0.28uM,Kd,uM,0.28,0.28,0.5528419686577808,"3v6b.pdf (424-mer) Kd=0.28uM for VEGF-A/VEGFR-2 D23 complex, not Kd=5.99uM for VEGF-A/VEGFR-2 ECD"
4g6m,1.81,2012,Kd=0.29nM,Kd,nM,0.29,0.00029,3.537602002101044,4g5z.pdf (220-mer)
3tsr,2.20,2012,Kd=0.2fM,Kd,fM,0.2,2.0000000000000003e-10,9.698970004336019,3tsr.pdf (457-mer) Kd=2x10-16M
4eee,2.71,2012,Kd=0.2nM,Kd,nM,0.2,0.0002,3.6989700043360187,4eee.pdf (157-mer)
4b1v,1.75,2012,Kd=0.32uM,Kd,uM,0.32,0.32,0.494850021680094,4b1v.pdf (32-mer) complex G-actin and RPEL-N; Kd=0.32+/-0.05uM
3thm,2.10,2012,Kd=0.35nM,Kd,nM,0.35,0.00035,3.4559319556497243,3thm.pdf (245-mer)
4hkx,2.50,2012,Kd=0.36uM,Kd,uM,0.36,0.36,0.44369749923271273,4hk0.pdf (231-mer)
4etp,2.30,2012,Kd=0.37uM,Kd,uM,0.37,0.37,0.431798275933005,4etp.pdf (333-mer) Kd=0.37+/-0.07uM for ADP
4am0,3.02,2012,Kd=0.42nM,Kd,nM,0.42,0.00042,3.3767507096020997,4al8.pdf (217-mer)
4g59,2.44,2012,Kd=0.42uM,Kd,uM,0.42,0.42,0.37675070960209955,4g59.pdf (205-mer)
3uzv,2.10,2012,Kd=0.43nM,Kd,nM,0.43,0.00043,3.3665315444204134,3uyp.pdf (253-mer)
3tkl,2.18,2012,Kd=0.43uM,Kd,uM,0.43,0.43,0.36653154442041347,3sfv.pdf (267-mer) GTP-bound
4al8,1.66,2012,Kd=0.45nM,Kd,nM,0.45,0.00045000000000000004,3.3467874862246565,4al8.pdf (217-mer)
4dgi,2.40,2012,Kd=0.45uM,Kd,uM,0.45,0.45,0.3467874862246563,4dgi.pdf (111-mer)
4ala,1.84,2012,Kd=0.47nM,Kd,nM,0.47,0.00047,3.3279021420642825,4al8.pdf (217-mer)
4auo,3.00,2012,Kd=0.4uM,Kd,uM,0.4,0.4,0.3979400086720376,4auo.pdf (40-mer) full length MMP-1 with collagen
4dbg,2.71,2012,Kd=0.52uM,Kd,uM,0.52,0.52,0.28399665636520083,4dbg.pdf (162-mer) Kd=5.2x10-7M
3uz0,2.82,2012,Kd=0.56uM,Kd,uM,0.56,0.56,0.25181197299379954,"3uz0.pdf (152-mer) binding constant Ka=1.8x10-6M-1, Kd=0.555uM"
4dt1,1.90,2012,Kd=0.56uM,Kd,uM,0.56,0.56,0.25181197299379954,4dt1.pdf (245-mer) Kd=0.56+/-0.04uM
3tei,2.40,2012,Kd=0.5uM,Kd,uM,0.5,0.5,0.3010299956639812,2xrw.pdf (24-mer) ligand is pepRSK1; incomplete ligand
3u9d,2.50,2012,Kd=0.5uM,Kd,uM,0.5,0.5,0.3010299956639812,3sjh.pdf (54-mer) Mg2+ and ATP containing
4ft4,2.70,2012,Kd=0.5uM,Kd,uM,0.5,0.5,0.3010299956639812,4fsx.pdf (32-mer) Intermolecular interaction between the BAH domain of ZMET2 and H3(1 C32)K9me2 peptide
4apf,3.10,2012,Kd=0.65uM,Kd,uM,0.65,0.65,0.18708664335714442,4ap2.pdf (388-mer)
4eef,2.70,2012,Kd=0.6nM,Kd,nM,0.6,0.0006,3.2218487496163566,"4eef.pdf (74-mer) ligand is F-HB80.4 (G12K, L17l, L21l, A35K, S42K mutants)"
3twi,2.55,2012,Kd=0.6uM,Kd,uM,0.6,0.6,0.2218487496163564,3twi.pdf (179-mer) method:biolayer interferometry.
4f3f,2.65,2012,Kd=0.72nM,Kd,nM,0.72,0.0007199999999999999,3.1426675035687315,4f33.pdf (69-mer)
3ux9,2.80,2012,Kd=0.747nM,Kd,nM,0.747,0.000747,3.126679398184601,3ux9.pdf (256-mer)
3vwj,3.09,2012,Kd=0.74uM,Kd,uM,0.74,0.74,0.13076828026902382,3vwj.pdf (284-mer) Kd=0.74+/-0.07uM
2luh,NMR,2012,Kd=0.7uM,Kd,uM,0.7,0.7,0.1549019599857432,2luh.pdf (59-mer)
3vwk,2.94,2012,Kd=0.83uM,Kd,uM,0.83,0.83,0.08092190762392612,3vwj.pdf (284-mer) Kd=0.83+/-0.03uM
4aei,2.30,2012,Kd=0.8nM,Kd,nM,0.8,0.0008,3.0969100130080562,4aeh.pdf (229-mer)
4afz,2.25,2012,Kd=0.9nM,Kd,nM,0.9,0.0009000000000000001,3.0457574905606752,4afq.pdf (84-mer)
4fqi,1.71,2012,Kd=0.9nM,Kd,nM,0.9,0.0009000000000000001,3.0457574905606752,4fqh.pdf (230-mer)
4fqj,2.50,2012,Kd=0.9nM,Kd,nM,0.9,0.0009000000000000001,3.0457574905606752,4fqh.pdf (234-mer)
4dra,2.41,2012,Kd=1.17uM,Kd,uM,1.17,1.17,-0.06818586174616162,4dra.pdf (84-mer)
4fqv,5.75,2012,Kd=1.1nM,Kd,nM,1.1,0.0011,2.958607314841775,4fqh.pdf (224-mer)
4ehq,1.90,2012,Kd=1.3uM,Kd,uM,1.3,1.3,-0.11394335230683679,4ehq.pdf (20-mer) Ca-containing; one CaM molecule binds two Orai1-CMBDs
3u9z,2.09,2012,Kd=1.54uM,Kd,uM,1.54,1.54,-0.18752072083646307,3sjh.pdf (58-mer) Mg2+ and ADP containing
3tq7,2.30,2012,Kd=1.5uM,Kd,uM,1.5,1.5,-0.17609125905568124,3tq7.pdf (71-mer)
4dm6,1.90,2012,Kd=1.5uM,Kd,uM,1.5,1.5,-0.17609125905568124,4dm6.pdf (25-mer) The SRC-1 NR2 peptide binds to RAR-beta LBD with a stoichiometry of 2 (2 NR2 peptides per homodimer) and a mean Kd of 1.5 uM.Kd=1.5+/-0.1uM
4dm8,2.30,2012,Kd=1.5uM,Kd,uM,1.5,1.5,-0.17609125905568124,4dm6.pdf (25-mer) The SRC-1 NR2 peptide binds to RAR-beta LBD with a stoichiometry of 2 (2 NR2 peptides per homodimer) and a mean Kd of 1.5 uM.Kd=1.5+/-0.1uM
4dxa,1.95,2012,Kd=1.8uM,Kd,uM,1.8,1.8,-0.25527250510330607,4dxa.pdf (322-mer) Kd(Pulldown Assays)
3ve0,3.35,2012,Kd=1.94uM,Kd,uM,1.94,1.94,-0.287801729930226,3ve0.pdf (220-mer)
3qt2,2.55,2012,Kd=1.9nM,Kd,nM,1.9,0.0019,2.721246399047171,3qt2.pdf (117-mer)
3vys,2.35,2012,Kd=1.9uM,Kd,uM,1.9,1.9,-0.2787536009528289,3vyr.pdf (338-mer) HypC-HypD-HypE complex (form I); Kd=1.9+/-0.2uM
2lpb,NMR,2012,Kd=10.1uM,Kd,uM,10.1,10.1,-1.0043213737826426,2ko4.pdf (34-mer) Kd=10.1+/-1.4uM
4fqr,4.10,2012,Kd=100nM,Kd,nM,100,0.1,1.0,4fnk.pdf (241-mer)
4hcn,2.60,2012,Kd=106.7uM,Kd,uM,106.7,106.7,-2.02816441942447,4hcn.pdf (98-mer)
3ul4,1.95,2012,Kd=11.4nM,Kd,nM,11.4,0.0114,1.9430951486635273,3ul4.pdf (65-mer) Ka=8.77E7+/-1.31E7M-1
4gg6,3.20,2012,Kd=11.4uM,Kd,uM,11.4,11.4,-1.0569048513364727,4gg6.pdf (215-mer) Kd=11.4+/-0.6uM
3zuv,2.72,2012,Kd=117nM,Kd,nM,117,0.117,0.9318141382538383,3zu7.pdf (136-mer)
3vfr,1.85,2012,Kd=119.0uM,Kd,uM,119.0,119.0,-2.0755469613925306,3vfm.pdf (100-mer) Kd=119.0+/-1.0uM
2lvo,NMR,2012,Kd=12.8uM,Kd,uM,12.8,12.8,-1.1072099696478683,2lvo.pdf (76-mer)
2lkm,NMR,2012,Kd=12nM,Kd,nM,12,0.012,1.9208187539523751,2lkm.pdf (42-mer)
4fzv,2.00,2012,Kd=13.3nM,Kd,nM,13.3,0.013300000000000001,1.8761483590329142,4fzv.pdf (239-mer) Kd=13.3+/-0.4nM
2lvp,NMR,2012,Kd=13.4uM,Kd,uM,13.4,13.4,-1.1271047983648077,2lvo.pdf (76-mer)
4auq,2.18,2012,Kd=136uM,Kd,uM,136,136.0,-2.1335389083702174,4auq.pdf (81-mer)
3vyr,2.55,2012,Kd=140nM,Kd,nM,140,0.14,0.8538719643217619,3vyr.pdf (372-mer) HypC-HypD complex; Kd=140+/-20nM
2l29,NMR,2012,Kd=15.3nM,Kd,nM,15.3,0.015300000000000001,1.8153085691824011,2l29.pdf (67-mer)
3rtq,2.80,2012,Kd=150nM,Kd,nM,150,0.15,0.8239087409443188,3rtq.pdf (99-mer)
3zwh,1.94,2012,Kd=1540nM,Kd,nM,1540,1.54,-0.18752072083646307,3zwh.pdf (45-mer)
4drx,2.22,2012,Kd=155nM,Kd,nM,155,0.155,0.8096683018297085,"4drx.pdf (169-mer) Kd=155+/-10nM, Mg-containing"
4f9p,3.52,2012,Kd=15nM,Kd,nM,15,0.015,1.8239087409443189,4f9l.pdf (254-mer)
3vhx,2.81,2012,Kd=15uM,Kd,uM,15,15.0,-1.1760912590556813,3vhx.pdf (120-mer) complex Arf6-MKLP1
3sri,1.60,2012,Kd=165nM,Kd,nM,165,0.165,0.7825160557860937,3sri.pdf (29-mer)
3p9w,2.41,2012,Kd=16nM,Kd,nM,16,0.016,1.7958800173440752,3p9w.pdf (123-mer)
3u82,3.16,2012,Kd=17.1nM,Kd,nM,17.1,0.0171,1.7670038896078462,3u82.pdf (317-mer)
4ei5,3.10,2012,Kd=17.6uM,Kd,uM,17.6,17.6,-1.24551266781415,"4ei5.pdf (302-mer) Kd=17.6+/-0.7uM, incomplete ligand structure"
3v4y,2.10,2012,Kd=17.8nM,Kd,nM,17.8,0.0178,1.749579997691106,3v4y.pdf (62-mer) structure is NIPP1(158-216):PP1a(7-307); binding data is for NIPP1(1-225) and PP1a(7-330)
4g6u,2.35,2012,Kd=17.8nM,Kd,nM,17.8,0.0178,1.749579997691106,4g6u.pdf (177-mer)
3rvv,1.90,2012,Kd=17nM,Kd,nM,17,0.017,1.7695510786217261,3rvt.pdf (255-mer)
3tje,1.93,2012,Kd=17nM,Kd,nM,17,0.017,1.7695510786217261,3thm.pdf (245-mer)
4g6f,2.10,2012,Kd=17nM,Kd,nM,17,0.017,1.7695510786217261,4g6f.pdf (236-mer)
4g8a,2.40,2012,Kd=186pM,Kd,pM,186,0.000186,3.7304870557820835,"4g8a.pdf (144-mer) X-ray(human TLR4(Asp299Gly/Thr399Ile)/MD-2/LPS), Kd(TLR4(D229G/T399I)/MD-2/endotoxin-CD14 comlpex)"
3vfn,1.50,2012,Kd=188uM,Kd,uM,188,188.0,-2.27415784926368,3vfm.pdf (99-mer) Kd=188+/-11.0uM
4ffy,2.50,2012,Kd=18nM,Kd,nM,18,0.018000000000000002,1.744727494896694,4ffy.pdf (111-mer)
2lox,NMR,2012,Kd=190nM,Kd,nM,190,0.19,0.721246399047171,2lox.pdf (52-mer)
4h6j,1.52,2012,Kd=190nM,Kd,nM,190,0.19,0.721246399047171,4h6j.pdf (116-mer) Kd=190nM(temperature is 20 degree);Kd=125nM(10 degrees centigrade)
3t0y,2.10,2012,Kd=193nM,Kd,nM,193,0.193,0.7144426909922262,3t0y.pdf (68-mer)
3rvw,1.95,2012,Kd=19nM,Kd,nM,19,0.019,1.7212463990471711,"3rvt.pdf (255-mer) 4C1 Fab fragment short, code 3rvx is 4C1 Fab fragment long"
3u43,1.72,2012,Kd=1fM,Kd,fM,1,1e-09,9.0,3u43.pdf (134-mer)
4f6r,2.64,2012,Kd=1nM,Kd,nM,1,0.001,3.0,4f61.pdf (87-mer) Mg-containing
3tjz,2.90,2012,Kd=1uM,Kd,uM,1,1.0,-0.0,"3tjz.pdf (355-mer) Kd(H. sapiens Arf1), X-ray(Saccharomyces cerevisiae S288c)"
4eoz,2.40,2012,Kd=1uM,Kd,uM,1,1.0,-0.0,4eoz.pdf (364-mer)
4giq,2.70,2012,Kd=2.09uM,Kd,uM,2.09,2.09,-0.32014628611105395,4giq.pdf (171-mer) Scatchard analysis
4fqy,5.25,2012,Kd=2.2nM,Kd,nM,2.2,0.0022,2.657577319177794,4fqh.pdf (224-mer)
3ul0,2.00,2012,Kd=2.3nM,Kd,nM,2.3,0.0023,2.638272163982407,3ukw.pdf (25-mer)
4b93,2.00,2012,Kd=2.3uM,Kd,uM,2.3,2.3,-0.36172783601759284,4b93.pdf (269-mer)
4eo5,2.35,2012,Kd=2.42nM,Kd,nM,2.42,0.00242,2.616184634019569,4eo5.pdf (83-mer) fluorescence quenching
4eqa,1.60,2012,Kd=2.42nM,Kd,nM,2.42,0.00242,2.616184634019569,4eqa.pdf (153-mer)
4b0m,1.80,2012,Kd=2.42uM,Kd,uM,2.42,2.42,-0.38381536598043126,4ayf.pdf (235-mer)
3ukz,2.30,2012,Kd=2.4nM,Kd,nM,2.4,0.0024,2.619788758288394,3ukw.pdf (25-mer)
4afq,1.51,2012,Kd=2.4nM,Kd,nM,2.4,0.0024,2.619788758288394,4afq.pdf (85-mer)
4aqe,2.27,2012,Kd=2.4uM,Kd,uM,2.4,2.4,-0.38021124171160603,4apx.pdf (242-mer)
3uez,3.41,2012,Kd=2.5pM,Kd,pM,2.5,2.4999999999999998e-06,5.6020599913279625,"3uez.pdf (208-mer) Using displacement ITC, titrate BARF1 into an established hCSF-1 RD1-D5 and hCSF-1 complex"
4en3,2.57,2012,Kd=2.5uM,Kd,uM,2.5,2.5,-0.3979400086720376,4en3.pdf (259-mer)
3vpj,2.50,2012,Kd=2.77nM,Kd,nM,2.77,0.00277,2.5575202309355514,3vpj.pdf (192-mer)
4g4s,2.49,2012,Kd=2.78uM,Kd,uM,2.78,2.78,-0.4440447959180762,4g4s.pdf (276-mer) Kd = 2.78 +/- 0.02 uM (150 nM NaCl);
3ul1,1.90,2012,Kd=2.7nM,Kd,nM,2.7,0.0027,2.5686362358410126,3ukw.pdf (22-mer)
3ula,3.60,2012,Kd=2.84nM,Kd,nM,2.84,0.00284,2.5466816599529625,3ul7.pdf (142-mer) complex of MD2 and F63W; Kd=2.84+/-1.66nM
4f38,2.80,2012,Kd=2.9nM,Kd,nM,2.9,0.0029,2.537602002101044,4f38.pdf (204-mer) Kd = 2.9 +/- 0.65 nM
2lqc,NMR,2012,Kd=2.9uM,Kd,uM,2.9,2.9,-0.4623979978989561,2lqc.pdf (24-mer)
4apx,1.65,2012,Kd=2.9uM,Kd,uM,2.9,2.9,-0.4623979978989561,4apx.pdf (242-mer)
3zwz,2.10,2012,Kd=20.3nM,Kd,nM,20.3,0.020300000000000002,1.692503962086787,3sri.pdf (39-mer)
4fxg,3.75,2012,Kd=20.7nM,Kd,nM,20.7,0.0207,1.6840296545430822,4fxg.pdf (242-mer)
3vfv,1.55,2012,Kd=20.9uM,Kd,uM,20.9,20.9,-1.320146286111054,3vfm.pdf (100-mer) Kd=20.9+/-0.4uM
4ap2,2.80,2012,Kd=20nM,Kd,nM,20,0.02,1.6989700043360187,4ap2.pdf (410-mer)
4gms,2.95,2012,Kd=20nM,Kd,nM,20,0.02,1.6989700043360187,4gms.pdf (225-mer) Kd values measured by bio-layer interferometry using an Octet RED instrument (ForteBio)
4g6v,2.64,2012,Kd=21.1nM,Kd,nM,21.1,0.0211,1.6757175447023074,4g6u.pdf (111-mer)
4fao,3.36,2012,Kd=21.64pM,Kd,pM,21.64,2.164e-05,4.664742743565468,"4fao.pdf (124-mer) ALK1-ECD/BMP9/ActRIIB-ECD ternary structure, BMP9 binds to both ALK1-ECD and ActRIIB-ECD, Kd=45.22pM for ALK1"
2lp0,NMR,2012,Kd=22.2uM,Kd,uM,22.2,22.2,-1.3463529744506386,2lp0.pdf (20-mer)
2lvq,NMR,2012,Kd=22.6uM,Kd,uM,22.6,22.6,-1.354108439147401,2lvo.pdf (76-mer)
4dn4,2.80,2012,Kd=22pM,Kd,pM,22,2.2e-05,4.657577319177793,4dn3.pdf (76-mer)
3swp,4.11,2012,Kd=24.2nM,Kd,nM,24.2,0.0242,1.6161846340195687,3swm.pdf (26-mer)
3uts,2.71,2012,Kd=278uM,Kd,uM,278,278.0,-2.444044795918076,3utp.pdf (276-mer) complex 1E6-ALW; monoclinic crystal; Kd=278+/-7.6uM(25 degree); Kd=274.5+/-14uM(5 degree); Kd=335+/-44uM(37 degree)
3qwr,3.25,2012,Kd=2nM,Kd,nM,2,0.002,2.6989700043360187,3qwq.pdf (109-mer)
3qwq,2.75,2012,Kd=2nM,Kd,nM,2,0.002,2.6989700043360187,3qwq.pdf (114-mer)
4ayi,2.31,2012,Kd=2nM,Kd,nM,2,0.002,2.6989700043360187,4ayd.pdf (270-mer)
2ypl,2.40,2012,Kd=3.0uM,Kd,uM,3.0,3.0,-0.47712125471966244,2ypk.pdf (238-mer)
4dkf,2.61,2012,Kd=3.1nM,Kd,nM,3.1,0.0031000000000000003,2.5086383061657274,4dkd.pdf (226-mer) method:biolayer interferometry.
4etw,2.05,2012,Kd=3.1uM,Kd,uM,3.1,3.1,-0.4913616938342727,4etw.pdf (77-mer)
4f48,3.00,2012,Kd=3.2uM,Kd,uM,3.2,3.2,-0.505149978319906,4f48.pdf (117-mer) the micromolecule is between the two proteins
2leh,NMR,2012,Kd=3.3nM,Kd,nM,3.3,0.0033,2.4814860601221125,2leh.pdf (26-mer) Kd measured in PBS
3u8x,2.00,2012,Kd=3.4uM,Kd,uM,3.4,3.4,-0.5314789170422551,3sjh.pdf (54-mer) Mg2+ and ATP containing
3sjh,1.75,2012,Kd=3.4uM,Kd,uM,3.4,3.4,-0.5314789170422551,"3sjh.pdf (54-mer) Mg2+, ATP and Lat.A containing"
3tl8,2.50,2012,Kd=3.5uM,Kd,uM,3.5,3.5,-0.5440680443502757,3tl8.pdf (117-mer)
4e05,2.30,2012,Kd=3.65nM,Kd,nM,3.65,0.00365,2.4377071355435254,"4e05.pdf (61-mer) code 4e05 is high-resolution dataset, 4e06 is low-resolution dataset"
4d9q,2.28,2012,Kd=30pM,Kd,pM,30,2.9999999999999997e-05,4.522878745280337,4d9q.pdf (217-mer) Kd(cynomolgus)=30pM;Kd(human)=4.0pM
3sjv,3.10,2012,Kd=31uM,Kd,uM,31,31.0,-1.4913616938342726,3sjv.pdf (286-mer)
4dh2,1.75,2012,Kd=32.6nM,Kd,nM,32.6,0.032600000000000004,1.4867823999320608,3ul4.pdf (82-mer) Ka=3.07E7+/-3.57E6
4aye,2.80,2012,Kd=3330nM,Kd,nM,3330,3.33,-0.5224442335063199,4ayd.pdf (257-mer)
2ly4,NMR,2012,Kd=346nM,Kd,nM,346,0.34600000000000003,0.4609239012072234,2ly4.pdf (83-mer)
4h1l,3.30,2012,Kd=38.3uM,Kd,uM,38.3,38.3,-1.5831987739686226,4h1l.pdf (113-mer) Kd=38.3uM+/-2.9uM; ANI2.3 TCR with DR52c-pHIR
4dge,2.20,2012,Kd=38.5uM,Kd,uM,38.5,38.5,-1.5854607295085006,"4dgb.pdf (146-mer) Kd=38.5 uM in the presence of DTT, Kd=47.8 uM in the absence of DTT"
4d9r,2.42,2012,Kd=4.0pM,Kd,pM,4.0,4e-06,5.3979400086720375,4d9q.pdf (218-mer) Kd(cynomolgus)=30pM;Kd(human)=4.0pM
4g6j,2.03,2012,Kd=4.1nM,Kd,nM,4.1,0.0040999999999999995,2.3872161432802645,4g5z.pdf (218-mer)
3uyp,2.00,2012,Kd=4.1uM,Kd,uM,4.1,4.1,-0.6127838567197355,3uyp.pdf (253-mer)
2y5b,2.70,2012,Kd=4.2uM,Kd,uM,4.2,4.2,-0.6232492903979004,2y5b.pdf (152-mer)
3vg9,2.70,2012,Kd=4.4nM,Kd,nM,4.4,0.0044,2.3565473235138126,3vg9.pdf (226-mer) complex A2AAR and Fab 2838(resolution=2.7)
4day,3.30,2012,Kd=4.5nM,Kd,nM,4.5,0.0045000000000000005,2.346787486224656,4day.pdf (37-mer)
4ffz,3.80,2012,Kd=416nM,Kd,nM,416,0.41600000000000004,0.38090666937325723,4ffy.pdf (217-mer)
4a49,2.21,2012,Kd=42uM,Kd,uM,42,42.0,-1.6232492903979006,2y1n.pdf (147-mer) Kd=42+/-2uM
3vfw,2.30,2012,Kd=44.5uM,Kd,uM,44.5,44.5,-1.6483600109809315,3vfm.pdf (99-mer) Kd=44.5+/-1.5uM
3qi2,2.80,2012,Kd=45nM,Kd,nM,45,0.045,1.3467874862246563,3qe0.pdf (36-mer) ligand is Regulator of G-protein signaling 14; GDP containing; Kd=45+/-7nM
3qbv,2.65,2012,Kd=478nM,Kd,nM,478,0.47800000000000004,0.3205721033878811,3qbv.pdf (351-mer) Kd=478+/-22nM
4hkj,3.00,2012,Kd=480nM,Kd,nM,480,0.48,0.3187587626244128,4hkj.pdf (206-mer)
2lp4,NMR,2012,Kd=4mM,Kd,mM,4,4000.0,-3.6020599913279625,"2lp4.pdf (128-mer) cheY-P2 Kd=2uM, cheA P1-cheY Kd=5mM, cheA P1-cheY/P2 Kd=4mM"
2lnk,NMR,2012,Kd=4nM,Kd,nM,4,0.004,2.3979400086720375,2lnk.pdf (39-mer)
2lfw,NMR,2012,Kd=5.6nM,Kd,nM,5.6,0.0056,2.2518119729937998,2lfw.pdf (62-mer)
4gh7,2.60,2012,Kd=5.77nM,Kd,nM,5.77,0.00577,2.2388241868442686,4gh7.pdf (285-mer)
4elm,3.48,2012,Kd=5.98uM,Kd,uM,5.98,5.98,-0.7767011839884109,4elk.pdf (244-mer) Kd=5.98+/-4.73 uM
4exp,2.80,2012,Kd=500nM,Kd,nM,500,0.5,0.3010299956639812,4exp.pdf (283-mer) Kd for (D1-D5) domains is 1.3nM
3tvm,2.80,2012,Kd=51.9nM,Kd,nM,51.9,0.0519,1.2848326421515421,3tvm.pdf (209-mer) Kd=51.9+/-6.6 nM
3tu3,1.92,2012,Kd=57nM,Kd,nM,57,0.057,1.2441251443275085,3tu3.pdf (711-mer) ExoU was titrated with SpcU
3oun,2.71,2012,Kd=58nM,Kd,nM,58,0.058,1.2365720064370627,3oun.pdf (288-mer) Kd=58+/-2nM
4a1s,2.10,2012,Kd=5nM,Kd,nM,5,0.005,2.3010299956639813,4a1s.pdf (40-mer)
3sqo,2.70,2012,Kd=5pM,Kd,pM,5,4.9999999999999996e-06,5.301029995663981,3sqo.pdf (219-mer)
4ag2,1.80,2012,Kd=6.2nM,Kd,nM,6.2,0.006200000000000001,2.207608310501746,4afq.pdf (84-mer)
4gxu,3.29,2012,Kd=6.2nM,Kd,nM,6.2,0.006200000000000001,2.207608310501746,4gxu.pdf (231-mer) Kd measured using anti-Penta-HIS tips on the Octet QK platform
3zu7,1.97,2012,Kd=6.6nM,Kd,nM,6.6,0.0066,2.1804560644581312,3zu7.pdf (169-mer)
4f9l,3.14,2012,Kd=66nM,Kd,nM,66,0.066,1.1804560644581312,4f9l.pdf (259-mer)
4doh,2.80,2012,Kd=687nM,Kd,nM,687,0.687,0.16304326294044955,4doh.pdf (153-mer)
4did,2.35,2012,Kd=6uM,Kd,uM,6,6.0,-0.7781512503836436,4did.pdf (152-mer) Protein 2 Source: Salmonella enterica subsp. enterica serovar Typhimurium; Kd = 6 +/- 2 uM; Mg-containing
4ds8,2.21,2012,Kd=7.7uM,Kd,uM,7.7,7.7,-0.8864907251724818,3oji.pdf (343-mer) in the presence of (+)-ABA
4dtg,1.80,2012,Kd=73pM,Kd,pM,73,7.3e-05,4.136677139879544,4dtg.pdf (66-mer) Kd=73+/-13pM
3v62,2.90,2012,Kd=79nM,Kd,nM,79,0.079,1.1023729087095586,"3v62.pdf (69-mer) Kd=79+/-18nM for SUMO-K164-PCNA-mono, Kd=26.3+/-3.1nM for SUMO-K164-PCNA-tri, Kd=25.1+/-4.9nM for SUMO-K127-PCNA-tri"
3vfp,1.85,2012,Kd=81.7uM,Kd,uM,81.7,81.7,-1.9122220565324155,3vfm.pdf (99-mer) Kd=81.7+/-3.0uM
4ayd,2.40,2012,Kd=820nM,Kd,nM,820,0.8200000000000001,0.08618614761628328,4ayd.pdf (257-mer)
2lqh,NMR,2012,Kd=85uM,Kd,uM,85,85.0,-1.9294189257142926,2lqh.pdf (87-mer)
3vfm,1.90,2012,Kd=89.8uM,Kd,uM,89.8,89.8,-1.9532763366673043,3vfm.pdf (100-mer) Kd=89.8+/-5.3uM
3uze,2.04,2012,Kd=8nM,Kd,nM,8,0.008,2.0969100130080562,3uyp.pdf (253-mer)
4hcp,2.52,2012,Kd=9.4uM,Kd,uM,9.4,9.4,-0.9731278535996987,4hcp.pdf (78-mer)
4dkd,3.00,2012,Kd=94nM,Kd,nM,94,0.094,1.0268721464003014,4dkd.pdf (292-mer) Kd=120nM(BLI method)
4dj9,2.25,2012,Kd=99nM,Kd,nM,99,0.099,1.00436480540245,4dj9.pdf (29-mer) Kd=97nM for a second independent experiment.
3vft,1.95,2012,Kd>200uM,Kd,uM,200,200.0,-2.3010299956639813,3vfm.pdf (100-mer)
3vfu,1.65,2012,Kd>200uM,Kd,uM,200,200.0,-2.3010299956639813,3vfm.pdf (100-mer)
3vfo,1.70,2012,Kd>200uM,Kd,uM,200,200.0,-2.3010299956639813,3vfm.pdf (99-mer)
3vfs,1.85,2012,Kd>200uM,Kd,uM,200,200.0,-2.3010299956639813,3vfm.pdf (99-mer)
4e41,2.60,2012,Kd>300uM,Kd,uM,300,300.0,-2.4771212547196626,4e41.pdf (239-mer)
4e42,2.70,2012,Kd>300uM,Kd,uM,300,300.0,-2.4771212547196626,"4e42.pdf (190-mer) Kd>300uM, not exact value"
3ukw,2.10,2012,Kd~0.11nM,Kd,nM,0.11,0.00011,3.958607314841775,3ukw.pdf (28-mer) estimated Kd value
4f0a,3.25,2012,Kd~2.4uM,Kd,uM,2.4,2.4,-0.38021124171160603,4f0a.pdf (316-mer)
4dcn,3.01,2012,Kd~3.3uM,Kd,uM,3.3,3.3,-0.5185139398778874,4dcn.pdf (198-mer) Mg-containing
4dvg,2.60,2012,Kd~3uM,Kd,uM,3,3.0,-0.47712125471966244,4dvg.pdf (353-mer) Mg-containing
4dzu,2.10,2012,Ki<0.2nM,Ki,nM,0.2,0.0002,3.6989700043360187,"4dzu.pdf (38-mer) FP assay, Ki<0.2nM"
3uir,2.78,2012,Ki=0.436nM,Ki,nM,0.436,0.000436,3.360513510731414,3uir.pdf (59-mer)
4gi3,1.75,2012,Ki=0.68nM,Ki,nM,0.68,0.00068,3.167491087293764,"4gi3.pdf (83-mer) affinity is Ki=0.68nM, not Kd=0.68nM"
3tg1,2.71,2012,Ki=1.01uM,Ki,uM,1.01,1.01,-0.004321373782642578,3tg1.pdf (158-mer) Ki=1.01+/-0.01uM
3v96,1.90,2012,Ki=1.1nM,Ki,nM,1.1,0.0011,2.958607314841775,3v96.pdf (165-mer)
4dzv,2.10,2012,Ki=11nM,Ki,nM,11,0.011,1.958607314841775,4dzu.pdf (39-mer) FP assay
4dg4,1.40,2012,Ki=2.7uM,Ki,uM,2.7,2.7,-0.43136376415898736,4dg4.pdf (58-mer) equilibrium inhibition constants (Ki) using classic competitive inhibition experiments
4an7,2.23,2012,Ki=3.2nM,Ki,nM,3.2,0.0032,2.494850021680094,4an7.pdf (185-mer)
2yq7,1.90,2012,Ki=35nM,Ki,nM,35,0.035,1.4559319556497243,2yq6.pdf (20-mer) ligand is BimLOCK; Ki=35+/-3.7nM
3so3,2.10,2012,Ki=392pM,Ki,pM,392,0.000392,3.406713932979543,3so3.pdf (228-mer) KI is calculated from the IC50 value
4g35,2.00,2012,Ki=54nM,Ki,nM,54,0.054,1.2676062401770316,4g35.pdf (21-mer) Ki=54+/-14nM
3tvj,1.28,2012,Ki=6nM,Ki,nM,6,0.006,2.221848749616356,3tvj.pdf (38-mer)
4hx3,2.70,2012,Ki=6nM,Ki,nM,6,0.006,2.221848749616356,4hx3.pdf (114-mer)
4djz,3.20,2012,Ki=7nM,Ki,nM,7,0.007,2.154901959985743,"3tvj.pdf (38-mer) RCSB says Protease inhibitor SGPI-2, paper says Protease inhibitor SGPI-1"
3w9e,2.30,2013,IC50=3.6nM,IC50,nM,3.6,0.0036000000000000003,2.4436974992327127,3w9e.pdf (222-mer)
4kvn,3.10,2013,IC50=3nM,IC50,nM,3,0.003,2.5228787452803374,4kvn.pdf (207-mer)
4ksd,4.10,2013,IC50=520nM,IC50,nM,520,0.52,0.28399665636520083,4ksd.pdf (124-mer) Nb592 is a strong inhibitor of ATP hydrolysis for P-glycoprotein
4i77,1.90,2013,Kd<0.01nM,Kd,nM,0.01,1e-05,5.0,"4i77.pdf (112-mer) Biacore-derived Kd for IL-13 binding to wt lebrikizumab is lower than the detection limit, 10 pM"
4k2u,2.45,2013,Kd=0.0153nM,Kd,nM,0.0153,1.53e-05,4.815308569182402,4k2u.pdf (234-mer)
2ypv,1.80,2013,Kd=0.03nM,Kd,nM,0.03,3e-05,4.522878745280337,2ypv.pdf (218-mer)
3wd5,3.10,2013,Kd=0.115nM,Kd,nM,0.115,0.000115,3.939302159646388,3wd5.pdf (219-mer) Kd=1.152+/-0.172x10-10M
3v6z,3.34,2013,Kd=0.12uM,Kd,uM,0.12,0.12,0.9208187539523752,3v6f.pdf (159-mer) The pdb code of HBeAg-e6 Fab complex in paper should be 3V6Z.
3tz1,1.80,2013,Kd=0.141uM,Kd,uM,0.141,0.141,0.8507808873446201,"3tz1.pdf (24-mer) ITC Ka=7.1x10 E6 M-1, Kd=0.141uM, TnI L was titrated by asTnC C"
3w8h,2.43,2013,Kd=0.164uM,Kd,uM,0.164,0.164,0.7851561519523022,3w8h.pdf (78-mer)
4k0a,2.13,2013,Kd=0.18nM,Kd,nM,0.18,0.00017999999999999998,3.744727494896694,4jzw.pdf (28-mer) Kd = 0.18 +/- 0.03 nm
4kbb,2.30,2013,Kd=0.18uM,Kd,uM,0.18,0.18,0.744727494896694,"4kbb.pdf (68-mer) Kd = 0.14 +/- 0.05 um(without GD1a),Kd = 0.18 +/- 0.06 um(with GD1a)"
4hgk,3.04,2013,Kd=0.19nM,Kd,nM,0.19,0.00019,3.721246399047171,4hgk.pdf (128-mer)
4gn4,1.86,2013,Kd=0.253uM,Kd,uM,0.253,0.253,0.5968794788241821,4gla.pdf (108-mer)
4bpx,3.40,2013,Kd=0.25uM,Kd,uM,0.25,0.25,0.6020599913279624,4bpu.pdf (269-mer)
4c4p,2.00,2013,Kd=0.25uM,Kd,uM,0.25,0.25,0.6020599913279624,4c4p.pdf (107-mer) Kd = 0.25 +/- 0.05 uM
4hff,2.40,2013,Kd=0.269nM,Kd,nM,0.269,0.00026900000000000003,3.570247719997592,4hff.pdf (104-mer) The crystal structure is Tae4-Tai4 complexes from Salmonella Typhimurium
4hfk,2.10,2013,Kd=0.269nM,Kd,nM,0.269,0.00026900000000000003,3.570247719997592,4hff.pdf (105-mer) The crystal structure is Tae4-Tai4 complexes from Enterobacter cloacae
4kt3,1.44,2013,Kd=0.26nM,Kd,nM,0.26,0.00026000000000000003,3.585026652029182,4kt3.pdf (137-mer)
4b1y,1.29,2013,Kd=0.27uM,Kd,uM,0.27,0.27,0.5686362358410126,"4b1u.pdf (32-mer) this is a prot-prot complex, ligand is not ATP"
3zet,2.31,2013,Kd=0.29uM,Kd,uM,0.29,0.29,0.5376020021010439,3zet.pdf (337-mer) Kd=0.29+/-0.1uM
3zeu,1.65,2013,Kd=0.29uM,Kd,uM,0.29,0.29,0.5376020021010439,3zet.pdf (337-mer) bound to ATPgammaS;Kd=0.29+/-0.1uM
4l67,2.80,2013,Kd=0.32uM,Kd,uM,0.32,0.32,0.494850021680094,4l67.pdf (25-mer)
4hdo,1.67,2013,Kd=0.36uM,Kd,uM,0.36,0.36,0.44369749923271273,4hdo.pdf (167-mer) Kd = 0.36 +/- 0.11 uM
4iyp,2.80,2013,Kd=0.3uM,Kd,uM,0.3,0.3,0.5228787452803376,4iyp.pdf (151-mer)
4kp3,2.40,2013,Kd=0.3uM,Kd,uM,0.3,0.3,0.5228787452803376,4kp3.pdf (103-mer) MLPH-GTBD and RILP2-RH1 bind to MyoVa-GTD with different interaction modes
4ic7,2.60,2013,Kd=0.43uM,Kd,uM,0.43,0.43,0.36653154442041347,4ic7.pdf (126-mer) Kd=0.43+/-0.06uM
3w2d,3.10,2013,Kd=0.5787nM,Kd,nM,0.5787,0.0005787,3.237546517636453,3w2d.pdf (223-mer)
4bqd,2.45,2013,Kd=0.5nM,Kd,nM,0.5,0.0005,3.3010299956639813,4bqd.pdf (21-mer)
4leo,2.64,2013,Kd=0.5nM,Kd,nM,0.5,0.0005,3.3010299956639813,4leo.pdf (621-mer)
4awx,2.30,2013,Kd=0.5uM,Kd,uM,0.5,0.5,0.3010299956639812,4awx.pdf (84-mer)
4k94,2.40,2013,Kd=0.63nM,Kd,nM,0.63,0.00063,3.2006594505464183,4k94.pdf (214-mer)
4iop,3.20,2013,Kd=0.67nM,Kd,nM,0.67,0.00067,3.1739251972991736,4iop.pdf (158-mer)
4gur,2.51,2013,Kd=0.68uM,Kd,uM,0.68,0.68,0.16749108729376366,"4gur.pdf (21-mer) Kd=0.68+/-0.07uM(H3K4M bind to LSD2 and WT NPAC);Kd=0.92+/-0.08uM(WT NPAC bind to LSD2,Supplementary Table S3.)"
4bfi,3.22,2013,Kd=0.6uM,Kd,uM,0.6,0.6,0.2218487496163564,4bfe.pdf (211-mer)
4gu0,3.10,2013,Kd=0.741uM,Kd,uM,0.741,0.741,0.13018179202067184,4gu0.pdf (26-mer)
4fq0,2.82,2013,Kd=0.87uM,Kd,uM,0.87,0.87,0.060480747381381476,4fq0.pdf (111-mer)
4lmq,2.77,2013,Kd=0.923nM,Kd,nM,0.923,0.0009230000000000001,3.034798298974088,"4lmq.pdf (221-mer) chains for antibody FAB on RCSB website should be wrong, assay by Biolayer Interferometry"
4hdq,1.95,2013,Kd=0.96uM,Kd,uM,0.96,0.96,0.017728766960431602,4hdo.pdf (26-mer) Kd = 0.96 +/- 0.14 uM
4mhh,3.56,2013,Kd=0.9nM,Kd,nM,0.9,0.0009000000000000001,3.0457574905606752,4mhh.pdf (222-mer) determined by biolayer interferometry
4c5g,2.10,2013,Kd=1.03uM,Kd,uM,1.03,1.03,-0.012837224705172217,4c5e.pdf (32-mer) P6122 space group
4g9f,1.90,2013,Kd=1.10uM,Kd,uM,1.10,1.1,-0.04139268515822508,4g8g.pdf (250-mer) Kd = 1.10 +/- 0.05 uM
4kt5,2.70,2013,Kd=1.1uM,Kd,uM,1.1,1.1,-0.04139268515822508,4kt5.pdf (137-mer)
2ma9,NMR,2013,Kd=1.225uM,Kd,uM,1.225,1.225,-0.0881360887005513,2ma9.pdf (118-mer)
4dx8,2.54,2013,Kd=1.24uM,Kd,uM,1.24,1.24,-0.09342168516223506,4dx8.pdf (203-mer) Kd = 1.24 +/- 0.03 uM
4j32,1.80,2013,Kd=1.28nM,Kd,nM,1.28,0.00128,2.8927900303521317,4j30.pdf (101-mer) Kd=1.28+/-3.29nM
3zkq,1.51,2013,Kd=1.2nM,Kd,nM,1.2,0.0012,2.9208187539523753,3zkg.pdf (122-mer)
4k3j,2.80,2013,Kd=1.2nM,Kd,nM,1.2,0.0012,2.9208187539523753,4k3j.pdf (224-mer)
4i2x,2.48,2013,Kd=1.2uM,Kd,uM,1.2,1.2,-0.07918124604762482,"4i2x.pdf (328-mer) equilibrium ultracentrifugation, Kd=1.2 +/- 0.3uM"
4hh3,1.75,2013,Kd=1.3uM,Kd,uM,1.3,1.3,-0.11394335230683679,"4hh3.pdf (240-mer) microscale thermophoresis, MST assay"
4jeu,3.20,2013,Kd=1.4nM,Kd,nM,1.4,0.0014,2.853871964321762,4jeh.pdf (242-mer)
4jo6,1.75,2013,Kd=1.53nM,Kd,nM,1.53,0.0015300000000000001,2.815308569182401,4jo6.pdf (38-mer)
4gko,3.30,2013,Kd=1.5mM,Kd,mM,1.5,1500.0,-3.1760912590556813,4gko.pdf (143-mer)
3vxu,2.70,2013,Kd=1.6uM,Kd,uM,1.6,1.6,-0.2041199826559248,3vxm.pdf (275-mer) Kd=1.6+/-0.3uM
4h2w,1.95,2013,Kd=1.73uM,Kd,uM,1.73,1.73,-0.2380461031287954,4h2s.pdf (103-mer)
4idj,3.36,2013,Kd=1.7pM,Kd,pM,1.7,1.6999999999999998e-06,5.769551078621726,4idj.pdf (239-mer) determined via the kinetic exclusion assay (KinExA)
4gaf,2.15,2013,Kd=1.8pM,Kd,pM,1.8,1.8e-06,5.7447274948966935,4gaf.pdf (319-mer) indirect SPR combined with competition assay
4hsa,3.15,2013,Kd=1.9nM,Kd,nM,1.9,0.0019,2.721246399047171,4hsa.pdf (301-mer)
3vep,2.50,2013,Kd=10.3uM,Kd,uM,10.3,10.3,-1.0128372247051722,3vep.pdf (86-mer)
4asw,NMR,2013,Kd=100nM,Kd,nM,100,0.1,1.0,4asw.pdf (83-mer) One Get5_UBL interacts with each Sgt2_NT dimer.
2m04,NMR,2013,Kd=10nM,Kd,nM,10,0.01,2.0,"2m04.pdf (25-mer) Results of analytical ultracentrifugation equilibrium experiment, Kd=10-30nM"
4hem,1.65,2013,Kd=10nM,Kd,nM,10,0.01,2.0,4hem.pdf (123-mer)
4imy,2.94,2013,Kd=10nM,Kd,nM,10,0.01,2.0,4imy.pdf (75-mer) Kd=10+/-1nM
2m49,NMR,2013,Kd=10uM,Kd,uM,10,10.0,-1.0,2m49.pdf (91-mer)
4geh,1.95,2013,Kd=11.7nM,Kd,nM,11.7,0.0117,1.9318141382538383,4geh.pdf (91-mer)
4i3r,3.00,2013,Kd=11.9nM,Kd,nM,11.9,0.0119,1.9244530386074692,4i3r.pdf (228-mer) Kd=11.9+/-0.1nM(SPR);Kd=36.8nM(biolayer interferometry) space group P3221
4c99,2.80,2013,Kd=114nM,Kd,nM,114,0.114,0.9430951486635274,4c99.pdf (121-mer) crystal form I
4h5s,1.70,2013,Kd=12.5uM,Kd,uM,12.5,12.5,-1.0969100130080565,4h5s.pdf (101-mer)
4may,2.20,2013,Kd=124uM,Kd,uM,124,124.0,-2.093421685162235,4grl.pdf (266-mer)
2m0j,NMR,2013,Kd=12nM,Kd,nM,12,0.012,1.9208187539523751,2m0j.pdf (28-mer) Kd=12+/-4 nM
4jeg,2.30,2013,Kd=12nM,Kd,nM,12,0.012,1.9208187539523751,4je4.pdf (94-mer)
2lz6,NMR,2013,Kd=12uM,Kd,uM,12,12.0,-1.0791812460476249,2lz6.pdf (60-mer)
4llo,2.00,2013,Kd=13.2uM,Kd,uM,13.2,13.2,-1.1205739312058498,4llo.pdf (134-mer) cannot download correct support info PDF
4jw3,2.60,2013,Kd=1450nM,Kd,nM,1450,1.45,-0.16136800223497488,4jw2.pdf (139-mer)
4je4,2.31,2013,Kd=14nM,Kd,nM,14,0.014,1.853871964321762,4je4.pdf (94-mer)
4jzw,1.78,2013,Kd=15.4pM,Kd,pM,15.4,1.5399999999999998e-05,4.812479279163537,4jzw.pdf (28-mer) Kd = 15.4 +/- 0.8 pM; in P212121 space group
4hix,2.20,2013,Kd=151nM,Kd,nM,151,0.151,0.8210230527068306,4hix.pdf (28-mer) Microscale Thermophoresis (MST) to measure the affinity
4kgg,2.78,2013,Kd=153nM,Kd,nM,153,0.153,0.8153085691824012,4j6g.pdf (174-mer) SPR Kd=153+/-54 nM
4grl,2.86,2013,Kd=154uM,Kd,uM,154,154.0,-2.187520720836463,4grl.pdf (268-mer)
4j6g,2.40,2013,Kd=16.3nM,Kd,nM,16.3,0.016300000000000002,1.787812395596042,4j6g.pdf (174-mer) SPR Kd=16.3+/-0.3 nM
4kr0,2.70,2013,Kd=16.7nM,Kd,nM,16.7,0.0167,1.7772835288524167,4kr0.pdf (251-mer) complex RBD-CD26
4hjj,2.10,2013,Kd=160pM,Kd,pM,160,0.00015999999999999999,3.7958800173440754,4hjj.pdf (348-mer)
4krp,2.82,2013,Kd=166nM,Kd,nM,166,0.166,0.7798919119599449,"4krl.pdf (220-mer) ternary complex of 9G8:FabC225:sEGFR, affinity is for 9G8:sEGFR complex"
4hgm,2.34,2013,Kd=16nM,Kd,nM,16,0.016,1.7958800173440752,4hgk.pdf (585-mer)
3znz,1.90,2013,Kd=196nM,Kd,nM,196,0.196,0.707743928643524,3znz.pdf (152-mer)
4ios,2.40,2013,Kd=19nM,Kd,nM,19,0.019,1.7212463990471711,4hem.pdf (123-mer)
4eig,2.50,2013,Kd=1nM,Kd,nM,1,0.001,3.0,4eig.pdf (123-mer)
4hrl,2.55,2013,Kd=1nM,Kd,nM,1,0.001,3.0,4hrl.pdf (171-mer)
4mhj,6.98,2013,Kd=1nM,Kd,nM,1,0.001,3.0,4mhh.pdf (222-mer) determined by biolayer interferometry
3w8i,2.40,2013,Kd=2.15nM,Kd,nM,2.15,0.00215,2.6675615400843946,3w8h.pdf (76-mer)
4nm8,4.00,2013,Kd=2.5nM,Kd,nM,2.5,0.0025,2.6020599913279625,4nm4.pdf (230-mer) determined by biolayer interferometry
2m86,NMR,2013,Kd=2.6nM,Kd,nM,2.6,0.0026000000000000003,2.585026652029182,2m86.pdf (51-mer)
4glv,2.57,2013,Kd=2.92nM,Kd,nM,2.92,0.00292,2.5346171485515816,4gla.pdf (107-mer)
4h88,1.90,2013,Kd=2.9nM,Kd,nM,2.9,0.0029,2.537602002101044,4h88.pdf (218-mer)
4iu3,1.97,2013,Kd=20.83nM,Kd,nM,20.83,0.020829999999999998,1.6813107300522543,4iu2.pdf (243-mer) SeMet derivative of the type IIIe RfCohE-XDoc complex
4bru,3.24,2013,Kd=200nM,Kd,nM,200,0.2,0.6989700043360187,4bru.pdf (43-mer)
4aoq,2.00,2013,Kd=201.8nM,Kd,nM,201.8,0.2018,0.6950788380991083,4aoq.pdf (37-mer) Kd=60.9+/-8.4nM(for SOTI-III);Kd=201.8+/-27.7nM(for F14A variant)
4i6l,2.49,2013,Kd=20nM,Kd,nM,20,0.02,1.6989700043360187,"4i6l.pdf (76-mer) Kd=20nM, not 20pM"
4jan,3.15,2013,Kd=20nM,Kd,nM,20,0.02,1.6989700043360187,4jam.pdf (226-mer)
4hmy,7.00,2013,Kd=20uM,Kd,uM,20,20.0,-1.3010299956639813,4hmy.pdf (172-mer) Kd = 20 +/- 0.6 uM
4h2s,2.15,2013,Kd=21.5uM,Kd,uM,21.5,21.5,-1.3324384599156054,4h2s.pdf (110-mer)
4ekc,7.40,2013,Kd=22nM,Kd,nM,22,0.022,1.6575773191777938,"4ekc.pdf (137-mer) Kd = 22 +/- 9 nM, IC50 = 0.27 +/- 0.06 uM"
4ekd,2.71,2013,Kd=22nM,Kd,nM,22,0.022,1.6575773191777938,"4ekc.pdf (137-mer) Kd = 22 +/- 9 nM, IC50 = 0.27 +/- 0.06 uM"
4hj0,3.00,2013,Kd=23nM,Kd,nM,23,0.023,1.6382721639824072,4hj0.pdf (227-mer)
4jry,2.80,2013,Kd=25uM,Kd,uM,25,25.0,-1.3979400086720377,4jrx.pdf (242-mer) SB47 TCR with the HLA-B*35:08LPEP
4kro,3.05,2013,Kd=276nM,Kd,nM,276,0.276,0.5590909179347823,"4krl.pdf (220-mer) ternary complex of EgA1:FabC225:sEGFR, affinity is for EgA1:sEGFR complex"
4bq6,2.30,2013,Kd=27nM,Kd,nM,27,0.027,1.5686362358410126,"4bq6.pdf (251-mer) Kd = 27 +/- 2 nM, crystal form I"
3wa5,1.90,2013,Kd=28.1nM,Kd,nM,28.1,0.028100000000000003,1.55129368009492,3wa5.pdf (153-mer)
4jgh,3.00,2013,Kd=28.1nM,Kd,nM,28.1,0.028100000000000003,1.55129368009492,4jgh.pdf (378-mer)
4c9b,2.00,2013,Kd=28.4nM,Kd,nM,28.4,0.028399999999999998,1.5466816599529623,4c9b.pdf (291-mer)
4jra,2.30,2013,Kd=28nM,Kd,nM,28,0.028,1.5528419686577808,4jra.pdf (136-mer)
4bsr,3.20,2013,Kd=2nM,Kd,nM,2,0.002,2.6989700043360187,"4bsr.pdf (126-mer) in P22121 crystal form, Kd=2-3uM from reference"
4hlz,2.90,2013,Kd=2nM,Kd,nM,2,0.002,2.6989700043360187,4hlz.pdf (229-mer) biolayer interferometry (BLI) assay
4h3p,2.30,2013,Kd=2uM,Kd,uM,2,2.0,-0.3010299956639812,4h3p.pdf (24-mer)
3zjy,3.60,2013,Kd=3.0uM,Kd,uM,3.0,3.0,-0.47712125471966244,3zjy.pdf (112-mer) Kd=3.0+/-0.4uM;differential scanning &#64258;uorimetry (DSF)
4ng2,2.41,2013,Kd=3.2uM,Kd,uM,3.2,3.2,-0.505149978319906,4ng2.pdf (113-mer)
4g01,2.20,2013,Kd=3.4uM,Kd,uM,3.4,3.4,-0.5314789170422551,4g01.pdf (181-mer) Ca-containing
4geq,2.01,2013,Kd=3.5uM,Kd,uM,3.5,3.5,-0.5440680443502757,4geq.pdf (25-mer)
4k81,2.40,2013,Kd=3.6uM,Kd,uM,3.6,3.6,-0.5563025007672873,4k81.pdf (171-mer) Kd = 3.6 +/- 0.6 um
4jrx,2.30,2013,Kd=3.75uM,Kd,uM,3.75,3.75,-0.5740312677277188,4jrx.pdf (238-mer) CA5 TCR with the HLA-B*35:08LPEP
4jw2,1.90,2013,Kd=3.7nM,Kd,nM,3.7,0.0037,2.431798275933005,4jw2.pdf (201-mer)
4bxz,4.80,2013,Kd=3.8uM,Kd,uM,3.8,3.8,-0.5797835966168101,4bxx.pdf (594-mer)
4hep,1.75,2013,Kd=300nM,Kd,nM,300,0.3,0.5228787452803376,4hem.pdf (131-mer)
4ftg,2.51,2013,Kd=30nM,Kd,nM,30,0.03,1.5228787452803376,4ftg.pdf (22-mer)
4bj5,3.29,2013,Kd=30uM,Kd,uM,30,30.0,-1.4771212547196624,4bj5.pdf (202-mer) Kd = 30 +/- 10 uM
4gn5,1.86,2013,Kd=31.1nM,Kd,nM,31.1,0.031100000000000003,1.5072396109731625,4gla.pdf (113-mer)
4iiq,2.86,2013,Kd=31uM,Kd,uM,31,31.0,-1.4913616938342726,4iiq.pdf (392-mer) human MAIT TCR (type F7)
4ihl,2.20,2013,Kd=346nM,Kd,nM,346,0.34600000000000003,0.4609239012072234,4iea.pdf (36-mer)
4gla,2.75,2013,Kd=35.3uM,Kd,uM,35.3,35.3,-1.5477747053878226,4gla.pdf (109-mer)
2m55,NMR,2013,Kd=35uM,Kd,uM,35,35.0,-1.5440680443502757,2m55.pdf (21-mer) ligand is  N-terminally acetylated peptide containing the &#64257;rst 19 residues (AcN19);Kd=35+/-10uM
4kgq,2.27,2013,Kd=36nM,Kd,nM,36,0.036000000000000004,1.4436974992327127,4j6g.pdf (174-mer) SPR Kd=36+/-1.8 nM
3v3k,3.49,2013,Kd=38.7nM,Kd,nM,38.7,0.038700000000000005,1.4122890349810886,"3v3k.pdf (165-mer) method: surface acoustic wave, mean Kd value of five assays is showed in Table S1"
4lad,2.30,2013,Kd=38nM,Kd,nM,38,0.038,1.4202164033831899,"2lxp.pdf (150-mer) crystal structure, same protein-ligand as 2lxp"
2lxp,NMR,2013,Kd=38nM,Kd,nM,38,0.038,1.4202164033831899,"2lxp.pdf (58-mer) NMR structure, same protein-ligand as 4lad"
4hnj,2.90,2013,Kd=3nM,Kd,nM,3,0.003,2.5228787452803374,2m04.pdf (25-mer) BCL-xL domain-swapped dimer in complex with PUMA BH3 peptide
4eiz,2.20,2013,Kd=3nM,Kd,nM,3,0.003,2.5228787452803374,4eig.pdf (134-mer)
4euk,1.95,2013,Kd=4.1uM,Kd,uM,4.1,4.1,-0.6127838567197355,4euk.pdf (159-mer)
4b1x,1.80,2013,Kd=4.34uM,Kd,uM,4.34,4.34,-0.6374897295125107,"4b1u.pdf (32-mer) this is a prot-prot complex, ligand is not ATP"
4g8g,2.40,2013,Kd=4.58uM,Kd,uM,4.58,4.58,-0.6608654780038692,4g8g.pdf (248-mer) Kd = 4.58 +/- 0.11 uM
4gn3,1.95,2013,Kd=4.6uM,Kd,uM,4.6,4.6,-0.6627578316815741,4gla.pdf (113-mer)
4ilg,2.10,2013,Kd=4.9nM,Kd,nM,4.9,0.004900000000000001,2.309803919971486,4ilg.pdf (270-mer)
4kjy,1.93,2013,Kd=41.3pM,Kd,pM,41.3,4.1299999999999994e-05,4.384049948343599,4kjy.pdf (133-mer)
4naw,2.19,2013,Kd=41nM,Kd,nM,41,0.041,1.3872161432802645,"4naw.pdf (34-mer) no direct Kd data for ATG3-RIA12, use Kd=41nM for longer ATG3-FR"
3zo0,1.99,2013,Kd=437nM,Kd,nM,437,0.437,0.3595185630295782,"2vol.pdf (207-mer) MURINE TRIM21 IN COMPLEX WITH MURINE IGG FC, Kd=4.3 X 10-7M"
4jb8,1.70,2013,Kd=44nM,Kd,nM,44,0.044,1.3565473235138126,4jb8.pdf (171-mer)
4jpk,2.40,2013,Kd=44nM,Kd,nM,44,0.044,1.3565473235138126,4jpi.pdf (172-mer)
4i0c,1.95,2013,Kd=460nM,Kd,nM,460,0.46,0.3372421683184259,4i0c.pdf (132-mer)
4krl,2.85,2013,Kd=47nM,Kd,nM,47,0.047,1.3279021420642825,4krl.pdf (214-mer) pH 6.0
3vza,1.90,2013,Kd=481nM,Kd,nM,481,0.481,0.31785492362616824,3vz9.pdf (39-mer)
2m5a,NMR,2013,Kd=48nM,Kd,nM,48,0.048,1.3187587626244128,2m5a.pdf (58-mer)
4f0z,1.70,2013,Kd=4nM,Kd,nM,4,0.004,2.3979400086720375,4f0z.pdf (43-mer)
4iof,3.35,2013,Kd=4nM,Kd,nM,4,0.004,2.3979400086720375,4iof.pdf (263-mer)
4cc4,2.60,2013,Kd=5.4uM,Kd,uM,5.4,5.4,-0.7323937598229685,4cc2.pdf (68-mer) Kd = 5.4 +/- 0.2 uM
4f37,2.57,2013,Kd=5.5nM,Kd,nM,5.5,0.0055,2.2596373105057563,4f37.pdf (219-mer)
4i18,3.24,2013,Kd=5.6nM,Kd,nM,5.6,0.0056,2.2518119729937998,4i18.pdf (211-mer)
4i9x,2.10,2013,Kd=5.96nM,Kd,nM,5.96,0.00596,2.2247537402597635,4i9x.pdf (127-mer) TRAIL-R2 as Immobilized ligand
4brw,2.80,2013,Kd=50nM,Kd,nM,50,0.05,1.3010299956639813,4bru.pdf (75-mer)
4jkp,2.82,2013,Kd=51nM,Kd,nM,51,0.051000000000000004,1.2924298239020635,4jkp.pdf (229-mer)
3vv2,1.83,2013,Kd=52pM,Kd,pM,52,5.2e-05,4.2839966563652006,"3vv2.pdf (69-mer) KD=5.2x10-11M, 52pM, not KD=52nM"
4kt1,2.50,2013,Kd=56.5nM,Kd,nM,56.5,0.0565,1.2479515521805615,4kt1.pdf (90-mer) STF reporter assays
4ika,2.70,2013,Kd=57.5uM,Kd,uM,57.5,57.5,-1.7596678446896306,4ika.pdf (22-mer)
2lww,NMR,2013,Kd=57nM,Kd,nM,57,0.057,1.2441251443275085,2lww.pdf (70-mer)
4ihh,2.13,2013,Kd=59nM,Kd,nM,59,0.059000000000000004,1.2291479883578558,4ihf.pdf (80-mer)
4m5z,2.25,2013,Kd=5nM,Kd,nM,5,0.005,2.3010299956639813,"4m4y.pdf (233-mer) assay by biolayer interferometry, Kd range is 5-50nM in table 2"
4bkx,3.00,2013,Kd=5uM,Kd,uM,5,5.0,-0.6989700043360189,4bkx.pdf (482-mer) HDAC1 activity was measured with the HDAC Assay Kit (Millipore)
4k9e,2.70,2013,Kd=6.4pM,Kd,pM,6.4,6.4e-06,5.1938200260161125,4k94.pdf (214-mer)
4aor,1.70,2013,Kd=60.9nM,Kd,nM,60.9,0.0609,1.2153827073671246,4aoq.pdf (37-mer) Kd=60.9+/-8.4nM(for SOTI-III);Kd=201.8+/-27.7nM(for F14A variant)
4iw4,3.20,2013,Kd=610nM,Kd,nM,610,0.61,0.21467016498923297,4iw4.pdf (279-mer)
3vxs,1.80,2013,Kd=64.8uM,Kd,uM,64.8,64.8,-1.8115750058705933,3vxm.pdf (275-mer) Kd=64.8+/-3.4uM
3wn7,1.57,2013,Kd=7.31nM,Kd,nM,7.31,0.00731,2.1360826230421397,3wn7.pdf (35-mer) SPR Kd=7.31 +/- 2.59 nM
4jeh,2.50,2013,Kd=8.1nM,Kd,nM,8.1,0.0081,2.0915149811213505,4jeh.pdf (243-mer)
4ka2,1.79,2013,Kd=8.4pM,Kd,pM,8.4,8.4e-06,5.075720713938118,4ka2.pdf (28-mer)
4g3y,2.60,2013,Kd=8.7nM,Kd,nM,8.7,0.0087,2.0604807473813813,4g3y.pdf (157-mer)
2m0g,NMR,2013,Kd=84nM,Kd,nM,84,0.084,1.0757207139381184,2m0g.pdf (104-mer)
4j2l,3.15,2013,Kd=88.5nM,Kd,nM,88.5,0.0885,1.0530567293021746,"4j2l.pdf (28-mer) ITC Kd is for Ataxin-1 and CIC-21 in PDB code 4j2j, CIC-28 has no data"
4k71,2.40,2013,Kd=8nM,Kd,nM,8,0.008,2.0969100130080562,4k71.pdf (274-mer) at PH 6.0
3vxr,2.40,2013,Kd=9.7uM,Kd,uM,9.7,9.7,-0.9867717342662449,3vxm.pdf (275-mer) Kd=9.7+/-0.7uM
4dpg,2.84,2013,Kd=90nM,Kd,nM,90,0.09,1.0457574905606752,4dpg.pdf (54-mer)
4lqw,1.95,2013,Kd=94uM,Kd,uM,94,94.0,-1.9731278535996986,4lqw.pdf (177-mer)
4fza,3.15,2013,Kd=99.1nM,Kd,nM,99.1,0.0991,1.0039263455147247,"4fza.pdf (283-mer) Kd1 = 99.1 nM, Kd2 = 69.5 nM, not full-length MST4, Kd1 = 9.12 nM, Kd2 = 80.0 nM"
3vux,1.70,2013,Kd=9uM,Kd,uM,9,9.0,-0.9542425094393249,3vuw.pdf (35-mer)
2m5b,NMR,2013,Kd~10uM,Kd,uM,10,10.0,-1.0,2m5b.pdf (23-mer)
3w6j,2.60,2013,Kd~56nM,Kd,nM,56,0.056,1.2518119729937995,3w6j.pdf (184-mer)
4j2y,2.00,2013,Ki=0.88nM,Ki,nM,0.88,0.00088,3.0555173278498313,4j2y.pdf (223-mer)
4ij3,2.70,2013,Ki=0.9nM,Ki,nM,0.9,0.0009000000000000001,3.0457574905606752,4ij3.pdf (484-mer)
4doq,2.00,2013,Ki=140nM,Ki,nM,140,0.14,0.8538719643217619,4doq.pdf (47-mer)
4gnk,4.00,2013,Ki=220nM,Ki,nM,220,0.22,0.6575773191777937,4gnk.pdf (235-mer) Ki = 220 +/- 30 nM
4bd9,2.20,2013,Ki=31nM,Ki,nM,31,0.031,1.5086383061657274,4bd9.pdf (165-mer)
3zia,2.50,2013,Ki=48mM,Ki,mM,48,48000.0,-4.681241237375588,3zia.pdf (63-mer) Ki=48+/-7mM
4ilw,2.10,2013,Ki=5.8nM,Ki,nM,5.8,0.0058,2.2365720064370627,4ilw.pdf (194-mer) competitive inhibition model
4boh,2.60,2013,Ki=55.56nM,Ki,nM,55.56,0.055560000000000005,1.255237762934422,4boh.pdf (60-mer)
4nst,2.20,2014,IC50=1.37uM,IC50,uM,1.37,1.37,-0.1367205671564068,4nst.pdf (268-mer)
4bpk,1.76,2014,IC50=25nM,IC50,nM,25,0.025,1.6020599913279623,4bpi.pdf (22-mer) Bcl-XL + peptide 5
4oqt,3.23,2014,Kd<50pM,Kd,pM,50,4.9999999999999996e-05,4.301029995663981,4oqt.pdf (235-mer) SPR Kd<=50 pM for the binding of the Li81 Fab to the LINGO-1 ectodomain
4plo,2.90,2014,Kd=0.038uM,Kd,uM,0.038,0.038,1.4202164033831899,4pln.pdf (205-mer) biolayer interferometry binding studies
4pbz,2.15,2014,Kd=0.05uM,Kd,uM,0.05,0.05,1.3010299956639813,4pbz.pdf (26-mer)
4u6h,3.10,2014,Kd=0.091nM,Kd,nM,0.091,9.1e-05,4.040958607678906,4u6h.pdf (184-mer) biolayer interferometry (BLI)- based assay
4lgr,1.65,2014,Kd=0.11nM,Kd,nM,0.11,0.00011,3.958607314841775,4lgp.pdf (122-mer)
4mit,2.35,2014,Kd=0.178uM,Kd,uM,0.178,0.178,0.7495799976911061,4mit.pdf (70-mer) kd=170+/-30 nM
4m1l,2.10,2014,Kd=0.18uM,Kd,uM,0.18,0.18,0.744727494896694,"4m1l.pdf (65-mer) SPR Kd=5.07nM for Ca2+-free CaM, PDB code 4lzx"
3wkt,4.30,2014,Kd=0.1uM,Kd,uM,0.1,0.1,1.0,3wkt.pdf (267-mer) SPR analysis showed that the dissociation constant (Kd) of the heme-rHO-1 complex for Delta TGEE was 0.1~0.2 uM
4pz6,2.41,2014,Kd=0.21uM,Kd,uM,0.21,0.21,0.6777807052660807,4pz6.pdf (21-mer) Pol2-CDT; Kd=0.21+/-0.03uM
4lgp,2.40,2014,Kd=0.23nM,Kd,nM,0.23,0.00023,3.638272163982407,4lgp.pdf (116-mer)
4bkl,3.25,2014,Kd=0.274uM,Kd,uM,0.274,0.274,0.562249437179612,4bkl.pdf (37-mer) SPR Kd=2.74 x 10-7M
4ml7,1.80,2014,Kd=0.27nM,Kd,nM,0.27,0.00027,3.5686362358410126,4ml7.pdf (99-mer)
4qt8,3.00,2014,Kd=0.28uM,Kd,uM,0.28,0.28,0.5528419686577808,4qt8.pdf (253-mer)
4jmf,2.10,2014,Kd=0.298uM,Kd,uM,0.298,0.298,0.5257837359237448,4jmf.pdf (116-mer) SPR Kd=0.298+/-0.06 uM
4mqw,2.90,2014,Kd=0.29nM,Kd,nM,0.29,0.00029,3.537602002101044,4mqw.pdf (361-mer) FSH binding to FSHR in the absence of Compound 5
4peq,2.21,2014,Kd=0.2fM,Kd,fM,0.2,2.0000000000000003e-10,9.698970004336019,3tsr.pdf (456-mer) Kd=2x10-16M
4cmh,1.53,2014,Kd=0.2nM,Kd,nM,0.2,0.0002,3.6989700043360187,4cmh.pdf (234-mer)
4liq,2.60,2014,Kd=0.2nM,Kd,nM,0.2,0.0002,3.6989700043360187,4liq.pdf (223-mer)
4pc0,2.50,2014,Kd=0.2uM,Kd,uM,0.2,0.2,0.6989700043360187,4pbz.pdf (42-mer)
3wry,2.30,2014,Kd=0.31uM,Kd,uM,0.31,0.31,0.5086383061657274,3wry.pdf (451-mer) complex type should be protein-protein
4pl8,2.00,2014,Kd=0.32uM,Kd,uM,0.32,0.32,0.494850021680094,4pl7.pdf (73-mer) T-belta4N full length; Kd=0.32+/-0.02uM
4qxa,2.30,2014,Kd=0.32uM,Kd,uM,0.32,0.32,0.494850021680094,4qxa.pdf (180-mer) Kd= 0.32+/- 0.08uM(Rab-9A Q66L mutant(WT));Kd=2.60+/-0.60uM(Rab-9A Q66L mutant(R68A)); Kd=45.0+/-13.0uM((Rab-9A Q66L mutant(L256AWT));Kd=1.41+/-0.30uM((Rab-9A Q66L mutant(Q361AWT))
4p1n,2.20,2014,Kd=0.36uM,Kd,uM,0.36,0.36,0.44369749923271273,4p1n.pdf (61-mer) Kd=0.36+/-0.03uM; Atg13 MIM(N+C) wild-type
4nqw,2.40,2014,Kd=0.42uM,Kd,uM,0.42,0.42,0.37675070960209955,"4nqw.pdf (80-mer) Oxidized sigma condition, Kd on reduced sigma condition is 1.15uM"
4r8g,3.50,2014,Kd=0.49uM,Kd,uM,0.49,0.49,0.3098039199714863,"4r8g.pdf (148-mer) Kd=0.49uM for IQ2 binding motifs, Kd=3.14uM for IQ3 motif, not the whole tail"
4n8c,1.60,2014,Kd=0.4nM,Kd,nM,0.4,0.0004,3.3979400086720375,4n8c.pdf (23-mer) unpublished data
4k24,4.50,2014,Kd=0.54uM,Kd,uM,0.54,0.54,0.26760624017703144,4k23.pdf (228-mer) measured by direct binding assays
4pwx,5.40,2014,Kd=0.54uM,Kd,uM,0.54,0.54,0.26760624017703144,4pwx.pdf (288-mer) Get4-5 prefers ATP bound state of Get3; Kd= 0.54+/-0.08uM
4lrz,2.32,2014,Kd=0.5uM,Kd,uM,0.5,0.5,0.3010299956639812,4lrx.pdf (318-mer)
4ofy,3.30,2014,Kd=0.602uM,Kd,uM,0.602,0.602,0.22040350874217546,"4ofy.pdf (420-mer) ITC assay is Protein SYG-1 D1, protein in crystal structure is Protein SYG-1 D1-D2"
4kdi,1.86,2014,Kd=0.71uM,Kd,uM,0.71,0.71,0.14874165128092473,4kdi.pdf (90-mer)
4kvg,1.65,2014,Kd=0.7uM,Kd,uM,0.7,0.7,0.1549019599857432,4kvg.pdf (260-mer)
4cmm,1.92,2014,Kd=0.8uM,Kd,uM,0.8,0.8,0.09691001300805639,4cmm.pdf (127-mer)
4od2,3.20,2014,Kd=0.92nM,Kd,nM,0.92,0.00092,3.036212172654445,4od2.pdf (111-mer) Kd=0.92+/-0.01 nM
4mrt,2.00,2014,Kd=0.92uM,Kd,uM,0.92,0.92,0.036212172654444715,4mrt.pdf (232-mer) in presence of coenzyme A
4nso,2.40,2014,Kd=0.98nM,Kd,nM,0.98,0.00098,3.0087739243075053,4nso.pdf (108-mer)
4byf,2.74,2014,Kd=0.9uM,Kd,uM,0.9,0.9,0.045757490560675115,4byf.pdf (149-mer) calmodulin in the pre-power stroke state
4pj8,3.30,2014,Kd=1.0uM,Kd,uM,1.0,1.0,-0.0,4pj5.pdf (247-mer) Kd=1.0+/-0.3uM; C-F7 (TRBV20) TCR
4ne9,2.60,2014,Kd=1.17uM,Kd,uM,1.17,1.17,-0.06818586174616162,4ne9.pdf (26-mer)
3wdg,2.20,2014,Kd=1.198nM,Kd,nM,1.198,0.001198,2.9215431819467073,3wdg.pdf (112-mer) SPR Kd=1.198+/-0.029nM
4pqt,2.05,2014,Kd=1.1uM,Kd,uM,1.1,1.1,-0.04139268515822508,4k1r.pdf (81-mer)
4u0q,3.10,2014,Kd=1.1uM,Kd,uM,1.1,1.1,-0.04139268515822508,"4u0q.pdf (269-mer) in paper, the protein is PfRH5 Delta NL, Kd=1.3 uM, length does not match that in RCSB PDB"
4cu4,2.30,2014,Kd=1.2uM,Kd,uM,1.2,1.2,-0.07918124604762482,4cu4.pdf (21-mer) FhuA-MccJ25
4re1,2.20,2014,Kd=1.2uM,Kd,uM,1.2,1.2,-0.07918124604762482,4re1.pdf (149-mer)
4mi8,2.10,2014,Kd=1.38uM,Kd,uM,1.38,1.38,-0.13987908640123647,4mi8.pdf (26-mer)
4w4l,2.45,2014,Kd=1.3nM,Kd,nM,1.3,0.0013000000000000002,2.886056647693163,4w4k.pdf (314-mer) assayed by biolayer interferometry
4wfd,2.40,2014,Kd=1.3uM,Kd,uM,1.3,1.3,-0.11394335230683679,4wfc.pdf (20-mer)
4ov6,2.69,2014,Kd=1.58nM,Kd,nM,1.58,0.00158,2.8013429130455774,"4ov6.pdf (99-mer) SPR kd=1.58 +/- 0.18 nM, for Form of Adnectin: 1459D05 (progenitor)"
4w6y,1.57,2014,Kd=1.58nM,Kd,nM,1.58,0.00158,2.8013429130455774,"4w6w.pdf (131-mer) Microscale thermophoresis (MST), Kd=1.58 +/- 0.65 nM"
4nn6,2.54,2014,Kd=1.5nM,Kd,nM,1.5,0.0015,2.8239087409443187,"4nn5.pdf (223-mer) TSLP N123Q and TSLPR N122Q in ternary complex with IL-7R alpha, complex at neutral pH, crystal form 1B"
3wkn,2.90,2014,Kd=1.6nM,Kd,nM,1.6,0.0016,2.795880017344075,3wkn.pdf (54-mer)
3wn5,2.78,2014,Kd=1.6uM,Kd,uM,1.6,1.6,-0.2041199826559248,3wn5.pdf (197-mer)
4qlb,2.60,2014,Kd=1.6uM,Kd,uM,1.6,1.6,-0.2041199826559248,4qlb.pdf (36-mer) Kd=1.6 +/- 0.3 uM
4kv5,3.00,2014,Kd=1.7nM,Kd,nM,1.7,0.0017,2.769551078621726,4kv5.pdf (136-mer) SPR Kd=1.7 +/- 0.6 nM for GC1008 scFv:TGF beta1
4nee,2.88,2014,Kd=1.8uM,Kd,uM,1.8,1.8,-0.25527250510330607,4nee.pdf (155-mer) ITC Kd=1.8 +/- 0.4uM
2mcn,NMR,2014,Kd=1.9uM,Kd,uM,1.9,1.9,-0.2787536009528289,2mcn.pdf (76-mer)
4cdk,2.80,2014,Kd=1.9uM,Kd,uM,1.9,1.9,-0.2787536009528289,4cdk.pdf (126-mer) SPR Kd=1.9 +/- 0.1uM
4k1r,1.63,2014,Kd=10.2uM,Kd,uM,10.2,10.2,-1.0086001717619175,4k1r.pdf (81-mer)
4k5a,1.50,2014,Kd=10.3nM,Kd,nM,10.3,0.0103,1.9871627752948278,4k5a.pdf (169-mer)
4cni,2.20,2014,Kd=10pM,Kd,pM,10,9.999999999999999e-06,5.0,4cni.pdf (171-mer)
4u6v,2.56,2014,Kd=10pM,Kd,pM,10,9.999999999999999e-06,5.0,4u6v.pdf (293-mer) Binding using the ProteOn platform
4q96,1.85,2014,Kd=114uM,Kd,uM,114,114.0,-2.0569048513364727,4q96.pdf (21-mer) Kd=114 +/- 2uM
4cj2,1.50,2014,Kd=11nM,Kd,nM,11,0.011,1.958607314841775,4cj0.pdf (78-mer) ITC Kd=11 +/- 2.8 nM
4pas,1.62,2014,Kd=126.6nM,Kd,nM,126.6,0.1266,0.8975662943186637,4pas.pdf (41-mer)
2ru4,NMR,2014,Kd=126nM,Kd,nM,126,0.126,0.8996294548824371,2ru4.pdf (84-mer) ITC Kd=126 +/- 5 nM
4m38,2.20,2014,Kd=12uM,Kd,uM,12,12.0,-1.0791812460476249,4m37.pdf (21-mer)
4m5f,2.50,2014,Kd=13.5pM,Kd,pM,13.5,1.35e-05,4.869666231504994,4m5f.pdf (127-mer) Kd was approximately 13.5 pM in the presence of 0.1 mM CaCl2
2mbb,NMR,2014,Kd=130uM,Kd,uM,130,130.0,-2.113943352306837,2mbb.pdf (78-mer)
4m1g,1.60,2014,Kd=14.4nM,Kd,nM,14.4,0.014400000000000001,1.8416375079047502,4lqf.pdf (220-mer) assay by BLI
4p3y,2.15,2014,Kd=146nM,Kd,nM,146,0.146,0.835647144215563,4p3y.pdf (182-mer) Kd=146+/-37nM; oxidized EF-Tu
4ons,2.80,2014,Kd=15.8nM,Kd,nM,15.8,0.0158,1.8013429130455774,4ons.pdf (88-mer) Kd is not for exact the same protein sequence
4ozg,3.00,2014,Kd=15.8uM,Kd,uM,15.8,15.8,-1.1986570869544226,4ozf.pdf (213-mer) this is a protein-protein complex
4pou,1.75,2014,Kd=157nM,Kd,nM,157,0.157,0.8041003475907662,4pou.pdf (122-mer) ITC Kd=157 +/- 3 nM
3wo4,3.10,2014,Kd=15nM,Kd,nM,15,0.015,1.8239087409443189,"3wo4.pdf (344-mer) IL-18 signaling ternary complex, SPR Kd=1.5+/-0.1 x10-8M"
4rdq,2.85,2014,Kd=15nM,Kd,nM,15,0.015,1.8239087409443189,4rdq.pdf (217-mer) Ca2+ containing
4lrx,3.25,2014,Kd=15uM,Kd,uM,15,15.0,-1.1760912590556813,4lrx.pdf (318-mer)
4u3j,2.81,2014,Kd=160nM,Kd,nM,160,0.16,0.7958800173440752,4u3j.pdf (249-mer)
4n7z,2.85,2014,Kd=177nM,Kd,nM,177,0.177,0.7520267336381934,4n7v.pdf (58-mer) CPB-binding affinity of Cep192-58mer is Kd= 177 +/- 23 nM
2mej,NMR,2014,Kd=17uM,Kd,uM,17,17.0,-1.2304489213782739,2mej.pdf (217-mer)
4c1n,2.53,2014,Kd=18.1nM,Kd,nM,18.1,0.0181,1.7423214251308154,4c1n.pdf (510-mer)
4d0n,2.10,2014,Kd=18.1uM,Kd,uM,18.1,18.1,-1.2576785748691846,"4d0n.pdf (373-mer) RhoA with GDP, Kd=18.1uM"
4v2c,4.00,2014,Kd=18uM,Kd,uM,18,18.0,-1.255272505103306,4v2c.pdf (161-mer)
4myw,3.19,2014,Kd=19.1nM,Kd,nM,19.1,0.019100000000000002,1.7189666327522723,4myw.pdf (331-mer)
4bwq,2.10,2014,Kd=19.7uM,Kd,uM,19.7,19.7,-1.294466226161593,4bwq.pdf (43-mer)
4np4,2.89,2014,Kd=19pM,Kd,pM,19,1.8999999999999998e-05,4.721246399047171,"4np4.pdf (222-mer) High affinity binding site Kd=19 +/- 5pM, low affinity binding site Kd=370 +/- 310 pM"
2mre,NMR,2014,Kd=19uM,Kd,uM,19,19.0,-1.2787536009528289,2mre.pdf (33-mer) NMR Kd=19 +/- 1.2 uM
4per,1.92,2014,Kd=1fM,Kd,fM,1,1e-09,9.0,3tsr.pdf (460-mer) Kd=1x10 -15M
4py8,2.91,2014,Kd=1nM,Kd,nM,1,0.001,3.0,"4py7.pdf (219-mer) biolayer interferometry (BLI) assay, KD=1nM"
4u2x,3.15,2014,Kd=1nM,Kd,nM,1,0.001,3.0,4u2x.pdf (175-mer) ITC Kd=1.0+/-0.3 nM
4odx,3.10,2014,Kd=2.06nM,Kd,nM,2.06,0.00206,2.6861327796308467,4m62.pdf (161-mer)
3wrx,2.50,2014,Kd=2.1uM,Kd,uM,2.1,2.1,-0.3222192947339193,3wrx.pdf (451-mer) complex type should be protein-protein
4pjd,2.78,2014,Kd=2.2uM,Kd,uM,2.2,2.2,-0.3424226808222063,4pj5.pdf (271-mer) Kd=2.2+/-0.3uM; C-C10  TCR
4qrp,2.90,2014,Kd=2.48uM,Kd,uM,2.48,2.48,-0.3944516808262163,4qrp.pdf (245-mer) HSKKKCDEL; Kd=2.48+/-0.11uM
4pbv,2.50,2014,Kd=2.4uM,Kd,uM,2.4,2.4,-0.38021124171160603,4pbv.pdf (299-mer)
4pj9,2.00,2014,Kd=2.4uM,Kd,uM,2.4,2.4,-0.38021124171160603,4pj5.pdf (271-mer) Kd=2.4+/-0.4uM; number 4 (TRAJ20) TCR
4m62,1.80,2014,Kd=2.57nM,Kd,nM,2.57,0.00257,2.5900668766687054,4m62.pdf (155-mer)
4u97,2.65,2014,Kd=2.5uM,Kd,uM,2.5,2.5,-0.3979400086720376,4u97.pdf (312-mer) IRAK4 FL-D311N; Asymmetric Dimerization with Kd=2.5+/-0.4uM
4u5w,1.86,2014,Kd=2.63uM,Kd,uM,2.63,2.63,-0.41995574848975786,4u5w.pdf (180-mer)
3wa0,2.31,2014,Kd=2.64uM,Kd,uM,2.64,2.64,-0.42160392686983106,"3wa0.pdf (96-mer) affinity is for C29 DCAF1(1478-1506), crystal is for DCAF1 (1417-1506)"
4ra0,3.07,2014,Kd=2.7pM,Kd,pM,2.7,2.7e-06,5.568636235841013,4ra0.pdf (195-mer) measured using the kinetic exclusion assay (KinExA)
4c4k,1.95,2014,Kd=2.7uM,Kd,uM,2.7,2.7,-0.43136376415898736,4c4k.pdf (102-mer) M10:O1 (orthorhombic)
4pj7,2.50,2014,Kd=2.7uM,Kd,uM,2.7,2.7,-0.43136376415898736,4pj5.pdf (271-mer) Kd=2.7+/-0.7uM; number 6 TRBV6-4 TCR
4qd2,2.40,2014,Kd=2.7uM,Kd,uM,2.7,2.7,-0.43136376415898736,4qd2.pdf (213-mer)
4mqv,1.95,2014,Kd=2.9uM,Kd,uM,2.9,2.9,-0.4623979978989561,4mqv.pdf (26-mer) Kd=2.9+/-0.1 uM
4mjs,2.50,2014,Kd=21.6nM,Kd,nM,21.6,0.0216,1.665546248849069,4mjs.pdf (104-mer) ITC Kd=21.6+/-2.09 nM
4n8v,2.50,2014,Kd=22.2uM,Kd,uM,22.2,22.2,-1.3463529744506386,4n8v.pdf (274-mer)
4oyd,1.80,2014,Kd=220pM,Kd,pM,220,0.00021999999999999998,3.657577319177794,4oyd.pdf (117-mer) bio-layer interferometry (BLI) assay
4ojk,2.66,2014,Kd=22uM,Kd,uM,22,22.0,-1.3424226808222062,4ojk.pdf (46-mer) Kd=22+/-0.3uM; PKG II LZ (residues 40-83) binds to Rab11b-GDP
2mnu,NMR,2014,Kd=230nM,Kd,nM,230,0.23,0.638272163982407,2mnu.pdf (26-mer) ITC Kd=230+/-36 nM
2ruk,NMR,2014,Kd=24.21uM,Kd,uM,24.21,24.21,-1.3839947894417328,2ruk.pdf (110-mer) ITC Kd=24.21+/-3 uM
4ozh,2.80,2014,Kd=24.8uM,Kd,uM,24.8,24.8,-1.3944516808262162,4ozf.pdf (213-mer) this is a protein-protein complex
4bxl,NMR,2014,Kd=240nM,Kd,nM,240,0.24,0.619788758288394,4bxl.pdf (22-mer)
4nl9,1.50,2014,Kd=249nM,Kd,nM,249,0.249,0.6038006529042637,4nl9.pdf (71-mer) SPR Kd= 249 +/- 8 nM
2mp0,NMR,2014,Kd=25mM,Kd,mM,25,25000.0,-4.3979400086720375,2mp0.pdf (168-mer)
4nzl,1.85,2014,Kd=25nM,Kd,nM,25,0.025,1.6020599913279623,4nzl.pdf (114-mer)
4o27,3.19,2014,Kd=25nM,Kd,nM,25,0.025,1.6020599913279623,4nzw.pdf (281-mer) between WT MO25-alpha and WT MST3
4ct0,2.45,2014,Kd=28nM,Kd,nM,28,0.028,1.5528419686577808,4ct0.pdf (143-mer)
4x7f,1.70,2014,Kd=28nM,Kd,nM,28,0.028,1.5528419686577808,4x7c.pdf (119-mer)
4jlr,2.71,2014,Kd=29.9pM,Kd,pM,29.9,2.99e-05,4.52432881167557,4jlr.pdf (123-mer)
4p6i,2.30,2014,Kd=290nM,Kd,nM,290,0.29,0.5376020021010439,4p6i.pdf (305-mer)
4w6w,2.51,2014,Kd=3.57nM,Kd,nM,3.57,0.00357,2.447331783887807,"4w6w.pdf (131-mer) Microscale thermophoresis (MST), Kd=3.57 +/- 2.59 nM"
4x7d,2.15,2014,Kd=3.5nM,Kd,nM,3.5,0.0035,2.4559319556497243,4x7c.pdf (126-mer)
4p2c,2.82,2014,Kd=3.95nM,Kd,nM,3.95,0.00395,2.40340290437354,4p2c.pdf (128-mer)
4m8q,2.89,2014,Kd=3.96nM,Kd,nM,3.96,0.00396,2.402304814074488,4m62.pdf (161-mer)
4u4c,2.40,2014,Kd=310nM,Kd,nM,310,0.31,0.5086383061657274,4u4c.pdf (116-mer)
2mak,NMR,2014,Kd=310uM,Kd,uM,310,310.0,-2.4913616938342726,"2mak.pdf (23-mer) NMR Kd values of 310, 160, 90 uM for A277, A280 and E272 curves, respectively"
4lyl,1.93,2014,Kd=31nM,Kd,nM,31,0.031,1.5086383061657274,4lyl.pdf (84-mer)
4n9g,2.50,2014,Kd=326pM,Kd,pM,326,0.000326,3.486782399932061,4jlr.pdf (123-mer)
4n7v,2.76,2014,Kd=32nM,Kd,nM,32,0.032,1.494850021680094,4n7v.pdf (60-mer) CPB-binding affinity of Cep152-60mer is Kd= 32 +/- 4 nM
4p59,3.40,2014,Kd=32pM,Kd,pM,32,3.2e-05,4.494850021680094,4p59.pdf (238-mer) solution equilibrium titration
4p46,2.85,2014,Kd=32uM,Kd,uM,32,32.0,-1.505149978319906,4p23.pdf (218-mer)
4p9h,3.00,2014,Kd=33.1nM,Kd,nM,33.1,0.033100000000000004,1.4801720062242811,4p9h.pdf (244-mer) 93TH057 gp120 mutant
4v0m,3.45,2014,Kd=348nM,Kd,nM,348,0.34800000000000003,0.45842075605341903,4v0k.pdf (425-mer) CrARL6 delta N-GTP-CrBBS1N; Kd=348+/-45nM
4v0o,3.35,2014,Kd=348nM,Kd,nM,348,0.34800000000000003,0.45842075605341903,4v0k.pdf (425-mer) CrARL6 delta N-GTP-CrBBS1N; Kd=348+/-45nM; lead soak; same as 4v0m
4v0n,3.13,2014,Kd=348nM,Kd,nM,348,0.34800000000000003,0.45842075605341903,4v0k.pdf (425-mer) CrARL6 delta N-GTP-CrBBS1N; Kd=348+/-45nM; mercury soak; same as 4v0m
4r2g,3.28,2014,Kd=34nM,Kd,nM,34,0.034,1.4685210829577449,4r26.pdf (236-mer) PGT124 Fab bind to precomplexed HIV-1 JRCSF gp120 core and CD4
4pjf,2.45,2014,Kd=35.4uM,Kd,uM,35.4,35.4,-1.5490032620257879,4pj5.pdf (271-mer) Kd=35.4+/-3.0uM
4qzv,2.59,2014,Kd=35.7uM,Kd,uM,35.7,35.7,-1.5526682161121932,4qzv.pdf (246-mer)
4kxz,2.83,2014,Kd=3nM,Kd,nM,3,0.003,2.5228787452803374,4kv5.pdf (224-mer) SPR Kd=3.0 +/- 1.2 nM for GC1008 FAB:TGF beta2
3wwk,2.98,2014,Kd=3uM,Kd,uM,3,3.0,-0.47712125471966244,3wsr.pdf (146-mer) estimated SPR Kd data
4msm,1.74,2014,Kd=3uM,Kd,uM,3,3.0,-0.47712125471966244,4k1r.pdf (81-mer)
4khx,2.92,2014,Kd=4.2nM,Kd,nM,4.2,0.004200000000000001,2.3767507096020997,"4kht.pdf (245-mer) A+B+B+B interaction, Kd1 based on a global analysis of the ITC, fluorescence and sedimentation data results"
4pjc,2.50,2014,Kd=4.2uM,Kd,uM,4.2,4.2,-0.6232492903979004,4pj5.pdf (271-mer) Kd=4.2+/-0.5uM; C-A11  TCR
4pja,2.68,2014,Kd=4.2uM,Kd,uM,4.2,4.2,-0.6232492903979004,4pj5.pdf (271-mer) Kd=4.2+/-0.6uM; B-B10 TCR
4kht,2.82,2014,Kd=4.3nM,Kd,nM,4.3,0.0043,2.3665315444204134,"4kht.pdf (245-mer) A+B+B+B interaction, Kd1 based on a global analysis of the ITC, fluorescence and sedimentation data results"
2mj5,NMR,2014,Kd=4.3uM,Kd,uM,4.3,4.3,-0.6334684555795865,"2mj5.pdf (76-mer) ITC Kd=4.3 +/- 0.4 uM, chemical shift Kd=3 +/- 0.9 uM"
4ol0,2.90,2014,Kd=4.7nM,Kd,nM,4.7,0.0047,2.3279021420642825,4ol0.pdf (921-mer) Kd=4.7+/-1.2nM; GTP containing
4noo,2.30,2014,Kd=4.92nM,Kd,nM,4.92,0.00492,2.30803489723264,4noo.pdf (98-mer) putative catalytic domain (VgrG3CCD) as ligand and TsiV3 as analyte
4j4p,2.91,2014,Kd=40nM,Kd,nM,40,0.04,1.3979400086720375,4j4p.pdf (249-mer)
4ovn,2.80,2014,Kd=46nM,Kd,nM,46,0.046,1.337242168318426,"4ovn.pdf (157-mer) Temperature is 28C, Kds ranging from 46 +/- 33 nM to 105 +/- 15 nM depending on the buffer conditions"
4pp8,1.95,2014,Kd=486nM,Kd,nM,486,0.486,0.3133637307377066,"1jsk.pdf (174-mer) RAE-1 BETA IN COMPLEX WITH murine NKG2D, Kd=486nM"
4cj1,1.63,2014,Kd=48nM,Kd,nM,48,0.048,1.3187587626244128,4cj0.pdf (81-mer) ITC Kd=48 +/- 10 nM
4jzj,2.80,2014,Kd=4nM,Kd,nM,4,0.004,2.3979400086720375,4jzj.pdf (221-mer)
4lzx,1.50,2014,Kd=5.07nM,Kd,nM,5.07,0.005070000000000001,2.294992040666664,"4lzx.pdf (40-mer) SPR Kd=0.18uM for Ca2+-bound CaM, PDB code 4m1l"
4w6x,1.88,2014,Kd=5.25nM,Kd,nM,5.25,0.00525,2.279840696594043,"4w6w.pdf (131-mer) Microscale thermophoresis (MST), Kd=5.25 +/- 3.08 nM"
2mfq,NMR,2014,Kd=5.2uM,Kd,uM,5.2,5.2,-0.7160033436347992,2mfq.pdf (23-mer)
4ps4,2.80,2014,Kd=5.7pM,Kd,pM,5.7,5.7e-06,5.2441251443275085,4ps4.pdf (113-mer) SPR Kd=5.7+/-1.3pM
4lxr,2.20,2014,Kd=5.9nM,Kd,nM,5.9,0.005900000000000001,2.2291479883578558,4lxr.pdf (114-mer)
4nzw,3.58,2014,Kd=504nM,Kd,nM,504,0.504,0.2975694635544747,4nzw.pdf (295-mer) between WT MO25-alpha and WT STK25
4pbw,3.05,2014,Kd=551nM,Kd,nM,551,0.551,0.2588484011482149,4pbv.pdf (299-mer)
4q5e,1.87,2014,Kd=580nM,Kd,nM,580,0.58,0.23657200643706275,4q5e.pdf (156-mer) OspG with UbcH7~Ub; Kd=580+/-20nM
4js0,1.90,2014,Kd=5uM,Kd,uM,5,5.0,-0.6989700043360189,4js0.pdf (32-mer) Kd measured by ITC
4p5t,3.26,2014,Kd=5uM,Kd,uM,5,5.0,-0.6989700043360189,4p23.pdf (217-mer)
2mjw,NMR,2014,Kd=6.2uM,Kd,uM,6.2,6.2,-0.7923916894982539,2mjw.pdf (94-mer)
4o1q,2.59,2014,Kd=6.2uM,Kd,uM,6.2,6.2,-0.7923916894982539,"4o1q.pdf (385-mer) affinity is for quinone MADH, not preMADH"
3wwn,1.85,2014,Kd=6.62uM,Kd,uM,6.62,6.62,-0.8208579894396999,3wwn.pdf (54-mer) ITC Kd=6.62+/-0.56 uM
4m0w,1.40,2014,Kd=6.7uM,Kd,uM,6.7,6.7,-0.8260748027008264,4m0w.pdf (76-mer)
4ln0,2.90,2014,Kd=6.8nM,Kd,nM,6.8,0.0068,2.167491087293764,4ln0.pdf (58-mer) BLI assay
4lqf,2.30,2014,Kd=64.5pM,Kd,pM,64.5,6.45e-05,4.1904402853647325,4lqf.pdf (219-mer) assay by BLI
4k5b,1.85,2014,Kd=643pM,Kd,pM,643,0.000643,3.191789027075778,4k5a.pdf (184-mer) The PDB website may label the two protein chains wrong
4lu5,2.90,2014,Kd=65.9pM,Kd,pM,65.9,6.59e-05,4.18111458540599,4lqf.pdf (219-mer) assay by BLI
4wo4,2.50,2014,Kd=66nM,Kd,nM,66,0.066,1.1804560644581312,4qrr.pdf (245-mer)
3wo3,3.10,2014,Kd=69nM,Kd,nM,69,0.069,1.1611509092627446,3wo3.pdf (312-mer) SPR Kd=6.9+/-0.2 x10-8M
4p23,2.25,2014,Kd=6uM,Kd,uM,6,6.0,-0.7781512503836436,4p23.pdf (218-mer)
4m6b,1.78,2014,Kd=7.1nM,Kd,nM,7.1,0.0070999999999999995,2.1487416512809245,"4m6b.pdf (55-mer) ITC Kd is for yeast Swr1 (504-650), length in RCSB PDB is only 55 aa"
2mkc,NMR,2014,Kd=7.8nM,Kd,nM,7.8,0.0078,2.1079053973095196,2mkc.pdf (118-mer) Kd of cPml1p to the cSnu17p-cBud13p dimer was 7.8 +/- 0.3 nM
4ozi,3.20,2014,Kd=70uM,Kd,uM,70,70.0,-1.845098040014257,4ozf.pdf (213-mer) this is a protein-protein complex
4ozf,2.70,2014,Kd=79.4uM,Kd,uM,79.4,79.4,-1.8998205024270962,4ozf.pdf (213-mer) this is a protein-protein complex
4x7e,2.11,2014,Kd=7nM,Kd,nM,7,0.007,2.154901959985743,4x7c.pdf (126-mer)
4mp0,2.10,2014,Kd=8.7nM,Kd,nM,8.7,0.0087,2.0604807473813813,4moy.pdf (44-mer) Kd=8.7 +/-0.8 nM
4pjb,2.85,2014,Kd=9.1uM,Kd,uM,9.1,9.1,-0.9590413923210935,4pj5.pdf (271-mer) Kd=9.1+/-1.0uM;  B-F3-C1 TCR
2mur,NMR,2014,Kd=9.26uM,Kd,uM,9.26,9.26,-0.9666109866819343,2mur.pdf (78-mer)
4c2a,2.08,2014,Kd=9.7nM,Kd,nM,9.7,0.0097,2.0132282657337552,4c2a.pdf (291-mer) KD values were determined by radiometric titration
4kfz,2.80,2014,Kd=94nM,Kd,nM,94,0.094,1.0268721464003014,"4kfz.pdf (129-mer) Mammalian two-hybrid data, Kd=9.4 x 10-8 M"
4cj0,1.10,2014,Kd=98nM,Kd,nM,98,0.098,1.0087739243075051,4cj0.pdf (81-mer) ITC Kd=98 +/- 36 nM
4c2b,2.80,2014,Kd=9nM,Kd,nM,9,0.009000000000000001,2.0457574905606752,4c2a.pdf (291-mer) KD values were determined by radiometric titration
4l0p,2.26,2014,Kd=9nM,Kd,nM,9,0.009000000000000001,2.0457574905606752,4l0p.pdf (143-mer)
4pje,1.95,2014,Kd>200uM,Kd,uM,200,200.0,-2.3010299956639813,4pj5.pdf (271-mer)
4pjg,2.40,2014,Kd>200uM,Kd,uM,200,200.0,-2.3010299956639813,4pj5.pdf (271-mer)
4pjh,2.00,2014,Kd>200uM,Kd,uM,200,200.0,-2.3010299956639813,4pj5.pdf (271-mer)
4pjx,2.25,2014,Kd>200uM,Kd,uM,200,200.0,-2.3010299956639813,4pj5.pdf (271-mer)
4pj5,2.00,2014,Kd>200uM,Kd,uM,200,200.0,-2.3010299956639813,4pj5.pdf (271-mer) wild-type TCR
4edw,2.48,2014,Kd~10nM,Kd,nM,10,0.01,2.0,4edw.pdf (231-mer)
2mlz,NMR,2014,Kd~14uM,Kd,uM,14,14.0,-1.146128035678238,2mlx.pdf (93-mer)
4c7n,2.10,2014,Kd~1nM,Kd,nM,1,0.001,3.0,4c7n.pdf (51-mer)
4q5u,1.95,2014,Kd~1pM,Kd,pM,1,1e-06,6.0,4q5u.pdf (24-mer)
4p2o,2.60,2014,Kd~1uM,Kd,uM,1,1.0,-0.0,4p2o.pdf (255-mer)
4p2q,3.30,2014,Kd~1uM,Kd,uM,1,1.0,-0.0,4p2o.pdf (266-mer)
4p2r,3.30,2014,Kd~1uM,Kd,uM,1,1.0,-0.0,4p2o.pdf (266-mer)
2mly,NMR,2014,Kd~2uM,Kd,uM,2,2.0,-0.3010299956639812,"2mlx.pdf (151-mer) characterization showed that TF formed complexes with the three PhoA fragments (PhoAa-c, PhoAd-e, and PhoAf-g) with Kd values of ~2uM, ~4uM, and ~14uM, respectively (Fig. 3A and fig. S14)."
4mne,2.85,2014,Kd~43nM,Kd,nM,43,0.043000000000000003,1.3665315444204134,4mne.pdf (308-mer) exact value in support information is not available
2mlx,NMR,2014,Kd~4uM,Kd,uM,4,4.0,-0.6020599913279624,"2mlx.pdf (93-mer) seems RCSB confuse the sequence range, should be d-e, not 220-310 as PDB code 2mlz"
4niq,2.30,2014,Kd~5uM,Kd,uM,5,5.0,-0.6989700043360189,"4niq.pdf (23-mer) ITC Kd is for full-length Vfa1 in this paper, Kd~5-10 uM in ref 32"
4u30,2.50,2014,Ki=138nM,Ki,nM,138,0.138,0.8601209135987634,4u30.pdf (59-mer)
4u32,1.65,2014,Ki=379nM,Ki,nM,379,0.379,0.42136079003192767,4u30.pdf (55-mer)
4nm3,2.10,2014,Ki=60uM,Ki,uM,60,60.0,-1.7781512503836436,4nm0.pdf (24-mer) phosphoylated Ser9 peptide(pS9); Ki= 60+/-11uM
4nu1,2.50,2014,Ki=60uM,Ki,uM,60,60.0,-1.7781512503836436,4nm0.pdf (24-mer) phosphoylated Ser9 peptide; AlF3 is a transition state mimicry ;pS9; Ki= 60+/-11uM
4zgm,1.80,2015,IC50=0.38nM,IC50,nM,0.38,0.00038,3.42021640338319,4zgm.pdf (31-mer) semaglutide;
4ywc,2.40,2015,IC50=0.49uM,IC50,uM,0.49,0.49,0.3098039199714863,"4ywc.pdf (22-mer) Jas motif peptide competitively inhibits the MYC3-MED25 interaction, AlphaScreen interaction assay"
5agw,2.70,2015,IC50=10.2nM,IC50,nM,10.2,0.010199999999999999,1.9913998282380825,5agw.pdf (22-mer) binding of oligomers to anti-apoptotic proteins determined by competition SPR assays
5agx,2.24,2015,IC50=50.5nM,IC50,nM,50.5,0.0505,1.2967086218813386,5agw.pdf (22-mer) binding of oligomers to anti-apoptotic proteins determined by competition SPR assays
4zii,2.19,2015,IC50=66nM,IC50,nM,66,0.066,1.1804560644581312,4zie.pdf (34-mer)
4rws,3.10,2015,IC50=6nM,IC50,nM,6,0.006,2.221848749616356,4rws.pdf (80-mer) vMIP-II is a high affinity antagonist of CXCR4 (IC50 6-15 nM)
4z5r,3.00,2015,Kd=0.018nM,Kd,nM,0.018,1.8e-05,4.7447274948966935,4z5r.pdf (225-mer)
5e4e,3.00,2015,Kd=0.084nM,Kd,nM,0.084,8.400000000000001e-05,4.075720713938118,5e4e.pdf (318-mer)
5c6t,3.60,2015,Kd=0.13nM,Kd,nM,0.13,0.00013000000000000002,3.886056647693163,5c6t.pdf (233-mer)
5bnq,2.80,2015,Kd=0.156nM,Kd,nM,0.156,0.000156,3.8068754016455384,5bnq.pdf (216-mer)
4yh7,4.40,2015,Kd=0.15uM,Kd,uM,0.15,0.15,0.8239087409443188,4yfc.pdf (348-mer)
4r8w,2.79,2015,Kd=0.183nM,Kd,nM,0.183,0.000183,3.7375489102695707,4r8w.pdf (231-mer)
4xhj,3.16,2015,Kd=0.194nM,Kd,nM,0.194,0.000194,3.712198270069774,4xhj.pdf (282-mer)
4wen,1.89,2015,Kd=0.1uM,Kd,uM,0.1,0.1,1.0,4wem.pdf (127-mer)
4zkc,3.15,2015,Kd=0.22nM,Kd,nM,0.22,0.00022,3.657577319177794,4zk9.pdf (82-mer)
4qlp,1.10,2015,Kd=0.23nM,Kd,nM,0.23,0.00023,3.638272163982407,4qlp.pdf (199-mer) ITC Kd=2.3 x 10E-10M
4rwt,2.98,2015,Kd=0.23uM,Kd,uM,0.23,0.23,0.638272163982407,4rwt.pdf (506-mer) Kd for whole Lmod2 (1-495) (B-GS); also provide Kd for three individual binding sites
4zk9,2.60,2015,Kd=0.24nM,Kd,nM,0.24,0.00024,3.619788758288394,4zk9.pdf (83-mer)
4uuz,2.90,2015,Kd=0.24uM,Kd,uM,0.24,0.24,0.619788758288394,4uuz.pdf (70-mer)
4x33,1.45,2015,Kd=0.25uM,Kd,uM,0.25,0.25,0.6020599913279624,4x33.pdf (333-mer) [Nonstandard assay: Temp 10]
4zs6,3.17,2015,Kd=0.312uM,Kd,uM,0.312,0.312,0.5058454059815573,4zs6.pdf (229-mer)
4yk4,2.80,2015,Kd=0.364uM,Kd,uM,0.364,0.364,0.438898616350944,4yjz.pdf (230-mer) assay by biolayer interferometry
4zi2,2.20,2015,Kd=0.42uM,Kd,uM,0.42,0.42,0.37675070960209955,4zi2.pdf (135-mer)
4xi5,3.90,2015,Kd=0.49nM,Kd,nM,0.49,0.00049,3.309803919971486,4xhj.pdf (283-mer)
5c7x,2.95,2015,Kd=0.4pM,Kd,pM,0.4,4e-07,6.3979400086720375,5c7x.pdf (238-mer) MOR04357 in complex with human GM-CSF
5abv,2.13,2015,Kd=0.52nM,Kd,nM,0.52,0.0005200000000000001,3.283996656365201,5abu.pdf (70-mer)
5bw8,2.80,2015,Kd=0.54uM,Kd,uM,0.54,0.54,0.26760624017703144,5bw8.pdf (305-mer)
5cjq,3.60,2015,Kd=0.5nM,Kd,nM,0.5,0.0005,3.3010299956639813,5cjq.pdf (230-mer) KD values were determined using biolayer interferometry
5dfv,2.80,2015,Kd=0.5nM,Kd,nM,0.5,0.0005,3.3010299956639813,5dfv.pdf (222-mer)
5dfw,2.33,2015,Kd=0.5nM,Kd,nM,0.5,0.0005,3.3010299956639813,5dfv.pdf (243-mer)
5d3i,3.20,2015,Kd=0.6nM,Kd,nM,0.6,0.0006,3.2218487496163566,"5d3i.pdf (195-mer) Kd=0.6+/-0.4nM, AlphaScreen assay"
4yoc,2.92,2015,Kd=0.6uM,Kd,uM,0.6,0.6,0.2218487496163564,4yoc.pdf (548-mer)
5bo1,2.56,2015,Kd=0.79nM,Kd,nM,0.79,0.00079,3.1023729087095586,5bo1.pdf (219-mer)
4zgy,2.63,2015,Kd=0.7uM,Kd,uM,0.7,0.7,0.1549019599857432,4zgy.pdf (135-mer)
2mzd,NMR,2015,Kd=0.877uM,Kd,uM,0.877,0.877,0.05700040663395948,2mzd.pdf (25-mer) Ka=1.14 x 10E6 /M
4wnn,1.80,2015,Kd=0.8uM,Kd,uM,0.8,0.8,0.09691001300805639,4wnn.pdf (20-mer)
4v3k,2.04,2015,Kd=0.92uM,Kd,uM,0.92,0.92,0.036212172654444715,4v3k.pdf (79-mer)
2n2h,NMR,2015,Kd=0.93uM,Kd,uM,0.93,0.93,0.03151705144606486,2n2h.pdf (125-mer) [Different protein in assay: the crystal structure is complex of SDS3(202-228) and Sin3A (605-729)]
5cff,2.50,2015,Kd=1.07uM,Kd,uM,1.07,1.07,-0.029383777685209667,5cff.pdf (72-mer) [Different protein in assay: the protein used in binding assay is Trx-Mira (514-595)] [Different ligand in assay: the protein used in binding assay is Trx-Stau (951-1018)]
5bqe,2.30,2015,Kd=1.10uM,Kd,uM,1.10,1.1,-0.04139268515822508,5bpu.pdf (149-mer) Norrin in complex with the cysteine-rich domain of Frizzled 4 -Methylated form
4xxb,2.40,2015,Kd=1.48uM,Kd,uM,1.48,1.48,-0.17026171539495738,4xxb.pdf (148-mer) Microscale thermophoresis (MST) measurements
4r8i,2.05,2015,Kd=1.4nM,Kd,nM,1.4,0.0014,2.853871964321762,4r8i.pdf (40-mer) [Nonstandard assay: temp=37C]
4xl5,2.00,2015,Kd=1.4nM,Kd,nM,1.4,0.0014,2.853871964321762,4xl5.pdf (263-mer)
4zlt,3.00,2015,Kd=1.4nM,Kd,nM,1.4,0.0014,2.853871964321762,4zlt.pdf (70-mer)
4y5o,2.35,2015,Kd=1.4uM,Kd,uM,1.4,1.4,-0.146128035678238,4y5o.pdf (126-mer)
2mv7,NMR,2015,Kd=1.56nM,Kd,nM,1.56,0.0015600000000000002,2.8068754016455384,2mv7.pdf (25-mer) [Multiple sites: site 1: Kd> 2uM; site 2: Kd=26.7 nM; site 3: Kd=1.56 nM] DOT1L has three binding sites
4yc7,2.50,2015,Kd=1.89uM,Kd,uM,1.89,1.89,-0.2764618041732441,4yc7.pdf (381-mer)
3wqb,1.41,2015,Kd=1.8nM,Kd,nM,1.8,0.0018000000000000002,2.744727494896694,3wqb.pdf (148-mer)
5e8e,1.90,2015,Kd=1.8nM,Kd,nM,1.8,0.0018000000000000002,2.744727494896694,5e8e.pdf (259-mer)
4d0g,2.50,2015,Kd=1.8uM,Kd,uM,1.8,1.8,-0.25527250510330607,4d0g.pdf (69-mer)
5anm,2.85,2015,Kd=1.95pM,Kd,pM,1.95,1.95e-06,5.709965388637482,5anm.pdf (229-mer) KinExA-determined affinity
4rey,1.96,2015,Kd=108nM,Kd,nM,108,0.108,0.9665762445130504,4rey.pdf (32-mer)
4x7s,1.90,2015,Kd=10nM,Kd,nM,10,0.01,2.0,"4x7s.pdf (218-mer) P212121 symmetry and resolution of 1.9 A, Kd=1x10-8M, data not shown"
4s0s,2.80,2015,Kd=11.4nM,Kd,nM,11.4,0.0114,1.9430951486635273,4s0s.pdf (120-mer)
5brm,2.65,2015,Kd=119nM,Kd,nM,119,0.11900000000000001,0.9244530386074692,5brk.pdf (31-mer)
5bn5,3.00,2015,Kd=11uM,Kd,uM,11,11.0,-1.0413926851582251,5bn3.pdf (416-mer) Kd=11+/-2uM
4ui1,2.35,2015,Kd=124nM,Kd,nM,124,0.124,0.906578314837765,4ui0.pdf (122-mer) RGMC-ND-BMP2
4z80,1.53,2015,Kd=12nM,Kd,nM,12,0.012,1.9208187539523751,4z80.pdf (37-mer)
4wuu,3.05,2015,Kd=13.2nM,Kd,nM,13.2,0.0132,1.8794260687941502,4wuu.pdf (216-mer)
4pw9,2.49,2015,Kd=13.5uM,Kd,uM,13.5,13.5,-1.130333768495006,4pw3.pdf (106-mer) SorT/SorU complex
5d1l,1.62,2015,Kd=141nM,Kd,nM,141,0.14100000000000001,0.8507808873446201,5d1k.pdf (133-mer) Binding was assessed by MST
2rvb,NMR,2015,Kd=143.3nM,Kd,nM,143.3,0.1433,0.8437538096026554,2rvb.pdf (110-mer)
4uu9,2.12,2015,Kd=14pM,Kd,pM,14,1.4e-05,4.853871964321762,4uu9.pdf (75-mer)
4uyq,1.81,2015,Kd=14pM,Kd,pM,14,1.4e-05,4.853871964321762,4uyp.pdf (75-mer)
4wwi,2.31,2015,Kd=15.2nM,Kd,nM,15.2,0.0152,1.8181564120552274,"4wwi.pdf (220-mer) Ka=6.6 (5.6, 9.5) x 107 M-1"
2mro,NMR,2015,Kd=150uM,Kd,uM,150,150.0,-2.1760912590556813,2mro.pdf (44-mer)
5do2,2.41,2015,Kd=162nM,Kd,nM,162,0.162,0.790484985457369,5do2.pdf (219-mer)
4zqu,2.09,2015,Kd=16nM,Kd,nM,16,0.016,1.7958800173440752,4zqu.pdf (185-mer) CdiA-CT/CdiIYPIII;
4qti,3.00,2015,Kd=17.2nM,Kd,nM,17.2,0.0172,1.764471553092451,4qth.pdf (283-mer)
4z8l,2.60,2015,Kd=170nM,Kd,nM,170,0.17,0.769551078621726,4z8l.pdf (118-mer)
4yeb,3.19,2015,Kd=17nM,Kd,nM,17,0.017,1.7695510786217261,4yeb.pdf (370-mer)
5d1k,1.78,2015,Kd=180nM,Kd,nM,180,0.18,0.744727494896694,5d1k.pdf (133-mer) Binding was assessed by MST
4ypi,3.71,2015,Kd=19.4nM,Kd,nM,19.4,0.0194,1.712198270069774,4ypi.pdf (28-mer)
3wih,1.70,2015,Kd=19nM,Kd,nM,19,0.019,1.7212463990471711,3wih.pdf (219-mer)
2n01,NMR,2015,Kd=1uM,Kd,uM,1,1.0,-0.0,2n01.pdf (106-mer) [Nonstandard assay: Temp 37C]
4zrk,2.32,2015,Kd=1uM,Kd,uM,1,1.0,-0.0,4zri.pdf (32-mer)
5dob,2.47,2015,Kd=1uM,Kd,uM,1,1.0,-0.0,5dob.pdf (165-mer)
4yvq,2.40,2015,Kd=2.03uM,Kd,uM,2.03,2.03,-0.3074960379132129,4yvq.pdf (159-mer)
4ydh,3.80,2015,Kd=2.55uM,Kd,uM,2.55,2.55,-0.4065401804339551,4yc7.pdf (181-mer)
4zgq,3.00,2015,Kd=2.5uM,Kd,uM,2.5,2.5,-0.3979400086720376,4zgn.pdf (118-mer)
4wv1,2.36,2015,Kd=2.6nM,Kd,nM,2.6,0.0026000000000000003,2.585026652029182,4wv1.pdf (230-mer) phage ELISA-binding assay
4zrj,2.30,2015,Kd=2.9uM,Kd,uM,2.9,2.9,-0.4623979978989561,"4zri.pdf (90-mer) S518D, A585W mutant Merlin CTD"
4wb2,1.80,2015,Kd=20.1pM,Kd,pM,20.1,2.01e-05,4.696803942579511,4wb2.pdf (40-mer)
5d70,2.06,2015,Kd=2000pM,Kd,pM,2000,0.002,2.6989700043360187,5c7x.pdf (236-mer) MOR03929 in complex with human GM-CSF
4uyp,1.49,2015,Kd=20pM,Kd,pM,20,1.9999999999999998e-05,4.698970004336019,4uyp.pdf (75-mer)
4zfo,1.90,2015,Kd=21pM,Kd,pM,21,2.1e-05,4.6777807052660805,4zfo.pdf (221-mer) SPR data under 1.1nM BCMA concentration
4rgm,2.69,2015,Kd=22.9nM,Kd,nM,22.9,0.0229,1.640164517660112,"4rgm.pdf (223-mer) BLI assay, data not shown"
5cmn,3.61,2015,Kd=220nM,Kd,nM,220,0.22,0.6575773191777937,5cmn.pdf (261-mer) determined by bio-layer interferometry
4rs1,2.68,2015,Kd=23.9nM,Kd,nM,23.9,0.023899999999999998,1.6216020990518623,4rs1.pdf (112-mer) saturation binding assays using radioiodinated GM-CSF and COS cells transiently expressing GMRa alone
4zv4,3.50,2015,Kd=23nM,Kd,nM,23,0.023,1.6382721639824072,4zv0.pdf (180-mer) Tse6265-CT with EF-TuPA/GDP
5di9,2.28,2015,Kd=2400nM,Kd,nM,2400,2.4,-0.38021124171160603,5dh9.pdf (21-mer)
5cyk,3.00,2015,Kd=249nM,Kd,nM,249,0.249,0.6038006529042637,5cxb.pdf (389-mer) Biolayer Interferometry assay
4rjf,2.01,2015,Kd=250nM,Kd,nM,250,0.25,0.6020599913279624,4rjf.pdf (22-mer)
4xlw,3.39,2015,Kd=262nM,Kd,nM,262,0.262,0.5816987086802545,4xl1.pdf (261-mer)
5ajk,2.55,2015,Kd=2640nM,Kd,nM,2640,2.64,-0.42160392686983106,5ajj.pdf (26-mer)
4pgj,2.60,2015,Kd=26nM,Kd,nM,26,0.026000000000000002,1.585026652029182,"4pgj.pdf (129-mer) crystal with well solution (100mM sodium citrate, pH 5.4, supplemented with 28% (w/v) PEG 1500"
4xhu,2.09,2015,Kd=26nM,Kd,nM,26,0.026000000000000002,1.585026652029182,4xhu.pdf (359-mer)
4pvz,2.50,2015,Kd=27.3nM,Kd,nM,27.3,0.0273,1.563837352959244,4pvz.pdf (43-mer)
5eiv,2.41,2015,Kd=28.2uM,Kd,uM,28.2,28.2,-1.4502491083193612,5eiv.pdf (21-mer) consensus THP
4yyp,2.60,2015,Kd=280nM,Kd,nM,280,0.28,0.5528419686577808,4yyp.pdf (32-mer)
4qci,2.30,2015,Kd=28pM,Kd,pM,28,2.8e-05,4.552841968657781,4qci.pdf (110-mer)
4yiq,1.85,2015,Kd=2uM,Kd,uM,2,2.0,-0.3010299956639812,4yiq.pdf (108-mer) heterodimer
5e6p,3.22,2015,Kd=2uM,Kd,uM,2,2.0,-0.3010299956639812,5e6p.pdf (88-mer)
5aam,2.49,2015,Kd=3.8nM,Kd,nM,3.8,0.0038,2.42021640338319,5aam.pdf (115-mer) Entry 5AAM supersedes 4UD3
5bvp,2.20,2015,Kd=30.5pM,Kd,pM,30.5,3.05e-05,4.515700160653214,5bvj.pdf (153-mer)
4xl1,2.30,2015,Kd=304nM,Kd,nM,304,0.304,0.5171264163912462,4xl1.pdf (230-mer)
4cvw,2.67,2015,Kd=30pM,Kd,pM,30,2.9999999999999997e-05,4.522878745280337,"4cvw.pdf (120-mer) PH=6.5, temp=25C"
5a6w,1.60,2015,Kd=31nM,Kd,nM,31,0.031,1.5086383061657274,5a6w.pdf (93-mer)
4wnd,1.50,2015,Kd=32.9nM,Kd,nM,32.9,0.0329,1.4828041020500258,4wnd.pdf (53-mer) [Different ligand in assay: MBP-Frmpd4 (978-1011)]
5ajj,1.75,2015,Kd=3220nM,Kd,nM,3220,3.22,-0.5078558716958309,5ajj.pdf (34-mer)
3wwq,1.90,2015,Kd=35.9uM,Kd,uM,35.9,35.9,-1.5550944485783191,3wwq.pdf (44-mer)
4tq1,1.80,2015,Kd=350uM,Kd,uM,350,350.0,-2.5440680443502757,"4tq0.pdf (39-mer) [Different ligand in assay: minimal peptide, 36 residue from Thr575 to Val610 of TECPR1]"
4y61,3.36,2015,Kd=355.5nM,Kd,nM,355.5,0.3555,0.4491603949342149,4y61.pdf (272-mer) PTPdelta Ig1-Fn1 meA9B+
5a3i,2.89,2015,Kd=36nM,Kd,nM,36,0.036000000000000004,1.4436974992327127,5a3i.pdf (230-mer)
5dh9,2.55,2015,Kd=37nM,Kd,nM,37,0.037,1.431798275933005,5dh9.pdf (20-mer)
4xkl,2.10,2015,Kd=39.1uM,Kd,uM,39.1,39.1,-1.5921767573958667,4xkl.pdf (80-mer)
4uwq,3.28,2015,Kd=3uM,Kd,uM,3,3.0,-0.47712125471966244,4uwq.pdf (136-mer) disulfide-linked complex
5c0n,3.00,2015,Kd=4.13uM,Kd,uM,4.13,4.13,-0.615950051656401,5c0n.pdf (222-mer) biomolecular interaction analysis
5aoq,2.70,2015,Kd=4.1nM,Kd,nM,4.1,0.0040999999999999995,2.3872161432802645,5aoq.pdf (109-mer) two sequential binding events
4w4o,1.80,2015,Kd=4.2nM,Kd,nM,4.2,0.004200000000000001,2.3767507096020997,4w4o.pdf (280-mer)
4xvp,3.40,2015,Kd=4.2nM,Kd,nM,4.2,0.004200000000000001,2.3767507096020997,4xl5.pdf (170-mer)
5aaw,3.27,2015,Kd=4.32nM,Kd,nM,4.32,0.00432,2.364516253185088,5aaw.pdf (115-mer)
4xwj,2.10,2015,Kd=4.45nM,Kd,nM,4.45,0.00445,2.3516399890190685,4xwj.pdf (85-mer) [Different protein in assay: The Rsd protein is A133S mutant]
5d2n,2.10,2015,Kd=4.7uM,Kd,uM,4.7,4.7,-0.6720978579357175,5d2n.pdf (276-mer)
5e3e,1.70,2015,Kd=40.9nM,Kd,nM,40.9,0.0409,1.3882766919926581,5e3e.pdf (114-mer) biolayer interferometry assay
4ypg,3.00,2015,Kd=44pM,Kd,pM,44,4.4e-05,4.356547323513813,4ypg.pdf (161-mer) KD was determined using a KinExa instrument
2mws,NMR,2015,Kd=45uM,Kd,uM,45,45.0,-1.6532125137753437,2mro.pdf (94-mer)
4pj2,1.24,2015,Kd=47pM,Kd,pM,47,4.7e-05,4.327902142064283,4pj2.pdf (122-mer) [Different ligand in assay: SPR assay is for  i-type lysozyme from V. philippinarium]
5dwu,3.97,2015,Kd=49nM,Kd,nM,49,0.049,1.3098039199714864,5dwu.pdf (222-mer)
5d2l,3.51,2015,Kd=5.1uM,Kd,uM,5.1,5.1,-0.7075701760979364,5d2l.pdf (276-mer)
4yl8,1.50,2015,Kd=5.4uM,Kd,uM,5.4,5.4,-0.7323937598229685,4yl8.pdf (43-mer) [Nonstandard assay: assay in the presence of 400 mM NaCl]
4d2g,2.65,2015,Kd=5.56uM,Kd,uM,5.56,5.56,-0.7450747915820575,"4d2g.pdf (21-mer) [Different ligand in assay: The protein in crystal structure is P15(51-71),the protein uesd in binding assay is P15(50-77)]"
4weu,2.61,2015,Kd=5.7uM,Kd,uM,5.7,5.7,-0.7558748556724915,4wem.pdf (127-mer) PDF is not editable
5bw7,3.00,2015,Kd=52.3nM,Kd,nM,52.3,0.0523,1.2814983111327258,5bw7.pdf (179-mer)
4zak,2.82,2015,Kd=56nM,Kd,nM,56,0.056,1.2518119729937995,4zak.pdf (241-mer) mCD1d/DB06-1/iNKTCR ternary complex;
4zfg,2.27,2015,Kd=5nM,Kd,nM,5,0.005,2.3010299956639813,4zff.pdf (228-mer)
4zff,2.75,2015,Kd=5nM,Kd,nM,5,0.005,2.3010299956639813,4zff.pdf (99-mer)
4s3o,2.00,2015,Kd=6.1uM,Kd,uM,6.1,6.1,-0.785329835010767,4s3o.pdf (118-mer) assay using bio-layer interferometry (BLI)
5ee4,2.30,2015,Kd=6.1uM,Kd,uM,6.1,6.1,-0.785329835010767,5ee4.pdf (146-mer)
4uem,2.82,2015,Kd=6.4nM,Kd,nM,6.4,0.0064,2.193820026016113,4uel.pdf (127-mer)
5e8d,2.50,2015,Kd=6.5nM,Kd,nM,6.5,0.006500000000000001,2.1870866433571443,5e8d.pdf (220-mer)
4wem,1.55,2015,Kd=6.8uM,Kd,uM,6.8,6.8,-0.8325089127062363,4wem.pdf (127-mer)
4uf1,2.30,2015,Kd=6.98uM,Kd,uM,6.98,6.98,-0.8438554226231612,4uf1.pdf (26-mer)
4tq0,2.70,2015,Kd=6.9uM,Kd,uM,6.9,6.9,-0.8388490907372553,"4tq0.pdf (69-mer) [Different ligand in assay: mininal peptide, 36 residues from Phe10 to Lys45 of ATG16L1]"
4uwx,1.65,2015,Kd=6.9uM,Kd,uM,6.9,6.9,-0.8388490907372553,4uwx.pdf (21-mer)
2n1d,NMR,2015,Kd=60nM,Kd,nM,60,0.06,1.2218487496163564,2n1d.pdf (172-mer)
5d1m,1.58,2015,Kd=62nM,Kd,nM,62,0.062,1.207608310501746,5d1k.pdf (133-mer) Binding was assessed by MST
5d71,2.25,2015,Kd=65pM,Kd,pM,65,6.5e-05,4.187086643357144,5c7x.pdf (236-mer) MOR04302 in complex with human GM-CSF
5d72,2.60,2015,Kd=6pM,Kd,pM,6,6e-06,5.221848749616356,5c7x.pdf (447-mer) MOR04252 in complex with human GM-CSF
4xoi,2.09,2015,Kd=7.3uM,Kd,uM,7.3,7.3,-0.8633228601204559,4xoi.pdf (270-mer)
5c0s,4.30,2015,Kd=7.7nM,Kd,nM,7.7,0.0077,2.113509274827518,5c0s.pdf (226-mer)
4rgo,1.80,2015,Kd=7.9nM,Kd,nM,7.9,0.0079,2.1023729087095586,"4rgm.pdf (222-mer) BLI assay, data not shown"
5dha,2.95,2015,Kd=780nM,Kd,nM,780,0.78,0.10790539730951958,5dh9.pdf (21-mer) competition test
4x4m,3.49,2015,Kd=8.8nM,Kd,nM,8.8,0.0088,2.0555173278498313,4x4m.pdf (275-mer) [Nonstandard assay: NaCl=0.15M]
4yn0,2.20,2015,Kd=85nM,Kd,nM,85,0.085,1.0705810742857071,4yn0.pdf (223-mer) assay by biolayer interferometry
4ui0,2.80,2015,Kd=88nM,Kd,nM,88,0.088,1.0555173278498313,4ui0.pdf (96-mer) crystal form 2
4xnm,2.51,2015,Kd=8nM,Kd,nM,8,0.008,2.0969100130080562,4xnm.pdf (212-mer) Measured on an Octet interferometry instrument
4yiz,2.20,2015,Kd=8nM,Kd,nM,8,0.008,2.0969100130080562,4yiz.pdf (40-mer)
5cxb,2.10,2015,Kd=9.19nM,Kd,nM,9.19,0.00919,2.0366844886138886,5cxb.pdf (369-mer)
5e7f,2.70,2015,Kd=9.1nM,Kd,nM,9.1,0.0091,2.0409586076789066,5e7f.pdf (131-mer) Biolayer interferometry (BLI)
5cjs,4.30,2015,Kd=9.5nM,Kd,nM,9.5,0.0095,2.0222763947111524,5cjq.pdf (230-mer) KD values were determined using biolayer interferometry
4zpt,2.59,2015,Kd=9.93nM,Kd,nM,9.93,0.00993,2.003050751504619,"4zpt.pdf (208-mer) Crystal Form 1, measured in triplicate by biolayer interferometry"
4yj4,2.10,2015,Kd=9.9nM,Kd,nM,9.9,0.0099,2.00436480540245,4yj4.pdf (21-mer)
4qnp,2.80,2015,Kd=95nM,Kd,nM,95,0.095,1.0222763947111522,4qnp.pdf (212-mer) BioLayer Interferometry
5c3f,1.43,2016,IC50=1.6uM,IC50,uM,1.6,1.6,-0.2041199826559248,5c3f.pdf (24-mer) FITC competition assay for inhibition of Mcl-1/NOXA-B interaction
5gpg,1.67,2016,IC50=2.61nM,IC50,nM,2.61,0.00261,2.583359492661719,5gpg.pdf (93-mer) with rapamycin
5ibk,2.50,2016,IC50=70nM,IC50,nM,70,0.07,1.154901959985743,5ibk.pdf (78-mer)
5e94,2.00,2016,IC50~3nM,IC50,nM,3,0.003,2.5228787452803374,5e94.pdf (126-mer) Fab 3F52 prevented binding of 125I-GLP-1 to human GLP-1R in a concentration-dependent manner
5d1z,3.17,2016,Kd<1pM,Kd,pM,1,1e-06,6.0,5d1q.pdf (157-mer)
5j57,1.70,2016,Kd=0.02nM,Kd,nM,0.02,2e-05,4.698970004336019,5boz.pdf (127-mer)
5hvf,2.85,2016,Kd=0.03nM,Kd,nM,0.03,3e-05,4.522878745280337,5hvf.pdf (119-mer) 0.3 x 10 -10M is not 3nM
5hgg,1.97,2016,Kd=0.054nM,Kd,nM,0.054,5.4e-05,4.267606240177032,5hgg.pdf (128-mer) +/-0.02
5eg3,2.61,2016,Kd=0.135uM,Kd,uM,0.135,0.135,0.8696662315049939,5eg3.pdf (114-mer) cSH2
5f6k,2.41,2016,Kd=0.13uM,Kd,uM,0.13,0.13,0.8860566476931632,5f59.pdf (184-mer)
5hpy,2.40,2016,Kd=0.13uM,Kd,uM,0.13,0.13,0.8860566476931632,5hpy.pdf (185-mer)
5jsb,2.74,2016,Kd=0.15uM,Kd,uM,0.15,0.15,0.8239087409443188,5jsb.pdf (116-mer) BLI assay
4ybl,3.10,2016,Kd=0.17nM,Kd,nM,0.17,0.00017,3.769551078621726,4ybl.pdf (224-mer)
5dcq,1.83,2016,Kd=0.18uM,Kd,uM,0.18,0.18,0.744727494896694,5dcq.pdf (271-mer)
5lxm,2.08,2016,Kd=0.18uM,Kd,uM,0.18,0.18,0.744727494896694,5lxm.pdf (38-mer) ligand is stapled TPX2 protein 10
5t5f,2.98,2016,Kd=0.19nM,Kd,nM,0.19,0.00019,3.721246399047171,5t5f.pdf (216-mer)
5eoa,2.50,2016,Kd=0.1uM,Kd,uM,0.1,0.1,1.0,"5eoa.pdf (57-mer) [Different protein in assay: Optineurin, OPTN(26-119) E50K mutant] ITC assay use OPTN(26-119) E50K mutant"
5j7c,2.54,2016,Kd=0.209nM,Kd,nM,0.209,0.00020899999999999998,3.679853713888946,5j7c.pdf (102-mer) bio-layer interferometry (BLI) assay
5ibw,1.90,2016,Kd=0.25nM,Kd,nM,0.25,0.00025,3.6020599913279625,"5ibw.pdf (43-mer) [Multiple sites: Kd1=0.25nM, Kd2=55nM] 2:1 MlcC / M1C-IQ1.2 Complex"
5cw7,2.83,2016,Kd=0.28pM,Kd,pM,0.28,2.8e-07,6.552841968657781,5cw7.pdf (100-mer) T=300.15K
5ifs,2.46,2016,Kd=0.2nM,Kd,nM,0.2,0.0002,3.6989700043360187,5ifs.pdf (481-mer)
5sx4,2.80,2016,Kd=0.34nM,Kd,nM,0.34,0.00034,3.4685210829577446,5sx4.pdf (201-mer)
5fo8,2.40,2016,Kd=0.35uM,Kd,uM,0.35,0.35,0.4559319556497244,5fo7.pdf (252-mer)
5ies,2.16,2016,Kd=0.368uM,Kd,uM,0.368,0.368,0.43415218132648237,5ies.pdf (183-mer)
5eo9,2.30,2016,Kd=0.37uM,Kd,uM,0.37,0.37,0.431798275933005,5eo9.pdf (206-mer) Dpr6 D1 / DIP-alpha (CG32791) D1-D2
5czv,3.19,2016,Kd=0.3nM,Kd,nM,0.3,0.0003,3.5228787452803374,5czv.pdf (223-mer) flow cytometric studies
5mi0,2.35,2016,Kd=0.41uM,Kd,uM,0.41,0.41,0.38721614328026455,5mi0.pdf (258-mer) SPR Kd after lyophilizing of PfRH5 Delta NL-HS1 is 0.30uM
4zi3,2.00,2016,Kd=0.42uM,Kd,uM,0.42,0.42,0.37675070960209955,4zi3.pdf (135-mer) [Nonstandard assay: Temp 20C]
5li1,2.00,2016,Kd=0.47uM,Kd,uM,0.47,0.47,0.3279021420642826,5li1.pdf (20-mer)
5ays,2.09,2016,Kd=0.508nM,Kd,nM,0.508,0.000508,3.2941362877160807,5ayr.pdf (112-mer)
5cx3,2.30,2016,Kd=0.54uM,Kd,uM,0.54,0.54,0.26760624017703144,5cx3.pdf (31-mer)
5c0b,2.03,2016,Kd=0.5uM,Kd,uM,0.5,0.5,0.3010299956639812,5c07.pdf (277-mer) complex of 1E6-A2-RQF[I]
5sv3,2.73,2016,Kd=0.627nM,Kd,nM,0.627,0.0006270000000000001,3.2027324591692836,5sv3.pdf (190-mer)
5hvg,3.05,2016,Kd=0.63nM,Kd,nM,0.63,0.00063,3.2006594505464183,5hvf.pdf (128-mer) 6.3 x 10 -10M is not 63nM
5lxq,3.34,2016,Kd=0.64uM,Kd,uM,0.64,0.64,0.1938200260161128,5lxq.pdf (156-mer)
5czx,2.10,2016,Kd=0.6nM,Kd,nM,0.6,0.0006,3.2218487496163566,5czv.pdf (226-mer) flow cytometric studies
5ep6,1.45,2016,Kd=0.72uM,Kd,uM,0.72,0.72,0.14266750356873156,5eoa.pdf (57-mer)
5boz,3.10,2016,Kd=0.7nM,Kd,nM,0.7,0.0007,3.154901959985743,5boz.pdf (127-mer)
5d5m,2.20,2016,Kd=0.7uM,Kd,uM,0.7,0.7,0.1549019599857432,5d5m.pdf (245-mer)
5eyp,1.90,2016,Kd=0.82nM,Kd,nM,0.82,0.00082,3.0861861476162833,5eyp.pdf (169-mer) +/-0.18
5bt1,2.62,2016,Kd=0.83uM,Kd,uM,0.83,0.83,0.08092190762392612,"5bt1.pdf (143-mer) ITC Kd1=0.83uM, Kd2=0.22uM; SPR Kd1=0.52uM, Kd2=0.21uM"
5ctr,3.01,2016,Kd=0.88uM,Kd,uM,0.88,0.88,0.05551732784983137,5ctr.pdf (233-mer)
5jsn,2.10,2016,Kd=0.8uM,Kd,uM,0.8,0.8,0.09691001300805639,5jsb.pdf (118-mer) BLI assay
5dmi,3.69,2016,Kd=0.91nM,Kd,nM,0.91,0.00091,3.0409586076789066,5dmi.pdf (223-mer)
4xkh,3.00,2016,Kd=0.94uM,Kd,uM,0.94,0.94,0.026872146400301365,4xkh.pdf (76-mer)
5k8q,1.74,2016,Kd=0.9nM,Kd,nM,0.9,0.0009000000000000001,3.0457574905606752,5k8q.pdf (29-mer) [Nonstandard assay: assay at temp 37C]
5kho,2.78,2016,Kd=0.9uM,Kd,uM,0.9,0.9,0.045757490560675115,"5kho.pdf (156-mer) Kd=0.9+/-0.2uM, Rasip1 in complex with Rap1B"
5sx5,2.50,2016,Kd=1.15nM,Kd,nM,1.15,0.00115,2.939302159646388,5sx4.pdf (201-mer)
5l2k,3.20,2016,Kd=1.15uM,Kd,uM,1.15,1.15,-0.06069784035361165,5l2j.pdf (300-mer)
5c4v,2.60,2016,Kd=1.1uM,Kd,uM,1.1,1.1,-0.04139268515822508,5c4v.pdf (127-mer)
5szk,2.80,2016,Kd=1.1uM,Kd,uM,1.1,1.1,-0.04139268515822508,5lpn.pdf (203-mer)
5hdq,1.83,2016,Kd=1.2nM,Kd,nM,1.2,0.0012,2.9208187539523753,5hdq.pdf (220-mer)
5j3d,4.08,2016,Kd=1.37nM,Kd,nM,1.37,0.0013700000000000001,2.8632794328435933,"5itb.pdf (73-mer) protein 2 in crystal is RSV A2 F, protein name for assay is FFL_001"
5fob,2.60,2016,Kd=1.3uM,Kd,uM,1.3,1.3,-0.11394335230683679,5fo7.pdf (245-mer)
5chv,3.01,2016,Kd=1.49uM,Kd,uM,1.49,1.49,-0.17318626841227402,5chv.pdf (155-mer)
5edv,3.48,2016,Kd=1.6uM,Kd,uM,1.6,1.6,-0.2041199826559248,5edv.pdf (149-mer)
5jg6,2.00,2016,Kd=1.6uM,Kd,uM,1.6,1.6,-0.2041199826559248,5jg6.pdf (84-mer) measured by BLI
5d8j,3.00,2016,Kd=1.78nM,Kd,nM,1.78,0.0017800000000000001,2.749579997691106,5c0n.pdf (221-mer) biomolecular interaction analysis
5kov,3.25,2016,Kd=1.87nM,Kd,nM,1.87,0.0018700000000000001,2.728158393463501,5kov.pdf (251-mer)
5b78,1.40,2016,Kd=1.88uM,Kd,uM,1.88,1.88,-0.2741578492636798,5b75.pdf (25-mer)
4zrp,2.10,2016,Kd=1.8nM,Kd,nM,1.8,0.0018000000000000002,2.744727494896694,4zrp.pdf (119-mer) Solid-phase binding assay
5fvk,1.66,2016,Kd=1.8uM,Kd,uM,1.8,1.8,-0.25527250510330607,5fvk.pdf (22-mer)
5ayr,2.40,2016,Kd=1.959nM,Kd,nM,1.959,0.0019590000000000002,2.7079655640052636,5ayr.pdf (112-mer)
5fo9,3.30,2016,Kd=1.9uM,Kd,uM,1.9,1.9,-0.2787536009528289,5fo7.pdf (196-mer)
5d7l,3.40,2016,Kd=10.4uM,Kd,uM,10.4,10.4,-1.0170333392987803,5d5m.pdf (243-mer)
2n8j,NMR,2016,Kd=10.7nM,Kd,nM,10.7,0.0107,1.9706162223147903,2n8j.pdf (22-mer) SPR assay at 225 nM free Ca2+
5b77,1.55,2016,Kd=10.8uM,Kd,uM,10.8,10.8,-1.0334237554869496,5b75.pdf (25-mer)
5czf,2.67,2016,Kd=100pM,Kd,pM,100,9.999999999999999e-05,4.0,5cw7.pdf (111-mer) T=300.15K
5kn5,2.80,2016,Kd=102pM,Kd,pM,102,0.000102,3.9913998282380825,5kn5.pdf (40-mer)
5et1,1.65,2016,Kd=107nM,Kd,nM,107,0.107,0.9706162223147904,5et1.pdf (36-mer)
5b75,1.70,2016,Kd=10uM,Kd,uM,10,10.0,-1.0,5b75.pdf (25-mer)
5dju,2.10,2016,Kd=11.4nM,Kd,nM,11.4,0.0114,1.9430951486635273,5djt.pdf (61-mer) A radiometric binding assay
5ft8,2.50,2016,Kd=117nM,Kd,nM,117,0.117,0.9318141382538383,"5ft8.pdf (154-mer) (CsdAper-CsdEper)2, interaction between the CsdA homodimer and each CsdE monomer"
5g1x,1.72,2016,Kd=12.1uM,Kd,uM,12.1,12.1,-1.08278537031645,5g1x.pdf (63-mer) [Nonstandard assay: 150mM NaCl] +/-0.6; phosphorylated Aurora-A
5inb,1.30,2016,Kd=123nM,Kd,nM,123,0.123,0.9100948885606021,5inb.pdf (46-mer)
5ius,2.89,2016,Kd=127pM,Kd,pM,127,0.000127,3.896196279044043,5ius.pdf (225-mer) SPR PH=7.4
5e9d,2.51,2016,Kd=129nM,Kd,nM,129,0.129,0.889410289700751,5e9d.pdf (156-mer)
5fhx,2.55,2016,Kd=12pM,Kd,pM,12,1.2e-05,4.920818753952375,"5fhx.pdf (345-mer) SPR Kd for antigen 1, IL4"
4z9v,2.10,2016,Kd=12uM,Kd,uM,12,12.0,-1.0791812460476249,4z9v.pdf (21-mer) [Different protein in assay: Bcl-xL]
4rt6,2.80,2016,Kd=13.2nM,Kd,nM,13.2,0.0132,1.8794260687941502,"4rt6.pdf (214-mer) SI page of nature is not accessible with internal error 500, please check ITC Kd data later"
5ij9,3.70,2016,Kd=13.4uM,Kd,uM,13.4,13.4,-1.1271047983648077,5ij0.pdf (426-mer) Kd=13.4+/-3.7uM
5d1q,3.22,2016,Kd=13pM,Kd,pM,13,1.3e-05,4.886056647693163,5d1q.pdf (118-mer) SPR Kd is 13-16pM
5eb1,1.80,2016,Kd=140nM,Kd,nM,140,0.14,0.8538719643217619,5eb1.pdf (135-mer)
5fr2,3.35,2016,Kd=141nM,Kd,nM,141,0.14100000000000001,0.8507808873446201,5fr2.pdf (213-mer) +/-45
5hk5,2.90,2016,Kd=146nM,Kd,nM,146,0.146,0.835647144215563,5hk5.pdf (120-mer)
5e95,1.40,2016,Kd=15.7nM,Kd,nM,15.7,0.0157,1.8041003475907662,5e95.pdf (97-mer) +/-2.7
5j8h,NMR,2016,Kd=153nM,Kd,nM,153,0.153,0.8153085691824012,5j8h.pdf (27-mer) average Kd over measurements in triplicate
5f1b,2.30,2016,Kd=158uM,Kd,uM,158,158.0,-2.1986570869544226,5f1b.pdf (256-mer)
5jlv,2.00,2016,Kd=15nM,Kd,nM,15,0.015,1.8239087409443189,5jlv.pdf (117-mer) ITC curve has two binding components
5i5k,4.20,2016,Kd=17.6pM,Kd,pM,17.6,1.76e-05,4.7544873321858505,5i5k.pdf (230-mer)
5djt,1.40,2016,Kd=17nM,Kd,nM,17,0.017,1.7695510786217261,5djt.pdf (61-mer) A radiometric binding assay
5j28,2.00,2016,Kd=193nM,Kd,nM,193,0.193,0.7144426909922262,5inb.pdf (46-mer)
5ejc,3.10,2016,Kd=197nM,Kd,nM,197,0.197,0.7055337738384071,5ejc.pdf (55-mer)
5lz3,3.00,2016,Kd=19uM,Kd,uM,19,19.0,-1.2787536009528289,5lz3.pdf (58-mer)
4z2m,2.98,2016,Kd=2.01uM,Kd,uM,2.01,2.01,-0.30319605742048883,4z2m.pdf (103-mer) 1:1 stoichiometry
5jhf,3.21,2016,Kd=2.0uM,Kd,uM,2.0,2.0,-0.3010299956639812,5jhf.pdf (413-mer) Kd=2.0+/-0.2uM
5ksb,2.90,2016,Kd=2.0uM,Kd,uM,2.0,2.0,-0.3010299956639812,5ks9.pdf (225-mer) Kd=2.0+/-0.1uM
4z9k,1.50,2016,Kd=2.2nM,Kd,nM,2.2,0.0022,2.657577319177794,4z9k.pdf (116-mer) another PDB code 5E1H for antibody F8 is not in PDBbind
5tar,1.90,2016,Kd=2.3uM,Kd,uM,2.3,2.3,-0.36172783601759284,5tar.pdf (148-mer)
5te6,2.40,2016,Kd=2.59nM,Kd,nM,2.59,0.00259,2.586700235918748,5te4.pdf (225-mer)
5j3h,3.27,2016,Kd=2.5nM,Kd,nM,2.5,0.0025,2.6020599913279625,5j3h.pdf (123-mer) Kd=2.5+/-0.6uM
5k59,2.84,2016,Kd=2.5pM,Kd,pM,2.5,2.4999999999999998e-06,5.6020599913279625,5k59.pdf (227-mer) measured by MSD
5d50,2.49,2016,Kd=2.6uM,Kd,uM,2.6,2.6,-0.414973347970818,5d50.pdf (86-mer) assay using bio-layer interferometry (BLI)
5jhl,3.00,2016,Kd=2.7nM,Kd,nM,2.7,0.0027,2.5686362358410126,5jhl.pdf (231-mer)
5te7,2.15,2016,Kd=2.81nM,Kd,nM,2.81,0.00281,2.55129368009492,5te4.pdf (225-mer)
5jh5,2.55,2016,Kd=2.8uM,Kd,uM,2.8,2.8,-0.4471580313422192,5jh5.pdf (281-mer) heterotetramer structure of two dimers
5ks9,2.55,2016,Kd=2.8uM,Kd,uM,2.8,2.8,-0.4471580313422192,5ks9.pdf (230-mer)
5kw9,2.30,2016,Kd=20.5nM,Kd,nM,20.5,0.0205,1.6882461389442456,5kw9.pdf (227-mer) biolayer interferometry (BLI)
5glh,2.80,2016,Kd=20.7pM,Kd,pM,20.7,2.07e-05,4.684029654543083,5glh.pdf (21-mer)
4zs7,2.93,2016,Kd=21pM,Kd,pM,21,2.1e-05,4.6777807052660805,"4zs7.pdf (222-mer) Kd=13-21pM, Dissociation kinetics outside the detection limit of the Biacore T200"
5d1x,3.21,2016,Kd=21pM,Kd,pM,21,2.1e-05,4.6777807052660805,5d1q.pdf (118-mer) SPR Kd is 21-31pM
4xr8,2.25,2016,Kd=22.1uM,Kd,uM,22.1,22.1,-1.3443922736851108,4xr8.pdf (199-mer)
5fqd,2.45,2016,Kd=220nM,Kd,nM,220,0.22,0.6575773191777937,"5fqd.pdf (341-mer) +/-4; lenalidomide induced, competes with CRL4CRBN"
5f5s,2.40,2016,Kd=22nM,Kd,nM,22,0.022,1.6575773191777938,5f5s.pdf (80-mer) [Nonstandard assay: ITC test at 10 centigrade] ITC test at 10 centigrade
5szi,2.85,2016,Kd=253nM,Kd,nM,253,0.253,0.5968794788241821,5lpn.pdf (153-mer)
5k22,3.00,2016,Kd=25nM,Kd,nM,25,0.025,1.6020599913279623,5k22.pdf (155-mer)
5kvd,1.65,2016,Kd=266nM,Kd,nM,266,0.266,0.575118363368933,5kvd.pdf (222-mer) KD (equilibrium) determined by BLI
5ee5,2.28,2016,Kd=26uM,Kd,uM,26,26.0,-1.414973347970818,5ee5.pdf (171-mer) [Nonstandard assay: pH 8.0] [Different protein in assay: Protein in binding assay is DCB domain of BIG1] ARL1 with ATP; +/-5
5d28,2.85,2016,Kd=27nM,Kd,nM,27,0.027,1.5686362358410126,5d28.pdf (127-mer) bio-layer interferometry (BLI) assay
5ikc,2.06,2016,Kd=27nM,Kd,nM,27,0.027,1.5686362358410126,5ikc.pdf (215-mer) [Different protein in assay: assay use length human doublecortin (hDCX)] SPR data is for length human doublecortin (hDCX)
5cd5,3.40,2016,Kd=289nM,Kd,nM,289,0.289,0.5391021572434522,5cd5.pdf (220-mer) Glycosylated Kd1
5mhs,3.70,2016,Kd=2nM,Kd,nM,2,0.002,2.6989700043360187,5mhs.pdf (221-mer)
5l8j,1.68,2016,Kd=2uM,Kd,uM,2,2.0,-0.3010299956639812,5l8j.pdf (117-mer) [Different ligand in assay: ligand protein in assay is wildtype vNAR-D01] SPR Kd=2uM for wt vNAR-D01
5f3x,2.65,2016,Kd=3.11nM,Kd,nM,3.11,0.00311,2.5072396109731625,5f3x.pdf (81-mer)
2n13,NMR,2016,Kd=3.1uM,Kd,uM,3.1,3.1,-0.4913616938342727,2n13.pdf (76-mer)
5j56,1.80,2016,Kd=3.2nM,Kd,nM,3.2,0.0032,2.494850021680094,5boz.pdf (129-mer)
5fr1,2.75,2016,Kd=3.3uM,Kd,uM,3.3,3.3,-0.5185139398778874,5fr1.pdf (213-mer)
5ibl,3.39,2016,Kd=3.6uM,Kd,uM,3.6,3.6,-0.5563025007672873,5ibl.pdf (230-mer) biolayer interferometry (BLI) assay
5eof,2.05,2016,Kd=3.8uM,Kd,uM,3.8,3.8,-0.5797835966168101,5eoa.pdf (57-mer)
4ww2,2.48,2016,Kd=3.9uM,Kd,uM,3.9,3.9,-0.5910646070264992,4ww1.pdf (284-mer)
5sws,2.86,2016,Kd=30uM,Kd,uM,30,30.0,-1.4771212547196624,5sws.pdf (242-mer) ligand is NP2-B17 TCR
2n73,NMR,2016,Kd=320nM,Kd,nM,320,0.32,0.494850021680094,2n73.pdf (80-mer) [Different protein in assay: recombinant full length ACBD3] [Different ligand in assay: recombinant full length PI4KB] Kd is for recombinant full length ACBD3 and PI4KB
5hps,2.05,2016,Kd=322.9nM,Kd,nM,322.9,0.32289999999999996,0.4909319549828384,5c7j.pdf (83-mer) BLI assay
5kvf,1.40,2016,Kd=32nM,Kd,nM,32,0.032,1.494850021680094,5kvd.pdf (221-mer) KD (equilibrium) determined by BLI
5m72,1.60,2016,Kd=33nM,Kd,nM,33,0.033,1.4814860601221125,5m72.pdf (71-mer)
5hxb,3.60,2016,Kd=347nM,Kd,nM,347,0.34700000000000003,0.45967052520912627,5hxb.pdf (1140-mer) [Nonstandard assay: 150 mM NaCl] CC-885
5men,2.81,2016,Kd=34uM,Kd,uM,34,34.0,-1.5314789170422551,5men.pdf (240-mer)
5dc4,1.48,2016,Kd=35nM,Kd,nM,35,0.035,1.4559319556497243,"5dc4.pdf (95-mer) crystal form A, mean fluorescence intensity (MFI)"
5kve,1.70,2016,Kd=35nM,Kd,nM,35,0.035,1.4559319556497243,5kvd.pdf (129-mer) KD (equilibrium) determined by BLI
5imt,2.70,2016,Kd=367nM,Kd,nM,367,0.367,0.4353339357479107,5imt.pdf (77-mer) [Different protein in assay: assay use wildtype ILY (ILY-wt)] assay by microscale thermophoresis
5hys,2.50,2016,Kd=38.9pM,Kd,pM,38.9,3.89e-05,4.410050398674293,5hys.pdf (222-mer)
5jdo,3.20,2016,Kd=3nM,Kd,nM,3,0.003,2.5228787452803374,5jdo.pdf (145-mer)
5f3b,1.76,2016,Kd=3pM,Kd,pM,3,3e-06,5.522878745280337,5f3b.pdf (109-mer)
5d7j,1.97,2016,Kd=3uM,Kd,uM,3,3.0,-0.47712125471966244,5d5m.pdf (245-mer)
4wwk,3.10,2016,Kd=4.0uM,Kd,uM,4.0,4.0,-0.6020599913279624,4ww1.pdf (278-mer)
5drz,2.54,2016,Kd=4.4nM,Kd,nM,4.4,0.0044,2.3565473235138126,"5drz.pdf (36-mer) SPR Kd=4.4nM, ITC Kd=34nM"
5fug,2.70,2016,Kd=4.4nM,Kd,nM,4.4,0.0044,2.3565473235138126,5fug.pdf (68-mer)
5ksa,2.00,2016,Kd=4.7uM,Kd,uM,4.7,4.7,-0.6720978579357175,5ks9.pdf (225-mer)
5eib,2.10,2016,Kd=4.8uM,Kd,uM,4.8,4.8,-0.6812412373755872,"5eib.pdf (23-mer) [Nonstandard assay: Temp 15C, pH 6.8] [Different protein in assay: protein in binding assay is tubulin-PN2-3c without DARPin] DARPin molecule didnot affect binding of PN2-3C to tubulin"
4zw2,1.86,2016,Kd=4.9nM,Kd,nM,4.9,0.004900000000000001,2.309803919971486,4zw2.pdf (20-mer)
5elu,2.35,2016,Kd=414nM,Kd,nM,414,0.41400000000000003,0.38299965887910103,5elu.pdf (77-mer)
5grj,3.21,2016,Kd=42.1pM,Kd,pM,42.1,4.21e-05,4.375717904164332,5grj.pdf (221-mer)
5kwy,2.41,2016,Kd=429nM,Kd,nM,429,0.429,0.36754270781527576,5kwy.pdf (133-mer) [Different protein in assay: Kd for murine NPC1 middle lumenal domain] Microscale thermophoresis; Kd for murine NPC1 middle lumenal domain bound to NPC2; SPR Kd is about 2uM
5c0c,1.97,2016,Kd=44.4uM,Kd,uM,44.4,44.4,-1.6473829701146199,5c07.pdf (277-mer) complex of 1E6-A2-RQF[A]
5ip4,1.81,2016,Kd=451nM,Kd,nM,451,0.451,0.34582345812203946,5ikc.pdf (121-mer) [Different protein in assay: assay use length human doublecortin (hDCX)] SPR data is for length human doublecortin (hDCX)
5f4e,2.40,2016,Kd=48nM,Kd,nM,48,0.048,1.3187587626244128,5f4e.pdf (215-mer)
5fzt,2.10,2016,Kd=48uM,Kd,uM,48,48.0,-1.6812412373755872,5fzt.pdf (23-mer)
4udm,2.96,2016,Kd=4nM,Kd,nM,4,0.004,2.3979400086720375,4udm.pdf (96-mer) under 20mM NaCl concentration
4xxw,2.26,2016,Kd=5.12uM,Kd,uM,5.12,5.12,-0.7092699609758307,4xxw.pdf (214-mer)
5szh,2.30,2016,Kd=5.2uM,Kd,uM,5.2,5.2,-0.7160033436347992,5lpn.pdf (203-mer)
5gzn,3.00,2016,Kd=5.39uM,Kd,uM,5.39,5.39,-0.7315887651867387,5gzn.pdf (228-mer) apparent KD was calculated by steady-state affinity mode
5dmj,2.79,2016,Kd=5.3nM,Kd,nM,5.3,0.0053,2.275724130399211,5dmi.pdf (121-mer) CD40/3h-56-5 dAb C2 crystal form
5b76,1.65,2016,Kd=5.8uM,Kd,uM,5.8,5.8,-0.7634279935629372,5b75.pdf (26-mer)
5l6y,1.99,2016,Kd=58pM,Kd,pM,58,5.8e-05,4.236572006437063,5l6y.pdf (238-mer) SPR Kd=58pM for Tralokinumab IgG4; Kd=63pM for Tralokinumab IgG1
5hlz,2.85,2016,Kd=5nM,Kd,nM,5,0.005,2.3010299956639813,5hlz.pdf (116-mer) biolayer interferometry (BLI) assay
5jem,2.50,2016,Kd=6.02uM,Kd,uM,6.02,6.02,-0.7795964912578245,5jek.pdf (47-mer) IRF-3/CBP complex
5foa,4.19,2016,Kd=6.1uM,Kd,uM,6.1,6.1,-0.785329835010767,5fo7.pdf (194-mer) [Different ligand in assay: The binding data is for C3b and DAF (CCP1-4)] Maybe author made a typo as DAF (CCP1-4)
5eu6,2.02,2016,Kd=6.3uM,Kd,uM,6.3,6.3,-0.7993405494535817,5eu3.pdf (276-mer) Kd for PMEL17 TCR and A2-YLE-9V
5eql,2.49,2016,Kd=68nM,Kd,nM,68,0.068,1.1674910872937636,5elu.pdf (77-mer)
5fcu,1.85,2016,Kd=6nM,Kd,nM,6,0.006,2.221848749616356,4ybl.pdf (233-mer)
5fv2,3.45,2016,Kd=7.17pM,Kd,pM,7.17,7.17e-06,5.1444808443322,5fv2.pdf (116-mer) [Different ligand in assay: ligand in assay is VEGF-A165]
5jze,2.47,2016,Kd=7.48uM,Kd,uM,7.48,7.48,-0.8739015978644614,5jze.pdf (76-mer) Kd=7.48+/-0.26uM
5c07,2.11,2016,Kd=7.4uM,Kd,uM,7.4,7.4,-0.8692317197309762,5c07.pdf (277-mer) complex of 1E6-A2-YQF
5c08,2.33,2016,Kd=7.8uM,Kd,uM,7.8,7.8,-0.8920946026904804,5c07.pdf (277-mer) complex of 1E6-A2-RQW
5ij0,3.80,2016,Kd=7.9uM,Kd,uM,7.9,7.9,-0.8976270912904415,5ij0.pdf (426-mer) Kd=7.9+/-3.2uM
5ixd,2.85,2016,Kd=70.5nM,Kd,nM,70.5,0.07050000000000001,1.1518108830086013,5ixd.pdf (55-mer) Biolayer Interferometry assay
5b64,2.70,2016,Kd=70nM,Kd,nM,70,0.07,1.154901959985743,5b64.pdf (126-mer)
5igx,3.39,2016,Kd=711nM,Kd,nM,711,0.711,0.14813039927023372,5f7e.pdf (236-mer)
5j4a,2.00,2016,Kd=72nM,Kd,nM,72,0.07200000000000001,1.1426675035687315,5j4a.pdf (120-mer) Biolayer interferometry (BLI) assay
5itz,2.20,2016,Kd=75nM,Kd,nM,75,0.075,1.1249387366083,5itz.pdf (127-mer) Kd=75+/-12nM
5ioh,2.57,2016,Kd=778nM,Kd,nM,778,0.778,0.10902040301031106,5inb.pdf (64-mer)
5imy,2.40,2016,Kd=779nM,Kd,nM,779,0.779,0.10846254232743553,5imt.pdf (78-mer) [Different protein in assay: assay use wildtype VLY (VLY-wt)] assay by microscale thermophoresis
5szj,2.66,2016,Kd=790uM,Kd,uM,790,790.0,-2.8976270912904414,5lpn.pdf (153-mer)
5d3f,2.74,2016,Kd=8.05uM,Kd,uM,8.05,8.05,-0.9057958803678685,"5d3f.pdf (28-mer) ligand is CFTR_R6 peptide, in presence of stabilizer FC-A; Kd=24uM when without FC-A"
5jyl,2.55,2016,Kd=8.7nM,Kd,nM,8.7,0.0087,2.0604807473813813,5jyl.pdf (253-mer)
5kvg,1.40,2016,Kd=8.8nM,Kd,nM,8.8,0.0088,2.0555173278498313,5kvd.pdf (219-mer) KD (equilibrium) determined by BLI
5fw5,1.92,2016,Kd=80nM,Kd,nM,80,0.08,1.0969100130080565,5fw5.pdf (25-mer) MST assay in a two-phase binding mode
5d7i,2.00,2016,Kd=81.4uM,Kd,uM,81.4,81.4,-1.9106244048892012,5d5m.pdf (245-mer)
5lcv,2.64,2016,Kd=840nM,Kd,nM,840,0.84,0.07572071393811836,5lcv.pdf (283-mer) Biolayer interferometry experiments
5t1d,3.10,2016,Kd=85.8nM,Kd,nM,85.8,0.0858,1.0665127121512945,5t1d.pdf (217-mer)
5jmc,2.64,2016,Kd=86nM,Kd,nM,86,0.08600000000000001,1.0655015487564323,5jlv.pdf (124-mer)
5lz6,2.60,2016,Kd=8uM,Kd,uM,8,8.0,-0.9030899869919435,5lz3.pdf (38-mer)
2nbv,NMR,2016,Kd=9.3uM,Kd,uM,9.3,9.3,-0.9684829485539351,2nbv.pdf (78-mer)
5lrw,2.00,2016,Kd=9.3uM,Kd,uM,9.3,9.3,-0.9684829485539351,5lrv.pdf (76-mer)
5ghw,2.40,2016,Kd=9.6nM,Kd,nM,9.6,0.0096,2.0177287669604316,5ghw.pdf (36-mer)
5hpk,2.43,2016,Kd=9.7nM,Kd,nM,9.7,0.0097,2.0132282657337552,5c7j.pdf (86-mer) BLI assay
5te4,2.75,2016,Kd=9.9nM,Kd,nM,9.9,0.0099,2.00436480540245,5te4.pdf (225-mer)
5jke,2.86,2016,Kd=91nM,Kd,nM,91,0.091,1.0409586076789064,5jkc.pdf (221-mer)
5hhm,2.50,2016,Kd>200uM,Kd,uM,200,200.0,-2.3010299956639813,5hhm.pdf (241-mer)
5hho,2.95,2016,Kd>200uM,Kd,uM,200,200.0,-2.3010299956639813,5hhm.pdf (241-mer)
5jtl,NMR,2016,Kd~0.5uM,Kd,uM,0.5,0.5,0.3010299956639812,5jtl.pdf (471-mer)
5jto,NMR,2016,Kd~11uM,Kd,uM,11,11.0,-1.0413926851582251,5jtl.pdf (40-mer)
5jtm,NMR,2016,Kd~15uM,Kd,uM,15,15.0,-1.1760912590556813,5jtl.pdf (25-mer)
5lqb,1.95,2016,Kd~1nM,Kd,nM,1,0.001,3.0,"5lqb.pdf (224-mer) near 1nM SPR data in figure S3A, but SI file is not freely available"
5jtr,NMR,2016,Kd~2.5uM,Kd,uM,2.5,2.5,-0.3979400086720376,5jtl.pdf (40-mer)
5c09,2.48,2016,Kd~400uM,Kd,uM,400,400.0,-2.6020599913279625,5c07.pdf (277-mer) complex of 1E6-A2-YLG
5jtp,NMR,2016,Kd~40uM,Kd,uM,40,40.0,-1.6020599913279623,5jtl.pdf (22-mer)
5swz,2.65,2016,Kd~40uM,Kd,uM,40,40.0,-1.6020599913279623,5sws.pdf (242-mer) ligand is NP1-B17 TCR
5jtq,NMR,2016,Kd~4uM,Kd,uM,4,4.0,-0.6020599913279624,5jtl.pdf (42-mer)
5c0a,2.46,2016,Kd~600uM,Kd,uM,600,600.0,-2.7781512503836434,5c07.pdf (276-mer) complex of 1E6-A2-MVW
5jtn,NMR,2016,Kd~8uM,Kd,uM,8,8.0,-0.9030899869919435,5jtl.pdf (55-mer)
5e6j,2.85,2016,Ki=12.07uM,Ki,uM,12.07,12.07,-1.0817072700973491,5e6j.pdf (76-mer)
5d93,2.20,2016,Ki=16nM,Ki,nM,16,0.016,1.7958800173440752,5d93.pdf (218-mer)
5d96,2.30,2016,Ki=2.2nM,Ki,nM,2.2,0.0022,2.657577319177794,5d93.pdf (220-mer)
5c67,1.83,2016,Ki=89pM,Ki,pM,89,8.9e-05,4.050609993355088,5c67.pdf (81-mer)
5jhw,2.35,2017,IC50=0.3nM,IC50,nM,0.3,0.0003,3.5228787452803374,5jhw.pdf (288-mer) GDF11:FS288
5gy2,2.10,2017,IC50=204pM,IC50,pM,204,0.000204,3.6903698325741012,5gy2.pdf (183-mer) competitive binding assay
5v62,1.90,2017,IC50=25nM,IC50,nM,25,0.025,1.6020599913279623,"5v62.pdf (20-mer) [Incomplete ligand] [Nonstandard assay: Temp 30] ligand is SBP3, the SBP3 linker is mostly not resolved by electron density!!!"
5t0f,2.40,2017,IC50=58nM,IC50,nM,58,0.058,1.2365720064370627,5t0f.pdf (43-mer) CMIDJAZ10 peptide competitively inhibit the MYC3-MED25 interaction
5th9,3.00,2017,Kd<0.008nM,Kd,nM,0.008,8e-06,5.096910013008056,5th9.pdf (231-mer) assay using a ProteOn XPR36 biosensor
5wql,2.30,2017,Kd<10nM,Kd,nM,10,0.01,2.0,5wql.pdf (682-mer) [Different protein in assay: protein in crystal is K477A] Prc-sNlpI
5nhu,1.45,2017,Kd<1nM,Kd,nM,1,0.001,3.0,5nhu.pdf (82-mer) another Kd=0.3nM from displacement titration experiments
5tdy,2.11,2017,Kd<40nM,Kd,nM,40,0.04,1.3979400086720375,5tdy.pdf (98-mer)
5usl,2.90,2017,Kd=0.016nM,Kd,nM,0.016,1.6e-05,4.795880017344075,5ush.pdf (224-mer) biolayer interferometry (BLI) assay
5nwm,NMR,2017,Kd=0.04uM,Kd,uM,0.04,0.04,1.3979400086720375,5nwm.pdf (32-mer) data from reference
5jw9,2.00,2017,Kd=0.086uM,Kd,uM,0.086,0.086,1.0655015487564323,5jw9.pdf (122-mer) Fluorescence anisotropy
5mj3,1.74,2017,Kd=0.11nM,Kd,nM,0.11,0.00011,3.958607314841775,4oe8.pdf (118-mer) Crystal form 1
5t5b,2.07,2017,Kd=0.123nM,Kd,nM,0.123,0.000123,3.910094888560602,5sy8.pdf (163-mer) mutant 5
5gjk,2.05,2017,Kd=0.12uM,Kd,uM,0.12,0.12,0.9208187539523752,5gjk.pdf (68-mer)
5m2j,1.90,2017,Kd=0.13nM,Kd,nM,0.13,0.00013000000000000002,3.886056647693163,5m2i.pdf (115-mer)
5w06,2.60,2017,Kd=0.14nM,Kd,nM,0.14,0.00014000000000000001,3.853871964321762,5w05.pdf (229-mer)
5b71,2.11,2017,Kd=0.152nM,Kd,nM,0.152,0.000152,3.8181564120552274,"5b71.pdf (110-mer) SKY59 bind human C5 at pH 7.4 with KD of 0.152nM, in a pH-dependent manner"
5vob,3.02,2017,Kd=0.15nM,Kd,nM,0.15,0.00015,3.8239087409443187,5vob.pdf (289-mer) SI file is not available
5gzo,2.76,2017,Kd=0.1636uM,Kd,uM,0.1636,0.1636,0.7862167006646958,5gzo.pdf (220-mer) real-time biophysical binding assays (BIAcore)
5thp,3.01,2017,Kd=0.21nM,Kd,nM,0.21,0.00021,3.677780705266081,5thp.pdf (217-mer) binds to close conformation of integrin alpha2-A domain
5o76,2.47,2017,Kd=0.25uM,Kd,uM,0.25,0.25,0.6020599913279624,5o76.pdf (82-mer) +/-0.04
5h3j,1.33,2017,Kd=0.27uM,Kd,uM,0.27,0.27,0.5686362358410126,5h3j.pdf (28-mer)
5xot,2.79,2017,Kd=0.27uM,Kd,uM,0.27,0.27,0.5686362358410126,5xos.pdf (276-mer) TU55/B35-pol448-9
6b9j,2.90,2017,Kd=0.35nM,Kd,nM,0.35,0.00035,3.4559319556497243,5ush.pdf (217-mer) biolayer interferometry (BLI) assay
5t29,2.03,2017,Kd=0.379nM,Kd,nM,0.379,0.000379,3.421360790031928,5sy8.pdf (163-mer) mutant 3
5u4m,2.50,2017,Kd=0.39nM,Kd,nM,0.39,0.00039000000000000005,3.408935392973501,5u4l.pdf (129-mer) crystal under no salt conditions
5nvl,2.30,2017,Kd=0.3nM,Kd,nM,0.3,0.0003,3.5228787452803374,5nvk.pdf (75-mer)
5vey,NMR,2017,Kd=0.3uM,Kd,uM,0.3,0.3,0.5228787452803376,5vey.pdf (59-mer)
5vmm,3.60,2017,Kd=0.42nM,Kd,nM,0.42,0.00042,3.3767507096020997,5vmm.pdf (146-mer) previous ITC assay for carboxyhemoglobin
5omb,1.94,2017,Kd=0.43uM,Kd,uM,0.43,0.43,0.36653154442041347,5omb.pdf (111-mer) [Different ligand in assay: ligand protein in bioassay is ScDdc2N] MST assay
6atk,3.51,2017,Kd=0.43uM,Kd,uM,0.43,0.43,0.36653154442041347,6atk.pdf (146-mer)
5kxh,1.33,2017,Kd=0.49uM,Kd,uM,0.49,0.49,0.3098039199714863,5kxh.pdf (40-mer) [Nonstandard assay: 500 uM GDP]
5nvk,2.90,2017,Kd=0.4nM,Kd,nM,0.4,0.0004,3.3979400086720375,5nvk.pdf (75-mer)
5vx3,1.95,2017,Kd=0.4nM,Kd,nM,0.4,0.0004,3.3979400086720375,5vwv.pdf (26-mer) Bcl-xL: Bim-h3Pc-RT
5xeq,3.14,2017,Kd=0.4nM,Kd,nM,0.4,0.0004,3.3979400086720375,"5xeq.pdf (319-mer) [Multiple sites: site 1: Kd=0.4 nM; site 2: Kd=11 nM] assay by biolayer light interferometry, dimeric NL2 contains two binding sites for MDGA1"
5lp5,2.74,2017,Kd=0.4uM,Kd,uM,0.4,0.4,0.3979400086720376,5lp5.pdf (248-mer)
5m2i,2.15,2017,Kd=0.54nM,Kd,nM,0.54,0.00054,3.2676062401770314,5m2i.pdf (121-mer)
5wy2,1.90,2017,Kd=0.54uM,Kd,uM,0.54,0.54,0.26760624017703144,5wy2.pdf (21-mer)
5o2u,2.76,2017,Kd=0.69nM,Kd,nM,0.69,0.00069,3.161150909262745,5o2u.pdf (132-mer) assay by biolayer Interferometry
5wrv,1.70,2017,Kd=0.73uM,Kd,uM,0.73,0.73,0.1366771398795441,5wrv.pdf (163-mer) microscale thermophoresis (MST) assay; length of SRP68 is not 103 as described on RCSB
5wb7,2.94,2017,Kd=0.76uM,Kd,uM,0.76,0.76,0.11918640771920865,5wb7.pdf (62-mer)
5jq6,2.40,2017,Kd=0.79nM,Kd,nM,0.79,0.00079,3.1023729087095586,"5jq6.pdf (222-mer) [Different protein in assay: Clumping factor A, ClfA (229-545)]"
5ky5,1.50,2017,Kd=0.79uM,Kd,uM,0.79,0.79,0.10237290870955855,5kxh.pdf (40-mer) [Nonstandard assay: 500 uM GDP]
5wgg,2.04,2017,Kd=0.7uM,Kd,uM,0.7,0.7,0.1549019599857432,"5wgg.pdf (21-mer) [Different ligand in assay: Ligand in binding assay is 5,6-TAMRA label  on the N-terminus] CteB+SAM +CteA-M1-C21"
5o05,2.00,2017,Kd=0.81nM,Kd,nM,0.81,0.0008100000000000001,3.09151498112135,5o02.pdf (120-mer)
5uk5,2.51,2017,Kd=0.81uM,Kd,uM,0.81,0.81,0.09151498112135022,5uk5.pdf (318-mer)
5tvq,2.35,2017,Kd=0.88uM,Kd,uM,0.88,0.88,0.05551732784983137,5tvp.pdf (86-mer)
5tuv,2.90,2017,Kd=0.8uM,Kd,uM,0.8,0.8,0.09691001300805639,5tuu.pdf (41-mer)
5npo,1.95,2017,Kd=0.95uM,Kd,uM,0.95,0.95,0.022276394711152253,5npo.pdf (265-mer)
5tgh,2.80,2017,Kd=0.95uM,Kd,uM,0.95,0.95,0.022276394711152253,5tgh.pdf (23-mer)
5n88,1.70,2017,Kd=1.013uM,Kd,uM,1.013,1.013,-0.005609445360280386,5n88.pdf (79-mer)
5xov,2.68,2017,Kd=1.06uM,Kd,uM,1.06,1.06,-0.02530586526477026,5xos.pdf (274-mer) S19-2/A24-nef138-10
5oo6,2.80,2017,Kd=1.0uM,Kd,uM,1.0,1.0,-0.0,"5oo6.pdf (48-mer) +/-0.2,  ARS2"
5tz2,2.30,2017,Kd=1.12nM,Kd,nM,1.12,0.0011200000000000001,2.9507819773298185,5tz2.pdf (129-mer)
5mad,1.53,2017,Kd=1.1nM,Kd,nM,1.1,0.0011,2.958607314841775,5ma3.pdf (160-mer)
5lgk,3.50,2017,Kd=1.2uM,Kd,uM,1.2,1.2,-0.07918124604762482,5lgk.pdf (120-mer) [Multiple sites: site 1: Kd=1.2 uM; site 2: Kd=14.4 uM] The two CD23 binding sites on IgE
5vwy,1.56,2017,Kd=1.3uM,Kd,uM,1.3,1.3,-0.11394335230683679,5vwv.pdf (26-mer) Bak Core/Latch Dimer: Bim-h3Pc-RT
5wt9,2.40,2017,Kd=1.45nM,Kd,nM,1.45,0.00145,2.838631997765025,5wt9.pdf (173-mer)
5mv8,1.88,2017,Kd=1.4uM,Kd,uM,1.4,1.4,-0.146128035678238,5mv8.pdf (130-mer) Myo7b MF2
5sxp,1.65,2017,Kd=1.59uM,Kd,uM,1.59,1.59,-0.2013971243204515,5sxp.pdf (27-mer)
5m2m,2.30,2017,Kd=1.5nM,Kd,nM,1.5,0.0015,2.8239087409443187,5m2i.pdf (129-mer)
5ush,2.30,2017,Kd=1.5nM,Kd,nM,1.5,0.0015,2.8239087409443187,5ush.pdf (224-mer) biolayer interferometry (BLI) assay
5xbf,1.80,2017,Kd=1.7uM,Kd,uM,1.7,1.7,-0.2304489213782739,5xbf.pdf (125-mer) Myo7b CMF/USH1C PDZ3; +/- 0.1
5iia,1.70,2017,Kd=1.81nM,Kd,nM,1.81,0.0018100000000000002,2.7423214251308154,5iia.pdf (136-mer) MST assay
5whk,2.50,2017,Kd=1.81nM,Kd,nM,1.81,0.0018100000000000002,2.7423214251308154,5whj.pdf (297-mer) SPR assay at pH 7.5
5tp6,NMR,2017,Kd=1.9nM,Kd,nM,1.9,0.0019,2.721246399047171,5tp6.pdf (29-mer)
5omm,1.70,2017,Kd=10.4nM,Kd,nM,10.4,0.010400000000000001,1.9829666607012195,5o02.pdf (119-mer)
5tru,3.00,2017,Kd=10.6nM,Kd,nM,10.6,0.0106,1.9746941347352298,5tru.pdf (118-mer)
5nt7,1.40,2017,Kd=10.6uM,Kd,uM,10.6,10.6,-1.0253058652647702,5nt7.pdf (107-mer)
5upk,2.40,2017,Kd=104uM,Kd,uM,104,104.0,-2.0170333392987803,"5upk.pdf (185-mer) Kd=104+/-38uM,  complex is PAK4cat-PAK4N45-CDC42"
5n4w,3.90,2017,Kd=10nM,Kd,nM,10,0.01,2.0,"5n4w.pdf (160-mer) ITC Kd=10nM at 298K, 42nM at 303K"
5uzu,2.40,2017,Kd=10nM,Kd,nM,10,0.01,2.0,"5uzu.pdf (578-mer) SPR Kd=10nM, AlphaScreen Kd=2nM"
5vt9,1.85,2017,Kd=10nM,Kd,nM,10,0.01,2.0,5vt9.pdf (37-mer)
5ky4,1.47,2017,Kd=10uM,Kd,uM,10,10.0,-1.0,5kxh.pdf (40-mer) [Nonstandard assay: 500 uM GDP]
5lhn,2.55,2017,Kd=11.2nM,Kd,nM,11.2,0.0112,1.9507819773298183,5lhn.pdf (152-mer) [Nonstandard assay: Temp 37] muPA:Nb7
5sy8,1.62,2017,Kd=11.2pM,Kd,pM,11.2,1.12e-05,4.950781977329818,5sy8.pdf (163-mer) mutant 1
5mjy,2.25,2017,Kd=11.3uM,Kd,uM,11.3,11.3,-1.0530784434834197,"5mjy.pdf (22-mer) +/-0.3, SARA"
5w1t,4.50,2017,Kd=112nM,Kd,nM,112,0.112,0.9507819773298184,5vsw.pdf (151-mer)
5vkl,2.20,2017,Kd=113nM,Kd,nM,113,0.113,0.9469215565165803,5vkl.pdf (23-mer) [Different ligand in assay: ligand in assay is RPB1 (1468-1500) pS1493 peptide]
5nus,2.20,2017,Kd=11nM,Kd,nM,11,0.011,1.958607314841775,5nus.pdf (113-mer)
5un7,2.10,2017,Kd=120nM,Kd,nM,120,0.12,0.9208187539523752,5un7.pdf (86-mer)
5b3h,2.70,2017,Kd=123.8nM,Kd,nM,123.8,0.1238,0.9072793553159009,5b3g.pdf (72-mer)
5h7y,2.20,2017,Kd=125nM,Kd,nM,125,0.125,0.9030899869919435,5h7y.pdf (27-mer)
6b3s,2.80,2017,Kd=12nM,Kd,nM,12,0.012,1.9208187539523751,6b3s.pdf (222-mer)
5xfs,2.90,2017,Kd=132.23nM,Kd,nM,132.23,0.13223,0.8786700020639097,5xfs.pdf (308-mer) MST assay
5vwx,2.49,2017,Kd=14.9nM,Kd,nM,14.9,0.0149,1.826813731587726,5vwv.pdf (23-mer) Bak core/latch dimer: Bim-h0-h3Glt
5nvm,2.00,2017,Kd=14nM,Kd,nM,14,0.014,1.853871964321762,5nvk.pdf (42-mer)
5hyc,2.40,2017,Kd=15.2uM,Kd,uM,15.2,15.2,-1.1818435879447726,5hyc.pdf (35-mer) [Different ligand in assay: ITC Kd for MoDyn1I2(122-143) peptide] ITC Kd for MoDyn1I2(122-143) peptide
5uws,2.40,2017,Kd=1500nM,Kd,nM,1500,1.5,-0.17609125905568124,5uwh.pdf (22-mer) protein2 is X11L2 NES Peptide.
5osh,4.30,2017,Kd=151nM,Kd,nM,151,0.151,0.8210230527068306,5osh.pdf (299-mer)
5v5h,1.50,2017,Kd=158nM,Kd,nM,158,0.158,0.8013429130455774,"5v5g.pdf (105-mer) assay by Bio-Layer Interferometry (BLI), ligand is ubiquitin variant CC.2"
5u4k,NMR,2017,Kd=15uM,Kd,uM,15,15.0,-1.1760912590556813,5u4k.pdf (33-mer)
5tfw,2.17,2017,Kd=16.4pM,Kd,pM,16.4,1.64e-05,4.785156151952302,5sy8.pdf (163-mer) mutant 2
5f5o,2.20,2017,Kd=162nM,Kd,nM,162,0.162,0.790484985457369,5f5o.pdf (29-mer)
6ba6,NMR,2017,Kd=162uM,Kd,uM,162,162.0,-2.2095150145426308,6ba6.pdf (168-mer) HSQC assay; interaction in a GTP-dependent manner
5o2t,2.19,2017,Kd=167nM,Kd,nM,167,0.167,0.7772835288524167,5o2s.pdf (187-mer) GTPgammaS forms
5nqf,1.90,2017,Kd=169nM,Kd,nM,169,0.169,0.7721132953863264,5nqf.pdf (39-mer)
5tzq,1.65,2017,Kd=16nM,Kd,nM,16,0.016,1.7958800173440752,5tzp.pdf (26-mer)
6b08,2.20,2017,Kd=16nM,Kd,nM,16,0.016,1.7958800173440752,6azz.pdf (183-mer) biolayer interferometry
5ngv,2.00,2017,Kd=16pM,Kd,pM,16,1.6e-05,4.795880017344075,5ngv.pdf (121-mer)
5t5w,2.85,2017,Kd=16uM,Kd,uM,16,16.0,-1.2041199826559248,5t5w.pdf (218-mer)
5nan,3.30,2017,Kd=17.5nM,Kd,nM,17.5,0.0175,1.7569619513137056,5n92.pdf (311-mer)
5wvo,2.00,2017,Kd=17.8nM,Kd,nM,17.8,0.0178,1.749579997691106,5wvo.pdf (250-mer)
6amb,2.50,2017,Kd=17.8uM,Kd,uM,17.8,17.8,-1.250420002308894,6amb.pdf (99-mer) AF6-RAS
6b0s,1.95,2017,Kd=178nM,Kd,nM,178,0.178,0.7495799976911061,6b0s.pdf (82-mer) biolayer interferometry assay
5vpl,1.90,2017,Kd=17nM,Kd,nM,17,0.017,1.7695510786217261,5vpg.pdf (255-mer) Entry 5VPL supersedes 3RVV
5uq3,3.60,2017,Kd=180nM,Kd,nM,180,0.18,0.744727494896694,5uq1.pdf (201-mer)
5ona,2.70,2017,Kd=183nM,Kd,nM,183,0.183,0.7375489102695706,5ona.pdf (24-mer)
5tl7,2.44,2017,Kd=1870uM,Kd,uM,1870,1870.0,-3.271841606536499,5tl6.pdf (79-mer) ligand is C-terminal domain of mouse ISG15
5mfc,2.40,2017,Kd=18nM,Kd,nM,18,0.018000000000000002,1.744727494896694,5mfc.pdf (257-mer)
5un5,2.99,2017,Kd=18nM,Kd,nM,18,0.018000000000000002,1.744727494896694,5un5.pdf (123-mer)
5vpg,1.95,2017,Kd=19nM,Kd,nM,19,0.019,1.7212463990471711,5vpg.pdf (255-mer) 5VPG supersedes 3RVW
5wko,3.49,2017,Kd=1nM,Kd,nM,1,0.001,3.0,"5wko.pdf (331-mer) biolayer interferometry (BLI), Kd is 1-10nM, marked as +++ level"
5hu3,1.89,2017,Kd=1uM,Kd,uM,1,1.0,-0.0,"5h9b.pdf (54-mer) [Nonstandard assay: MG2+, ADP] Kd=1+/-0.1uM"
5mv9,2.60,2017,Kd=1uM,Kd,uM,1,1.0,-0.0,5mv8.pdf (130-mer) Myo7a MF2
5w6g,2.79,2017,Kd=2.12uM,Kd,uM,2.12,2.12,-0.32633586092875144,5w6c.pdf (230-mer) measured by BLI assay
5me5,1.90,2017,Kd=2.15uM,Kd,uM,2.15,2.15,-0.33243845991560533,5me5.pdf (90-mer) MBP pull-down assay
5gwp,2.58,2017,Kd=2.1nM,Kd,nM,2.1,0.0021000000000000003,2.6777807052660805,5gwo.pdf (175-mer)
5gvi,1.87,2017,Kd=2.2uM,Kd,uM,2.2,2.2,-0.3424226808222063,5gvi.pdf (76-mer) [Different protein in assay: bioassay use catalytically inactive zUSP30 mutant (C73A)] bioassay use catalytically inactive zUSP30 mutant (C73A)
5x4l,2.40,2017,Kd=2.34uM,Kd,uM,2.34,2.34,-0.3692158574101428,5x4l.pdf (83-mer)
5swk,1.92,2017,Kd=2.57uM,Kd,uM,2.57,2.57,-0.4099331233312945,5swk.pdf (153-mer) measured by biolayer interferometry
5vx2,1.85,2017,Kd=2.5nM,Kd,nM,2.5,0.0025,2.6020599913279625,5vwv.pdf (26-mer) Mcl-1/Bim-h3Pc-RT
6bit,2.19,2017,Kd=2.6nM,Kd,nM,2.6,0.0026000000000000003,2.585026652029182,6bit.pdf (117-mer) SPR Kd for prevalent Allele 1 and 2
5mn2,2.35,2017,Kd=2.6uM,Kd,uM,2.6,2.6,-0.414973347970818,5ml9.pdf (101-mer)
5m36,2.45,2017,Kd=2.75uM,Kd,uM,2.75,2.75,-0.43933269383026263,"5m35.pdf (38-mer) [Nonstandard assay: 250 uM CLR01] +/-0.57, Cdc25CpS216"
5h07,2.59,2017,Kd=2.82uM,Kd,uM,2.82,2.82,-0.45024910831936105,5h07.pdf (91-mer)
5tzt,2.89,2017,Kd=2.87nM,Kd,nM,2.87,0.00287,2.5421181032660076,5tz2.pdf (129-mer)
5wb8,3.00,2017,Kd=2.8uM,Kd,uM,2.8,2.8,-0.4471580313422192,5wb7.pdf (61-mer)
6b6u,1.35,2017,Kd=20.1uM,Kd,uM,20.1,20.1,-1.3031960574204888,6b6u.pdf (525-mer) monomer/dimer equilibrium;+/- 1.3
5uwq,2.28,2017,Kd=20000nM,Kd,nM,20000,20.0,-1.3010299956639813,5uwh.pdf (22-mer) protein2 is CDC7 NES Peptide.
5ml9,2.35,2017,Kd=217nM,Kd,nM,217,0.217,0.6635402661514705,5ml9.pdf (115-mer)
5v5v,4.11,2017,Kd=21nM,Kd,nM,21,0.021,1.6777807052660807,5v5v.pdf (230-mer)
5vx0,1.60,2017,Kd=21uM,Kd,uM,21,21.0,-1.3222192947339193,5vwv.pdf (26-mer) Bim-h3Glg;+/-3
5mtn,2.85,2017,Kd=23.5nM,Kd,nM,23.5,0.0235,1.6289321377282637,"5mtj.pdf (95-mer) +/-7.6, Mb(Lck_1)/Lck SH2"
5toj,3.30,2017,Kd=23nM,Kd,nM,23,0.023,1.6382721639824072,"5toj.pdf (131-mer) KD of F-VHH-4 for monomeric prefusion F was 23nM, while for tri-meric prefusion F is < 18pM"
5odw,2.80,2017,Kd=240pM,Kd,pM,240,0.00023999999999999998,3.619788758288394,5odw.pdf (217-mer)
5y11,2.10,2017,Kd=25.9nM,Kd,nM,25.9,0.0259,1.586700235918748,5y11.pdf (321-mer)
5u4y,2.50,2017,Kd=25nM,Kd,nM,25,0.025,1.6020599913279623,"5u4y.pdf (55-mer) Kd=25+/-2nM, complex is Fc/Z-domain"
5ua4,2.60,2017,Kd=26nM,Kd,nM,26,0.026000000000000002,1.585026652029182,5ua4.pdf (34-mer)
5w8t,2.76,2017,Kd=27.06uM,Kd,uM,27.06,27.06,-1.4323277922616042,5w8t.pdf (322-mer)
5wux,2.90,2017,Kd=27.4pM,Kd,pM,27.4,2.74e-05,4.562249437179612,5wuv.pdf (157-mer)
5tte,3.50,2017,Kd=272nM,Kd,nM,272,0.272,0.5654310959658012,5tte.pdf (167-mer)
5u52,1.94,2017,Kd=27nM,Kd,nM,27,0.027,1.5686362358410126,"5u4y.pdf (34-mer) Kd=27+/-1.4nM, complex is Fc/Z34C"
5t6l,2.10,2017,Kd=28.5pM,Kd,pM,28.5,2.8499999999999998e-05,4.54515513999149,5sy8.pdf (163-mer) mature wild-type
5y4r,2.30,2017,Kd=28.6nM,Kd,nM,28.6,0.0286,1.5436339668709569,5y4r.pdf (294-mer) CheR1/MapZ/c-di-GMP
5j11,2.56,2017,Kd=29nM,Kd,nM,29,0.029,1.537602002101044,5j11.pdf (240-mer) bio-layer interferometry (BLI) assay
5mak,2.50,2017,Kd=29pM,Kd,pM,29,2.9e-05,4.5376020021010435,5ma3.pdf (298-mer)
5ma5,1.85,2017,Kd=29pM,Kd,pM,29,2.9e-05,4.5376020021010435,5ma3.pdf (302-mer)
5knm,3.30,2017,Kd=2uM,Kd,uM,2,2.0,-0.3010299956639812,5iue.pdf (267-mer) biolayer interferometry (BLI) assay
5mk0,1.77,2017,Kd=3.1uM,Kd,uM,3.1,3.1,-0.4913616938342727,"5mjy.pdf (22-mer) +/-0.1, Endofin"
5w3x,2.00,2017,Kd=3.37uM,Kd,uM,3.37,3.37,-0.5276299008713387,"5w3t.pdf (80-mer) [Different protein in assay: protein in binding assay is PopP2 C321A] assay in presence of IP6, AcCoA"
5oob,2.79,2017,Kd=3.3uM,Kd,uM,3.3,3.3,-0.5185139398778874,"5oo6.pdf (21-mer) +/-1.1, NELF-E"
5imm,1.20,2017,Kd=3.5nM,Kd,nM,3.5,0.0035,2.4559319556497243,5imk.pdf (127-mer) crystal form 1 with lower resolution
5ohp,2.80,2017,Kd=3.5uM,Kd,uM,3.5,3.5,-0.5440680443502757,5ohk.pdf (76-mer)
5l21,1.68,2017,Kd=3.7nM,Kd,nM,3.7,0.0037,2.431798275933005,5l21.pdf (119-mer) HCA1-ciA-C2 (PDB: 5L21)
6b0a,2.50,2017,Kd=3.7nM,Kd,nM,3.7,0.0037,2.431798275933005,6azz.pdf (183-mer) biolayer interferometry
5v52,3.10,2017,Kd=3.7uM,Kd,uM,3.7,3.7,-0.568201724066995,5v52.pdf (140-mer)
5x0w,3.00,2017,Kd=3.7uM,Kd,uM,3.7,3.7,-0.568201724066995,5x0w.pdf (108-mer)
5my6,2.25,2017,Kd=3.99nM,Kd,nM,3.99,0.0039900000000000005,2.3990271043132516,5my6.pdf (115-mer)
5o2s,3.22,2017,Kd=3.9nM,Kd,nM,3.9,0.0039,2.408935392973501,5o2s.pdf (178-mer) GDP forms
5o4e,2.15,2017,Kd=3.9nM,Kd,nM,3.9,0.0039,2.408935392973501,5o4e.pdf (96-mer)
5uwo,2.35,2017,Kd=3000nM,Kd,nM,3000,3.0,-0.47712125471966244,5uwh.pdf (20-mer) protein2 is FMRP-1b NES Peptide.
5ma6,2.30,2017,Kd=303pM,Kd,pM,303,0.000303,3.518557371497695,5ma3.pdf (161-mer)
5gwo,2.82,2017,Kd=30nM,Kd,nM,30,0.03,1.5228787452803376,5gwo.pdf (175-mer) [Nonstandard assay: PH=8]
5tzp,1.35,2017,Kd=30nM,Kd,nM,30,0.03,1.5228787452803376,5tzp.pdf (25-mer)
6b0g,1.90,2017,Kd=31nM,Kd,nM,31,0.031,1.5086383061657274,6azz.pdf (183-mer) biolayer interferometry
5mtj,1.95,2017,Kd=338nM,Kd,nM,338,0.338,0.47108329972234525,5mtj.pdf (98-mer) Mb(Yes_1)/Yes SH2;determined by the yeast binding assay;
5oc7,1.65,2017,Kd=33nM,Kd,nM,33,0.033,1.4814860601221125,5oc7.pdf (92-mer) +/-8 PH/Mb(Bcr-PH_4)
6azp,2.29,2017,Kd=35.1nM,Kd,nM,35.1,0.0351,1.454692883534176,6azp.pdf (60-mer)
5v69,2.55,2017,Kd=35.9nM,Kd,nM,35.9,0.0359,1.4449055514216809,"5v5g.pdf (104-mer) assay by Bio-Layer Interferometry (BLI), ligand is ubiquitin variant ME.4"
5wos,2.45,2017,Kd=353nM,Kd,nM,353,0.353,0.4522252946121775,5wos.pdf (26-mer)
5ma3,1.70,2017,Kd=38pM,Kd,pM,38,3.7999999999999995e-05,4.42021640338319,5ma3.pdf (302-mer)
5jds,1.70,2017,Kd=3nM,Kd,nM,3,0.003,2.5228787452803374,5jds.pdf (124-mer) assay by differential scanning calorimetry (DSC)
5y1z,2.68,2017,Kd=4.3uM,Kd,uM,4.3,4.3,-0.6334684555795865,5y1z.pdf (137-mer)
5xjg,2.40,2017,Kd=4.52uM,Kd,uM,4.52,4.52,-0.6551384348113821,5xjg.pdf (93-mer) Vac8p-Nvj1p
6b0e,3.30,2017,Kd=41nM,Kd,nM,41,0.041,1.3872161432802645,6azz.pdf (183-mer) biolayer interferometry
5wuj,2.30,2017,Kd=422nM,Kd,nM,422,0.422,0.37468754903832613,5wuj.pdf (105-mer)
5mu3,2.10,2017,Kd=43nM,Kd,nM,43,0.043000000000000003,1.3665315444204134,5mu3.pdf (67-mer)
5nnp,2.60,2017,Kd=46.9nM,Kd,nM,46.9,0.0469,1.3288271572849168,5nnp.pdf (195-mer) ligand protein is HypK-THB
5uwu,2.24,2017,Kd=4600nM,Kd,nM,4600,4.6000000000000005,-0.6627578316815741,5uwh.pdf (20-mer) protein2 is SMAD4 NES Peptide.
5v5i,2.20,2017,Kd=463nM,Kd,nM,463,0.463,0.33441900898204685,"5v5g.pdf (105-mer) assay by Bio-Layer Interferometry (BLI), ligand is ubiquitin variant CC.1"
5gtb,2.87,2017,Kd=46uM,Kd,uM,46,46.0,-1.662757831681574,5gtb.pdf (24-mer) [Different protein in assay: protein in assay is ARC6 (674-801)] [Different ligand in assay: ligand protein in assay is PDV2 (282-307)] ITC Kd data is for ARC6 (674-801) and PDV2 (282-307)
5ohm,3.80,2017,Kd=47pM,Kd,pM,47,4.7e-05,4.327902142064283,"5ohm.pdf (116-mer) (MST) binding assay, in paper code 5ohm is K6 Affimer: K6 diUb, but in RCSB is K33 Affimer: K33 diUb"
5vko,1.80,2017,Kd=4nM,Kd,nM,4,0.004,2.3979400086720375,5vkl.pdf (34-mer) [Different ligand in assay: ]
5tzn,2.60,2017,Kd=5.8uM,Kd,uM,5.8,5.8,-0.7634279935629372,5tzn.pdf (190-mer)
5ky9,1.83,2017,Kd=5.9uM,Kd,uM,5.9,5.9,-0.7708520116421442,5kxh.pdf (40-mer) [Nonstandard assay: 500 uM GDP]
5ufe,2.30,2017,Kd=50.3nM,Kd,nM,50.3,0.0503,1.2984320149440727,5ufe.pdf (61-mer) Wild-type K-Ras(GNP)/R11.1.6 complex
5nqg,2.15,2017,Kd=50nM,Kd,nM,50,0.05,1.3010299956639813,5nqf.pdf (39-mer)
5ma4,1.40,2017,Kd=52pM,Kd,pM,52,5.2e-05,4.2839966563652006,5ma3.pdf (298-mer)
5v6a,2.70,2017,Kd=53.2nM,Kd,nM,53.2,0.053200000000000004,1.2740883677049517,"5v5g.pdf (104-mer) assay by Bio-Layer Interferometry (BLI), ligand is ubiquitin variant ME.2"
5nvn,1.90,2017,Kd=55nM,Kd,nM,55,0.055,1.2596373105057561,5nvk.pdf (38-mer)
5tl6,2.62,2017,Kd=57.6uM,Kd,uM,57.6,57.6,-1.760422483423212,5tl6.pdf (79-mer) ligand is C-terminal domain of human ISG15
5oaq,1.95,2017,Kd=58nM,Kd,nM,58,0.058,1.2365720064370627,5oaq.pdf (41-mer) [Different protein in assay: Non-Acyl-TEAD4] [Different ligand in assay: hYAP51-99] +/-3
5ufq,2.20,2017,Kd=6.4nM,Kd,nM,6.4,0.0064,2.193820026016113,5ufe.pdf (61-mer) K-RasG12D(GNP)/R11.1.6 complex
5ky0,1.53,2017,Kd=6.5uM,Kd,uM,6.5,6.5,-0.8129133566428556,5kxh.pdf (40-mer) [Nonstandard assay: 500 uM GDP]
6azz,2.40,2017,Kd=6.7nM,Kd,nM,6.7,0.0067,2.1739251972991736,6azz.pdf (183-mer) biolayer interferometry
5o03,2.19,2017,Kd=60nM,Kd,nM,60,0.06,1.2218487496163564,5o02.pdf (135-mer)
5j13,2.30,2017,Kd=60pM,Kd,pM,60,5.9999999999999995e-05,4.221848749616356,5j11.pdf (263-mer) bio-layer interferometry (BLI) assay
5vcb,4.10,2017,Kd=62nM,Kd,nM,62,0.062,1.207608310501746,"5vcb.pdf (79-mer) [Multiple sites: Kd1: 62+/-13nM; Kd2: 1.2+/=0.2uM] Kd=62+/-13nM, complex is Holo-ACPP:ACPS"
5twa,1.85,2017,Kd=66nM,Kd,nM,66,0.066,1.1804560644581312,"5twa.pdf (25-mer) Kd=66+/-30nM, protein2 is LB-Bak."
5uwh,2.26,2017,Kd=670nM,Kd,nM,670,0.67,0.17392519729917355,5uwh.pdf (22-mer) protein2 is Paxillin NES Peptide.
5h9b,2.25,2017,Kd=674.1nM,Kd,nM,674.1,0.6741,0.17127567286120862,"5h9b.pdf (54-mer) [Nonstandard assay: MG2+, AMPPNP] Kd(dEAG-long)=674.1+/-82.4nM"
5w0k,3.10,2017,Kd=68.8nM,Kd,nM,68.8,0.0688,1.1624115617644888,5w0k.pdf (217-mer)
5mtm,2.41,2017,Kd=7.0nM,Kd,nM,7.0,0.007,2.154901959985743,"5mtj.pdf (95-mer) +/-3.9, Mb(Lck_3)/Lck SH2"
5xsq,2.60,2017,Kd=7.35nM,Kd,nM,7.35,0.00735,2.1337126609158052,5xsq.pdf (28-mer)
5lpu,2.10,2017,Kd=7.8uM,Kd,uM,7.8,7.8,-0.8920946026904804,5lpu.pdf (104-mer)
5m5e,2.30,2017,Kd=70pM,Kd,pM,70,7e-05,4.154901959985743,"5m5e.pdf (259-mer) KDkin,"
5xv8,NMR,2017,Kd=71.4nM,Kd,nM,71.4,0.0714,1.1463017882238256,5xv8.pdf (110-mer)
5vxz,2.30,2017,Kd=720fM,Kd,fM,720,7.200000000000001e-07,6.142667503568732,5vxz.pdf (102-mer) On-rates were directly measured using the KinExA
5o0w,2.57,2017,Kd=73.83pM,Kd,pM,73.83,7.382999999999999e-05,4.1317671315775355,5o0w.pdf (143-mer)
5tez,1.70,2017,Kd=76uM,Kd,uM,76,76.0,-1.8808135922807914,"5tez.pdf (243-mer) Kd=76+/-4uM, complex is M1-HLA-A2/TCR F50"
6b12,1.71,2017,Kd=8.1nM,Kd,nM,8.1,0.0081,2.0915149811213505,6b12.pdf (153-mer)
5ffo,3.49,2017,Kd=8.2nM,Kd,nM,8.2,0.008199999999999999,2.0861861476162833,5ffg.pdf (363-mer)
5xco,1.25,2017,Kd=8.9nM,Kd,nM,8.9,0.0089,2.050609993355087,5xco.pdf (21-mer) KRas(G12D) mutant  WITH GDP and KRpep-2d
5imk,1.23,2017,Kd=850nM,Kd,nM,850,0.85,0.07058107428570728,5imk.pdf (220-mer) crystal form 1 with lower resolution
5vz4,2.20,2017,Kd=8nM,Kd,nM,8,0.008,2.0969100130080562,5vz4.pdf (245-mer)
5jw7,2.85,2017,Kd=9.09uM,Kd,uM,9.09,9.09,-0.9585638832219674,5jw7.pdf (93-mer) [Different protein in assay: protein in bioassay is SopA (163-782)] protein in bioassay is SopA (163-782)
5jjd,2.40,2017,Kd=9.2uM,Kd,uM,9.2,9.2,-0.9637878273455552,5jjd.pdf (106-mer)
5vag,1.90,2017,Kd=9.4nM,Kd,nM,9.4,0.0094,2.0268721464003012,"5vag.pdf (247-mer) BLI assay, pH-sensitive binding to HA; at PH 7.4, Kd=9.4nM; at PH=5.0, Kd=0.8nM"
5omn,2.68,2017,Kd=9.5nM,Kd,nM,9.5,0.0095,2.0222763947111524,5o02.pdf (119-mer)
5xxy,2.90,2017,Kd=9.96nM,Kd,nM,9.96,0.009960000000000002,2.001740661576301,"5xxy.pdf (124-mer) Assay by forteBio Octet K2 2-channel system, described in ref. 19"
5nh3,2.35,2017,Kd=973pM,Kd,pM,973,0.0009729999999999999,3.011887159731648,5ngv.pdf (121-mer)
5v5g,2.10,2017,Kd=9nM,Kd,nM,9,0.009000000000000001,2.0457574905606752,"5v5g.pdf (105-mer) assay by Bio-Layer Interferometry (BLI), ligand is ubiquitin variant CC.4"
5xku,1.78,2017,Kd>17.4pM,Kd,pM,17.4,1.74e-05,4.7594507517174005,5xku.pdf (233-mer)
5ivx,2.10,2017,Kd~0.54uM,Kd,uM,0.54,0.54,0.26760624017703144,"5ivx.pdf (277-mer) ligand is P18-I10/H2-Dd, not P18-I10 peptide"
5o74,2.50,2017,Kd~10uM,Kd,uM,10,10.0,-1.0,"5o74.pdf (180-mer) 10~30 uM, in present of GDP"
5ezo,3.63,2017,Kd~1nM,Kd,nM,1,0.001,3.0,"5ezi.pdf (222-mer) RCSB made a mistake, mark AL chain as antibody"
5x60,2.69,2017,Ki=0.03uM,Ki,uM,0.03,0.03,1.5228787452803376,5h6q.pdf (20-mer) ligand is peptide 9
5h6q,2.53,2017,Ki=0.06uM,Ki,uM,0.06,0.06,1.2218487496163564,5h6q.pdf (21-mer) ligand is peptide 11
5ovw,2.65,2017,Ki=0.94nM,Ki,nM,0.94,0.00094,3.0268721464003012,5ovw.pdf (159-mer) competitive binding equilibria
5l6n,1.63,2017,Ki=3.05nM,Ki,nM,3.05,0.0030499999999999998,2.515700160653214,5l6n.pdf (35-mer)
5uul,1.33,2017,Ki=4.8nM,Ki,nM,4.8,0.0048,2.318758762624413,5uuk.pdf (25-mer)
5gim,2.09,2017,Ki=545pM,Ki,pM,545,0.000545,3.2636034977233574,5gim.pdf (20-mer)
5h6r,2.60,2017,Ki=6.3uM,Ki,uM,6.3,6.3,-0.7993405494535817,5h6q.pdf (21-mer) ligand is peptide 13
5otx,2.00,2018,IC50=187nM,IC50,nM,187,0.187,0.7281583934635011,5otx.pdf (31-mer) ligand is GLP-1 analogues 2; cAMP-dependent reporter gene assay
5w89,1.42,2018,IC50=25nM,IC50,nM,25,0.025,1.6020599913279623,5w89.pdf (22-mer)
5yqz,3.00,2018,IC50=8.1nM,IC50,nM,8.1,0.0081,2.0915149811213505,"5yqz.pdf (28-mer) [Incomplete ligand] ligand is NNC1702,IC50=8.1+/-1.9nM,ligand is incomplete in PDB"
6dnq,2.35,2018,Kd=0.042uM,Kd,uM,0.042,0.042,1.3767507096020994,6dmx.pdf (88-mer) KIX:c-Myb:HBZ(3-77) complex
5w08,2.60,2018,Kd=0.04uM,Kd,uM,0.04,0.04,1.3979400086720375,"5w08.pdf (244-mer) ligand is K03.12 Fab, measured by biolayer interferometry"
6c48,2.32,2018,Kd=0.04uM,Kd,uM,0.04,0.04,1.3979400086720375,"6c48.pdf (32-mer) Kd for ITC assay is 0.04uM, Kd for FP assay is 0.53nM"
6dmx,2.80,2018,Kd=0.11uM,Kd,uM,0.11,0.11,0.958607314841775,6dmx.pdf (88-mer) KIX:c-Myb:HBZ(3-56) complex
6h6y,1.58,2018,Kd=0.163nM,Kd,nM,0.163,0.000163,3.7878123955960423,6h6y.pdf (132-mer)
5otj,2.35,2018,Kd=0.17nM,Kd,nM,0.17,0.00017,3.769551078621726,5otj.pdf (110-mer)
5g15,2.06,2018,Kd=0.17uM,Kd,uM,0.17,0.17,0.769551078621726,5g15.pdf (96-mer) [Nonstandard assay: with AMPPCP] Kd(Mb1)=0.17+/-0.02uM
5vyf,2.90,2018,Kd=0.187nM,Kd,nM,0.187,0.000187,3.728158393463501,5vyf.pdf (199-mer) SPR data
6ehg,2.65,2018,Kd=0.24nM,Kd,nM,0.24,0.00024,3.619788758288394,6ehg.pdf (130-mer)
5yir,2.75,2018,Kd=0.27nM,Kd,nM,0.27,0.00027,3.5686362358410126,5yip.pdf (27-mer)
6mkz,2.65,2018,Kd=0.2nM,Kd,nM,0.2,0.0002,3.6989700043360187,6mkz.pdf (139-mer)
6ath,1.82,2018,Kd=0.33nM,Kd,nM,0.33,0.00033,3.4814860601221125,6ath.pdf (68-mer)
6hul,2.55,2018,Kd=0.3uM,Kd,uM,0.3,0.3,0.5228787452803376,6hul.pdf (425-mer)
6ddm,1.30,2018,Kd=0.42nM,Kd,nM,0.42,0.00042,3.3767507096020997,6ddm.pdf (94-mer)
6aqr,2.10,2018,Kd=0.43uM,Kd,uM,0.43,0.43,0.36653154442041347,6aqr.pdf (76-mer)
6bli,2.12,2018,Kd=0.52nM,Kd,nM,0.52,0.0005200000000000001,3.283996656365201,6blh.pdf (45-mer) ligand is 45-mer G peptide
5wpa,2.29,2018,Kd=0.55uM,Kd,uM,0.55,0.55,0.2596373105057561,"5wpa.pdf (261-mer) sedimentation equilibrium experiments,  KD for heterodimer"
5xj4,2.30,2018,Kd=0.667nM,Kd,nM,0.667,0.0006670000000000001,3.175874166083451,5xj4.pdf (121-mer)
6b3m,3.92,2018,Kd=0.688nM,Kd,nM,0.688,0.0006879999999999999,3.162411561764489,6b3m.pdf (221-mer) biolayer interferometry assay
6a7v,1.67,2018,Kd=0.6nM,Kd,nM,0.6,0.0006,3.2218487496163566,6a7v.pdf (62-mer)
6g04,NMR,2018,Kd=0.7uM,Kd,uM,0.7,0.7,0.1549019599857432,6g04.pdf (26-mer) Kd for human source TSR2-N is 2uM
6ejg,2.82,2018,Kd=0.81nM,Kd,nM,0.81,0.0008100000000000001,3.09151498112135,6ejg.pdf (251-mer)
6hpr,1.70,2018,Kd=0.83uM,Kd,uM,0.83,0.83,0.08092190762392612,6hpr.pdf (147-mer)
6bck,2.70,2018,Kd=0.86nM,Kd,nM,0.86,0.00086,3.065501548756432,5wb9.pdf (228-mer)
6ejm,2.15,2018,Kd=0.86nM,Kd,nM,0.86,0.00086,3.065501548756432,6ejg.pdf (249-mer)
6bkc,2.60,2018,Kd=0.8nM,Kd,nM,0.8,0.0008,3.0969100130080562,6bkc.pdf (189-mer) KD values were determined by biolayer interferometry
6h9n,2.60,2018,Kd=0.8uM,Kd,uM,0.8,0.8,0.09691001300805639,6h9n.pdf (103-mer)
6ddr,1.90,2018,Kd=0.94nM,Kd,nM,0.94,0.00094,3.0268721464003012,6ddm.pdf (94-mer)
6fg8,1.25,2018,Kd=0.98uM,Kd,uM,0.98,0.98,0.00877392430750515,6fg8.pdf (241-mer)
5y9j,2.05,2018,Kd=0.995nM,Kd,nM,0.995,0.000995,3.0021769192542744,5y9j.pdf (152-mer)
5z78,1.76,2018,Kd=0.9uM,Kd,uM,0.9,0.9,0.045757490560675115,5z78.pdf (123-mer)
6a67,2.33,2018,Kd=1.004nM,Kd,nM,1.004,0.0010040000000000001,2.9982662871909995,6a67.pdf (230-mer)
6cql,2.40,2018,Kd=1.16uM,Kd,uM,1.16,1.16,-0.06445798922691845,6cph.pdf (190-mer) Kdeq values previously published (10)
5bk1,2.15,2018,Kd=1.1nM,Kd,nM,1.1,0.0011,2.958607314841775,5bk1.pdf (236-mer) in the absence of maltose
5o90,2.49,2018,Kd=1.1uM,Kd,uM,1.1,1.1,-0.04139268515822508,5o90.pdf (29-mer)
6co2,2.49,2018,Kd=1.2uM,Kd,uM,1.2,1.2,-0.07918124604762482,6co1.pdf (123-mer)
5nqw,3.40,2018,Kd=1.4nM,Kd,nM,1.4,0.0014,2.853871964321762,5nqw.pdf (134-mer)
6dcn,2.44,2018,Kd=1.4uM,Kd,uM,1.4,1.4,-0.146128035678238,6dcn.pdf (26-mer) MST Kd=1.4uM; SPR IC50=1.2uM
6bkb,2.80,2018,Kd=1.5nM,Kd,nM,1.5,0.0015,2.8239087409443187,6bkb.pdf (189-mer) KD values were determined by biolayer interferometry
6f9s,3.03,2018,Kd=1.62uM,Kd,uM,1.62,1.62,-0.20951501454263097,6f9s.pdf (90-mer)
5xda,3.29,2018,Kd=1.6uM,Kd,uM,1.6,1.6,-0.2041199826559248,5xda.pdf (84-mer)
6fv0,2.29,2018,Kd=1.72uM,Kd,uM,1.72,1.72,-0.2355284469075489,6fuz.pdf (121-mer)
5nzz,2.60,2018,Kd=1.7uM,Kd,uM,1.7,1.7,-0.2304489213782739,5nzz.pdf (360-mer) [Different protein in assay: TAB1 in binding assay is pSer423]
6brs,2.30,2018,Kd=1.7uM,Kd,uM,1.7,1.7,-0.2304489213782739,6b05.pdf (104-mer) crystal of Ethylmercury phosphate soaked dataset
5yi8,2.00,2018,Kd=1.8uM,Kd,uM,1.8,1.8,-0.25527250510330607,5yi8.pdf (33-mer)
6b05,1.90,2018,Kd=1.9uM,Kd,uM,1.9,1.9,-0.2787536009528289,6b05.pdf (104-mer)
6arq,2.88,2018,Kd=10.2uM,Kd,uM,10.2,10.2,-1.0086001717619175,6arq.pdf (317-mer)
6cqr,3.04,2018,Kd=10.56uM,Kd,uM,10.56,10.56,-1.0236639181977936,6cph.pdf (190-mer) Kdeq values previously published (10)
5w9a,2.74,2018,Kd=103uM,Kd,uM,103,103.0,-2.012837224705172,5w9a.pdf (114-mer) binding by SV-AUC
5oen,2.92,2018,Kd=10nM,Kd,nM,10,0.01,2.0,5oen.pdf (175-mer) [Different protein in assay: ITC Kd is for STAT2 133-679] ITC Kd is for STAT2 133-679
6bkd,3.25,2018,Kd=113nM,Kd,nM,113,0.113,0.9469215565165803,6bkd.pdf (189-mer) KD values were determined by biolayer interferometry
5xqz,2.10,2018,Kd=12.3uM,Kd,uM,12.3,12.3,-1.089905111439398,5xqz.pdf (68-mer)
6ff3,2.57,2018,Kd=13.6nM,Kd,nM,13.6,0.0136,1.8664610916297826,6ff3.pdf (70-mer)
6e3j,1.48,2018,Kd=13.98nM,Kd,nM,13.98,0.013980000000000001,1.8544928285903373,6e3i.pdf (23-mer) assay by yeast cell surface display
6bxc,2.50,2018,Kd=13nM,Kd,nM,13,0.013000000000000001,1.8860566476931633,6bxa.pdf (178-mer)
6mlk,2.45,2018,Kd=13nM,Kd,nM,13,0.013000000000000001,1.8860566476931633,"6mlk.pdf (251-mer) ELISA Kd=13nM, BLI Kd = 16 nM"
6cqn,2.50,2018,Kd=14.33uM,Kd,uM,14.33,14.33,-1.1562461903973444,6cph.pdf (190-mer) Kdeq values previously published (10)
5xwt,4.18,2018,Kd=14.4uM,Kd,uM,14.4,14.4,-1.1583624920952498,5xwt.pdf (367-mer)
6asr,2.36,2018,Kd=14.9uM,Kd,uM,14.9,14.9,-1.173186268412274,6asr.pdf (51-mer)
5uv8,2.70,2018,Kd=140.6nM,Kd,nM,140.6,0.1406,0.8520146793161948,5uv8.pdf (122-mer) measured in saturation binding assays using radioiodinated cytokine
6bx5,3.00,2018,Kd=14nM,Kd,nM,14,0.014,1.853871964321762,6bx4.pdf (97-mer)
6bb4,2.10,2018,Kd=15.4nM,Kd,nM,15.4,0.0154,1.812479279163537,6bb4.pdf (23-mer)
5nt1,2.82,2018,Kd=16.1uM,Kd,uM,16.1,16.1,-1.2068258760318498,5nt1.pdf (154-mer) biolayer interferometry (BLI) assay
5w1m,3.91,2018,Kd=16.3nM,Kd,nM,16.3,0.016300000000000002,1.787812395596042,5w1g.pdf (152-mer)
6ii4,3.30,2018,Kd=16.6nM,Kd,nM,16.6,0.0166,1.779891911959945,6ii4.pdf (225-mer)
6fq0,2.50,2018,Kd=160nM,Kd,nM,160,0.16,0.7958800173440752,6fq0.pdf (152-mer)
5xmh,2.80,2018,Kd=160uM,Kd,uM,160,160.0,-2.2041199826559246,5xmh.pdf (208-mer)
6aaf,2.20,2018,Kd=161nM,Kd,nM,161,0.161,0.7931741239681502,6aaf.pdf (31-mer)
6aod,1.80,2018,Kd=162pM,Kd,pM,162,0.00016199999999999998,3.7904849854573692,6aod.pdf (245-mer)
5uwc,2.40,2018,Kd=17.8nM,Kd,nM,17.8,0.0178,1.749579997691106,5uv8.pdf (122-mer) measured in saturation binding assays using radioiodinated cytokine
5nl1,2.50,2018,Kd=174nM,Kd,nM,174,0.17400000000000002,0.7594507517174003,5nl1.pdf (46-mer)
6flc,2.00,2018,Kd=176.7nM,Kd,nM,176.7,0.1767,0.7527634504932359,6fla.pdf (231-mer)
6bf4,2.38,2018,Kd=178nM,Kd,nM,178,0.178,0.7495799976911061,"6bf4.pdf (229-mer) Kd for fully glycosylated HXB2 gp120, while no binding for deglycosylated HXB2 gp120"
5xj3,3.20,2018,Kd=18.2nM,Kd,nM,18.2,0.0182,1.739928612014925,5xj3.pdf (127-mer)
6e2p,2.83,2018,Kd=18.7uM,Kd,uM,18.7,18.7,-1.271841606536499,6e2p.pdf (75-mer) Biolayer Interferometry assay
5yc5,2.71,2018,Kd=180nM,Kd,nM,180,0.18,0.744727494896694,5yc5.pdf (182-mer) SPR Kd for peak 1
5utz,2.75,2018,Kd=1879pM,Kd,pM,1879,0.0018789999999999998,2.7260732198994746,"5utz.pdf (133-mer) further, Ab can inhibit IL-2 binding to IL-2R alpha or beta"
5yoy,2.73,2018,Kd=18pM,Kd,pM,18,1.8e-05,4.7447274948966935,5yoy.pdf (119-mer) measured using soluble form of TNFa and golimumab IgG
6ii9,3.50,2018,Kd=19.4nM,Kd,nM,19.4,0.0194,1.712198270069774,6ii4.pdf (221-mer)
5nmv,1.65,2018,Kd=1nM,Kd,nM,1,0.001,3.0,5nmv.pdf (86-mer)
6flb,2.20,2018,Kd=1nM,Kd,nM,1,0.001,3.0,6fla.pdf (227-mer)
6a3w,2.00,2018,Kd=2.3nM,Kd,nM,2.3,0.0023,2.638272163982407,6a3v.pdf (163-mer)
5ock,1.60,2018,Kd=2.3uM,Kd,uM,2.3,2.3,-0.36172783601759284,"5ock.pdf (21-mer) Human ACPA E4 Fab L/H, 217, 221"
6mft,2.32,2018,Kd=2.3uM,Kd,uM,2.3,2.3,-0.36172783601759284,6mft.pdf (347-mer) BLI binding data
5xln,1.90,2018,Kd=2.48uM,Kd,uM,2.48,2.48,-0.3944516808262163,5xln.pdf (190-mer)
5u8q,3.27,2018,Kd=2.4uM,Kd,uM,2.4,2.4,-0.38021124171160603,"5u8q.pdf (70-mer) Kd = 2.4 +/- 0.5 uM, IGF-I for IGF-1Rdeltabeta pre-complexed with Fv 24-60"
6isc,2.20,2018,Kd=2.4uM,Kd,uM,2.4,2.4,-0.38021124171160603,6isc.pdf (118-mer)
5vu0,2.26,2018,Kd=2.5nM,Kd,nM,2.5,0.0025,2.6020599913279625,5vu0.pdf (172-mer)
5ywp,4.60,2018,Kd=2.91nM,Kd,nM,2.91,0.0029100000000000003,2.5361070110140926,5ywf.pdf (218-mer)
6i3f,2.55,2018,Kd=20.3nM,Kd,nM,20.3,0.020300000000000002,1.692503962086787,6i3f.pdf (340-mer) Bio-layer interferometry assay
6fc3,1.75,2018,Kd=20nM,Kd,nM,20,0.02,1.6989700043360187,6fbz.pdf (52-mer)
6eyo,3.70,2018,Kd=20pM,Kd,pM,20,1.9999999999999998e-05,4.698970004336019,6eyn.pdf (227-mer)
6b8n,2.20,2018,Kd=210nM,Kd,nM,210,0.21,0.6777807052660807,6b8l.pdf (149-mer) 1 uM CaCl2 soak
6bx4,2.55,2018,Kd=210nM,Kd,nM,210,0.21,0.6777807052660807,6bx4.pdf (96-mer)
6c74,1.36,2018,Kd=219uM,Kd,uM,219,219.0,-2.3404441148401185,6c6q.pdf (113-mer)
5mr4,2.40,2018,Kd=220nM,Kd,nM,220,0.22,0.6575773191777937,5mr4.pdf (458-mer) ligand is GFRa2 D1-D3
6mhr,2.80,2018,Kd=22nM,Kd,nM,22,0.022,1.6575773191777938,6mhr.pdf (235-mer)
6h0e,1.95,2018,Kd=240nM,Kd,nM,240,0.24,0.619788758288394,6h06.pdf (24-mer) assay by octet biolayer interferometry
6gbu,3.44,2018,Kd=248nM,Kd,nM,248,0.248,0.6055483191737837,6gbu.pdf (65-mer)
6imf,2.30,2018,Kd=24nM,Kd,nM,24,0.024,1.6197887582883939,6imf.pdf (109-mer) use assay method as ref. 14
6byh,2.61,2018,Kd=25nM,Kd,nM,25,0.025,1.6020599913279623,6bva.pdf (87-mer)
5xiu,1.80,2018,Kd=25uM,Kd,uM,25,25.0,-1.3979400086720377,5xis.pdf (76-mer) [Different ligand in assay: ]
5ydr,2.00,2018,Kd=26.4uM,Kd,uM,26.4,26.4,-1.421603926869831,5ydr.pdf (250-mer)
6cmg,2.70,2018,Kd=27.4nM,Kd,nM,27.4,0.0274,1.562249437179612,6cmg.pdf (235-mer) assay by BioLayer Interferometry
5xod,1.85,2018,Kd=28.1nM,Kd,nM,28.1,0.028100000000000003,1.55129368009492,5xoc.pdf (31-mer)
5xnp,3.73,2018,Kd=281.8nM,Kd,nM,281.8,0.2818,0.5500590112266623,5xnp.pdf (291-mer)
5xis,1.78,2018,Kd=283uM,Kd,uM,283,283.0,-2.45178643552429,"5xis.pdf (77-mer) [Different ligand in assay: assay use RNF168 UDM1-UM1, not full UDM1] crystal form I"
6d01,3.20,2018,Kd=286nM,Kd,nM,286,0.28600000000000003,0.543633966870957,6d01.pdf (20-mer)
6fub,1.30,2018,Kd=29nM,Kd,nM,29,0.029,1.537602002101044,6fu9.pdf (93-mer) Pikm-HMA and AVR-PikE
6cwt,3.15,2018,Kd=2pM,Kd,pM,2,2e-06,5.698970004336019,6cvk.pdf (149-mer)
6fuz,2.70,2018,Kd=3.19uM,Kd,uM,3.19,3.19,-0.5037906830571811,6fuz.pdf (121-mer) ITC Kd for His6-KLC1 TPR and JIP1 C-term
6e3i,1.48,2018,Kd=3.21nM,Kd,nM,3.21,0.00321,2.4934949675951277,6e3i.pdf (23-mer) assay by yeast cell surface display
6e62,2.70,2018,Kd=3.2nM,Kd,nM,3.2,0.0032,2.494850021680094,6e62.pdf (222-mer) BLI assay
6ce9,4.30,2018,Kd=3.5nM,Kd,nM,3.5,0.0035,2.4559319556497243,6ce7.pdf (30-mer) Insulin Receptor ectodomain in complex with two insulin molecules
5oy9,3.60,2018,Kd=3.75uM,Kd,uM,3.75,3.75,-0.5740312677277188,5oy9.pdf (37-mer)
5yip,1.85,2018,Kd=3.7nM,Kd,nM,3.7,0.0037,2.431798275933005,5yip.pdf (26-mer)
6e63,2.60,2018,Kd=3.7nM,Kd,nM,3.7,0.0037,2.431798275933005,6e62.pdf (222-mer) BLI assay
6gd5,NMR,2018,Kd=3.8nM,Kd,nM,3.8,0.0038,2.42021640338319,6gd5.pdf (21-mer)
6bmt,2.40,2018,Kd=310nM,Kd,nM,310,0.31,0.5086383061657274,6bmt.pdf (105-mer)
6fc2,1.92,2018,Kd=3400nM,Kd,nM,3400,3.4,-0.5314789170422551,6fbz.pdf (64-mer)
5mzv,2.80,2018,Kd=36nM,Kd,nM,36,0.036000000000000004,1.4436974992327127,5mzv.pdf (328-mer)
5nx3,2.30,2018,Kd=36pM,Kd,pM,36,3.6e-05,4.443697499232712,5nx1.pdf (25-mer)
5kof,2.40,2018,Kd=37.6uM,Kd,uM,37.6,37.6,-1.575187844927661,5kof.pdf (78-mer) Kd=37.6+/-6.6uM
6ii8,3.32,2018,Kd=386nM,Kd,nM,386,0.386,0.41341269532824504,6ii4.pdf (223-mer)
5ywr,1.47,2018,Kd=39nM,Kd,nM,39,0.039,1.408935392973501,5ywr.pdf (89-mer)
6fp7,1.58,2018,Kd=3nM,Kd,nM,3,0.003,2.5228787452803374,6fp7.pdf (164-mer) mTFP1/DARPin 1238_E11 complex in space group P6522
6blh,2.00,2018,Kd=4.1nM,Kd,nM,4.1,0.0040999999999999995,2.3872161432802645,6blh.pdf (45-mer) ligand is 45-mer G peptide
5yis,2.20,2018,Kd=4.2nM,Kd,nM,4.2,0.004200000000000001,2.3767507096020997,5yip.pdf (27-mer)
6bw9,1.60,2018,Kd=4.39nM,Kd,nM,4.39,0.00439,2.3575354797578787,6bw9.pdf (459-mer) MST assay; code 6bvv and 6bwa in other crystal form
6h6z,2.09,2018,Kd=4.58nM,Kd,nM,4.58,0.00458,2.339134521996131,6h6y.pdf (141-mer)
6fu9,1.20,2018,Kd=4.7nM,Kd,nM,4.7,0.0047,2.3279021420642825,6fu9.pdf (93-mer) Pikm-HMA and AVR-PikD
6avg,2.60,2018,Kd=40.6uM,Kd,uM,40.6,40.6,-1.608526033577194,6at5.pdf (362-mer)
6f3z,2.00,2018,Kd=405nM,Kd,nM,405,0.405,0.3925449767853314,6f3z.pdf (206-mer)
6bxa,2.30,2018,Kd=40nM,Kd,nM,40,0.04,1.3979400086720375,6bxa.pdf (209-mer)
6gbg,2.80,2018,Kd=417nM,Kd,nM,417,0.417,0.3798639450262425,6gbg.pdf (115-mer)
6c16,3.27,2018,Kd=421nM,Kd,nM,421,0.421,0.3757179041643317,6bva.pdf (86-mer)
6h71,2.31,2018,Kd=43.4nM,Kd,nM,43.4,0.0434,1.3625102704874892,6h6y.pdf (136-mer)
5w42,3.57,2018,Kd=44.3nM,Kd,nM,44.3,0.0443,1.3535962737769305,5w42.pdf (236-mer) Kd values were determined by bio-layer interferometry
6fgo,2.50,2018,Kd=440nM,Kd,nM,440,0.44,0.3565473235138126,"6fgo.pdf (69-mer) (KD) of ZCa to Fc of human IgG1 in the presence of calcium is 440 nM as estimated by the SPR analysis, which is in the"
5vzm,NMR,2018,Kd=48.8uM,Kd,uM,48.8,48.8,-1.6884198220027107,"5vzm.pdf (111-mer) ITC Kd=48.8uM, NMR Kd=27.2uM"
6fhp,1.70,2018,Kd=48nM,Kd,nM,48,0.048,1.3187587626244128,6fhp.pdf (62-mer)
6h06,2.63,2018,Kd=5.6uM,Kd,uM,5.6,5.6,-0.7481880270062004,6h06.pdf (26-mer) assay by octet biolayer interferometry
6ddv,2.05,2018,Kd=5.78nM,Kd,nM,5.78,0.00578,2.238072161579471,6ddm.pdf (94-mer)
5xwd,2.89,2018,Kd=5.9nM,Kd,nM,5.9,0.005900000000000001,2.2291479883578558,5xwd.pdf (132-mer)
6g10,1.35,2018,Kd=5.9nM,Kd,nM,5.9,0.005900000000000001,2.2291479883578558,6fu9.pdf (93-mer) Pikp1-HMA and AVR-PikD
6dsl,NMR,2018,Kd=500pM,Kd,pM,500,0.0005,3.3010299956639813,6dsl.pdf (118-mer)
5nx1,1.85,2018,Kd=5290pM,Kd,pM,5290,0.0052899999999999996,2.2765443279648143,5nx1.pdf (25-mer)
6a0z,2.33,2018,Kd=53nM,Kd,nM,53,0.053,1.275724130399211,6a0x.pdf (224-mer)
5zxv,4.48,2018,Kd=57.6nM,Kd,nM,57.6,0.057600000000000005,1.239577516576788,5zxv.pdf (215-mer)
6aw2,2.68,2018,Kd=57nM,Kd,nM,57,0.057,1.2441251443275085,6aw2.pdf (439-mer) [Nonstandard assay: PH=4.5]
6ewb,2.78,2018,Kd=59nM,Kd,nM,59,0.059000000000000004,1.2291479883578558,6ewb.pdf (216-mer)
6fgb,2.90,2018,Kd=59pM,Kd,pM,59,5.9e-05,4.229147988357856,6fgb.pdf (228-mer)
5n48,1.60,2018,Kd=5nM,Kd,nM,5,0.005,2.3010299956639813,5n47.pdf (106-mer) data from previous biochemical analysis
5ywo,4.70,2018,Kd=6.53nM,Kd,nM,6.53,0.00653,2.185086818724926,5ywf.pdf (215-mer)
6cqq,2.80,2018,Kd=6.9uM,Kd,uM,6.9,6.9,-0.8388490907372553,6cph.pdf (190-mer) Kdeq values previously published (10)
6mgp,2.13,2018,Kd=680nM,Kd,nM,680,0.68,0.16749108729376366,6mgp.pdf (144-mer)
6gbh,2.59,2018,Kd=69nM,Kd,nM,69,0.069,1.1611509092627446,6gbh.pdf (115-mer)
6mi2,2.72,2018,Kd=69nM,Kd,nM,69,0.069,1.1611509092627446,6mhr.pdf (230-mer)
5oyl,2.25,2018,Kd=7.5uM,Kd,uM,7.5,7.5,-0.8750612633917001,5oy9.pdf (46-mer)
5yr0,1.90,2018,Kd=7.6uM,Kd,uM,7.6,7.6,-0.8808135922807914,5yr0.pdf (48-mer)
6and,1.75,2018,Kd=7.8nM,Kd,nM,7.8,0.0078,2.1079053973095196,6ana.pdf (223-mer) Biolayer interferometry (BLI) experiments
6ani,2.40,2018,Kd=7.8nM,Kd,nM,7.8,0.0078,2.1079053973095196,6ana.pdf (223-mer) Biolayer interferometry (BLI) experiments
6fud,1.30,2018,Kd=73nM,Kd,nM,73,0.073,1.136677139879544,6fu9.pdf (93-mer) Pikm-HMA and AVR-PikA
6eg1,2.95,2018,Kd=76.6uM,Kd,uM,76.6,76.6,-1.8842287696326039,6eg0.pdf (314-mer)
6eg0,2.90,2018,Kd=77.7uM,Kd,uM,77.7,77.7,-1.8904210188009143,6eg0.pdf (314-mer)
5n47,3.00,2018,Kd=7nM,Kd,nM,7,0.007,2.154901959985743,5n47.pdf (284-mer) data from previous biochemical analysis
6cbp,2.17,2018,Kd=7uM,Kd,uM,7,7.0,-0.8450980400142568,6cbj.pdf (30-mer) BLI measurements
5mr5,2.00,2018,Kd=80nM,Kd,nM,80,0.08,1.0969100130080565,5mr4.pdf (216-mer) ligand is GFRa2 D2-D3
5n7w,1.96,2018,Kd=80nM,Kd,nM,80,0.08,1.0969100130080565,5n7w.pdf (155-mer) assay by Octet RED system (ForteBio)
6a3v,3.39,2018,Kd=85.6nM,Kd,nM,85.6,0.0856,1.0675262353228467,6a3v.pdf (163-mer)
5wi9,2.70,2018,Kd=86pM,Kd,pM,86,8.599999999999999e-05,4.0655015487564325,5wi9.pdf (225-mer)
5vmo,1.70,2018,Kd=887nM,Kd,nM,887,0.887,0.0520763801682736,5vmo.pdf (26-mer)
5xoc,2.40,2018,Kd=8uM,Kd,uM,8,8.0,-0.9030899869919435,5xoc.pdf (141-mer)
6d13,3.06,2018,Kd=9.3nM,Kd,nM,9.3,0.009300000000000001,2.0315170514460648,"6d13.pdf (177-mer) determined by bio-layer interferometry (BLI), RppH in surface and DapF in solution"
6fe4,3.00,2018,Kd=9.6nM,Kd,nM,9.6,0.0096,2.0177287669604316,6fe4.pdf (119-mer)
6bva,2.66,2018,Kd=91nM,Kd,nM,91,0.091,1.0409586076789064,6bva.pdf (86-mer)
6ana,1.70,2018,Kd=9nM,Kd,nM,9,0.009000000000000001,2.0457574905606752,6ana.pdf (219-mer) Biolayer interferometry (BLI) experiments
6avf,2.03,2018,Kd>200uM,Kd,uM,200,200.0,-2.3010299956639813,6at5.pdf (99-mer)
6ch3,2.68,2018,Kd~10uM,Kd,uM,10,10.0,-1.0,6ch2.pdf (198-mer)
6ch2,2.70,2018,Kd~29uM,Kd,uM,29,29.0,-1.462397997898956,6ch2.pdf (179-mer)
6eyd,4.20,2018,Kd~90nM,Kd,nM,90,0.09,1.0457574905606752,6eyd.pdf (466-mer) ITC data not shown
5mrv,1.85,2018,Ki=3.8uM,Ki,uM,3.8,3.8,-0.5797835966168101,"5mrv.pdf (53-mer) Michaelis-Menten kinetic analysis, NvCI displays a typical competitive inhibition behavior"
6gfi,2.30,2018,Ki=494pM,Ki,pM,494,0.000494,3.306273051076353,6gfi.pdf (81-mer) competitive inhibition assay
5zvm,3.30,2019,IC50=0.21uM,IC50,uM,0.21,0.21,0.6777807052660807,5zvk.pdf (44-mer) HR1(SARS)-EK1
6oao,3.50,2019,IC50=1.63nM,IC50,nM,1.63,0.00163,2.7878123955960423,6oan.pdf (251-mer)
6d68,2.36,2019,IC50=250nM,IC50,nM,250,0.25,0.6020599913279624,6d4p.pdf (86-mer)
6oan,2.90,2019,IC50=4.88nM,IC50,nM,4.88,0.00488,2.3115801779972895,6oan.pdf (266-mer)
6d4p,2.11,2019,IC50=65nM,IC50,nM,65,0.065,1.1870866433571443,6d4p.pdf (88-mer)
6dgf,2.34,2019,IC50=9.5nM,IC50,nM,9.5,0.0095,2.0222763947111524,6dgf.pdf (93-mer) UbV.2.6- USP2 complex
6mlm,3.50,2019,Kd<0.1nM,Kd,nM,0.1,0.0001,4.0,6mlm.pdf (219-mer)
6mam,4.10,2019,Kd<1pM,Kd,pM,1,1e-06,6.0,6mam.pdf (234-mer)
6sak,2.00,2019,Kd=0.031uM,Kd,uM,0.031,0.031,1.5086383061657274,6sak.pdf (96-mer) C129A mutation do not change too much affinity
6f0g,2.30,2019,Kd=0.055uM,Kd,uM,0.055,0.055,1.2596373105057561,6f0f.pdf (26-mer) Kd(ip3)=0.055+/-0.02uM
6cwg,2.60,2019,Kd=0.102nM,Kd,nM,0.102,0.000102,3.9913998282380825,6cwg.pdf (137-mer)
6nmv,2.61,2019,Kd=0.123nM,Kd,nM,0.123,0.000123,3.910094888560602,6nmr.pdf (127-mer)
6jb8,1.65,2019,Kd=0.129nM,Kd,nM,0.129,0.00012900000000000002,3.8894102897007508,6jb2.pdf (129-mer)
6nmt,1.83,2019,Kd=0.162nM,Kd,nM,0.162,0.000162,3.7904849854573692,6nmr.pdf (127-mer)
6j4s,2.80,2019,Kd=0.16uM,Kd,uM,0.16,0.16,0.7958800173440752,6j4o.pdf (66-mer) V2-SVBP complex
6nr8,7.80,2019,Kd=0.16uM,Kd,uM,0.16,0.16,0.7958800173440752,6nr8.pdf (517-mer) hTRiC-hPFD Class6
6q69,2.75,2019,Kd=0.17uM,Kd,uM,0.17,0.17,0.769551078621726,6q67.pdf (59-mer)
6nmr,2.42,2019,Kd=0.183nM,Kd,nM,0.183,0.000183,3.7375489102695707,6nmr.pdf (127-mer)
6f0f,2.00,2019,Kd=0.18uM,Kd,uM,0.18,0.18,0.744727494896694,6f0f.pdf (29-mer) Kd(ip2_s)=0.18+/-0.04uM
6mvl,1.61,2019,Kd=0.18uM,Kd,uM,0.18,0.18,0.744727494896694,"6mvl.pdf (229-mer) pH-selective antibody, Kd at PH=6.7"
6ird,2.81,2019,Kd=0.21uM,Kd,uM,0.21,0.21,0.6777807052660807,6ird.pdf (216-mer) PLCb4 CC8KA-PBM and INADL PDZ89 complex
6dld,3.30,2019,Kd=0.24nM,Kd,nM,0.24,0.00024,3.619788758288394,6dld.pdf (304-mer) affinity for IgLON5-fc/NEGR1-AP heterodimer
6p7s,3.49,2019,Kd=0.24nM,Kd,nM,0.24,0.00024,3.619788758288394,6p7s.pdf (429-mer)
6n85,2.50,2019,Kd=0.24uM,Kd,uM,0.24,0.24,0.619788758288394,6n85.pdf (415-mer) [Different ligand in assay: Kd is for MBP-tagged transducin-alpha residues 333-350] Kd is for MBP-tagged transducin-alpha residues 333-350
6o1f,2.15,2019,Kd=0.25nM,Kd,nM,0.25,0.00025,3.6020599913279625,6o1f.pdf (227-mer)
5zqv,2.95,2019,Kd=0.26uM,Kd,uM,0.26,0.26,0.585026652029182,"5zqv.pdf (99-mer) Kd(ITC)=0.26+/-0.03uM, PP1Calpha(6-299)"
6jcs,3.18,2019,Kd=0.287uM,Kd,uM,0.287,0.287,0.5421181032660077,6jcs.pdf (97-mer)
6ndz,2.26,2019,Kd=0.2nM,Kd,nM,0.2,0.0002,3.6989700043360187,6ndz.pdf (200-mer)
6jbt,2.47,2019,Kd=0.324nM,Kd,nM,0.324,0.000324,3.489454989793388,6jbt.pdf (223-mer)
6u2h,2.50,2019,Kd=0.33nM,Kd,nM,0.33,0.00033,3.4814860601221125,6u2g.pdf (232-mer) average affinity of two-state model
6qmq,2.50,2019,Kd=0.37uM,Kd,uM,0.37,0.37,0.431798275933005,6qmp.pdf (21-mer)
6j6y,2.15,2019,Kd=0.3nM,Kd,nM,0.3,0.0003,3.5228787452803374,6j6y.pdf (249-mer)
6j7w,2.60,2019,Kd=0.3nM,Kd,nM,0.3,0.0003,3.5228787452803374,6j7w.pdf (118-mer)
6nmu,2.55,2019,Kd=0.426nM,Kd,nM,0.426,0.000426,3.370590400897281,"6nmr.pdf (127-mer) value 4,26 E-10 in the table should be 4.26 E-10"
6n5w,2.15,2019,Kd=0.44uM,Kd,uM,0.44,0.44,0.3565473235138126,6n5w.pdf (149-mer) Kd=0.44uM for A domain of KCNQ2-4; Kd=0.24uM for B domain
6nms,2.11,2019,Kd=0.458nM,Kd,nM,0.458,0.000458,3.339134521996131,6nmr.pdf (127-mer)
6q0o,3.00,2019,Kd=0.4uM,Kd,uM,0.4,0.4,0.3979400086720376,6q0h.pdf (241-mer)
6p7y,2.84,2019,Kd=0.56nM,Kd,nM,0.56,0.0005600000000000001,3.2518119729937993,6p7s.pdf (430-mer)
6kbm,2.90,2019,Kd=0.60uM,Kd,uM,0.60,0.6,0.2218487496163564,6kbm.pdf (506-mer)
6qj4,5.80,2019,Kd=0.63uM,Kd,uM,0.63,0.63,0.2006594505464183,6qj2.pdf (197-mer)
5z2w,3.00,2019,Kd=0.67uM,Kd,uM,0.67,0.67,0.17392519729917355,5z2w.pdf (35-mer) bio-layer interferometry (BLI) experiment
6j56,1.80,2019,Kd=0.67uM,Kd,uM,0.67,0.67,0.17392519729917355,6j56.pdf (27-mer)
6q18,2.55,2019,Kd=0.6uM,Kd,uM,0.6,0.6,0.2218487496163564,6q0h.pdf (243-mer)
6r2g,1.90,2019,Kd=0.758pM,Kd,pM,0.758,7.58e-07,6.120330794367947,6r2g.pdf (36-mer)
6qmp,2.00,2019,Kd=0.7uM,Kd,uM,0.7,0.7,0.1549019599857432,6qmp.pdf (31-mer)
6k0y,1.70,2019,Kd=0.892nM,Kd,nM,0.892,0.000892,3.049635145623877,"6k0y.pdf (143-mer) glycosylated hPD-1 protein Kd=0.892nM, deglycosylated hPD-1 protein Kd=40.3nM"
6gho,1.79,2019,Kd=0.8uM,Kd,uM,0.8,0.8,0.09691001300805639,6ghb.pdf (298-mer)
6fg1,2.03,2019,Kd=0.9nM,Kd,nM,0.9,0.0009000000000000001,3.0457574905606752,6fg1.pdf (234-mer)
6gku,1.91,2019,Kd=0.9nM,Kd,nM,0.9,0.0009000000000000001,3.0457574905606752,6gku.pdf (228-mer)
6iu7,1.90,2019,Kd=0.9nM,Kd,nM,0.9,0.0009000000000000001,3.0457574905606752,6iu7.pdf (22-mer) microtiter-plate binding assay
6mud,2.69,2019,Kd=1.02uM,Kd,uM,1.02,1.02,-0.00860017176191757,"6mud.pdf (140-mer) [Different ligand in assay: bioassay use hNav1.5 1773-1927, crystal use NaV 1.5 (1786-1922)] bioassay use hNav1.5 1773-1927, crystal use NaV 1.5 (1786-1922)"
6jep,2.32,2019,Kd=1.06nM,Kd,nM,1.06,0.0010600000000000002,2.9746941347352296,6jep.pdf (101-mer) PH=7.5
6qms,1.80,2019,Kd=1.08uM,Kd,uM,1.08,1.08,-0.03342375548694973,6qmp.pdf (21-mer)
6c83,2.55,2019,Kd=1.0uM,Kd,uM,1.0,1.0,-0.0,5g15.pdf (93-mer) [Nonstandard assay: with AMPPCP] Kd(Mb2)=1.0+/-0.06uM
6qb6,2.24,2019,Kd=1.14uM,Kd,uM,1.14,1.14,-0.05690485133647256,6qb3.pdf (230-mer)
6plk,2.30,2019,Kd=1.15nM,Kd,nM,1.15,0.00115,2.939302159646388,6plk.pdf (110-mer)
6nha,2.38,2019,Kd=1.19nM,Kd,nM,1.19,0.0011899999999999999,2.9244530386074694,6nha.pdf (434-mer) Kd=1.19nM at pH =  7.4
5xkj,3.48,2019,Kd=1.1uM,Kd,uM,1.1,1.1,-0.04139268515822508,5xkj.pdf (52-mer)
5zo2,3.29,2019,Kd=1.1uM,Kd,uM,1.1,1.1,-0.04139268515822508,5zo2.pdf (147-mer)
6og4,1.70,2019,Kd=1.29nM,Kd,nM,1.29,0.0012900000000000001,2.889410289700751,6og4.pdf (77-mer)
6mnr,2.20,2019,Kd=1.2nM,Kd,nM,1.2,0.0012,2.9208187539523753,6mnq.pdf (227-mer)
5z7l,2.02,2019,Kd=1.2uM,Kd,uM,1.2,1.2,-0.07918124604762482,5z7g.pdf (43-mer) NDP52(10-126)/NAP1(33-75) complex
6gum,1.79,2019,Kd=1.2uM,Kd,uM,1.2,1.2,-0.07918124604762482,6gum.pdf (180-mer)
6in9,1.80,2019,Kd=1.2uM,Kd,uM,1.2,1.2,-0.07918124604762482,6in7.pdf (89-mer)
6e4z,2.20,2019,Kd=1.3nM,Kd,nM,1.3,0.0013000000000000002,2.886056647693163,6e4z.pdf (22-mer)
6ne2,1.30,2019,Kd=1.3nM,Kd,nM,1.3,0.0013000000000000002,2.886056647693163,6ndz.pdf (200-mer)
5xjo,2.63,2019,Kd=1.3uM,Kd,uM,1.3,1.3,-0.11394335230683679,5xjo.pdf (52-mer)
6kbn,3.20,2019,Kd=1.46uM,Kd,uM,1.46,1.46,-0.1643528557844371,6kbm.pdf (563-mer)
6msl,3.10,2019,Kd=1.4nM,Kd,nM,1.4,0.0014,2.853871964321762,6msl.pdf (32-mer)
6ne1,3.01,2019,Kd=1.4nM,Kd,nM,1.4,0.0014,2.853871964321762,6ndz.pdf (192-mer)
6j14,1.40,2019,Kd=1.54nM,Kd,nM,1.54,0.0015400000000000001,2.812479279163537,"6j14.pdf (115-mer) humanized GY-14 for PD-1 Kd=2.21nM, chimeric GY-14 for PD-1 Kd=1.54nM"
6ne4,1.65,2019,Kd=1.6nM,Kd,nM,1.6,0.0016,2.795880017344075,6ndz.pdf (200-mer)
6uys,1.59,2019,Kd=1.6uM,Kd,uM,1.6,1.6,-0.2041199826559248,6uys.pdf (29-mer) Kd = 1.6 +/- 0.1 uM
6o39,1.80,2019,Kd=1.7nM,Kd,nM,1.7,0.0017,2.769551078621726,6o39.pdf (123-mer)
6ob1,NMR,2019,Kd=1.7uM,Kd,uM,1.7,1.7,-0.2304489213782739,6ob1.pdf (90-mer)
6moe,2.09,2019,Kd=1.89nM,Kd,nM,1.89,0.00189,2.7235381958267557,6moe.pdf (229-mer)
6o3o,2.80,2019,Kd=1.8uM,Kd,uM,1.8,1.8,-0.25527250510330607,6o3o.pdf (317-mer)
6q0h,2.75,2019,Kd=1.8uM,Kd,uM,1.8,1.8,-0.25527250510330607,6q0h.pdf (241-mer)
6cxg,2.30,2019,Kd=1.9nM,Kd,nM,1.9,0.0019,2.721246399047171,6cxg.pdf (40-mer) previously reported affinity data
6m7l,2.65,2019,Kd=10.4uM,Kd,uM,10.4,10.4,-1.0170333392987803,6m7l.pdf (404-mer)
6ire,3.25,2019,Kd=10.6nM,Kd,nM,10.6,0.0106,1.9746941347352298,6ird.pdf (194-mer) NORPA CC8KA-PBM and INAD PDZ45 complex; assay PH=7.8
6mnq,1.80,2019,Kd=10.9nM,Kd,nM,10.9,0.0109,1.9625735020593764,6mnq.pdf (221-mer)
6fpg,1.80,2019,Kd=101.9nM,Kd,nM,101.9,0.1019,0.9918258159935736,6fpg.pdf (175-mer)
6h47,1.70,2019,Kd=10nM,Kd,nM,10,0.01,2.0,6h46.pdf (178-mer) ForteBio Octet Red384 bioassay
6i07,2.35,2019,Kd=10nM,Kd,nM,10,0.01,2.0,6i07.pdf (253-mer)
6on9,2.00,2019,Kd=10uM,Kd,uM,10,10.0,-1.0,"6on9.pdf (118-mer) ZIG-8-RIG-5 IG1-IG1 heterodimer, tetragonal form"
6cug,2.40,2019,Kd=11.2uM,Kd,uM,11.2,11.2,-1.0492180226701815,6cug.pdf (245-mer) Kd(CD1b-PC-BC8B)=11.2+/-2.2uM
6fg2,2.79,2019,Kd=11pM,Kd,pM,11,1.1e-05,4.958607314841775,6fg1.pdf (234-mer)
6ivu,NMR,2019,Kd=11pM,Kd,pM,11,1.1e-05,4.958607314841775,6ivu.pdf (118-mer)
6o8b,3.40,2019,Kd=11uM,Kd,uM,11,11.0,-1.0413926851582251,6o8b.pdf (39-mer)
6oor,2.45,2019,Kd=12.5nM,Kd,nM,12.5,0.0125,1.9030899869919435,6oor.pdf (234-mer)
6h15,2.60,2019,Kd=12.8nM,Kd,nM,12.8,0.0128,1.8927900303521317,6h15.pdf (123-mer)
6iwa,2.40,2019,Kd=126nM,Kd,nM,126,0.126,0.8996294548824371,6iw8.pdf (433-mer)
6m9k,2.30,2019,Kd=12uM,Kd,uM,12,12.0,-1.0791812460476249,6m9k.pdf (67-mer)
6oro,3.90,2019,Kd=12uM,Kd,uM,12,12.0,-1.0791812460476249,"6orn.pdf (254-mer) Germline Kd=12uM, BLI assay"
6iw0,3.60,2019,Kd=13.5nM,Kd,nM,13.5,0.0135,1.869666231504994,6ivz.pdf (145-mer)
6mss,3.00,2019,Kd=14.6uM,Kd,uM,14.6,14.6,-1.1643528557844371,6mra.pdf (302-mer)
6dc9,3.00,2019,Kd=15.23nM,Kd,nM,15.23,0.01523,1.8173000966639574,6dc7.pdf (30-mer)
6dg5,2.52,2019,Kd=16.1nM,Kd,nM,16.1,0.016100000000000003,1.7931741239681502,6dg5.pdf (104-mer)
6isu,1.87,2019,Kd=160nM,Kd,nM,160,0.16,0.7958800173440752,6isu.pdf (76-mer)
6mba,1.80,2019,Kd=17nM,Kd,nM,17,0.017,1.7695510786217261,6mba.pdf (149-mer)
6o07,2.70,2019,Kd=17nM,Kd,nM,17,0.017,1.7695510786217261,6o07.pdf (854-mer)
6iwd,1.80,2019,Kd=18.2nM,Kd,nM,18.2,0.0182,1.739928612014925,6iwd.pdf (55-mer)
6ieb,2.41,2019,Kd=18.5nM,Kd,nM,18.5,0.0185,1.7328282715969863,6iea.pdf (316-mer)
6j4o,2.30,2019,Kd=18nM,Kd,nM,18,0.018000000000000002,1.744727494896694,6j4o.pdf (66-mer)
6jhw,2.04,2019,Kd=18nM,Kd,nM,18,0.018000000000000002,1.744727494896694,6jhw.pdf (139-mer)
6phb,2.00,2019,Kd=19.2nM,Kd,nM,19.2,0.0192,1.7166987712964503,6phb.pdf (220-mer)
6tzc,2.41,2019,Kd=1985nM,Kd,nM,1985,1.985,-0.2977605110991339,6tzc.pdf (26-mer)
6p50,2.90,2019,Kd=1nM,Kd,nM,1,0.001,3.0,6p4y.pdf (225-mer)
6mun,NMR,2019,Kd=1uM,Kd,uM,1,1.0,-0.0,"6mun.pdf (78-mer) [Multiple sites: Kd for UIM-1 site is 1uM, Kd for UIM-2 site is 24.8uM] Kd for UIM-1 site is 1uM, Kd for UIM-2 site is 24.8uM"
5z7g,2.30,2019,Kd=2.05uM,Kd,uM,2.05,2.05,-0.31175386105575426,5z7g.pdf (43-mer) TAX1BP1(1-121)/NAP1(33-75) complex
6iua,1.70,2019,Kd=2.0nM,Kd,nM,2.0,0.002,2.6989700043360187,6iu7.pdf (22-mer) microtiter-plate binding assay
6gvk,1.55,2019,Kd=2.0uM,Kd,uM,2.0,2.0,-0.3010299956639812,6gvk.pdf (30-mer)
6uyu,1.66,2019,Kd=2.0uM,Kd,uM,2.0,2.0,-0.3010299956639812,6uys.pdf (29-mer) Kd = 2.0 +/- 0.2 uM
6qb3,1.90,2019,Kd=2.38uM,Kd,uM,2.38,2.38,-0.37657695705651195,"6qb3.pdf (255-mer) ITC Kd=2.38uM, SPR Kd=17.1uM"
6cxl,3.59,2019,Kd=2.4nM,Kd,nM,2.4,0.0024,2.619788758288394,6cxg.pdf (40-mer) previously reported affinity data; why glycopeptide 10F5M not listed in PDB
6hhc,2.70,2019,Kd=2.4nM,Kd,nM,2.4,0.0024,2.619788758288394,6hhc.pdf (238-mer)
6phd,3.10,2019,Kd=2.5nM,Kd,nM,2.5,0.0025,2.6020599913279625,6phb.pdf (231-mer)
6fto,1.60,2019,Kd=2.6nM,Kd,nM,2.6,0.0026000000000000003,2.585026652029182,6fto.pdf (81-mer)
6umt,1.99,2019,Kd=2.6nM,Kd,nM,2.6,0.0026000000000000003,2.585026652029182,6umt.pdf (123-mer)
6h2y,2.65,2019,Kd=2.7nM,Kd,nM,2.7,0.0027,2.5686362358410126,6h2y.pdf (224-mer)
6k7o,3.00,2019,Kd=2.9nM,Kd,nM,2.9,0.0029,2.537602002101044,6k7o.pdf (228-mer)
6d7g,2.75,2019,Kd=2.9uM,Kd,uM,2.9,2.9,-0.4623979978989561,6d7g.pdf (258-mer) biolayer interferometry (BLI) assay
6jdj,2.60,2019,Kd=200nM,Kd,nM,200,0.2,0.6989700043360187,6jdj.pdf (78-mer)
6r2s,3.04,2019,Kd=20pM,Kd,pM,20,1.9999999999999998e-05,4.698970004336019,6r2s.pdf (300-mer)
6dfs,3.10,2019,Kd=21.4uM,Kd,uM,21.4,21.4,-1.3304137733491908,6dfs.pdf (183-mer)
6dc8,1.80,2019,Kd=21.5nM,Kd,nM,21.5,0.021500000000000002,1.6675615400843946,6dc7.pdf (31-mer)
6j9l,1.78,2019,Kd=2115nM,Kd,nM,2115,2.115,-0.3253103717110612,6j9l.pdf (47-mer)
6nfj,3.19,2019,Kd=211nM,Kd,nM,211,0.211,0.6757175447023074,6nfj.pdf (50-mer) sKLB:Nb30:FGF19CT ternary structure
6nuc,1.90,2019,Kd=21nM,Kd,nM,21,0.021,1.6777807052660807,6nuc.pdf (48-mer)
6nuf,1.90,2019,Kd=21nM,Kd,nM,21,0.021,1.6777807052660807,6nuc.pdf (48-mer)
6k06,1.75,2019,Kd=227nM,Kd,nM,227,0.227,0.6439741428068773,6iw8.pdf (433-mer)
6ous,3.40,2019,Kd=22pM,Kd,pM,22,2.2e-05,4.657577319177793,"6ous.pdf (231-mer) Pre-fusion F Protein Kd=22pM, Post-fusion F Protein Kd=1.35pM"
6a78,2.10,2019,Kd=239nM,Kd,nM,239,0.23900000000000002,0.6216020990518623,6a76.pdf (138-mer)
6nrw,2.40,2019,Kd=23uM,Kd,uM,23,23.0,-1.3617278360175928,6nrq.pdf (112-mer) when DIP-eta IG1 is captured on SPR chip; Kd=4uM when non-dimerizing Dpr1 is captured on SPR chip
6ilm,3.40,2019,Kd=242nM,Kd,nM,242,0.242,0.6161846340195687,6ilj.pdf (263-mer) at PH 7.4
6a6x,2.70,2019,Kd=25.8nM,Kd,nM,25.8,0.0258,1.58838029403677,6a6x.pdf (83-mer)
6cxf,2.50,2019,Kd=252nM,Kd,nM,252,0.252,0.5985994592184559,"6cw6.pdf (285-mer) [Nonstandard assay: linking with alphaGSA[26,P5p]]"
6gjq,2.49,2019,Kd=25nM,Kd,nM,25,0.025,1.6020599913279623,6gjq.pdf (147-mer)
6im9,3.30,2019,Kd=25nM,Kd,nM,25,0.025,1.6020599913279623,6im9.pdf (122-mer)
6j11,3.00,2019,Kd=25nM,Kd,nM,25,0.025,1.6020599913279623,6j11.pdf (132-mer)
6gwc,2.60,2019,Kd=270nM,Kd,nM,270,0.27,0.5686362358410126,6gwc.pdf (217-mer)
6pxh,2.30,2019,Kd=28.0nM,Kd,nM,28.0,0.028,1.5528419686577808,6pxg.pdf (447-mer)
6oqq,2.10,2019,Kd=28nM,Kd,nM,28,0.028,1.5528419686577808,6oqq.pdf (147-mer) [Different protein in assay: Calmodulin in binding assay is from human;] [Different ligand in assay: Kd for Legionella pneumophila SidJ D542A]
6iea,2.00,2019,Kd=295nM,Kd,nM,295,0.295,0.530177984021837,6iea.pdf (316-mer)
6jb2,1.50,2019,Kd=295nM,Kd,nM,295,0.295,0.530177984021837,6jb2.pdf (129-mer)
6pnp,1.94,2019,Kd=299.2nM,Kd,nM,299.2,0.2992,0.5240384108075762,6pnp.pdf (168-mer)
6oc3,2.85,2019,Kd=2nM,Kd,nM,2,0.002,2.6989700043360187,6obz.pdf (227-mer)
6osw,NMR,2019,Kd=2uM,Kd,uM,2,2.0,-0.3010299956639812,6osw.pdf (56-mer)
6nzu,3.20,2019,Kd=3.32uM,Kd,uM,3.32,3.32,-0.5211380837040362,6nzu.pdf (132-mer)
6idx,1.70,2019,Kd=3.36uM,Kd,uM,3.36,3.36,-0.526339277389844,6idx.pdf (25-mer)
6jjp,2.90,2019,Kd=3.55nM,Kd,nM,3.55,0.0035499999999999998,2.449771646944906,6jjp.pdf (147-mer)
6ov2,3.20,2019,Kd=3.58nM,Kd,nM,3.58,0.0035800000000000003,2.4461169733561254,6ov2.pdf (131-mer)
6e4y,2.24,2019,Kd=3.8uM,Kd,uM,3.8,3.8,-0.5797835966168101,6e4y.pdf (22-mer)
6n6r,1.95,2019,Kd=3.8uM,Kd,uM,3.8,3.8,-0.5797835966168101,6n6r.pdf (70-mer)
6f2g,2.92,2019,Kd=3.9nM,Kd,nM,3.9,0.0039,2.408935392973501,6f2g.pdf (134-mer) Kd=3.9+/-1.4nM
6obn,2.70,2019,Kd=30.4nM,Kd,nM,30.4,0.0304,1.5171264163912463,6obn.pdf (305-mer) No Mn2+ metal ion
6mc9,3.30,2019,Kd=305nM,Kd,nM,305,0.305,0.5157001606532142,6mc9.pdf (149-mer)
6h46,2.22,2019,Kd=30nM,Kd,nM,30,0.03,1.5228787452803376,6h46.pdf (156-mer) ForteBio Octet Red384 bioassay
6orq,4.40,2019,Kd=30nM,Kd,nM,30,0.03,1.5228787452803376,6orn.pdf (218-mer)
6h16,2.90,2019,Kd=31.8nM,Kd,nM,31.8,0.0318,1.4975728800155672,6h15.pdf (119-mer)
5ymy,NMR,2019,Kd=33.1nM,Kd,nM,33.1,0.033100000000000004,1.4801720062242811,5ymy.pdf (76-mer) Rpn13NTD:K48-diUb complex
6iw8,2.80,2019,Kd=332nM,Kd,nM,332,0.332,0.4788619162959637,6iw8.pdf (433-mer)
6fbx,1.64,2019,Kd=343nM,Kd,nM,343,0.343,0.46470587995722945,6fbx.pdf (26-mer)
6dc3,3.50,2019,Kd=34nM,Kd,nM,34,0.034,1.4685210829577449,6dc3.pdf (568-mer) RSV F subtype A Kd=34nM; RSV F subtype B Kd<0.016nM
6oy4,2.45,2019,Kd=35nM,Kd,nM,35,0.035,1.4559319556497243,6oy4.pdf (221-mer)
6a6i,2.60,2019,Kd=36.1uM,Kd,uM,36.1,36.1,-1.557507201905658,6a6i.pdf (76-mer)
6gtq,2.49,2019,Kd=367nM,Kd,nM,367,0.367,0.4353339357479107,6gtq.pdf (46-mer)
6h3u,3.17,2019,Kd=36nM,Kd,nM,36,0.036000000000000004,1.4436974992327127,6h3t.pdf (248-mer)
6ilk,3.00,2019,Kd=375nM,Kd,nM,375,0.375,0.42596873227228116,6ilj.pdf (192-mer) at PH 7.4
6j5f,1.80,2019,Kd=390nM,Kd,nM,390,0.39,0.4089353929735008,6j5d.pdf (120-mer)
6f0h,1.98,2019,Kd=3nM,Kd,nM,3,0.003,2.5228787452803374,6f0f.pdf (26-mer) Kd(ip4)=3+/-1nM
6o3b,2.50,2019,Kd=4.5nM,Kd,nM,4.5,0.0045000000000000005,2.346787486224656,6o39.pdf (140-mer)
6phc,2.90,2019,Kd=4.6nM,Kd,nM,4.6,0.0046,2.337242168318426,6phb.pdf (228-mer)
6r8x,2.04,2019,Kd=4.7pM,Kd,pM,4.7,4.7e-06,5.327902142064283,6r8x.pdf (236-mer) solution equilibrium titration measurements
6otc,1.70,2019,Kd=4.9nM,Kd,nM,4.9,0.004900000000000001,2.309803919971486,6otc.pdf (240-mer)
6her,1.20,2019,Kd=40nM,Kd,nM,40,0.04,1.3979400086720375,6her.pdf (124-mer) Crystal 1 at pH 8.0
6s8s,2.21,2019,Kd=410nM,Kd,nM,410,0.41000000000000003,0.3872161432802645,6s8r.pdf (44-mer)
6j9h,2.31,2019,Kd=42nM,Kd,nM,42,0.042,1.3767507096020994,6j7b.pdf (238-mer)
6oqk,NMR,2019,Kd=42nM,Kd,nM,42,0.042,1.3767507096020994,6oqj.pdf (52-mer)
6gvl,2.05,2019,Kd=44uM,Kd,uM,44,44.0,-1.6434526764861874,6gvk.pdf (30-mer)
6j5d,1.80,2019,Kd=45.4nM,Kd,nM,45.4,0.0454,1.342944147142896,6j5d.pdf (120-mer)
6pnq,1.95,2019,Kd=49nM,Kd,nM,49,0.049,1.3098039199714864,6pnp.pdf (168-mer)
6rhw,2.75,2019,Kd=4nM,Kd,nM,4,0.004,2.3979400086720375,6rhv.pdf (195-mer)
6thg,4.07,2019,Kd=4nM,Kd,nM,4,0.004,2.3979400086720375,6thg.pdf (151-mer) binding was assessed by flow cytometry
6o3a,2.10,2019,Kd=5.2nM,Kd,nM,5.2,0.005200000000000001,2.283996656365201,6o39.pdf (138-mer)
6km7,1.80,2019,Kd=5.2uM,Kd,uM,5.2,5.2,-0.7160033436347992,6km7.pdf (69-mer)
6i2m,2.30,2019,Kd=5.31nM,Kd,nM,5.31,0.00531,2.274905478918531,6i2m.pdf (388-mer)
6h3t,2.84,2019,Kd=5.4nM,Kd,nM,5.4,0.0054,2.2676062401770314,6h3t.pdf (248-mer)
6u8c,2.61,2019,Kd=50nM,Kd,nM,50,0.05,1.3010299956639813,6u8c.pdf (238-mer)
6er6,1.56,2019,Kd=51nM,Kd,nM,51,0.051000000000000004,1.2924298239020635,6er6.pdf (93-mer)
6um5,4.20,2019,Kd=532nM,Kd,nM,532,0.532,0.2740883677049518,6um5.pdf (238-mer)
6uvo,2.90,2019,Kd=579pM,Kd,pM,579,0.000579,3.237321436272564,6uvo.pdf (232-mer)
6ihb,2.84,2019,Kd=57nM,Kd,nM,57,0.057,1.2441251443275085,6ihb.pdf (735-mer)
6s53,2.80,2019,Kd=5uM,Kd,uM,5,5.0,-0.6989700043360189,6s53.pdf (152-mer)
6jo8,3.50,2019,Kd=6.02uM,Kd,uM,6.02,6.02,-0.7795964912578245,6jo8.pdf (269-mer)
6k4k,2.72,2019,Kd=6.51nM,Kd,nM,6.51,0.00651,2.186419011431808,6k4k.pdf (149-mer)
6akm,2.30,2019,Kd=6.9uM,Kd,uM,6.9,6.9,-0.8388490907372553,6akm.pdf (64-mer)
5zau,NMR,2019,Kd=60nM,Kd,nM,60,0.06,1.2218487496163564,5zau.pdf (64-mer)
6dkj,1.95,2019,Kd=61pM,Kd,pM,61,6.1e-05,4.214670164989233,6dkj.pdf (117-mer) Binding of hGIPR-Ab to human GIPR membranes measured using KinExA technology
6rhv,2.29,2019,Kd=63nM,Kd,nM,63,0.063,1.2006594505464183,6rhv.pdf (195-mer)
6o60,2.50,2019,Kd=69nM,Kd,nM,69,0.069,1.1611509092627446,6o60.pdf (424-mer)
6s29,1.99,2019,Kd=7.75nM,Kd,nM,7.75,0.00775,2.11069829749369,6s29.pdf (61-mer)
6ppg,2.75,2019,Kd=7.78pM,Kd,pM,7.78,7.78e-06,5.1090204030103115,6ppg.pdf (226-mer)
6mm6,2.39,2019,Kd=73.5uM,Kd,uM,73.5,73.5,-1.866287339084195,6mm6.pdf (209-mer)
6ere,2.25,2019,Kd=73nM,Kd,nM,73,0.073,1.136677139879544,6er6.pdf (95-mer)
6iec,3.20,2019,Kd=743nM,Kd,nM,743,0.743,0.1290111862394247,6iea.pdf (316-mer)
6a79,2.31,2019,Kd=8.2nM,Kd,nM,8.2,0.008199999999999999,2.0861861476162833,6a76.pdf (138-mer)
6jjw,2.40,2019,Kd=8.2nM,Kd,nM,8.2,0.008199999999999999,2.0861861476162833,6jjw.pdf (32-mer)
6p67,2.90,2019,Kd=8.7nM,Kd,nM,8.7,0.0087,2.0604807473813813,6p4y.pdf (225-mer)
6kbr,2.00,2019,Kd=8.91pM,Kd,pM,8.91,8.91e-06,5.050122295963125,6kbr.pdf (65-mer) KLK4-K41043 complex
6j9m,2.39,2019,Kd=81nM,Kd,nM,81,0.081,1.0915149811213503,6j9l.pdf (74-mer)
6nk7,4.99,2019,Kd=83.9nM,Kd,nM,83.9,0.0839,1.0762380391712998,6nk5.pdf (261-mer) Cryo-EM Structure
6dca,2.60,2019,Kd=84.44nM,Kd,nM,84.44,0.08444,1.0734517753643813,6dc7.pdf (31-mer)
6jwj,1.58,2019,Kd=85.7nM,Kd,nM,85.7,0.0857,1.067019178076802,6jwj.pdf (23-mer)
6oel,3.10,2019,Kd=880nM,Kd,nM,880,0.88,0.05551732784983137,6oel.pdf (229-mer)
6plm,2.59,2019,Kd=89.6nM,Kd,nM,89.6,0.0896,1.0476919903378747,6plm.pdf (147-mer)
6czo,2.95,2019,Kd=89nM,Kd,nM,89,0.089,1.0506099933550872,6czo.pdf (62-mer)
6msu,3.11,2019,Kd=9.2nM,Kd,nM,9.2,0.0092,2.036212172654445,6msl.pdf (32-mer)
6pdx,3.99,2019,Kd=9.74pM,Kd,pM,9.74,9.74e-06,5.011441043121384,6pdx.pdf (237-mer)
6ivz,2.40,2019,Kd=9.7nM,Kd,nM,9.7,0.0097,2.0132282657337552,6ivz.pdf (131-mer)
6ib8,1.65,2019,Kd=94nM,Kd,nM,94,0.094,1.0268721464003014,6ib8.pdf (72-mer)
6oqj,NMR,2019,Kd=9nM,Kd,nM,9,0.009000000000000001,2.0457574905606752,6oqj.pdf (52-mer)
6uda,4.20,2019,Kd=9nM,Kd,nM,9,0.009000000000000001,2.0457574905606752,6uda.pdf (249-mer) protein was generated in GnT1- cell line
6saz,3.00,2019,Ki=0.14nM,Ki,nM,0.14,0.00014000000000000001,3.853871964321762,6saz.pdf (202-mer) determined in vitro in a Varioskan Flash 3001 spectral plate reader
6ht9,3.10,2019,Ki=0.1nM,Ki,nM,0.1,0.0001,4.0,6ht9.pdf (378-mer)
6dwh,2.00,2019,Ki=0.2nM,Ki,nM,0.2,0.0002,3.6989700043360187,6dwh.pdf (175-mer) wildtype BBKI
6bx8,1.98,2019,Ki=0.2uM,Ki,uM,0.2,0.2,0.6989700043360187,6bx8.pdf (80-mer)
6dwf,1.94,2019,Ki=1.3nM,Ki,nM,1.3,0.0013000000000000002,2.886056647693163,6dwf.pdf (169-mer)
6n9d,2.67,2019,Ki=17.8pM,Ki,pM,17.8,1.78e-05,4.749579997691106,6mav.pdf (184-mer)
6mav,2.37,2019,Ki=33.5pM,Ki,pM,33.5,3.35e-05,4.474955192963154,6mav.pdf (184-mer)
6har,1.50,2019,Ki=61pM,Ki,pM,61,6.1e-05,4.214670164989233,6bx8.pdf (80-mer)
